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Electronic prescribing (ePrescribing) is the process of ordering medicines electronically for a 
patient and has been associated with reduced medication errors and improved patient 
safety. However, these systems have also been associated with unintended adverse 
consequences. There is a lack of published research about users’ experiences of these 
systems in UK hospitals. The aim of this research was therefore to firstly describe the 
literature pertaining to the recent developments and persisting issues with ePrescribing and 
clinical decision support systems (CDS) (chapter 2). Two further systematic literature reviews 
(chapters 3 and 4) were then conducted to understand the unintended consequences of 
ePrescribing and clinical decision support (CDS) systems across both adult and paediatric 
patients. These revealed a taxonomy of factors, which have contributed to errors during use 
of these systems e.g., the screen layout, default settings and inappropriate drug-dosage 
support. The researcher then conducted a qualitative study (chapters 7-10) to explore users’ 
experiences of using and being trained to use ePrescribing systems. This study involved 
conducting semi-structured interviews and observations, which revealed key challenges 
facing users, including issues with using the ‘Medication List’ and how information was 
presented. Users experienced benefits and challenges when customising the system, 
including the screen display; however, the process was sometimes overly complex. Users 
also described the benefits and challenges associated with different forms of interruptive 
and passive CDS. Order sets, for instance, encouraged more efficient prescribing, yet users 
often found them difficult to find within the system. A lack of training resulted in users failing 
to use all features of the ePrescribing system and left some healthcare staff feeling 
underprepared for using the system in their role. A further literature review (chapter 5) was 
then performed to complement emerging themes relating to how users were trained to use 
ePrescribing systems, which were generated as part of a qualitative study. This review 
revealed the range of approaches used to train users and the need for further research in 
this area. The literature review and qualitative study-based findings led to a follow-on study 
(chapter 10), whereby the researcher conducted semi-structured interviews to examine how 
users were trained to use ePrescribing systems across four NHS Hospital Trusts. A range of 
approaches were used to train users; tailored training, using clinically specific scenarios or 
matching the user’s profession to that of the trainer were preferred over lectures and e-
learning may offer an efficient way of training large numbers of staff. However, further 
research is needed to investigate this and whether alternative approaches such as the use of 
students as trainers could be useful. 
ii 
 
This programme of work revealed the importance of human factors and user involvement in 
the design and ongoing development of ePrescribing systems. Training also played a role in 
users’ experiences of using the system and hospitals should carefully consider the training 
approaches used. This thesis provides recommendations gathered from the literature and 
primary data collection that can help inform organisations, system developers and further 
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Medication Errors, Adverse Drug Events and the Role of 
Healthcare Information Technologies 
 
1.1 Medication Errors and Adverse Drug Events 
In the United Kingdom (UK), 9% of all reported incidents to the former National Patient Safety 
Agency (NPSA) in 2007 involved medicines.[1]  The vast majority of medication incidents (96%, 
n=69,664) caused no or low patient harm; however, 100 cases of death or severe patient harm 
were also reported with a potentially devastating impact on their caregivers and relatives.[1] 
Hospital admissions as a result of patient injury from a medicine or lack of an intended medicine, 
also known as an adverse drug event (ADE), may incur large costs for the National Health Service 
(NHS), in addition to increased morbidity and mortality.[2] In the United States (US), the Institute 
of Medicine reported that between 44,000 and 98,000 people die in US hospitals each year due 
to potentially preventable medical errors.[3] More recent evidence suggests that as many as 
400,000 premature deaths occur each year in the US due to preventable harm in hospitals.[4] In 
England, a Department of Health report published in 2018, estimated that 237 million 
medication errors occur each year, these were associated with causing 712 deaths and 
contributing to 1708 deaths.[5] A further systematic review found that 3.7% (range 1.4–15.4) of 
hospital admissions were drug-related and also preventable, demonstrating the global scale of 
the problem posed by medical and medication errors.[6] 
Medication errors can occur when prescribing, dispensing, administering medications or 
monitoring patients. Prescribing errors are one of the most common types of medication 
error.[7] A systematic review of 65 studies conducted worldwide, found a median hospital 
inpatient prescription error rate of 7%, and notably that 50% of hospital admissions were 
affected by prescribing errors.[8] Indeed, many medication errors often go unreported, which 




Medication errors that result in harm may be classified as either ADEs or potential ADEs (Figure 
1).[10] Bates and colleagues found that almost a third of ADEs are preventable.[11] In particular, 
the most serious and life-threatening ADEs were more likely to be avoidable, and therefore could 
be targeted for intervention.[11] Such findings have led to the development of methods to 































1.2 Causes of Errors 
Human error can be considered in two ways; a person approach and a systems approach.[12] A 
person approach focuses error causation onto the individual who made the error, usually due to 
unsafe practice as a result of forgetfulness, inattention, negligence and/or recklessness.[12] A 
systems approach of error causation accepts and expects humans to make errors, which are not 
deliberate, and occur as a result of the conditions in which individuals work. This paradigm 
assumes that human conditions cannot be changed; however, the conditions in which humans 
work can be.[13] Crucially, when errors inevitably do occur the analysis will search not for who 
caused the error but why and how this error occurred, so as to introduce safeguarding measures 
and standardised processes.  
Prescribing is a complex process;[3] the errors that occur can be defined as slips, lapses, mistakes 
and violations.[12] Slips occur when an action is not carried out as planned (e.g., prescribing a 
medicine with the incorrect measurement units or for the wrong patient).[14, 15] Lapses also 
describe errors that occur when an action is not carried out as planned, but are more covert in 
nature (e.g., forgetting to enter a piece of information on a prescription). Mistakes describe 
errors in which there is a failure in the judgement or process involved in the selection of an 
objective, regardless of whether the chosen process was carried out effectively (e.g., failing to 
use reference sources or making a decision despite lacking knowledge about the patient). 
Violations describe errors that occur as a result of consciously ignoring known rules[16] (e.g.,  
writing ‘U’ instead of units).[12, 14]  
The EQUIP study carried out a detailed investigation into the causes of prescribing errors by 
foundation medical trainees in hospital Trusts in North West England.[14] They found that lack 
of knowledge was a common cause in addition to slips and lapses.[14, 17] The design of the drug 
chart or electronic prescribing system may have also contributed to errors as the space to enter 
information was inadequate or poorly organised.[14] The PRACtICe study investigated the 
prevalence and causes of prescribing errors in General Practice and found that almost 5% 
(n=296/6048) of prescriptions included in the study were associated with a prescribing and/or 
monitoring error.[18] Slight et al. identified causes of prescribing errors in English General 
Practices, highlighting seven ‘high-level’ categories such as the prescriber, the patient, the team, 




interface.[19] Additional factors, which may contribute to the occurrence of medication errors, 
include an increasingly complex medical practice (e.g., an ageing population) with an increased 
risk of polypharmacy.[3, 4] 
1.3 The Use of Information Technology in Health 
Due to the high potential for errors throughout the medication use process (i.e., during the 
prescribing, dispensing, administering and monitoring of patients), attention has now focused 
on the development of strategies to minimise these with a particular focus on information 
technology (IT). Electronic health records (EHRs) are one such example, the term used to 
describe a digital version of a patient’s medical record that can be shared and accessed by 
different healthcare providers.[20] Other examples include: automated dispensing robots, 
electronic prescribing (ePrescribing), clinical decision support (CDS), patient barcode scanning, 
electronic administration, computerised lab results and prescription tracking systems (Figure 2). 
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1.4 IT Interventions Related to Prescribing 
 ePrescribing is the process of ordering medicines electronically for a patient and has broadly 
been associated with reduced medication errors,[10, 22] increased prescription legibility and 
completeness,[23] improved patient safety, patient care and reduced healthcare costs.[22, 24] 
Terms related to ePrescribing include: Computerised Provider Order Entry (CPOE) to describe 
the electronic ordering of medications and other treatments e.g., laboratory or procedures; 
Electronic Prescribing and Medication Administration (EPMA), which denotes a system with 
combined electronic ordering and administration functionality, and may include additional 
clinical support for example drug-allergy checks; and Clinical Decision Support (CDS), a term used 
to describe technology, which provides automated guidance and support at the point of 
prescribing, administration or validation. CDS is typically used alongside an electronic medication 
ordering system.   
A systematic review by Ammenwerth et al. found 23 out of 25 studies reported a significant 
relative risk reduction (between 13% to 99%) in medication errors with ePrescribing.[25]  This 
review also suggested that advanced forms of CDS were associated with a higher relative risk 
reduction than studies that investigated systems with minimal or no CDS.[25] A subsequent 
systematic review by Radley et al. found eight out of nine studies reported a pooled reduction 
in medication error rates of 48% after ePrescribing implementation.[26] Nuckols et al. similarly 
found that medication errors post-ePrescribing were approximately half as common (pooled RR= 
0.46, 95% CI 0.35- 0.60) than when orders where written on paper charts in adult hospital-
related acute care settings.[27] In this study the majority (n=12) of the 16 included articles 
included CDS. Ascertaining the effect of ePrescribing on ADEs compared to medication errors 
can be more difficult and has provided more variable results.[25] Ammenwerth et al. 
demonstrated a significant relative risk reduction in ADEs (between 30% to 84%) in four out of 
six studies; however, one study showed a non-significant increase of 9%.[25] Leung et al. also 
found that implementation of ePrescribing in five community hospitals in the US was associated 
with a reduction of over one third of all preventable ADEs; however, an increase in potential 
ADEs was also reported.[28] In their systematic review, Nuckols et al. also noted a reduction in 
preventable ADEs, which were half as common (pooled risk ratio (RR) = 0.47, 95% CI 0.31 to 0.71) 
post-ePrescribing compared to pre-ePrescribing when paper-orders were used.[27] Medication 




however, a significant reduction in ADEs or mortality rates has yet to be shown.[29] The evidence 
suggests that ePrescribing and CDS systems have been strongly associated with a reduction in 
medication errors and to a slightly lesser extent ADEs. Furthermore, such technology can be used 
effectively in combination with other approaches such as a pharmacist review of the patient’s 
medications and education interventions to reduce medication errors.[30] In particular, these 
systems can ‘facilitate and enhance the communication of a prescription, aiding the choice, 
administration or supply of a medicine through decision support and provide a robust audit trail 
for the entire medicines use process’.[31] The UK government has recognised these benefits and 
provided incentives for its use through the Integrated Digital Care Fund and the Safer Hospitals 
Safer Wards Fund.[32] This has contributed to an expansion in the use of such technology in 
hospitals, with the overall vision to ‘raise our [NHS] game on health technology’.[33]   
1.5 Chapter Summary 
This chapter provides background information about the incidence and impact of medication 
errors and ADEs on the healthcare system, the causes of these, and finally the role of IT 
interventions in reducing errors and ADEs, focusing particularly on interventions that target the 
prescribing stage, such as ePrescribing and CDS. The next chapter will provide further details 
about the use of ePrescribing in the UK, the role of CDS, including recent advances and future 





Chapter 2  
Electronic Prescribing and Clinical Decision Support 
 
2.1 Introduction 
The aim of this chapter is to provide a comprehensive overview of two healthcare IT 
interventions (ePrescribing and CDS) that are used to prevent medication errors. These are 
traditionally targeted towards the prescribing stage, but can also play a role in the administration 
and monitoring stages of the medication process. A summary of the ePrescribing systems 
currently available in the UK is provided in this chapter, which is then followed by a detailed 
literature review of medication-related CDS.   
2.2 The electronic systems currently available in the UK 
As a result of government financial incentives such as the NHS Integrated Digital Care Fund, the 
Safer Hospitals Safer Wards Fund and the recent government recommendations to encourage 
increased productivity, UK hospitals have been encouraged to implement electronic 
systems.[34-36] In 2010, a questionnaire based survey of hospital and non-hospital attendees of 
the National ePrescribing Forum found that 82% of the 56 Trusts represented at the Forum were 
‘thinking of implementing’ or ‘currently implementing’ an ePrescribing system.[37] In 2011 a 
postal questionnaire of acute NHS hospital Trusts in England found that 69% (n=70) of 
respondents had at least one form of ePrescribing system in use at their Trust. However, only 
one hospital used a single system across inpatient, discharge and outpatient prescribing and 
typically multiple different ePrescribing systems were used within the same organisation for 
specific processes (e.g.,  discharge prescribing) or for certain clinical areas (e.g.,  chemotherapy 
or critical care prescribing).[38] It is probable that the adoption rates of ePrescribing systems will 
increase further across secondary care in the coming years as their use becomes more common, 
similar to that seen in primary care whereby nearly all General Practices in the UK now have an 
EHR system in place.[39] The adoption and use of CPOE systems has also increased in the US, 
with a recent survey revealing that CPOE with CDS systems are now used in 95.6% of hospitals 




Information Technology for Economic and Clinical Health (HITECH) Act, which offered financial 
incentives to organisations that could demonstrate ‘meaningful use’ of (EHRs).[41] Australian 
government financial incentives have also been associated with increased uptake of 
computerised prescribing in primary care.[42] 
In the UK, organisations are able to choose from a range of different systems that provide 
electronic prescribing functionality. These include home-grown systems, which have been 
designed and developed internally by a Trust such as the Prescribing Information and 
Communication System (PICS) developed by staff at University Hospitals Birmingham NHS 
Foundation Trust and commercial systems both developed nationally e.g., ‘Emis’ and ‘JAC EPMA’ 
and internationally such as ‘Cerner’ and ‘Epic’. Table 1 provides a list of current UK hospital 
ePrescribing and medication administration system suppliers that has been reproduced from the 
ePrescribing toolkit website.[43] Following the selection of a system, the organisation must 
consider where it will be implemented (e.g., across all wards or limited to certain clinical 
specialities), how the system will be implemented, the training required, and the ongoing 
maintenance of the system, in addition to many other factors. In the US, issues surrounding 
process changes that impacted on prescribing and administration have been recognised as 
factors that have hindered adoption of new systems. These include: training requirements, staff 
resistance, poor design interface, product immaturity, considerable costs and the risk of new 
errors encountered during use of the system.[44, 45] Furthermore, organisations must also face 
the difficult challenge of deciding what features of their ePrescribing system will be ‘switched 









Table 1: Suppliers of current hospital ePrescribing systems used in the UK (reproduced from 
ePrescribing Toolkit website) 
 
Supplier System Date and 
country of 
origin 











Edifício Lake Towers 
Rua Daciano Baptista Marques, 
245 
4400-617 Vila Nova de Gaia 
Portugal 
 






1995, US http://uk.allscripts.com/  Battersea Studios  
80 Silverthorne Road London, 
SW8 3HE 
+44 (0)20 7819 0444 
And  
15 Oxford Court, Manchester 

















Tel: +44(0)1942 852 400 
Email: info@ascribe.com  
 
Emis Health Head Office 
Leeds - Rawdon House  










1979, US http://www.cerner.com/  Cerner Limited 
6th Floor, The Point 
37 North Wharf Road 
London  
W2 1AF 
Tel: +44 (0) 20 7432 8100 
Email: cerneruk@cerner.com  
 





Civica UK Ltd 
Station House 













CSC Lorenzo  http://www.csc.com/he
alth_services/offerings/9
9982/103601-lorenzo 


















PICS UK, 1998 http://www.servelec-
healthcare.com 
Servelec Healthcare  
The Straddle  




Tel: +44 (0) 1246 437500 










RiO ePMA  http://www.servelec-
healthcare.com/index.ht
ml  
Servelec Healthcare The 
Straddle  




Tel: +44 (0) 1246 437500 








Epic EpicCare EMR US, 1979  http://www.epic.com  1979 Milky Way 
Verona, Wisconsin 53593 
Tel: 608-271-9000 
Email: info@epic.com  











Tel: +44 (0) 1268 416348 




MEDITECH  Version 6.0 US, 1969 http://home.meditech.c
om/en/d/home/  
One Northumberland Avenue, 
London, WC2N 5BW 
 
Tel: 0207 872 5583 
Noema Life Galileo 
Medication 
1996, Italy  Registered Office: 
Monica House,  



















12110 Sunset Hills Road, Suite 
600 Reston, VA 20190 
 
Tel: 703-709-2300  
System C Medway  UK, 1983 http://www.systemc.co
m  
Medway EPR 
System C Healthcare Ltd 
+44 (0) 1622 691 616 
enquire@systemc.com 





Tel: +44 (0)113 2050080 
Email: enquiries@tpp-uk.com  
 
2.3 Medication-related Clinical Decision Support 
Medication-related CDS provides guidance and decision-making support to clinicians, through 
the use of alerts and passive methods such as default drug dosages. Kuperman et al. categorised 
medication-related CDS functionalities as basic and advanced.[46] Basic medication-related CDS 
included drug-drug interaction (DDI) and drug-allergy checks, basic dosing guidance, duplicate 
therapy checks and formulary decision support. Advanced functionality included dosing support 
for renal insufficiency and older patients, guidance for medication-related laboratory testing, 
drug-pregnancy checking, and drug-disease contraindication checking. Medication-related CDS 
contributes to reduced morbidity,[47] improved prescribing practices,[47-50] facilitation of 
preventative care services,[47, 51] improved patient monitoring,[47, 51] reduced healthcare 
costs,[46, 52] and reduced ADE rates.[53] However, there is also evidence to suggest that many 




be satisfied with CDS systems,[47] possibly due in part to poor consideration of environmental, 
organisational and individual requirements during the design and implementation stages.[53, 
56]  
Kuperman et al. published a review of the literature pertaining to medication-related CDS in 
2007[46]. For this PhD the researcher reviewed the literature to summarise some of the more 
recent and important developments that have occurred with regards to medication-related CDS. 
The researcher also reflected on both exemplary practices and limitations of current approaches 
and made recommendations to inform future system development. This review has been 
published in the American Journal of Health-System Pharmacy: Tolley, C, Slight, SP, Husband, A, 
Watson, NW, Bates, DW (2018) Improving Medication-Related Clinical Decision Support. 
American Journal of Health System Pharmacy (Appendix 1).[57] The remainder of this chapter 
will describe the methods used for this literature review, the findings, and discuss some of the 
key recommendations in this area.  
2.3.1 Methods 
The researcher searched for articles across two large databases, Medline (Ovid) and Embase 
(Ovid), including various combinations of MeSH terms and keywords such as ‘clinical decision 
support’, ‘computerized provider order entry’ and ‘electronic prescribing’ with a date range of 
2007 to 2014. Specific MeSH terms relevant to the five basic medication-related CDS 
functionalities: DDI checks (e.g., Drug Interactions), drug allergy checks (e.g., Drug 
Hypersensitivity), drug dosage support (e.g., Dosage or Drug Dosage Calculations), drug 
duplication checks (e.g., Drug duplication) and drug formulary support (e.g., Formulary) were 
also used. The search strategy used for DDI checks can be found in appendix 2. Papers were 
included if they specifically discussed medication-related CDS functionality and their application; 
articles which did not primarily focus on medication-related CDS or were not concerned with the 
use of specific types of functionality were excluded. We limited our review to CDS linked with an 
ePrescribing system. The search included all publication types (e.g.,  commentaries and non-peer 
reviewed material), all types of order entry systems (e.g.,  commercial and home-grown), and all 
types of clinical setting (e.g.,  primary care, hospital, ambulatory care) that were presented to all 
healthcare professionals (e.g., doctors, nurses and pharmacists). Only English language papers 




screened to identify relevant papers, followed by the full text. The reference lists of included 
studies were also searched for other suitable papers, as well as a separate search conducted for 
pertinent articles by leading world experts, who have a strong publication history in the field. 
This was to ensure that papers describing important recent developments were included. The 
‘other citing articles function’ was also used to retrieve additional studies. Papers were read and 
re-read, and key recurring themes and sub-themes related to each type of medication-related 
CDS were identified iteratively from the data.  
2.3.2 Results  
A total of 896 articles were identified across each of the five areas, of which 184 were considered 
relevant. This included 156 full text articles and 28 conference abstracts across the following 
functionalities: DDI checks: 78; drug-allergy checks: 20; drug-dose support: 55; drug-duplication 
checks: 11; and drug formulary support: 20. Each of the five medication-related CDS areas will 
be discussed in turn, before describing the importance of human factors principles in alert 
design.  
2.3.2.1 DDI checking  
Drug-Drug interactions occur when the action of one drug is affected by the presence of another 
and medication-related CDS can be used to warn clinicians about these.[58] However, to be 
successful, users must find DDI alerts clinically relevant and act on the information received, 
otherwise they can result in large numbers of unnecessary alerts, which the user becomes de-
sensitised to, contributing to alert fatigue and the risk of missing important warnings. A range of 
commercially available order entry systems are available, which provide DDI CDS (e.g., Epic, 
Meditech, Allscripts Sunrise and Cerner); there are also a range of different knowledge bases 
available to support these systems (e.g., Medi-Span, First DataBank, Lexi-Comp). However, 
significant variability has been found in how DDI alerts are implemented and presented between 
organisations, even when the same ePrescribing system was used.[59]  Three important aspects 
of DDI alerts will be discussed below including: (1) alert severity, (2) alert overrides, and (3) alert 




Alert severity  
Many medication-related CDS systems assign a severity level to DDI alerts. For example, level 1 
(contraindicated) alerts indicate a very serious drug-drug interaction and require the clinician to 
either discontinue one of the drugs or cancel the order; level 2 alerts (moderate to severe) are 
less serious, but also require a response from the clinician, such as providing an override reason; 
level 3 (mild to moderate) alerts are the least serious and may appear as information only boxes 
on the screen[60] or even be suppressed by the organisation. Tiering alerts in this way has been 
associated with a significant reduction in override rates, where the user cancels or bypasses the 
alert, and can essentially eliminate overrides of level 1 alerts.[60] This reduction is likely to have 
improved patient safety, but further research is needed to show improvements in specific 
patient outcomes.[60] However, it is not clear whether displaying level 3 alerts is beneficial. 
Assigning specific tiers to drug-drug interactions has been controversial, and there is poor 
agreement among reference sources regarding severity level. At the extremes, though, 
agreement is good, for example Phansalkar et al. created a list of 15 high priority drug pairs that 
should almost never be overridden.[61] This group also identified low severity DDIs that should 
be made non-interruptible in the medication-related CDS system in order to reduce alert 
fatigue.[62] However, most important drug-drug interactions fall into the level in between and 
sometimes should be overridden, as severity is greatly dependent on the individual patient and 
clinical context.[61] More work is needed to define which drug-drug interactions should be 
included as Level 2 alerts; a key effort should be to focus on making patient specific information 
usable by the medication-related CDS system so that alerts are only triggered when necessary 
and take into account human factors principles with the use of colour, placement and text.[56]  
Alert overrides  
High DDI alert override rates have been reported in the literature.[63, 64] Slight et al. evaluated 
the reasons why healthcare providers overrode these alerts e.g., 'will monitor the patient' and 
what actions were taken as a consequence of overriding the alert. They found that these 
intended actions were only carried out in two thirds of cases, thus potentially exposing patients 
to harm.[64] Therefore, whilst improving design is important, it may also be necessary to address 




may affect clinicians’ ability to respond to alerts appropriately.[64] Nanji et al. found that class-
class (e.g., an ACE inhibitor prescribed with another ACE inhibitor) and drug-class (e.g., a 
Hypnotic and benzodiazepine prescribed simultaneously) alerts were appropriately overridden 
more often than individual drug-drug alerts.[65] It was posed that clinicians may generally agree 
with alerts based on the larger categories, however make exceptions for individual drugs in these 
groups, where the benefit of the drug-drug combination outweighs the risk.[65] Studies using 
retrospective methods to assess the appropriateness of clinicians’ overrides of DDI alerts may 
fail to record other interventions, such as additional patient counselling or a discussion between 
colleagues about the risks of a particular DDI. Further research should focus on such 
interventions made by clinicians as a result of the alert, which may not be captured in 
medication-related CDS systems.  
Alert sensitivity and specificity 
Low alert specificity (i.e., lack of clinical relevance for an individual patient) and poor alert 
content were commonly cited reasons for high DDI alert override rates and alert fatigue.[66-68] 
Systems with high sensitivity (i.e., ability to detect potential errors), but with low specificity can 
result in a large volume of potentially inappropriate alerts.[63, 69, 70] Such alerts are 
troublesome as they can lead to clinicians following erroneous alert recommendations or 
distrusting the system.[63, 71] Seidling and colleagues found that only 10% of DDI alerts were 
applicable in all circumstances, but by incorporating additional prescription information, such as 
dosage and route of administration into the decision-making algorithms, up to 25% of alerts 
could be appropriate.[72] This percentage could be further increased if laboratory results and 
other clinical parameters were included.[72] Duke and Bolchini developed the relatively new 
concept of context-aware DDI alerts, which focused on the potential outcome of the drug-drug 
interaction.[73] For example, if the outcome was bleeding, specific information such as 
prothrombin time and platelet count would be incorporated into the alert algorithm, and an 
alert would only be generated if laboratory markers were out of range. Although these prototype 
alerts were largely successful in a simulated environment,[73] adherence rates were found to be 
low (<20%) in routine clinical practice.[74] This may be due to the differences in alert design 




2.3.2.2 Drug-Allergy Alerts 
Drug allergy alerts are generated when a drug is prescribed that has been recorded as previously 
causing an adverse reaction. Some evidence suggests that drug-allergy alerts were accepted by 
clinicians more often than other types of medication-related CDS alerts,[75, 76] but high override 
rates have still been reported.[70] In this section, we concentrate on the importance of 
accurately recording allergy information in the patient’s EHR and cross sensitivity checking. 
Recording of accurate allergy information  
The inclusion of inaccurate or incomplete allergy information in the EHR can lead to the 
production of clinically inappropriate alerts. Thirty-five percent of records in one study lacked 
allergy information, potentially exposing these patients to harm.[77] Computers require coded 
data in order to perform specific checks and thus may not detect errors in unstructured data 
(e.g., free-text), or discourage prescribers from entering such information.[78-80] A lack of 
information about the type and severity of the allergic reaction also limits the usefulness of a 
system.[46, 79] Clinicians may fail to distinguish between drug allergies and intolerances,[46, 76] 
or be reluctant to remove information that is no longer relevant.[46, 79] One of the most 
common override reasons for drug-allergy alerts was ‘patient took previously without allergic 
reaction’.[65, 81] Suppressing alerts that have been previously overridden for an individual 
patient [63, 82] and refining the categorisation of drug allergies, in a similar way to drug-drug 
interactions, may help to reduce the numbers of inappropriate drug-allergy alerts. However, a 
recent study also suggested exploring the reasons why clinicians did not update a patient’s 
allergy information in the EHR, and work has been conducted in this area.[83] Further research 
is needed to ascertain how best to record allergy information and present the user with useful 
drug-allergy alerts. The alert could also provide an automatic link to the user to help them update 
the patient’s allergy information if needed.[81] 
Cross sensitivity checking 
Drug-allergy algorithms vary in their ability to perform cross-sensitivity checks (sensitivity to a 
substance, which has a chemical structure similar to a known allergen) or checks on existing and 




improved through development of an alerting system based on chemical structure, which would 
aim to include only relevant drugs from a drug class or those with a high risk of cross-
sensitivity.[70] This can be complicated and checks, which are overly inclusive, can be one of the 
main causes of false-positive drug-allergy warnings, thus knowledge bases must also incorporate 
clinical evidence on cross-reactivity.[82]  
2.3.2.3 Drug Dose Support  
Prescribing the wrong dose(s) of medicines can cause patient harm. Medication-related CDS can 
decrease the likelihood of these errors occurring by suggesting a drug dosage or utilising order 
sentences, which include drug name, form and dosage (thereby restricting the range of incorrect 
entries).[46, 84, 85] Medication-related CDS systems may perform clinical checks on existing or 
newly prescribed medicines[46] and with advanced functionality, take into account patient 
specific factors such as weight, co-morbidities, renal function and age, the latter two being the 
most important.[46, 86, 87]  
Patient specific parameters 
Kuperman et al. suggested that appropriate CDS dosing required integration of patient specific 
factors; however, recent evidence indicates drug-dose support is still underutilised [46, 88, 89] 
Missing data is often an issue; one study in the paediatric inpatient setting found patient weight 
was not recorded in 31% of cases, thus preventing many checks from being performed.[85] 
However, it may not be possible to accurately weigh a patient in certain situations, and therefore 
flexibility needs to be built into the system to accommodate this. Even when a patient’s weight 
is recorded correctly doses may conflict based on different sources of evidence.[90, 91] System 
design and procedural issues may also unintentionally facilitate dose errors.[54] For example a 
39-fold overdose of an antibiotic was administered to a patient when the total dose in milligrams 
was erroneously entered into a mg/kg dosage calculator.[92] The dose required to cause a 
maximum tolerated effect is dependent on patient specific factors like drug indication and 
laboratory results, thus the creation of a ‘one rule fits all’ standardised dose may not be 
appropriate for all patients.[93] The development of more advanced dosage support, which can 
calculate doses based on therapeutic drug levels or clinical parameters is therefore needed. 




to review and maintain; this is an important consideration, particularly for smaller informatics 
teams. [85] 
Drug administration 
Some system calculated doses are often not easily administered, which can lead to clinicians 
altering doses inappropriately or difficulties measuring doses accurately. Drug-dosage support 
can recommend appropriately rounded doses to maximise usability and safety.[93] However, to 
realise their full potential, dosage recommendations should be combined with other factors like 
age, route of administration and patient preferences.[93] In some instances, the dose, calculated 
according to the patient’s weight, may exceed the maximum daily dose based on the patient’s 
age. Therefore, it is also important to consider not only the patient’s age, but also their weight, 
relative to the specific drug indication. 
Renal dosing and age-related dosing 
Renal dosing alerts inform clinicians of appropriate doses for patients with impaired renal 
function. The timing of these alerts is important, as dosing suggestion(s) before the selection of 
a dose is obviously more beneficial to the prescriber than after both the drug and dose have 
been chosen.[56] Furthermore, the recommended dose should be relevant and specific. Sellier 
et al. were unable to demonstrate a significant reduction in inappropriate dosing, possibly due 
to the use of a ‘dosage adjustment’ table that displayed a range of values, in comparison to an 
exact recommended dose.[88] The inclusion of drug indication into decision-making algorithms 
is considered to be particularly important for age-related dosing alerts,[89] due to the wide 
range of doses for different conditions. The reasons for alert non-adherence, such as disease 
severity,[87] should also be explored and systems updated accordingly.   
2.3.2.4 Drug Duplication Alerts 
Medication-related CDS systems can generate drug duplication alerts when duplicates of the 
same medicinal product are prescribed, or drug therapy alerts for prescriptions of medicines 
with similar therapeutic effects. Some systems are not configured to generate alerts for different 
routes of the same medication (e.g., intravenous and oral),[94] thus potentially exposing the 




duplicate drugs if, for example, different morning and night-time doses are required, or a topical 
and oral preparation are to be deliberately used in combination. This should be taken into 
consideration when designing the system, although one study reported an increase in 
duplication errors with ePrescribing and CDS implementation.[94] The authors noted how many 
patients might have received duplicate doses because the system failed to consider recently 
discontinued medications that might still be exerting a therapeutic effect.[94] An additional 
factor to consider when designing drug-duplication checks is the half-life of the medication(s) 
(i.e., the time it takes for the concentration of a drug to half its initial value) and associated effect 
on concomitantly prescribed medications, and also whether the combination is intentional e.g., 
tapering crossover of antipsychotics and antidepressants.[65, 76, 94] It has been suggested that 
intentional duplicate orders e.g.,  an order for paracetamol for mild pain (when required) and 
for paracetamol/codeine to be taken if the pain is more severe (also when required) should be 
accompanied with an explanatory note for both the patient and/or nurse responsible for 
administering the drug product, so that they are both fully aware of when one should be 
administered over the other.[95] Medication-related CDS, which displays the drug indication, 
can be a useful guide for users. Although multiple healthcare providers should be able to 
prescribe for a single patient at any one time within an organisation, careful consideration should 
be given at the development stage as to how this can be conducted safely in order to avoid 
unnecessary duplicate orders or fragmented care.[96] 
2.3.2.5 Drug Formulary Support 
Drug formularies are lists of medications which have been approved for use by an organisation 
and offer benefits such as standardised prescribing and locally targeted therapies. Variable, 
incomplete and inaccurate electronic drug formularies may result in inappropriate drug 
formulary support.[97, 98] One study found that almost two thirds of reviewed drugs lacked 
information about drug restrictions after migration to an EHR, which could lead to clinicians 
deviating from hospital protocols.[99] Medication lists that do not distinguish between generic 
and brand formulations when prescribed by free-text may also contribute to the same drug being 
prescribed twice in both forms (due to a lack of prescriber knowledge).[80] Fischer and 
colleagues found a system that utilised colour coding to help distinguish between ‘preferred’ 
(green), ‘non-preferred’ (blue) and ‘not approved’(red) drugs, helped increase prescriptions for 




restrictive as users were still able to select a non-preferred item; the colour simply guided the 
selection.[100] 
2.3.2.6 Human Factors 
Human factors is defined as the study of interrelationships between humans, the tools they use, 
and the environment in which they live and work.[101] Phansalkar et al. identified human factors 
principles that could be used to inform the design of CDS systems. These include alarm 
philosophy (presence of a reason for the alert and severity of consequences)[56], false alarms, 
placement, visibility, prioritisation, colour, learnability and confusability, textual information, 
habituation, mental models and proximity of task components being displayed.[56] Alert display 
has been found to strongly correlate with alert acceptance and should be considered when 
selecting a suitable CDS system.[67, 102, 103] Furthermore, greater consideration of how alerts 
should be presented to different users is clearly needed.[104]  
2.3.3 Discussion 
Medication-related CDS functionality is continually evolving, though there are many specific 
opportunities for improvement. Refining alert sensitivity and specificity, by including more 
patient-specific parameters, and greater consideration of human factors principles is important 
across all domains.  
2.3.3.1 Standardisation: Benefits and Challenges 
Alerts are produced when decision-making checks are performed on prescribed drugs. 
Information may be integrated into computerised algorithms from a variety of sources including: 
a knowledge base (which stores information about the drug e.g., dosage and contraindications), 
clinical parameters (age and renal function), and from the EHR (medication history, co-
morbidities) to assess prescription suitability. The extent to which organisations choose to utilise 
features varies widely between systems, for example, systems may assign different severity 
levels to particular drug interactions.[105] A lack of standardisation is potentially a source of user 
confusion and frustration, particularly for those working across multiple sites or clinical areas; it 
also makes determining an acceptable severity level and creating generalisable 




previously defined level 1 DDI alerts, that should be generated in all EHRs were not always 
switched on across different systems in different countries.[106]The maintenance of an up-to-
date knowledge base is also resource intensive; Johnson et al. estimated that a set of paediatric 
dosages would need to be fully reviewed at least every three years to reflect the addition of new 
therapies to the market.[93] Additionally, the evidence pertaining to the safety and efficacy of 
medications during use should be continually reviewed and the systems updated accordingly. 
Therefore, commercial knowledge vendors should consider the development of a nationalised 
knowledge base, which is managed centrally, similar to the Netherlands national drug database 
the ‘G-Standard’.[107] Such a system would potentially require less input from individual 
organisations to review and update guidelines according to the latest evidence. In particular, 
McEvoy et al. recently suggested the creation of an officially approved, standardised knowledge 
base for DDIs in order to address the significant variation in DDI alert presentation observed in 
their study.[59] Payne et al. also recommended the consistent use of colour and terminology in 
how DDI alerts were presented. [104] However, such an initiative may be hindered by 
heterogeneity of vendors. Furthermore, studies have identified significant variation between 
vendors and organisational approaches to the implementation of medication-related CDS. [59, 
105] Thus, there is a need for improved communication and standardisation of practices across 
systems and healthcare settings, where appropriate, to aid development of more universally 
applicable medication-related CDS.  
Challenges to the development of standardised recommendations have been frequently 
reported and should be acknowledged. For example, producing dosage recommendations for 
drugs like aminoglycosides requires knowledge of patient specific information such as laboratory 
results and serum drug levels.[108] The sequence in which drugs are administered is also 
important, particularly for time dependent drug interactions. Determining whether a 
prescription is suitable according to hospital policies requires knowledge of the intended 
indication of the drug. Contextual factors such as the patient setting should also be considered. 
For example, alerts that advise patient monitoring are potentially superfluous in the hospital 
setting where some patients already receive intensive monitoring.[107] However, eliminating 
certain alerts across an entire care setting may be problematic. Seidling et al. described 
difficulties relating to the range of perceptions held by clinicians of variable experience and 




both patient-specific and contextual information. Examples include customising alerts to 
individual clinical settings, certain clinicians (e.g., doctor, nurse or pharmacist specific alerts) and 
encouraging local review of medication-related CDS rules.[109] This will also require the 
cooperation of commercial knowledge vendors and system suppliers to help facilitate such 
customisation. A difficulty for organisations is utilising and incorporating a range of clinical 
parameters into medication-related CDS decision-making algorithms from multiple stand-alone 
systems.[110] System developers should also aim to improve the interoperability between 
different standalone systems, e.g., a prescribing system and a lab test result system, to facilitate 
the production of patient specific alerts. As such, selecting systems that integrate with the 
medication-related CDS system is important so that information can be utilised.  
2.3.3.2 Human Factors Design 
It is of central importance to carefully consider human factors design principles during the design 
and development of medication-related CDS systems.[56] A number of principles such as alarm 
philosophy, prioritisation, and learnability and confusability are absent in many systems.[103] In 
addition to improving alert relevance, it is also important that systems are built with an 
appreciation of environmental factors, including existing pressures and workflow.[111, 112] This 
is a challenge for commercial system developers, who may lack insight into how individual 
organisations or clinical areas function. Capturing users’ experiences of medication-related CDS, 
such as the reasons for alert overrides and perceptions of usability, are very important if 
problems are to be exposed and refinements made to a system. One study found that the main 
reason nurses overrode recommended doses of insulin were due to concerns that the dose was 
set too high.[113] Such findings allow organisations to address clinicians’ concerns through 
education and review of practice.[90, 113]  System design should support users moving between 
tasks,[114] and any actions taken by users in response to medication-related CDS may highlight 
design flaws, which promote the use of workarounds.[105, 115] Investigating errors that 
occurred as a result of ePrescribing and medication-related CDS is also important and may 
highlight design flaws in the system.[116] For example, Horsky et al. identified a potassium 
chloride overdose that was partly caused by the provider’s confusion between the parameters 
used for limiting the amount of medication delivered between drip (IV infusion) and IV bolus 
administration.[117] In another publication (Appendix 3), the researcher highlighted how drop-




As technology plays an increasingly important role in healthcare, organisations will need to 
consider the use of medication-related CDS alongside other systems, such as diagnostic support, 
which may put additional demands on clinicians. There is clearly a need for further research, 
particularly in sites with commercial systems, to identify the lessons learned from specific 
customisations and how these may be transferred to other sites. 
2.4 Chapter Summary 
This chapter has been divided into two sections; firstly the researcher has provided an overview 
of the use of ePrescribing systems, including a brief description of the types of systems currently 
available and factors that have influenced adoption rates in the UK. This was followed by a 
narrative literature review, which described the role of CDS and important recent developments 
that have been made in this area, over the last ten years, such as the importance of tiering drug 
interaction alerts, the need for more specific and sensitive recommendations and the 
significance of applying human factors design principles during the design and use of these 
systems.  This review also highlighted areas in which there is scope for further research, for 
instance it raises the question of what is the best way to deliver CDS to clinicians. The issue of 
standardisation was also raised and the researcher discussed some of the advantages and 
disadvantages of standardising CDS systems. It was also clear from this review that there is a 
need for further research in sites that have implemented CDS systems in order to gather lessons 
learnt and share knowledge about these systems. Reports have also emerged that suggest that 
ePrescribing and CDS systems have been associated with some ‘unintended adverse 
consequences’ including ‘new types’ of errors. The following chapter will discuss some of the 









Chapter 3  
The Challenges of Electronic Prescribing and Clinical 
Decision Support Systems: Prescribing Errors 
ePrescribing systems have been associated with unintended adverse consequences; in particular, use 
of these systems has been found to contribute to new types of prescribing errors.[115]The researcher 
conducted a systematic review to understand the different types and causes of errors that occur 
during the prescribing process when using ePrescribing systems and describes her findings in this 
chapter; this systematic review has been published: Clare L Brown, Helen L Mulcaster, Katherine L 
Triffitt, Dean F Sittig, Joan S Ash, Katie Reygate, Andrew K Husband, David W Bates, Sarah P Slight; A 
systematic review of the types and causes of prescribing errors generated from using computerized 
provider order entry systems in primary and secondary care, Journal of the American Medical 
Informatics Association, Volume 24, Issue 2, 1 March 2017, Pages 432–440, 
https://doi.org/10.1093/jamia/ocw119.[119]  (Appendix 3) 
3.1 Introduction 
ePrescribing systems with CDS functionality have been shown to reduce the occurrence of 
prescribing errors.[22, 27, 51, 52] However, reports have also emerged that these systems (with 
or without CDS) have contributed to new types of errors in both primary and secondary care. 
[115, 120, 121] Some of these errors are potentially serious in nature, like a prescription for a 70 
times overdose of diamorphine that occurred due to mis-selection of a dose from a drop down 
menu.[122] These errors have been frequently referred to as the ‘unintended adverse 
consequences’ of technology,[120, 123] a term which describes both the unexpected and 
undesirable nature of these events.[124]  
Due to the relative newness of ePrescribing systems in many health care organisations, 
developers and users may be unaware of the generation or causes of these ‘new’ errors. A lack 
of consideration of human factors principles during the design stage has contributed to these 
issues emerging.[66, 125] Furthermore, despite certification requirements from the Office of the 
National Coordinator for Health Information Technology (an organisation tasked with supporting 




centred design process, a recent study reported that just over half of vendors studied actually 
employed usability staff and that use of this approach was variable at best. [126] 
A study by Koppel et al. in 2005 sought to identify and quantify the role of CPOE in facilitating 
prescribing errors.[115] Since then, many more studies have used qualitative techniques to 
provide a rich understanding of the types and causes of these errors.[127] The researcher 
conducted a systematic review to understand the different types and causes of errors that occur 
during the prescribing process when using ePrescribing systems, and to make recommendations 
about how these systems could be improved.  
3.2 Methods 
Our review was conducted according to PRISMA guidelines;[128] each step is summarised below. 
3.2.1 Eligibility criteria 
Primary research studies that focused on prescribing errors associated with ePrescribing systems 
were eligible for inclusion. Studies that included qualitative data about the types and causes of 
these errors were included. Our search strategy covered the use of any type of ePrescribing 
system (e.g., self-developed or commercial) in any clinical setting (e.g., hospitals, outpatients 
and primary care). Quantitative data were not included because this review was aimed at 
describing the types and causes of ePrescribing related errors and not the frequency of errors. 
Studies published in peer-reviewed journals or conference proceedings between 1st January 
2004 and 22nd June 2015 were eligible for inclusion. The search was restricted to English 
language publications. Editorials, commentaries, letters and opinion articles were excluded.  
3.2.2 Information sources and search  
Three large databases were searched: the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), Embase (via OVID) and Medline (via OVID). Appropriate search terms were 
developed and grouped into ‘sets’, specifically relating to ‘electronic prescribing’, ‘computerised 
provider order entry’, ‘clinical decision support’, ‘electronic health records’ and ‘errors’. In each 
set, terms were combined with the ‘OR’ operator and  sets were then combined with the ‘AND’ 




studies. This search was conducted on the 22nd June 2015. Appendix 4 details the search strategy 
conducted in Medline and Embase (Ovid). 
3.2.3 Study selection  
After duplicate articles were removed, three independent reviewers (CB, HM and KT) screened 
the titles to determine if the articles met the inclusion criteria. Two authors (CB and HM, or CB 
and KT) then independently reviewed all abstracts and full texts, with one author (CB) acting as 
a constant across all publications. Disagreements were resolved by discussion, with arbitration 
by a fourth additional reviewer (SPS), if necessary. The reason why a publication was rejected 
was also documented.  
3.2.4 Data collection and analysis  
A customised data extraction sheet was used by each of the three independent reviewers (CB, 
HM and KT) to extract specific details about each study’s location, objectives, methods and key 
findings. A narrative synthesis of all eligible studies was undertaken. Papers were read and re-
read by three authors (CB, KT and HT), and key recurring themes and sub-themes were identified 
iteratively from the data.  
3.2.5 Bias Assessment 
Due to the subjective nature of qualitative research, bias may occur. A critical analysis of included 
studies was performed using the Critical Appraisal Skills Programme (CASP) tool for qualitative 
research.[129] Mays and Pope have advocated the use of methodological triangulation (use of 
two or more methods) as a way of strengthening the research design and safeguarding the 


























Figure 3: Diagrammatic representation of the steps involved in the literature search 
3.3 Results 
A total of 1,185 publications were identified through the database search, with 1,036 excluded 
after removing duplicates and screening the titles and abstracts. On reviewing 149 full text 
articles, 115 were excluded; a total of 34 were therefore included in the final review. These 
comprised of 31 full text articles and 3 conference abstracts. Studies were conducted in the US 
(n=19), between the US and Canada (n=4), Canada (n=1), UK (n=4), Australia (n=2), Spain (n=1), 
Sweden (n=1), Netherlands (n=1) and Denmark (n=1). The bias assessment revealed three 
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included as they provided valuable insights. A table summarising the key findings of the included 
articles has been provided (Appendix 5). 
A descriptive and narrative synthesis of the data was undertaken to understand the different 
types and causes of prescribing errors associated with ePrescribing systems, and eight key 
themes were identified and are discussed in detail below.  
3.3.1 Computer Screen Display 
The layout of the computer screen display affected how users viewed patient information. 
Displaying an incomplete list of a patient’s medications on the computer screen was found by 
Horsky et al. to have contributed to an incident where a patient was prescribed an overdose of 
potassium chloride and subsequently developed severe hyperkalaemia.[117] Analysis of the 
same incident also revealed how intravenous (IV) medications were not displayed in the area of 
the screen where the patient’s other medications were. This was likely to result in users missing 
or not considering these medicines when prescribing.[117] Similar issues have been raised in 
other studies by Wetterneck et al. and Koppel et al. who suggested that a failure to display all 
orders, including active, recently administered, PRN (when required) and STAT (immediate), may 
inhibit the user from reviewing the entirety of a patient’s medications and result in duplicate 
doses being prescribed.[94, 115] The use of multiple screens, which require users to click 
through various parts of the ePrescribing system in order to access the necessary information, 
has been found to disrupt workflow and also led to users incorrectly entering information ‘where 
it might fit’ rather than where it was intended to go. The danger is that such information might 
not then be visible to other users and clinical safety checks may be bypassed.[120] Horsky et al. 
also found that similarly designed screens in one system had important functional differences 
e.g.,  the parameter for limiting the amount of medication delivered was time dependent for 
drip (IV infusion) administration yet dose dependent for IV bolus administration, and 
subsequently could be easily confused by prescribers.[117] The ease of moving between 
different patients on an electronic system was also felt by Adelman et al. to have contributed to 






3.3.2 Drop-down menus and Auto-population 
It is no surprise that selection errors associated with different drop down lists (e.g., patient 
names, medication names, drug dosages, etc.) have been frequently reported.[19, 115, 134-136] 
Westbrook et al. examined the system related errors that occurred across two commercial CPOE 
systems and found numerous examples of selection errors. These included specific cases where 
the wrong route of a medication, e.g., sodium chloride 0.9% infusion via the epidural route 
instead of the IV route were selected and the system did not restrict the list to only those 
potentially appropriate options.[137] Juxtaposition errors, whereby a medication listed before 
or after the desired medication was erroneously chosen, also resulted in orders being placed for 
drugs with an entirely different indication than what was intended.[120] One example included 
users’ mis-selection of ethamsylate (a haemostatic agent) instead of ethambutol (an antibiotic) 
from a drug list.[135] Delays in system response time resulted in prescribers using ‘multiple 
clicks’ to select a drug item, which increased the risk of mis-selection.[19] Odukoya et al. 
highlighted that inadvertent ‘mouse wheeling’ (selecting an incorrect item by unknowingly 
scrolling past it) could also have contributed to incorrect orders being placed.[138] A range of 
prescribing errors have been attributed to the presence of auto-population functionality, 
whereby on entering the first few letters (or numbers) of a drug name (or dose), the system 
‘suggests’ information that could be easily selected in error.[54, 138] Snyder et al. encountered 
a wrong drug order when “vir” was typed for the intended drug “Viread”, and “efa” “vir” “enz”, 
an alternative antiretroviral was suggested, as a prescribing option by the system autofill 
functionality and erroneously selected. [139] 
3.3.3 Wording 
The wording of the text used within ePrescribing systems has also been shown to contribute to 
prescribing errors. For example, in one study users misinterpreted the data label ‘total volume’, 
which they thought meant the total volume of dose that should be administered, rather than 
the system ‘meaning’ (i.e., the total volume of an individual bag of fluid).[117] Horsky et al. 
described these misinterpretations as a ‘user-design mismatch’.[117] Another example included 
a dose of 20 mg written as 0020.000 MG, which could be misinterpreted due to the additional 
zeros presented.[140] One study that explored ePrescribing related prescribing errors in a 




wording that would allow them to select certain drugs, e.g.,  a particular type of insulin from a 
pick-list.[19]  
3.3.4 Default Settings 
Overly restrictive default settings have been associated with a number of ePrescribing related 
prescribing errors. Prescribers may simply fail to change a default order sentence containing 
drug name, form and dosage, or a default time presented by the system, thus resulting in a 
patient receiving the wrong dose, missing a dose or receiving it at an unintended time.[115, 135, 
137] Koppel et al. found that some ‘late in the day orders’, where the prescriber had intended 
the patient to receive the drug on the same day, were delayed until the next day, with potential 
consequences for the patient.[115] If the drug combination carbidopa/levodopa (Sinemet®), for 
example, is not administered at the appropriate time, then a patient with Parkinson’s disease 
can experience adverse motor-symptoms. Similarly, duplicate dose errors have been reported, 
with a patient being administered a night-time dose of the antiviral efavirenz (Sustiva) and an 
inappropriate second dose the following morning because the system automatically defaulted 
to a 09:00am daily dose.[139] Lack of knowledge about the default stop dates and times of 
certain medications can also lead to errors.[117] Some systems combine default order sentences 
as part of an order set to make it easier to prescribe a group of medicines, e.g. for post-surgical 
analgesia. Doctors interviewed in one study described an instance where a non-steroidal anti-
inflammatory drug was ‘hidden’ in an order set and inappropriately prescribed to an asthmatic 
patient.[135] Default settings for some medicines used in certain clinical specialities therefore 
may not be appropriate due to the range of prescribing options, which are dependent on patient 
specific factors. For example, the dose of azathioprine (an immunosuppressant) is often 
dependent on the patient’s weight, indication, laboratory results and thiopurine S-
methyltransferase (TPMT) activity, thus a list of suggested doses may be confusing unless the 
system is able to guide the user by taking these other patient factors into consideration. 
3.3.5 Non-intuitive ordering or information transmission 
Inflexible or complex ordering processes made entering some orders particularly difficult and 
resulted in users employing workarounds to avoid some of the issues encountered. These 
included selecting a default drug order sentence (e.g., give twice daily) and adding a 




give three times daily). Unfamiliar abbreviations were also entered in free-text boxes, which in 
turn were open to misinterpretation by different users.[140] Zhan et al. found that a system 
failed to recognise the abbreviation ‘TID’ (take three times a day) and therefore did not record 
this order.[141] Odukoya et al. described an example of confusing directions written in free-text: 
“take a half tablet and there will be a period and then it will say take two tablets…”.[142] Users 
employed workarounds to prescribe complex prescriptions, which were generally very difficult 
to write electronically, such as tapering courses of prednisolone.[105] ‘Copy and paste’ 
functionality, which is designed to save users time, was also found to unintentionally give rise to 
the generation of incorrect orders.[131] Wentzer et al. also observed instances where 
medications, which had been previously prescribed on a prior hospital admission and stopped, 
were transferred to the new admission as an ‘active’ medication and inappropriately 
continued.[143] 
3.3.5.1 Interoperability Issues 
One study described the compatibility issues between a prescribing system and a community 
pharmacy system, which related to a failure of one system to correctly interpret the terminology, 
possibly due to a lack of standardised codes in requests, e.g.,  ‘magnesium citrate’ or ‘mag. 
citrate’. Certain requests (e.g., mag. citrate) were translated incorrectly by the community 
pharmacy system once received, and led to prescriptions being generated for the inappropriate 
drug name, quantity package size, and patient name.[138]  Similarly, Nanji et al. identified 
important information that was omitted from prescriptions electronically ordered from either 
inpatient or outpatient prescribing systems and received by a community pharmacy system. It 
was felt that this was related to a mismatch between the text-box size in the prescribing system 
(on which the order was originally placed) and the pharmacy system (on which the order was 
received), thus leading to certain information being missed or not communicated.[144] 
3.3.6 Repeat prescriptions and automated processes 
An important difference between handwritten and electronic prescriptions is the ease with 
which a repeat electronic prescription can be generated with a few simple clicks.[136] This is 
clearly more efficient for users, but there is a downside. There have been cases where 




contained the error) were not updated in the system and subsequently repeated.[138] 
[144]These erroneous electronic prescriptions may be harder to detect as one study participant 
describes: “But if there's a black and white typed document that includes nonsense, it is harder 
to recognise it and it's more easily overlooked or assumed to be correct…”.[136] 
3.3.7 Users work processes 
Inappropriate work processes, for example, entering all of a patient’s medicines in batches at 
the end of a ward round on the ePrescribing system, pose safety risks.[110] Issues can arise 
around whether a prescriber can correctly recall potentially large lists of medications.[143] 
Delays in entering information can result in clinicians, who were not present on the ward round, 
being unable to immediately utilise such information for their own decision making.[110] 
Similarly, an inconvenient log-in process can give rise to users working under other colleagues’ 
log-ins, which has both legal and professional implications.[145] Wentzer et al. found that some 
doctors would login to the ePrescribing system and allow a nurse to work under their account, 
thus the person whose ID the system recognised as making an order was not actually the true 
prescriber of that order.[143] 
3.3.8 CDS systems 
As previously discussed, the consequences of over-alerting and alert fatigue are well described 
in the literature.[54, 55] However, a lack of appropriate safeguards may also prevent prescribing 
errors from being detected, particularly if users have wrongly assumed that their orders are 
being checked. For example, Schiff et al. identified one hospital site that was unaware that their 
CDS alerts had been switched off following a system update.[105] This study also identified many 
CDS systems that did not offer sufficient protection against many common errors.[105] 
Wetterneck et al. found that orders for different forms of the same medication e.g.,  metoprolol 
25mg tablets (oral) and metoprolol 5mg IV, were not identified as potential duplicates when 
prescribed together, and therefore did not generate an alert.[94] Underutilisation of CDS 
functionality was reported by Khajouei et al. who found that a button prescribers needed to click 
to perform a dosage calculation was not clearly displayed, and therefore prescribers continued 
to manually calculate doses, which increased the risk of potental human errors.[145] CDS 




that do not take into account patient specific factors (e.g., reduced renal function)[54] or orders 
based on outdated drug information.[105] 
3.4 Discussion 
This evaluation describes the types and causes of prescribing errors associated with ePrescribing 
systems, specifically identifying themes from qualitative studies. The eight key areas were: 
computer screen display; drop-down menus and autopopulation; wording; default settings; non-
intuitive ordering or information transmission; repeat prescriptions and automated processes; 
users work processes; and CDS alerting. All of these relate closely to human factors and user-
centred design. Table 2 provides a summary of the key themes, associated issues and 
recommendations, and whether the error could be classified (predominantly) as system related, 

























 Incomplete Display.[94, 115, 117] 
 Navigation between multiple Screens.[120, 
134] 
 Confusing data labels.[117] 
 All medications (oral, intravenous etc.) 
and all statuses (active and discontinued 
etc.) should be clearly displayed in one area 
if possible. 
 The naming of data labels should be 
unambiguous. 
 Post-implementation testing is crucial to 
identify any issues.  
 Consistent use of colour and design 







 Mis-selection errors:[19, 115, 120, 134-138] 
o Similar named medications or 
patients located next to each other 
o Orders listed above or below the 
intended order 
o Delays in the system response 
time and use of ‘multiple clicks’ 
o Scrolling onto the wrong order 
 Erroneous suggestions of medications, 
doses or patients.[54, 138, 139] 
 Avoid overly long lists of patient’s names 
or medications. 
 Distinction between ‘look-alike-sound-
alike’ medications using tall man lettering, 
colour or bold font. 
 Indication based CDS alerts. 




Wording  Confusion between the system’s wording 
and user’s interpretation of that meaning.[19, 
117] 
 Unnecessary ‘trailing zeros’ i.e.,0020.000mg 
instead of 20mg.[140] 
 Pre and post-evaluation of user’s normal 
workflow and practice to ensure user-
informed design. 
 Enable local customisation according to 




related   
Default 
Settings 
 User related 
 Failure to change suggested default 
settings.[115, 135, 137, 139] 
 Lack of knowledge about default 
settings.[117] 
 System related 
 Orders hidden within pre-defined order 
sentences and order sets.[135] 
 User education and training about 
complex prescribing functions and 
challenges that may be encountered with 
using the system. 
 Development of more sophisticated, 
patient specific pre-defined order 








 Lack of standardised terminology.[138, 140-
142] 
 Interoperability issues.[138, 144] 
 Facilitate local customisation to 
incorporate local terminology. 
 Consistent use of key terms between 
systems. 
 Addressing interoperability issues 
between standalone systems, particularly 








 Repetition of previously corrected 
errors.[136, 138, 144] 
 Reduced visibility of computerised 
errors.[136] 
 Introduce additional checks into the 
prescribing process. 
 User training and education about the 





 Batch order entry [110, 143] 
 Users working under another colleague’s 
log-in. [143, 145] 
 User education and training about the 





CDS Systems User related 
 Lack of knowledge about the CDS checks 
that are performed.[105] 
System related 
 Inconsistent and insufficient use of CDS to 
safeguard against errors. [94, 105] 
 Poor CDS design.[145] 
 Erroneous suggestions due to issues with, 
CDS sensitivity, specificity and accuracy of 
information.[54, 105] 
 Education and training about the systems 
functions (and lack of) 
 Use of CDS, where a clinical need has 
been identified. 








This systematic review described errors relating to the way information was displayed on the 
computer screens.[110, 117]  One simple solution might be to organise the screen layout such 
that all medications (including both oral, IV, rectal and vaginal etc.) are listed in one area, with 
minimal navigation required. Additionally, data labels should be clear to the user and guide them 
to separate areas where further specific information can be obtained.[125, 146] System 
developers and implementers should consider the potential for a ‘user-design mismatch’ and 
the importance of designing the system according to the users’ workflow and the terminology 
that they use.[117] Indeed, as many issues may not be identified until after system 
implementation, there is a clear need for post-implementation testing to ensure that these 
systems are working as intended.[110] There may also be additional organisational benefits of 
improving the design of such systems; Chan et al. found that a well-designed ePrescribing system 
could also possibly reduce the need for training.[147] In this study, no participants requested 
assistance when ordering a medicine using the user-centred design format compared to over 
one third of participants requesting assistance on a ‘standard’ ePrescribing test system.[147] 
Horsky et al. demonstrated the potential for confusion amongst users who used functions that 
were visually very similar on the order screen but behaved differently e.g.,  the function to 
calculate total dose for infusion or IV bolus orders.[117] Design tools, such as colour and 
language, should be applied consistently throughout a system (and possibly all systems) to 
prevent users misinterpreting information during the prescribing process and further research 
is needed to establish what colours, language and terminologies are effective.[125] 
The design of ePrescribing systems is a critical consideration. Drop-down menus can provide a 
list of drug dosing options in ascending or descending order, so as to make it easier for 
prescribers to find exactly what they are looking for. However, long lists of medications, 
particularly those listed alphabetically, with names which look-alike or sound-alike are prone to 
selection errors. Westbrook et al. found that 43% of system-related errors were due to selection 
errors, which led the authors to conclude that reducing the opportunities for users to ‘select’ 
items from lists during the course of prescribing may reduce ePrescribing related errors. [137] 
This should be weighed against the potential consequences of prescribers entering erroneous 
doses in free-text, and the additional time this manual entry of information may take.[125] Tall 




hydrOXYzine and hydrALAzine.[148] There is some limited evidence from experimental studies 
to support its use more generally;[149] however, there is currently a lack of robust studies 
relating specifically to ePrescribing systems and the effect of tall man lettering in certain users, 
such as those with dyslexia.[148] Galanter et al. showed that indication-based alerts can help 
intercept wrong drug and wrong patient orders (commonly encountered with selection and 
autofill entry errors), by halting the prescriber’s workflow and allowing them to self-correct the 
order.[150] Due to the potential burden of excessive CDS alerting, the use of indication alerts for 
high-risk, look-alike-sound-alike, drug pairs should be considered.[151] 
The issues identified in this review pertaining to default doses have been supported in the 
quantitative literature. Eslami et al. found that 86% (n=113) of orders placed for two 
aminoglycoside antibiotics (gentamycin and tobramycin) using the suggested default dose were 
associated with an overdose, compared to only 53% (n=66) cases when the default dose was not 
selected.[152] This default dose was based on an average sized adult with normal renal function, 
and thus poses the question about whether such default doses are well placed in certain clinical 
specialities where patients are more likely to have parameters that frequently fluctuate outside 
of normal limits (e.g. Intensive Care Unit (ICU) or a nephrology ward).[152] Order sets can 
standardise prescribing and improve adherence to guidelines. However, we found that certain 
items were inadvertently prescribed for some patients (via an order set) as they were ‘hidden’ 
among a list of medications, which included both suitable and unsuitable items. Bobb et al. 
suggested that order sets should be more patient specific, presenting only relevant 
recommendations e.g., a non-penicillin drug for a penicillin allergic patient as first-line 
treatment.[153] They also recommended that individual items within an order are linked, so that 
they are updated in unison. For instance, if an order set contains supportive therapy (e.g.,  a 
proton pump inhibitor) for an indicated medication (e.g.,  corticosteroid), the supportive therapy 
should be ceased when the indicated medicine is discontinued.[153] 
We found that free-text orders were commonly used as a method of bypassing system 
requirements or CDS alerts. A quantitative study conducted by Palchuk et al. found discrepancies 
between the information contained in the structured and free-text fields in 16% (n=470) of 
electronic prescriptions.[154] System developers should consider the development of more 
sophisticated CDS, which can perform checks on free-text orders.[154] Furthermore, the 




Dhavle et al. found that many free-text comments encountered in their study could be avoided 
by using an updated version of the ePrescribing system, which incorporated additional 
structured fields.[155] Developers should address this need by providing prescribing options, 
such as a tapering course of steroids or alternate day dosing, as part of ongoing system 
optimisation and development,[156] in addition to accelerating the rate at which new 
functionality reaches users.[155] Certain ePrescribing systems are unable to accommodate 
prescriptions for drugs given via multiple routes (for example providing an oral and rectal option 
so the nurse can decide how to give the medication depending on the clinical context); this 
suggests a possible lack of understanding and consideration of actual prescribing and 
administration practices that would need to be addressed. Ongoing testing and evaluation of 
systems (and any customisations made) is needed in order to optimise and enhance ePrescribing 
systems following initial implementation.[157] 
CDS has undoubtedly contributed to a reduction in errors and has huge potential to further 
improve safety in the future.[47] However, as this review has found, there is still much to be 
done to improve the safety of these systems. Schiff et al. discovered that only 26.6% (n=95) of a 
sample of erroneous test-orders generated warnings thus allowing many potentially harmful 
orders to be placed.[105] Additionally, there was considerable variability in the way 
organisations implemented CDS functionality and the ability of different systems to warn 
clinicians about errors,[105] which may confuse users who work across multiple sites. Wright et 
al. also found examples of malfunctioning CDS, resulting in a failure to generate warnings when 
needed or the production of unnecessary alerts. Such malfunctions were due to software 
upgrades, code changes, accidental alteration of CDS rules, and faults with external 
systems.[158] Customisation is crucial for organisations striving to achieve safer patient care 
following ePrescribing implementation. One study found that even a small 5% increase in the 
Leapfrog score (an evaluation tool, which tests CPOE systems ability to safeguard against 
erroneous test orders) was associated with a significant reduction in preventable adverse drug 
events.[159] Thus, organisations should be reassured of the benefits of customising their system 
to include a range of CDS checks. Perhaps one of the most crucial developments will be the 
production of more patient specific and better worded alerts to reduce the impact of alert 
fatigue and erroneous suggestions.[69] A recently published study by Slight et al. found that 




describe the error present, (e.g., “(the drug) already exists . . . under the selected assessment”, 
highlighting the need to improve system usability.[151] 
Human factors and user-centred design is key across all of these eight areas and should be 
prioritised when developing these systems. There is a need to thoroughly evaluate ePrescribing 
related incidents so as to better understand system failings, using various (or a combination of 
different) approaches [160] such as failure mode and effect analysis,[161] visual and cognitive 
walkthrough evaluation,[117] and usability evaluation techniques (including semi-structured 
interviews and observations).[162] Phansalkar et al. created a list of such principles specific to 
the design of CDS alerts to prevent confusion and maximise their impact.[56] Russ et al. saw a 
significant reduction in prescribing errors when they redesigned CDS alerts according to human 
factors principles;[163] this was attributed to improved visibility of text, more logical 
organisation of information and more informative alerts.  
This systematic review has provided strong insights into the key structural design elements 
associated with ePrescribing related prescribing errors. However, the review only reported what 
has been published in the peer-reviewed literature and there may be unpublished work that 
could also provide valuable insights. Another possible limitation is that this review spans over 
ten years and it is possible that some system vendors may be currently working on or have 
already addressed some of the issues highlighted. [115] For instance, all six EHRs evaluated in 
one study displayed patient identifiers on the top of the computer screen throughout the 
prescribing process, thus helping to reduce wrong patient errors. [140] Finally, there may also 
have been a publication bias towards studies that reported more positive findings and 
consequently the number of different types of ePrescribing related prescribing errors may be 
much higher. However, the findings of this review highlight the need for further research into 
uncovering these specific types of errors and for the establishment of a national reporting 
database where these types of errors should be logged and addressed (both by vendors and by 
local customisation teams). [127, 164] 
3.5 Chapter Summary 
This chapter is based on a systematic review, which identified eight key areas that have been 




factors and user-centred design. The design and layout of the computer screen display should 
be carefully considered. Drop-down menus should be designed with safeguards to prevent the 
occurrence of selection errors. Local customisation and development of more sophisticated CDS, 
which can perform checks on free-text and provide users with adequate prescribing functions, 
is clearly needed. Developers must aim to improve the specificity, sensitivity and usability of 
these systems in light of the recent research in this area. The following chapter specifically 
focuses on the literature that describes the factors that have contributed to medication errors 



















Medication errors made when using ePrescribing systems 
in paediatrics 
 
Paediatric patients are particularly vulnerable to medication errors. The researcher conducted a 
systematic review to identify and understand the factors that contribute to medication errors 
when using ePrescribing and CDS systems in paediatrics, and describes her findings in this 
chapter. This systematic review has been published: Clare L Tolley, Niamh E Forde, Katherine L 
Coffey, Dean F Sittig, Joan S Ash, Andrew K Husband, David W Bates, Sarah P Slight; Factors 
contributing to medication errors made when using computerized order entry in paediatrics: a 
systematic review, Journal of the American Medical Informatics Association, ocx124, 
https://doi.org/10.1093/jamia/ocx124 (Appendix 6). [165]  
 
4.1 Introduction 
Medication errors in the paediatric population are common; one study estimated that a child 
experiences an out-of-hospital medication error every eight minutes in the US [166] An earlier 
study found that as many as 27% of paediatric inpatient medication orders contain an error.[167] 
The potential ADE rate for children has been found to be three times higher than that of the rate 
for adults.[168] Paediatric patients are particularly vulnerable to medication errors; their 
physiology is continuously changing and their ability to tolerate errors is limited.[169] There is 
also a lack of paediatric-specific medications currently available on the market. This leads to 
medications being used ‘off label’ (outside the terms of license i.e., for an unapproved clinical 
use) more often than in adults. Also, as physicians often need to calculate doses based on a 
child’s weight or body surface area, the opportunity for calculation errors is potentially greater 
than in adults.[170]  
ePrescribing and CDS have been associated with a reduction in medication errors[25, 26, 171] 
not only in the adult population but also in paediatrics.[172] The introduction of an ePrescribing 




medication error rate (Rate Ratio 0.93 95% CI 0.76-1.13, pre CPOE and 0.60 95% CI 0.48-0.74 
post CPOE).[172] However, we also know that the introduction of these systems can introduce 
new types of error.[115, 119] A systematic review conducted by Reckmann et al. identified four 
studies that explored the quantitative effects of ePrescribing systems on medication errors in 
paediatric hospital inpatients.[173] All four of these studies demonstrated a reduction in errors, 
but further details about those errors that were generated when using ePrescribing were beyond 
the scope of this review.[173] Another review by Ghaleb et al. identified dosing errors (often 
those associated with 10-fold overdoses) as the most common medication error type in 
paediatrics;[174] however, this review did not focus on errors that occurred with the use of an 
ePrescribing system.[174]  
In a previous systematic review, the researcher identified eight factors that contributed to the 
occurrence of ePrescribing related prescribing errors.[119] These included issues with the 
computer screen display, drop-down menus and auto-population, wording, default settings, 
non-intuitive or inflexible ordering, repeat prescriptions and automated processes, users’ work 
processes and CDS systems. However, the design and functionality of CPOE systems in the 
paediatric setting may differ substantially from those used in the adult setting, with paediatric 
specific functionality or completely specialised paediatric systems.[175] Furthermore, current 
ePrescribing systems have been criticised for ‘falling short’ of providing recommended 
characteristics, for example, availability of the patient’s current medication history, alerts and 
reminders, prescribing practice feedback and others,[176] so the researcher was eager to 
identify and understand the factors that contribute to medication errors associated with their 
use, and provide recommendations on how these systems could be improved.  
4.2 Methods 
Our review was conducted according to PRISMA guidelines and registered with PROSPERO: 
PCRD42016039984.[128] 
4.2.1 Eligibility criteria 
Quantitative and qualitative primary research studies that focused on medication errors (e.g., 
before and after comparative studies, evaluations of error reports, and failure modes and effect 




population (<18 years or population defined by the study as ‘paediatric’), which included data 
about the types and/or causes of these errors, were eligible for inclusion. Our search strategy 
covered the use of all types of ePrescribing systems (e.g., home-grown or commercial) in any 
type of clinical setting (e.g., hospitals, outpatients and primary care). Studies published in peer-
reviewed journals or conference proceedings were included. The timeframe of the search was 
not restricted. Only articles published in the English language were included. Editorials, 
commentaries, letters and opinion articles were excluded.  
4.2.2 Information sources and search  
Three large databases were searched on 3rd May 2016: Cumulative Index to Nursing and Allied 
Health Literature (CINAHL) (1982 - present), Embase (via OVID) (1974 - present) and Medline (via 
OVID) (1946 - present). Appropriate search terms were developed and grouped into ‘sets’, 
specifically relating to ‘computerised provider order entry’, ‘clinical decision support’, ‘electronic 
health records (EHR)’ and ‘errors’. In each set, terms were combined with the ‘OR’ operator and 
sets were then combined with the ‘AND’ operator. Appendix 7 includes the search strategy 
conducted in Embase (Ovid). 
4.2.3 Study selection  
After duplicate articles were removed, three independent reviewers (CLT, NF and KC) screened 
the titles to determine if the articles met the inclusion criteria. Two authors (CLT and NF, or CLT 
and KC) then independently reviewed all abstracts and full texts, with one author (CLT) acting as 
a constant across all publications. Disagreements were resolved by discussion with a fourth 
reviewer (SPS), if necessary. The reason why a publication was rejected was also documented.  
4.2.4 Data collection and analysis  
We developed a customised data extraction sheet to be used by each of the three reviewers 
(CLT, NF and KC) to independently extract specific details about each study’s location, objectives, 
methods and key findings. This included both qualitative and quantitative data related to the 
occurrence of medication errors that were made when using ePrescribing systems in paediatrics 
and the factors (e.g., system design) that contributed to such errors occurring. A narrative 




(CLT, NF and KC), and key recurring themes and sub-themes were identified iteratively from the 
data, using an inductive approach. This involved summarising the raw data into a brief format, 
deriving clear links in these data, and developing a thematic framework into which main-themes 
and sub-themes could be grouped.[177] This framework was validated through peer de-briefing 
with a further author (SPS).[178] Sub-themes that lacked sufficient detail in the included studies 
were noted in Appendix 8 and Table 3: Key factors, specific issues and recommendations; hence, 
these sub-themes were not discussed further in this review. Authors from two papers were 
contacted by email to obtain further information.[179, 180] The data pertaining to the specific 
causes of the error was of particular interest to meet our objectives.  
4.2.5 Risk of Bias (Quality) Assessment 
It was anticipated that the included studies would be too heterogeneous (e.g., a range of pre-
post intervention studies with a qualitative element, surveys, and studies using failure modes 
and effects analysis to identify risk in a system) to allow for systematic application of a quality 
assessment tool, therefore quality assessment was not conducted. All scientific studies were 
included; this included large quantitative retrospective reviews of error reports, or before and 
after studies using chart review methods to identify errors, and in-depth failure modes and effect 
causality analysis about a stage of a process at one organisation. We included all studies due to 
their potential to add valuable insight in this area. The examples included were intended to be 
illustrative of the point(s) being made and provided specific details about the causes of errors to 




























Studies included in qualitative 
synthesis: 
(n = 47) 
Articles identified in the search  
(n = 419) 
(Medline n=167, Embase n=144, CINAHL 
n=108) 



























Number of titles screened: 
(n=419) 
Number of abstracts 
screened: 
(n = 227) 
Full-text articles assessed for 
eligibility: 
(n = 132) 
Full-text articles excluded 
(n=85) for the following 
reasons:  
 Lack of detail about types and 
causes of CPOE related errors 
(n=31) 
 Study not conducted in 
paediatrics or paediatric data 
not distinguishable (n=12) 
 Not CPOE (n=15) 
 Not original, peer reviewed 
research (n=26) 
 Focus on reporting of errors 
(n=1) 
Records excluded: 
(n = 95) 
Duplicate articles removed 
(n= 134) and titles (n= 58) 
excluded:  
(n = 192) 





Our search identified a total of 419 papers, duplicates were removed. Articles were removed at 
the title (n=58), abstract (n=95) and full-text stage (n=85). Forty-seven articles (44 full texts and 
three conference abstracts, two of which had corresponding full text papers based on the same 
study data[181, 182]), were included in this review. Studies were conducted in the US (n=29), UK 
(n=4), Canada (n=2), Iran (n=2), Netherlands (n=2), Sweden (n=2), with the remaining countries 
(France, Israel, Singapore, Spain and Taiwan) publishing just one paper each. Of these, 38 used 
quantitative methods, 6 used mixed-methods (with two papers reporting on the same data), and 
3 used either failure modes and effect analysis or qualitative methods. The qualitative data 
ranged from larger studies that performed a qualitative analysis of 613 overridden CDS alerts to 
smaller studies that interviewed prescribers on a 17-bed ward.[63, 183] Non-English language 
papers were excluded. Further details about the included studies, methods used and key findings 
of relevance can be found in Appendix 8.  
We identified five key factors that contributed to errors with the use of an ePrescribing system 
in paediatrics: (1) lack of drug dosing alerts, (2) the generation of inappropriate drug dosing 
alerts, (3) inappropriate drug duplication alerts, (4) drop down menu selection errors, and (5) 
system design. We describe each of these in turn using examples that the authors felt best 
illustrated the issues being discussed. Out of the 47 individual articles, 40 had subthemes which 
were included in the five overarching themes. Other areas that lacked sufficient detail such as 
documentation discrepancies or omission of information on the electronic order have not been 
discussed in depth within this review as it was not possible to explore such topics fully.  
4.3.1 Lack of drug dosing alerts  
Doses were often calculated according to a patient’s weight with one minimum and maximum 
dose value recorded on the system. Stultz et al. noted how these minimum and maximum doses 
were based on a specific drug indication (e.g., lupus nephritis) and sometimes lacked drug dosing 
alerts for other indications (e.g., status asthmaticus).[184] For example, an alert was not 
presented for an overdose of methylprednisolone prescribed at 2mg/kg (instead of 1mg/kg) 
intravenously every 6 hours for status asthmaticus, as the maximum dose for lupus nephritis was 




possible dose on the system was exceeded, regardless of the indication for which the drug was 
prescribed.[184] Studies also highlighted how users were not alerted to calculation errors 
because the system did not include any automated dosing support functionality.[185]  Similarly, 
Jani et al. noted how the system used in their study failed to alert the prescriber to an overdose 
of prednisolone (49.5mg instead of 15mg). In this example, the user had mistakenly requested 
all doses of a titrating dose (15 mg once a day for 2 days, 10 mg once a day for 2 days, etc.) to 
start on the same day. This was reported as quite a significant incident as this patient could have 
potentially received almost two weeks of treatment in one day,[186] which could have resulted 
in increased serum glucose concentrations, effects on mental state and cardiovascular 
issues.[38] Crucially, there was no active dosing support in this ePrescribing system, such as 
minimum and maximum dose checks, or indication based dosing suggestions.[186]  
4.3.2 The generation of inappropriate drug dosing alerts 
The existence of minimum and maximum dose values on the ePrescribing system also led to 
inappropriate alerts being generated. Scharnweber et al. described how amoxicillin/clavulanate 
(an antibiotic) was calculated according to a patient’s weight, with one minimum (26 mg/kg) and 
one maximum (875mg) dose value recorded on the system.[187] The authors explained how, 
when a 36kg patient was prescribed 900mg BID (twice daily), two contradictory and 
inappropriate alerts were generated: an under-dose alert because the dose (900mg) was under 
the system calculated dose of 936mg (based on the 26mg/kg calculation), and an overdose alert 
because the dose (900mg) exceed the system’s maximum dose of 875mg.[187] Scharnweber et 
al. also found that a large number (n=500) of under-dosing alerts were inappropriately 
generated for enteral erythromycin orders, which users ignored. Investigation of these events 
revealed that the dosing rule logic had not been updated to reflect the more recent use of 
erythromycin as a pro-kinetic agent (rather than as an antibiotic), which used a lower dose.[187] 
The risk here was that users inappropriately prescribed erythromycin at the higher dose with the 
increased likelihood of gastrointestinal side effects. Kirkendall et al. evaluated a set of vendor-
supplied dosing rules against the most common dose from a selection of gold standard paediatric 
dosing sources (e.g., Harriet Lane Handbook (19th edition), PDR.net (Physician's Desk Reference), 
Epocrates Online, Micromedex and Lexi-Comp Online (CCHMC formulary), and found that they 
only exactly matched in 55.1% of cases.[91] It is possible that this could have contributed to the 




found that providers did not trust the computer calculated doses and often manually adjusted 
these doses, which were associated with paracetamol over and under-dosing.[188]  
 
Missing or out-of-date patient information within the ePrescribing system may have also 
contributed to either a lack of appropriate alerts or the generation of dosing errors. Killelea et 
al. found that 31.1% (n=17,051) of medication orders lacked a bodyweight for the patient in the 
system and, although age could be used in some cases to determine the dose, the authors 
reported that over 4,500 orders could not utilise the available CDS because this information was 
missing.[85] Similarly, Kazemi et al. discovered that prescribers in a neonatal intensive care unit 
rarely updated the dose or frequency according to the patient’s age on the system and so ran 
the risk of under-dosing the patient for a period of their admission.[183] Kazemi et al. posed that 
some users ignored alerts because they could not understand the recommended dose, 
particularly for more complex doses such as  those that were based on renal function, where the 
calculation method was not clear.[183]  
4.3.3 Inappropriate drug duplication alerts 
Jani et al. found that drug duplication alerts were not generated when the same medication was 
ordered via a different drug name, strength or formulation in a system, even though this would 
have resulted in a duplicate order.[189] For example, a patient who was prescribed prednisolone 
12.5 mg once a day as part of a clinical trial, was also prescribed a second dose of prednisolone 
12.5 mg once a day (out-with the trial), because the system did not generate an alert for this 
‘non-trial’ dose.[189] Mille et al. however encountered false-positive drug duplication alerts 
because the system had failed to consider either the route of administration or the dates over 
which the drugs were administered.[63] For example, an inappropriate alert was generated 
when nalbuphine (opioid) was prescribed over the time period 20th-25th December, when there 
was an existing prescription for codeine (opioid) over the time period 1st-5th December in the 
system. Similarly, inappropriate drug duplication alerts were generated when a duplicate 
prescription of salbutamol was made but by different routes (e.g., inhaled and intravenously), 
although this would not have resulted in any significant interaction.[63] A ‘not advised’ warning 
was also encountered when medications (that contained alcohol) were prescribed for a child 




little value to the health care provider because no suitable alternative product existed, increasing 
the likelihood of alert fatigue.[63]   
4.3.4 Drop down menu selection errors 
Selection errors with drop down menus were relatively common. Walsh et al. reviewed 352 
inpatient ward admissions and discovered that almost 20% (20/107) of the medication errors 
identified in their study were computer related; the majority (n=9) of these were due to drop-
down menu errors e.g., mis-selection of an option alphabetically listed above or below the 
intended order.[156] Four of these mis-selections were classed as serious errors, as they had the 
potential to cause substantial harm to the patient. Ceftriaxone, an antibiotic may be prescribed 
in mg or g (maximum dose of 4g in adults and children >12 years).[190] However, Walsh et al. 
reported a 1,000x overdose of this antibiotic (900g selected rather than 900mg) as a result of a 
drop-down menu selection error; luckily, this error was intercepted before reaching the patient, 
although such a dose would have been very difficult to administer (i.e., the nurse would have to 
administer 900 x 1g ceftriaxone vials).[156]  
 
Caruso et al. also encountered serious dose errors, which they felt were due to user mis-
selections; such as 100-1,000 under and overdoses of paracetamol and some antibiotics.[191] 
They posed that this was because of the ease with which the ‘ml (milliliter)’ option could be 
selected from a drop down menu, instead of ‘mg’ (milligram).[191] Kazemi et al. suggested that 
non-patient specific drop-down menus and default order-sentences may fail to achieve the same 
success in the neonatal paediatric population compared to the adult population, owing to the 
huge range of doses that may be appropriate for a paediatric patient based on their individual 
age or weight.[183] The use of non-standardised concentrations in a system, for example 
mg/5ml and mg/1ml for different drugs, e.g., amoxicillin 400mg/5ml and fluconazole 10mg/ml 
was also found to be more commonly associated with calculation errors than non-liquid dosage 
forms in one study. The route associated with different concentrations for oral and intravenous 
preparations was also unclear on the system and felt by the authors to have contributed to 
errors.[192] Holdsworth et al. reported how the suggested doses from a drop-down menu of a 
paediatric dosing table for opioid based analgesics were based on the lower end of the standard 
dose.[180] This was intentional as the expectation was that providers would choose the lower 




users to adjust the dose after first ordering and thus patients were often under-dosed.[180] 
Cochran et al. posed that drop-down menu selection errors of a pre-defined order sentence were 
potentially more likely to reach the patient as the pharmacist would be less likely to detect an 
inadvertent mis-selection of an incorrect option.[193] Errors involving mis-selection of a patient 
name or wrong drug product were also reported.[186, 189, 194] 
4.3.5 Inappropriate System Design 
Users resorted to including free-text dosing instructions in some systems due to a lack of 
available dosing options. For example, Cochran et al. found that a physician was forced to select 
‘1 drop by mouth’ from a drop-down menu and add the free-text instruction ‘1 dropper daily’, 
because the desired option did not exist on the system.[193] Discrepancies between the free-
text comment and electronic orders were felt to be particularly common in paediatrics because 
‘non-standard’ doses, volumes, or directions for oral liquids, drops or topical preparations were 
more frequently used.[193] Nelson et al. also found that omission errors were more likely to 
occur when users entered an order in free-text, and thus missed important prescription 
information (e.g., directions for ‘when required’ usage).[195]  
Walsh et al. highlighted how easy it was to make a prescribing error while using order set system 
functionality. The authors described how one provider had mistakenly selected all items from an 
order set, thus prescribing a duplicate dose of a hepatitis B vaccine for a patient who had already 
received the vaccination at another hospital.[156] This order set also contributed to erroneous 
orders of the hepatitis B vaccine being placed for premature infants weighing less than 2kg. Kim 
et al. also found an increase (n=14/1253 pre-ePrescribing to 67/1112 post-ePrescribing) in the 
risk of medication orders that did not match the chemotherapy treatment plan after ePrescribing 
was implemented.[196] Secondly, new or experimental drugs did not always appear on the pre-
defined drug menu, thus had to be entered manually.[196] 
4.4 Discussion 
We identified five key factors that contribute to errors with the use of ePrescribing systems in 
the paediatric population: (1) lack of drug dosing alerts, which failed to detect calculation errors, 
(2) the generation of inappropriate dosing alerts, such as warnings based on the incorrect drug 




factors such as the route of administration or the dates over which the drugs were administered, 
(4) drop down menu selection errors that resulted in large overdoses of antibiotics being 
ordered, and (5) system design issues, such as a lack of suitable dosing options for a particular 
drug. Below the researcher will comment on each of the five factors and summarise 
recommendations made by prior authors that we deem especially useful. Table 3 provides an 
overview of the key factors, specific issues and recommendations arising from this review. Table 




Table 3: Key factors, specific issues and recommendations 
Key Factor Specific Issues Example Recommendations 
Lack of drug 
dosing alerts  
 Absence of indication specific dose 
ranges thus dose errors were not 
identified.[184, 197, 198] 
 Lack of dosing-support functionality in 
use.[179, 182, 185, 186, 192, 199-202] 
 Lack of support for dosing calculations. 
[203-206] 
 Failure to alert when an overdose of 
methylprednisolone was prescribed at 2mg/kg 
(instead of 1mg/kg) intravenously every 6 hours for 
status asthmaticus, as the maximum dose for lupus 
nephritis was 30 mg/kg/day.[184] 
 Encourage use of dosing support. 
 Indication-based dosing alerts. 
 Indication based order sentences.  
 Documentation of relevant historical 
data within the system e.g., 





drug dosing alerts 
 Ambiguous dose ranges that had 
conflicting over-dose and under-dose 
alerts for certain patient weights.[187] 
 Inappropriate under-dose alerts due to a 
failure to update drug dosing logic to 
reflect most recent doses for certain 
medications.[187] 
 Lack of agreement between vendor-
supplied dosing rules and suggested 
doses from gold-standard courses.[91] 
 Lack of trust in computer calculated 
doses.[188] 
 Absence/ lack of information e.g. patient 
weight entered into the system 
preventing utilisation of available 
CDS.[85, 183, 208] 
 Failure to display calculation method for 
suggested doses.[183] 
 Failure to consider normal dose rounding 
procedures.[209] 
 Alert overrides.[63, 188, 208, 210] 
 Inappropriate generation of under-dosing alerts for 
enteral erythromycin orders, because the dosing 
logic did not include the more recent use of 
erythromycin as an anti-motility agent (rather than 
as an antibiotic), which used a lower dose.[187] 
 Enforce entry of patient weight before 
dosing medications.[85] 
 Suggest system prompts up to date 
values for certain parameters e.g., age 
or weight when reasonable.[85] 
 Systems should provide condition 
specific growth charts and age-
appropriate references throughout a 
patient’s care.[211] 
 Standardised fixed dose order sets for 
most high-risk drugs.[179] 
 Dose rounding.[207] 





 False- positive and false negative alerts 
because of a lack of consideration of 
medication name, strength, route and 
time of administration, formulation or 
reasonable alternatives.[63, 189] 
 Inappropriate drug duplication alerts were 
generated when salbutamol was prescribed twice 
but by different routes (e.g., inhaled and 
intravenously), although this would not have 
resulted in any significant interaction.[63] 






 Miss-selecting from a list.[183, 186, 189, 
194, 210, 212, 213]  
 Alphabetical listing and juxtaposition 
selection errors.[156, 191, 214] 
 Presence of non-standardised 
concentrations in the system contributing 
to calculation errors.[192] 
 Non- patient specific drop down menus 
and suggested order-sentences prone to 
error.[183] 
 Presented doses did not include the full 
range of clinical possibilities or provide 
sufficient guidance related to titrating 
doses.[180]  
 Selection errors possibly less able to 
detect as potentially gives a reasonable 
order, though inappropriate for a specific 
patient.[193]  
 A 1,000x overdose of the antibiotic ceftriaxone 
(900g selected rather than 900mg) was prescribed 
as a result of a drop-down menu selection 
error.[156]  
 Avoidance of long drop-down 
menus.[215]  
 Ensure list is up to date and 
comprehensive based on the 
organisation’s usual prescribing 
habits. 
 Indication based dosing CDS (order 
sentences or required information 
prior to dose selection).[150, 216]  
 Interventions to reduce wrong patient 
selection errors e.g., non-sequential 
identification numbers, identification 
re-entry or distinct naming 
convention.[134, 217]  
Inappropriate 
System Design  
 Error prone free-text orders as a result of 
insufficient structured dosing 
options.[193, 195, 218-220] 
 Select all functionality on an order set 
resulted in drug-duplication errors.[156]  
 Failure to link protocols with ePrescribing 
system.[196] 
 Manual order entry (rather than selecting 
an option from an order sentence) 
because drug dictionary had not been 
updated to reflect current formulary. 
 Inappropriate system design which 
impacts on clinical workflow.[221-224]  
 Omission errors, potentially due to a lack 
of mandatory fields or pre-populated 
information.[225-227] 
 A physician was forced to inappropriately select ‘1 
drop by mouth’ from a drop-down menu and add 
the free-text instruction ‘1 dropper daily’, because 
the desired option did not exist on the system.[193] 
 Use of standardised units throughout 
a patient’s care or automated 
conversion between units.[228] 
 Evaluation of normal work processes 
and effects of intervention on ‘down-
stream’ effects of ePrescribing.[221] 
 Limit use of select all functionality 
where feasible.[156] 
 Linkage of data e.g., maternal and 
child data with EHR.[207] 




Table 4: Major Recommendation: Pros and Cons 
  Major Recommendations: Pros and Cons  
Major Recommendation Pros Cons 
Provision of dosing support 
with calculations based on 
body weight. 
Likely to improve safety and reduce 
medication errors. 
Improving the sensitivity and 
specificity of any dosing support 
may require additional information 
such as the drug indication.  
Mandate entry of patient’s 
weight.  
Important for dosage calculations. 
Potential for time savings due to 
reduced calls from pharmacy. 
Potential to disrupt the user’s 
workflow and impact on 
satisfaction.  
Availability of treatment 
protocols, age specific 
growth charts and reference 
ranges at the point of 
ordering. 
Supports safer prescribing and may 
reduce medication errors.  
Possibility of overloading the 
clinician with information if these 
tools are not incorporated correctly.  
Provide details of the 
calculation method for 
dosing suggestions 
generated by the system. 
Users can understand the way 
doses were calculated by the 
system, which may provide users 
with a learning opportunity.  
May impact on the user’s workflow 
unless system designed in such a 
way that the calculation method is 
available on request. 
Evaluation of dosing alert 
overrides. 
Provide insight into potential 
system design flaws e.g., 
inappropriate dosing limits. 
May require additional tools and 
resources to undertake such 
evaluations.   
Greater standardisation of 
paediatric doses and units. 
Potential to improve medication 
safety. 
Difficult to reach consensus on 
specific paediatric doses and 
possible variability in expert opinion.  
Providers to document a 
patient’s exposure to an 
agent(s) over time and 
vaccination history. 
Complete records that will help to 
better inform future prescribing 
decisions. 
Increased documentation load for 
users.  
Prompt provider to enter 
the drug indication. 
Potential to improve the specificity 
of the system’s decision support 
and reduce selection errors. 
Increased documentation load for 
users, and certain information may 
not be readily available.  
Use of non-sequential 
naming format and ID re-
entry for children born from 
multiple births. 
Reduce wrong patient errors.  Increase the time needed to enter 
the patient’s ID.  
Pre-implementation 
assessment of wards and 
clinical workflow, and pre-
emptive considerations of 
potential challenges and 
risks to inform the system 
design. 
Anticipate, prevent or minimise 
risks as a result of workflow 
changes. 
Resources and expertise to perform 
robust pre-assessment. 
Opportunities to modify the system 
design will depend on the 
commercial system vendor.  
 
4.4.1 Dosing support and Recommendations 
Dose errors have been commonly reported both in adults and paediatrics, before and after 
implementation of an ePrescribing system.[105, 115, 168, 185, 186, 188, 230] Indeed Schiff 
et al. found that ‘ordered wrong dose or strength errors’ were one of the most common 
error codes (alongside missing or incorrect directions) that they assigned when reviewing 
10,060 US MEDMARX error reports.[105] Dean-Franklin et al. also found dose errors 
following the implementation of a closed-loop electronic prescribing and administration 




found to be more common than dose errors.[231] Paediatric patients are particularly prone 
to dosing errors, as calculations are often needed to determine the amount of drug to be 
given (weight based dosing), thus increasing the opportunity for human error. A key feature 
of ePrescribing systems is the ability to support prescribers by helping to calculate a dose 
based on a patient’s weight, body surface area, and drug indication, particularly for high risk 
drugs.[30] However, this review highlighted how there was a lack of CDS tools, such as 
weight-based dosing calculators, in many of the ePrescribing systems studied.[179, 185, 199, 
200] Even if such tools existed, some systems were missing key information e.g., a patient 
weight, which prevented certain checks from being carried out[85]. Furthermore, missing 
data can increase the need for prescribers to be contacted at a later date to add this 
information.[232] Thus, we propose that system developers should mandate the entry of 
certain key pieces of information, e.g., an up-to-date weight estimate before ordering a 
particular medicine or prompt providers to provide an up-to-date value when needed.[85] 
However, increasing the documentation load for clinicians may also be undesirable and 
reduce satisfaction with the system.[233] Furthermore, where possible, treatment protocols 
should be incorporated into the ePrescribing system to guide the physician to reduce errors 
at the ordering stage due to slips and lapses.[196] Lehmann suggested that systems must 
provide clinicians with condition specific growth charts, age appropriate reference ranges, 
and decision support throughout the patient’s care.[30]  
Available dosing tools were also in need of some improvements. The setting of minimum and 
maximum doses on the system for example was responsible for the generation of 
inappropriate dosing alerts.[91, 184, 198] Non-specific or erroneous alerts can contribute to 
alert fatigue and high override rates, which have been well discussed in the literature.[54, 
55, 76] Therefore, understanding the reasons behind alert overrides is vital to ensure that 
systems are designed appropriately. In particular, the dosing support did not always consider 
the drug indication that the medication was prescribed for.[187] Scharnweber et al. 
suggested that at the very least CDS dose limits should include the lowest and highest ranges 
to ensure that all potential errors would be identified,[187]  and the researcher would also 
add that this should be tailored to the drug indication where possible. Kazemi et al. also 
suggested that the ePrescribing system should display the calculation method used in the 
alert logic to help improve transparency and reduce any confusion about how the dosing 




The lack of standardised and approved paediatric drug doses, which in turn were not or could 
not be incorporated into ePrescribing and CDS systems, contributed to some systems failing 
to detect certain 10-fold under-dosing errors. It would therefore be reasonable to suggest 
greater standardisation of paediatric doses in the future.[179] However, there are important 
challenges here in developing standardised guidelines for the paediatric population, such as 
the use of drugs ‘off-label’ or a lack of agreement between clinicians.[179] Doherty et al. 
suggested the creation of standardised fixed-dose order sets that were based on a patient’s 
weight, specifically focusing on the most high-risk drugs.[179] Condren et al. also suggested 
that measurement units be standardised to prevent miss-calculation associated errors.[192] 
Standardised units therefore should be used consistently in ePrescribing systems across all 
aspects of a patient’s care e.g., a patient’s weight should be documented in kilograms and 
grams rather than pounds and ounces. ePrescribing systems again could guide the user to 
enter information in the desired format or automatically convert or display the units in a 
particular format depending on the user’s preference e.g., the patient may prefer to discuss 
their weight in pounds and ounces.[228] Patterson et al. suggested that it should be possible 
for providers to document a patient’s cumulative radiation exposure and vaccination history, 
including those given at different organisations, to ensure a comprehensive history is 
available on the ePrescribing system.[28]   
4.4.2 Drop-down menus 
ePrescribing systems can assist clinicians by providing drop down menus with a list of pre-
defined order sentences to choose from (including the drug, dose and route), thereby 
reducing the risk of placing an erroneous free-text order.[46] However, as reported in our 
previous review, these drop-down menus can be error-prone and can contribute to wrong 
patient, medication, and dose errors, amongst others being selected.[119] Furthermore, it 
has been suggested that these tools, which have been successfully employed in systems used 
in the adult population, may fail to achieve the same results in paediatrics.[183] There are a 
wide range of doses that may be appropriate for a child depending on their age, weight, 
comorbidities, and the drug indication. Compared to adults where doses are usually available 
as a full dosage form unit e.g., ‘1 tablet’ or ‘1 ampoule’, in paediatrics the dose may consist 
of a portion of the full dosage form e.g., one tenth of a tablet.[183] Khajouei and Jaspers 
suggested that long drop-down menus, which require the user to scroll up and down, should 
be avoided as these can be non-user friendly and may contribute to selection errors.[215] 




in the user adding contradictory free-text comments[193], which may be confusing and lead 
to patient harm.[154] 
As the drug dose is closely related to the drug indication, it would seem reasonable for 
systems to prompt the provider to enter this information first, from which indication-specific 
doses could then be selected.[216] Schiff et al. and Galanter et al. have pointed out that such 
an approach would not only help the provider select the correct dose but also potentially 
reduce mis-selection errors.[150, 216] Furthermore, if information about the drug indication 
was available to other healthcare professionals, such as pharmacists, they could also perform 
a more detailed clinical check of that order and potentially be better equipped to identify 
errors.[216] The use of indication-specific order sentences should be considered, so the 
provider is clear about the specific indication that the order sentence relates to. This could 
represent a relatively easy adjustment to the system and is relevant to both adult and 
paediatric patients.  
 Lowry et al. also suggested that non-sequential identification numbers be assigned to 
newborns in the same hospital, particularly if the child was from a multiple birth (e.g., twins 
or triplets), to prevent the risk of patient name mis-selection.[217] Adelman et al. found that 
interventions such as the introduction of ID re-entry (providers must verify the patient’s 
identity by re-entering the patient’s initials and sex before they have access to the order 
entry screen), and use of a distinct naming convention (replacing non-distinct naming of 
newborns e.g., ‘baby-girl’ with a naming format that includes the mother’s name and birth 
number e.g., ‘1firstnamesexsurname’ ‘2firstnamesexsurname’ etc.), particularly for multiple 
births in a Neonatal Intensive Care Unit setting may significantly reduce the risk of wrong 
patient errors.[134]  
4.4.3 System design and workflow considerations 
There is a clear need for systems to be developed with an understanding of normal work 
processes and prescribing habits in both the adult and paediatric settings.[234] Han et al. for 
example, reported an increase in mortality after an ePrescribing system was implemented in 
a paediatric setting.[221] Workflow changes may not be associated with a specific type of 
error, but rather impact the entire medication process, making it more error prone. Prior to 
system implementation, a team of physicians and nurses worked together to stabilise 
critically unwell patients; post-implementation, one physician was required to remain on the 




examples demonstrate the down–stream effects of ePrescribing implementation, especially 
when poorly done, on the entire work process and emphasise the need to evaluate the 
impact of such systems on patient outcomes e.g., ADEs and mortality, including those that 
measure users’ experiences and system usability.  
Walsh et al. suggested that the ‘select all’ option within an order set should be 
removed.[156] According to the authors, this could possibly reduce the risk of patients 
receiving inappropriate or duplicate doses of a medication with prescribers ‘selecting all’ and 
not taking the time to check the appropriateness of each drug in the order set. Further 
research is clearly needed to determine what the positive and negative impact would be of 
removing such an option, particularly if it increased the time taken to prescribe. 
A key finding from this review was that included studies mostly focused on the effect of 
ePrescribing on medication error rates and ADEs, and only a handful fully explored the errors 
encountered during use of these systems. A lack of such information limits the ability of 
organisations and system developers to recognise and address system flaws, and thus 
further research is needed to understand the wide range of issues that are specific to a 
paediatric population. In 2015, the Agency for Healthcare Research and Quality produced an 
updated list of high priority recommendations for the formatting of paediatric EHR 
systems.[207]  Examples include linkage of maternal and child data within the EHR, age 
specific decision support, rounding of administrable doses and re-prescribing medications, 
based on the most recent information about the patient (e.g., increasing the dose on a re-fill 
prescription according to the patient’s age). Studies have highlighted the importance of 
designing and customising systems according to human factors design principles[56] and 
incorporating recommendations from those with expertise in human factors.[28] These must 
be considered by system developers, healthcare organisations, practitioners and other key 
stakeholders involved in the use of healthcare information technology in paediatrics.[39]    
Previous literature reviews have mainly focused on the rates of medication errors following 
the introduction of an ePrescribing system in paediatrics.[29, 173, 235] This review adds to 
the literature by outlining specific factors that have contributed to medication errors arising 
or persisting with the use of such systems, specifically in paediatrics. It is important for 
system developers and healthcare organisations to not only be aware of these areas, but 
also help address them to improve patient safety. There are a number of recommendations 




settings e.g., the use of indication specific doses and use of standardised units within the 
system; it is important that these changes are independently validated in both settings. 
There are limitations to this review; firstly, although the researcher searched for papers 
across three large databases she only reported the findings from the published literature and 
therefore may have failed to capture relevant content within unpublished work. Secondly, 
owing to the heterogeneity between the included studies, it was not possible to use one 
assessment tool to assess the quality of these studies.  
4.5 Conclusion  
This review identified five key factors that contributed to errors when using an ePrescribing 
system in paediatrics. These include (1) lack of drug dosing alerts, (2) the generation of 
inappropriate dosing alerts, (3) inappropriate drug duplication alerts, (4) drop down menu 
selection errors, and (5) system design. Improvements are needed, such as development of 
dosing support that is based on the drug indication, and use of patient specific order sets and 
order sentences. Safeguards to prevent patient selection errors, for example, using non-
consecutive patient identification numbers for children born from multiple births, or adding 
in CDS that encourages users to ‘second check’ their selection may also prevent errors. The 
system should also prompt users to enter up-to-date information about clinical parameters, 
e.g., child’s weight, which are used in CDS algorithms, and importantly there should be better 
integration and use of information between the patient’s EHR and CDS systems. The 
concentrations for medications and units used within the system should be standardised 
where possible. Although medications may be prepared to a range of specific concentrations 
by pharmaceutical companies, it may be worth considering whether these could be 
potentially standardised at a system level to prevent calculation errors. Finally, ePrescribing 
systems should be designed with an understanding of normal work processes and 
incorporate human factors design principles and usability standards during the development 
and implementation stages.  
Ash et al. stressed the importance of educating clinicians about the unintended 
consequences of ePrescribing systems so as to prevent them from over relying on the 
technology and making them aware of the potential risk of patient harm.[236] Furthermore, 
training users on how to use healthcare information systems is important to ensure proper 




educate prescribers about how to use ePrescribing systems and whether this training 





Chapter 5: The training approaches used to train 
qualified prescribers to use electronic prescribing 
systems 
 
It is important that users are appropriately trained to use ePrescribing systems and are aware 
of how to avoid some of their known pitfalls and challenges. The researcher conducted a 
review of the literature to (a) describe the approaches used to train qualified prescribers on 
ePrescribing systems in a hospital setting, and (b) whether training covered the pitfalls and 
challenges of using these systems. This narrative review has been published: Brown, C. L. 
Reygate, K. Slee, A. Coleman, J. J. Pontefract, S. K. Bates, D. W. Husband, A. K. Watson, N. 
Slight, S. P. A literature review of the training offered to qualified prescribers to use electronic 
prescribing systems: Why is it so important? Int J Pharm Pract. 2017 Jun;25(3):195-202. doi: 
10.1111/ijpp.12296. Epub 2016 Aug 4.[118] (Appendix 9) 
 
5.1 Introduction 
As discussed, ePrescribing systems have been associated with a range of potential benefits 
over paper-based systems, particularly when implemented with CDS.[10, 27, 51, 52] 
Benefits, including improved patient outcomes, safer patient care and potential cost savings 
e.g., by prompting clinicians to prescribe generic rather than branded medications,[237] 
have meant that the number of systems implemented across a diverse range of settings is 
growing. A key element of the implementation and on-going use of an ePrescribing system 
is ensuring that users are, and remain, sufficiently trained and competent to use the system 
effectively. The user training should be comprehensive enough to cover all aspects of how a 
user may need to interact with a system to undertake their role, but also highlight potential 
pitfalls and challenges that they may encounter. Ash et al. stressed the importance of 
educating clinicians about the unintended consequences of ePrescribing systems, so that 
clinicians do not fall into the trap of over reliance on technology and risk patient harm.[236] 
The number of different professionals (e.g., nurse or pharmacists) who prescribe is also 
expanding, thus the training provided needs to accommodate users of varying backgrounds 
and roles. These systems are continuously evolving and offer an ever increasing range of new 




is important. Training is not sufficient to overcome poor design, but vendors should be 
incentivised to develop systems using user-centred design principles.  
Organisations face challenges in delivering effective training such as: large numbers of staff, 
staff resistance/availability to attend training, rotation between wards and specialties, and 
temporary/short term staff. Little evidence has been published on the training strategies 
used to familiarise staff with these systems. Online training strategies have been utilised in 
medical education and can offer a potentially convenient and efficient way of training large 
numbers of practitioners;[238] however, the effectiveness of this approach for users of 
ePrescribing systems is not clear.   
Some studies suggest that insufficient training is associated with suboptimal use of 
ePrescribing and EHR systems.[133, 239] Baysari et al. found that large numbers of CDS alerts 
were generated by the improper use of the system, leading to the production of ‘technically 
preventable’ alerts.[133] For example, a duplicate drug alert was generated for a new order 
of ‘Paracetamol (500 mg) Tablet: 1g oral Four Times Daily’ when there was an existing order 
for ‘Paracetamol (500 mg) Tablet: 1g oral PRN: minimum dosage interval 4h: up to 4 doses 
per day’ already on the system.[133] Shulman et al. also found that the rate of errors made 
by users when using an ePrescribing system decreased over time, demonstrating a learning 
curve that had taken place.[122] Such studies highlight the pitfalls of these systems and the 
importance of training and education both in facilitating successful implementation of 
electronic systems and averting errors. Furthermore, although there are fundamental 
differences between the provision of healthcare services between clinical settings and 
countries, there are key elements of the prescribing process that all prescribers must 
perform, such as the selection of a drug dose and frequency. 
The focus of this narrative literature review therefore was to describe the approaches used 
to train qualified prescribers on ePrescribing systems in a hospital setting. A secondary aim 
was to investigate whether online training approaches were used and whether information 








5.2.1 Literature Review: Inclusion and Exclusion Criteria 
Articles that explored the training of qualified prescribers (including medical and non-
medical practitioners) on ePrescribing systems in a hospital setting were included. The 
researcher chose to focus on the training of qualified and practicing prescribers due to the 
specific challenges associated with training large groups of busy clinicians, which can be 
different to the challenges faced with training undergraduate students in a more ‘relaxed’ 
environment.  The researcher was interested in the types of training approaches used, the 
relative effectiveness of any specific approach (if discussed), and any challenges 
encountered. Studies that explored training of undergraduate medical students, training of 
clinical skills other than prescribing, or the use of ePrescribing or EHRs in medical education 
(e.g.,  to enable students to monitor patient progress) were excluded. Studies did not need 
to include a comparator group, as this may have presented practical and ethical challenges 
to carrying out the study in a hospital population.  
5.2.2 Search Strategy and Study Selection 
Three large databases were searched including: Cumulative Index Nursing and Allied Health 
Literature (CINAHL), Embase (OVID), and Medline (OVID). Sets of search terms employed 
included “Electronic Prescribing” OR “Computerised Provider Order Entry” in Set 1;  “Clinical 
Decision Support” OR “Decision Support System” in Set 2;  “Electronic Medical Record” in Set 
3;  “Education Clinical” OR “Medical Education” in Set 4;  “Education Distance” in Set 5. These 
sets were combined with the ‘AND, OR Boolean operators. The searches were performed on 
the 15th May 2015. Only papers published in English were considered.  Separate searches 
were conducted for ‘all training’ and ‘online training’. Appendix 10 shows the search strategy 
for the ‘all training’ search in Medline (Ovid).. The timeframe was not restricted. The 
researcher also searched the websites of vendors of ePrescribing systems supplied in the UK 
for suggested training approaches. All publication types were included (including editorials 
and opinion pieces).  
5.2.3 Data Extraction and Synthesis 
All duplicate articles were removed. Titles and abstracts were initially reviewed followed by 




(SPS), if necessary.  Reference lists were also examined for additional papers. Data were 
abstracted onto a customised data extraction sheet by one author (CLT), which included 
variables such as: title of the study; country of origin; and justification for the decision to 
include (Appendix 11). A narrative synthesis of all eligible studies was undertaken. Papers 
were read and re-read, and key recurring themes and sub-themes were identified iteratively 
from the data. In keeping with the aim of this review, we focused on the types of training 
approaches used to train qualified prescribers in the hospital setting and the challenges 
associated with training.  
5.2.4 Vendor Enquiry 
The websites of vendors of electronic prescribing systems supplied in the UK were also 
searched and companies contacted for more details about the training approaches provided. 
A table of reported findings is provided in the results section:  Table 5: Current training 
approaches provided by vendors of ePrescribing systems in the UK. 
5.3 Results  
The search for ‘all training’ returned a total of 1,155 publications; after reviewing titles, 
abstracts and full texts, a total of 1,149 were excluded (Figure 5). After reviewing the 
reference lists of the remaining publications, one further article was included. A total of 
seven articles were included, comprising of three full text publications from the US,[240-242] 
and two from Canada.[241, 243] The remaining two articles were conference abstracts, one 
from the UK [244] and one from Pakistan/Tanzania.[245]  The authors of the conference 
abstracts were contacted and asked for additional information, including (i) the type of 
training delivered and whether online training methods were used (if unclear from the 
publication), (ii) whether an assessment of user’s competency post training was carried out 
and (iii) whether the training was developed internally or by the vendor.  Responses were 
obtained from one of the two authors.[244]  Two studies by Borycki et al. and Kushniruk et 
al. were included as there was potential for these training methods to be used for practicing 
prescribers.[241, 243] 
The separate search for the use of ‘online’ training methods returned 25 publications. After 
reviewing the titles, abstracts and full text, three relevant articles were identified (Figure 6), 




approaches. The additional article found in this separate ‘online’ search was included making 
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Typically, a variety of training methods were used such as classroom-based sessions, which 
included ‘run through’ demonstrations and practical exercises, as well as face-to-face or 
ward-based training facilitated by ‘super-users’ (expert staff members that have received 
additional training). Super-users were found to play a valuable role in providing ward-level 
support and reduce the need for costly external training.[248] Tools such as e-learning 
packages, quick reference guides, a list for keyboard short cuts and ‘how to’ guides, were 
also provided.[242, 244]  
5.3.1 Traditional Training  
Three studies used traditional classroom-based learning to train users; one on a paediatric 
intensive care unit,[244] another across an integrated delivery system[242], and a third study 
conducted at two US hospitals.[248] Users were given an overview of the specific features 
of their system, using a combination of demonstrations, lectures and practical exercises, thus 
allowing the users to gain ‘hands-on’ experience of using the system.[242, 244] In particular 
Bredfeldt et al. encouraged staff to customise their own live version of the EHR by creating 
preference lists, which in turn allowed them to experience the benefits of this functionality 
immediately.[242] Ensuring clinicians had ample opportunities to attend training sessions 
was important, so weekend and out-of-hour sessions were organised in one study.[248] 
In terms of evaluating user’s performance, formal assessments, quizzes and feedback 
methods were utilised in three studies.[242, 244, 245] Bredfeldt et al. evaluated post-
training performance of two skills (covered during the training session) to measure the effect 
of training.[242] Classroom-based training and ‘hands-on’ activities were found to have been 
associated with improved utility of certain functions.[242] However, users would have 
appreciated more opportunities to receive training on the ‘live’ system and felt that the 
range of topics covered should be broader.[242] Bredfeldt et al. also sent e-mails to users to 
report their usage of specific features and compared their activity with that of their peers, 
serving to remind users of the learning material and tracking their progress.[242]  
5.3.2 Online training approaches 
Web-based demonstrations were used in only one study.[245] Three papers described the 
work of one team that developed an online portal, which housed a range of simulated 
versions of different EHRs containing electronic prescribing functionality. Healthcare 




access to this portal where they could prescribe for fictitious patients in a safe 
environment.[241, 243, 247] The portal also provided an opportunity for users to learn about 
the design of different systems that may be used in clinical practice.[241, 243, 247]  
Evaluation of online training methods was limited. Experiences and lessons learned from the 
University of Victoria’s EHR portal appeared to be positive, with users perceiving the 
experience as valuable and having a greater understanding of how EHR systems were to be 
used in practice.[241] Ayoub et al. did not specify how quizzes were developed or which 
areas were assessed, although trainees reportedly scored highly in these.[245] Jimenez 
highlighted the importance of providing timely feedback to users after completing 
exercises.[240] 
5.3.3 Clinical scenarios and exercises 
Two studies used targeted clinical scenarios that focused on particular problem areas to train 
staff. Foster et al. developed exercises based on commonly encountered prescribing errors, 
such as the prescribing of Tazocin® (piperacillin-tazobactam, an antibacterial) at non-
standard times.[244] Bredfeldt et al. targeted training to specific clinical areas, such as pre-
operative patient visits, where there had been a number of support requests from existing 
users.[242] Developing expertise-specific scenarios relevant to clinicians from different 
specialist areas was considered important.[240, 247] 
5.3.4 Vendor supplied training approaches  
Table 5 presents an overview of the training approaches provided by vendors of ePrescribing 











































ALERT eLearning  
 Alert e-Learning programme for Alert 
products can be offered as an alternative or 
a complement to ‘traditional teaching’.  
 Flexible learning is provided with the ability 
to access training anytime and anywhere 
depending on the availability of individual 
staff. Staff can learn at their own pace and 
tailor their learning towards key areas of 
interest.  
 The e-learning programme uses a variety of 
multimedia to support learning such as 
demonstration videos, trainer instructions 
and animations. It is possible to 
communicate within the system via chat 
and forums, which allows end-users to 
exchange their experiences.  
 The system also supports tutor-trainee 
communication through the chat and forum 
tools.  The e-learning programme provides 
continuous performance evaluation to 
support end-users as they learn. The 
content continues to be available after 
completing individual courses to enable 
review of learning material.  
 A specific course ALERT EDIS PHYSICIAN® is 
available and targeted towards doctors 
working in the emergency department. This 
course uses active and demonstrative 
methods to cover a range of areas 
including: documenting a chief complaint, 
ordering medication and exams, access 
results and discharging a patient. A 
certificate is awarded to the trainee once 
80% of the course has been completed, 
suggested tasks have been performed and 
have achieved a pass in the final evaluation. 
The course takes approximately 4 hours.  
Further courses are available for example 
an Introduction to ALERT ® v2.6 which 
allows end-users to learn more about the 
functionality of the ALERT prescribing 
system. 
































 Experiential Learning: Scenario-based 
simulation learning tool designed for staff 
members. These self-paced courses allow 
learners to practice workflows using real-
world scenarios in a simulation learning 
environment. 
 Training Consulting: Training Consultants 
provide strategy, guidance and 
recommendations for any size group who 
needs end-user “best practice” training 
guidance. 
Formal instructor-led classes: 
 These classes are held in Allscripts training 
facilities, where attention is given to the 
learning needs of each individual student. 
The sessions include extensive training 
materials, hands on exercises and 
interactive discussions. 
 Web-based instructor led classes: 
These smaller web-based classes are for 
single topics or customised training needs. 
Students learn from their onsite 
organisation, while still receiving the 
individual attention and hands-on time 
provided in a classroom setting. 
 eLearning: Budget-friendly, self-paced form 
of training is scalable for small offices that 
need to provide training around a busy 
office schedule. For very large 
organisations, the company reported 
having more staff to train clinicians and 
office personnel. 
 Custom Solutions: Any combination of 
services are available for clients who want 
to design their own learning path.” 























 Range of training packages 
 Training can be delivered on-site or within 
Ascribe office in Bolton or an external venue 
in London.  
 Training is typically provided to 
approximately 6 members of the 
organisation (a multidisciplinary team is 
preferred). ‘Train the trainer’ sessions are 
delivered to give an overview of the system 
and features so that they can then carry out 
end-user training at their organisation. 
Workshop sessions are also held whereby 
wider members of the hospital organisation 
can ask questions and provide comments 
about features that they would like to see, 
thereby having some influence into system 
build. 
 The ‘train the trainers’ then deliver end-






customised according to the specific 
organisation. For example, lecture sessions, 
one-to-one training on the ward and, 
simulation ‘dummy stations’ whereby staff 
can access and practice using the system 
even before it has ‘gone live’. Standard 
training manuals are available from the 
company however, due to the variations in 
systems post customisation, organisations 
typically develop their own training 
packages. 
 
 E-Learning packages have recently been 
developed to train the trainers; however 
there is no provision of e-learning material 
currently for end-users. Although 
experience suggests trusts often develop 
their own e-learning training packages or 
outsource e-learning from external 









































Cerner Learning Services: 
 
A range of training options are available which 
are delivered by learning consultants and 
educators.  
 
Managed Learning Services are available, which 
offers training across a range of areas to end-
users. This service is available as an optional 
extra and is therefore subject to additional 
costs. 
 
Managed Learning Services include 
implementation education, technical education, 
clinical education and leadership and 
professional skills education.  
 
The full range of teams include: 
1. Learning consultant/coordinator: Involved 
in training learning staff and recommending 
and planning end-user learning.  
2. Learning Plan Development Session: A team 
that works onsite to identify learning needs, 
resource constraints and best practices in 
order to develop a tailored learning strategy 
for the organisation. 
3. Learning Task Analysis: A team helps 
develop end-user learning materials. 
Critical tasks and assessment questions that 
validate competency are also identified.  
4. Custom Learning Materials Development: 
Examples include organisation-specific 
facilitator guide, performance based 
assessment and supporting materials to 





5. Web-Based Training for End Users: Online 
learning tools, these can be standard or 
customised.  
6. Train the Trainer: Trainer-Advanced training 
for organisational trainers.  
7. Super-User Training: training of designated 
super-users in specific areas so that they are 
able to facilitate system use and support 
staff. 
8. End-User Training: Typically a combination 
of web-based training, instructor led 
training; activities are performed both in a 
training setting and as job aids.   
9. Advancing Conversion Excellence (ACE) 
Programme: A team provides support with 
health care staff during the early stages of 
implementation. The ACE team assist end-
users with limited Cerner experience to gain 
confidence and expertise.  
10. Learning LIVE: An e-learning program to 
deliver training and support continuous 
learning. Training is accessible, offering 
‘just-in-time learning at the point of need’  
After speaking to Lindsey Whittaker on 13th May 
2015, she explained that e-learning is typically 
not provided to UK organisations unless 
requested. This is because the UK market tends 
to want an e-learning package that is exactly 
customised to the system that the organisation 
will use and therefore the standard version of e-
learning system is seen as less attractive. 
However e-learning packages can be built and 
developed with the organisation if needed.  
 
Alternative online material such as video clips, 
which give demos of specific functions, are 
available and can be accessed at any time.  
 





















Lorenzo and Medchart are systems provided by 
CSC and therefore have similar training 
available. 
 
Training is delivered through a ‘train the trainer’ 
model at the hospital site to selected 
individuals. Training is classroom based and 
given to small groups of approximately eight 
trainees using hands on activities. Training is 







depending on local needs. Sessions will take 
place on a standard version of the system. There 
is a test at the end of the ‘train the trainer’ 
sessions to assess competence, after which the 
in house-trainers will deliver sessions to end-
users.   
 
End-user training is supported by CSC trainers 
but is delivered by in-house trainers. Training 
content and delivery varies between 
organisations, and it is up to the organisation to 
develop with end-users what training methods 
will be used.  
 
e-Learning modules can be provided or 
developed in collaboration with the trust, 
however no trust has used e-learning as a sole 
method of training due to the complexity of the 
system. Typically classroom based end-user 
sessions are delivered. A benefit of the e-
learning is that it may be accessed off site and at 














There are four strands of learning: 
1. Set-up training e.g. setting up a drug 
formulary and new users on the 
system. 
2. Training around the rules which drive 
the EPMA and decision support system 
and ensure these are appropriate for 
the organisation e.g. Venous 
Thromboembolism assessments. 
3. End-user training; core training about 
how to use the system e.g. how to 
prescribe, how to administer.  
4. Report training; training on how to 
manage alerts and utilise information 
that is gathered on the system. 
The NHS Trust will identify a multidisciplinary 
team who will develop training that is delivered 
to end-users. Servelec will then train these 
individuals who will then deliver their own 
training sessions, typically classroom or ward 
based face-to-face teaching. Standard training 
materials are available however Trusts are 
encouraged to develop their own customised 
versions, which are more specific. Test and 
training environments exist, which allow 
clinicians to work safely through the system. 
Increasingly trusts are requesting to use test 
patients that are in fact anonymised versions of 
a real patient to ensure the content and scenario 
is realistic.   
 
E-learning or distance based learning is available 




for teaching specific features or as a refresher 
for end-users rather than as an alternative to 
face-to-face sessions. The PICS system is 
complex and therefore e-learning would 
perhaps not be a sufficient sole training method. 
Video tutorials and demos have also be used 
which would allow trainees to access learning 
material from their intranet at a convenient time 













As for PICS system.  
 
Both supplied by Servelec. 
















on 1st May 
(Company 
called) 
Total recall training: Project team members and 
key end users from the hospital organisation 
receive training at a training site in Verona, 
Wisconsin.  
 
Classes are delivered to introduce the system 
and discuss how it will impact workflows. An 
end-user learning package is delivered called 
‘Training Wheels’, which aims to prepare end-
users in usage of the system. This incorporates 
e-learning lessons, lesson plans, hands-on 
experience; post e-learning lessons ‘quick start 
guides’ and optimisation materials. Materials 
are tailored to the specific roles in which they 
are intended to be used and are scenario based.  
 
e-Learning: Scenario based programmes are 
available. The tutorials guide clinicians through 
workflows, allowing them to learn at their own 
pace in a flexible manner. E-Learning may be 
used as an alternative to or in conjunction with 
instructor led end-user training.  
 
 













System Management Training 
 
 Refresher training and new training for 
system managers 
 Ensure the system is configured to specific 
needs 
 Optimisation of the system. 
 
Training is typically on-site, and instructor led. 
 
(No information provided about specific end-





























Training is provided as part of full system 
implementation. Meditech trainers from the US 
are deployed within the trust and will work with 
the organisation to plan training according to 
specific needs (i.e. medical training will differ to 
pharmacist or nursing training content).  
 
Meditech will work with the Trust to arrange 
who exactly will be trained and that decision will 
be on a case-by-case basis.  
 
The format of training is flexible. Options include 
classroom delivered sessions, which are 
considered more effective than lectures and 
one-to-one sessions if needed.  
 
The training support is ongoing after the initial 
implementation. Meditech trainers will visit the 
Trust after one year to perform ‘optimisation 
usage’ to effectively assess how the system is 
being used and also carry out additional training 
when new versions are released.  
 
An online e-learning module was being 
developed but was only available for internal 
use.    










The format of the training was dependent upon 
the needs of the Trust and users. The vendor 
could provide class-room based, ward-based, 
one-to-one and e-learning training. 
  
2.       Who receives training delivered from 
yourselves? Is it only key members of the 
hospital team who are trained? Or do you 
provide full hospital training programmes? 
 
The vendor can simply provide train the trainer 
training or deliver hospital/Trust wide training. 
Dependent on the client’s preferences.  
  
The vendor recommended that the training 




get staff to attend, although it could be done off-
site if needed.  
  
The duration of training depended upon the 
users being trained as well as how IT literate 
they were and if they have experience of 
previous EPMA systems. It can range from 2-3 
hours to a whole day, particularly for users that 
require knowledge of different user role 
functionalities. 
  
If e-learning was provided, this would cover the 
same topics as would be covered in any other 































Targeted Customised Training: 
A range of classes are offered, including- new 
implementation training, database support 
training, upgrade service training and 
customised training.  
 
Training is offered both on and off site.  
 
(No information was provided regarding online 
training) 











A dedicated System C Business Education 
Specialist is supplied to the Trust, who works in 
partnership with the Trust training team to 
provide guidance, training and support.  
 
System C deliver Train the Trainer (TtT) training 
for the Trust training team, and offer advice on 
how to deliver end user training. The System C 
Training Lead will continually assess Trust 
training staff to ensure that they meet the 
required competency levels to deliver to end 
users, and additional training/support can be 
given to Trust trainers who do not meet the 





Following completion of TtT the Trust trainers 
will work on developing the End User Training 
courses. Once this activity has been completed 
the Trust Trainers will be asked to deliver their 
courses to the System C Training Lead to ensure 
that the system is fully understood. If necessary, 
the System C Training Lead will provide 
additional training to supplement any gaps.  
 
Aside from the above, it is a Trust responsibility 
to organise, plan and deliver end user training, 
and their decision whether to include 
consolidation type exercises during this training. 
 
It is the responsibility of each Trust to deliver 
end-user training. In their experience, Trusts 
deliver a mixture of training styles dependant on 
the content and the type of user attending the 
sessions. 
 
Online learning material is provided for access 
throughout a project deployment. 
 













‘Train the trainer’ sessions were provided by TPP 
to designated staff members within the hospital 
who are given the knowledge and skills to then 
train end-users within the specific organisation.  
 
TPP will also assist hospital trainers to develop 
learning materials and tools specific to the 
organisation’s needs. Full end-user training can 
be provided by TPP, however this is not the 
preferred method. Top-up sessions are available 
if required to re-train staff.  
 
Train the trainer sessions are delivered onsite at 
the hospital and typically last for 5 days, 
however this will vary by site.  
 
Training on the ‘train the trainer’ course is 
typically classroom based. There is no provision 
for e-learning however the system is integrated 
with a question and answer style 
communication functionality to allow queries to 





The papers identified a range of approaches used to train qualified prescribers, including the 




use of a range of different approaches may appeal to different individuals with users 
appreciative of relevant and tailored clinical-scenarios in particular. The researcher searched 
for published studies in three large databases. However, it is possible that studies may have 
been published in other databases or unpublished work (e.g., reports or working papers) 
may exist in the grey literature. The search only focused on the training of qualified 
prescribers due to the specific requirements of their training. However, some training 
approaches used for other groups, such as undergraduate students, may have been 
potentially applicable and possibly useful. Notwithstanding these limitations, it is clear that 
there is a lack of published research in this area, thus more evidence is needed. Organisations 
should also share any lessons learnt from their experiences of training prescribers during the 
implementation stage and also any follow-up training at a later stage to fill any knowledge 
gaps.[249]  
The papers identified outlined a number of methods used to train qualified prescribers, 
including classroom-based sessions,[242, 244, 248] demonstrations and ‘hands-on’ 
exercises. Some studies incorporated assessment(s), which allowed users to track their own 
progress and informed senior staff about those who may need further assistance.[242, 244, 
245] Clinical scenarios aimed at addressing commonly encountered prescribing errors or 
frequent technical support requests were also used.[242, 244] Such problem areas may 
reveal systems flaws that may contribute to the occurrence of errors or poor usability. For 
instance, although ePrescribing can decrease prescribing of ‘non-formulary medicines’,[100] 
formulary alerts were often inappropriately overridden.[237] Therefore, understanding how 
users interact with these systems is important to inform future training strategies.  
This review found that combinations of different learning methods were used, which 
appealed to the learning styles of different users. For example, Ross and Banchy used a 
combination of one-to-one and group classroom-training sessions to address the specific 
needs of medical staff and maximise attendance.[248] This approach was also used when 
training staff on other non-ePrescribing forms of healthcare-information systems. For 
instance, McCain et al. reported how challenging it was to get nurse and physician users to 
attend classroom-based training sessions on an EHR system (as opposed to an ePrescribing 
system) due to their other clinical commitments. Users felt that these sessions failed to 
address their learning needs by either being too simplistic or too advanced. This resulted in 
a blended learning strategy being provided that included a combination of computer-based 




train at a convenient time and pace,[250] and may be beneficial when training prescribers 
on ePrescribing systems.  Due to the heavy workloads and often unpredictable schedules of 
prescribers, it would seem reasonable to suggest a training approach that allows users to 
train at their own pace and convenience. Laramee et al. found that participants preferred 
written guidance on how to perform tasks rather than computer ‘help’ functions. 
Organisations should therefore consider providing a range of learning tools to meet users’ 
needs.[250-252] Notably, we only found a relatively small number of studies, which have 
been conducted either on one particular ward or organisation, thus they may not be 
generalisable to other settings. The workforce in rural or remote locations for instance, may 
lack sufficient resources to hire healthcare informatics staff who are important for the 
deployment and ongoing support of ePrescribing systems. More targeted and accessible 
approaches such as checklists and toolkits may therefore be useful.[41]  
Other training methods employed in practice were not discussed in depth in the small 
number of articles found in this review. Vendors of UK ePrescribing systems offered a range 
of training options, such as workshops or e-learning. However, these were typically focused 
towards key internal staff who disseminated training to others during the implementation 
phase. Vendors should provide a range of flexible training approaches that can 
accommodate the requirements and training needs of different organisations.  
Many of the vendors contacted described the limited provision of online training, possibly 
restricted to super-users or for specific training (e.g., about a system upgrade) or explained 
how such functionality was currently in development. The use of e-learning as a method of 
training clinicians on an ePrescribing system was considered important in the included 
studies.[240, 242] A study, which used an e-learning tutorial to deliver educational material 
primarily to nurses, was associated with high completion rates of the training module (74% 
of the 2,080 nurses) and perceived improvements in the completeness of documentation 
within the EHR.[253] The American Health Information Management Association (AHIMA) 
and the American Medical Informatics Association (AMIA) developed recommendations 
related to workforce issues during EHR implementation and suggested that a range of 
innovative learning techniques, including electronic-methods, should be used.[249] E-
learning material should be engaging, potentially including interactive scenarios. It should 
also be simple and concise, clearly specify the learning outcomes, and take care to limit the 
amount of information presented.[253] With organisations choosing to migrate from one 




grown system to a commercial system in 2015), and clinicians often rotating between sites 
(e.g., between a tertiary care and a community hospital) or specialities (e.g., between a 
medical and a surgical rotation), it is important that users feel able to carry out their key 
tasks on different systems. Tools such as the University of Victoria’s EHR portal that provided 
users with an opportunity to train on a range of systems may be particularly useful. These 
‘virtual learning environments’ should replicate as much as possible the interoperability 
issues associated with using multiple systems (e.g. failure to integrate allergy information 
from the EHR into the ePrescribing software)[254] so that prescribers are prepared for these 
challenges. The importance of intra system interoperability and the need to improve the 
transfer and use of information between systems is well-recognised in the literature.[45, 
255] 
Training specifically aimed towards educating prescribers about the challenges and pitfalls 
of ePrescribing was rarely discussed. However, studies frequently include education and 
training as a solution to some of “the issues” encountered, or as an explanation for why users 
fail to use the system as intended.[80, 133, 256, 257] Sittig et al. made specific 
recommendations, such as, providing adequate training opportunities for clinicians to 
experience the system before implementation; this attempted to enforce a minimum level 
of training before users were authorised to use the system. They also proposed that 
organisations deliver ‘walk-throughs’ of the different processes for specific clinical staff.[257] 
Foster et al. and Bredfeldt et al. also highlighted the need to tailor the clinical scenarios and 
content of training to the role, expertise and tasks performed by the user.[242, 244, 248, 
258] Training and assessment approaches should encompass both procedural tasks (e.g., 
prescribing) and cognitive tasks (e.g., interpreting CDS alerts) so that prescribers realise the 
full potential of the system.[258] Furthermore, the assessment should measure the user’s 
competency to ensure that they are using the system effectively and appropriately. 
Importantly, prescribers should be able to identify and address gaps in their own 
knowledge;[249] learning outcomes can provide a benchmark for users to judge themselves 
against.[259] Alongside training, it is important for system developers to improve the design 
and usability of ePrescribing and CDS systems. Increasing CDS alert specificity and sensitivity 
to produce more ‘patient-centred’ recommendations is likely to reduce the impact of alert-
fatigue and improve patient outcomes.[69, 72] Implementation is costly,[52] therefore the 





Organisations are currently using a range of learning methods to train qualified prescribers 
how to use electronic systems, including classroom-based sessions, demonstrations and 
‘hands-on’ exercises. Online learning may facilitate the training for many users. Clinical 
scenarios aimed at addressing commonly encountered prescribing errors or frequent 
technical support requests were also used. However, the lack of papers retrieved suggests a 
need for additional studies to inform training and assessment methods. Finally, further 
research should explore the best way of training users about the pitfalls and challenges 
associated with electronic systems.   
5.6 Summary of Introduction Section 
Chapters 1 to 5 have provided background information about the role of ePrescribing and 
CDS systems in the prevention of medication errors, incorporating the findings from four 
comprehensive literature reviews. These reviews have outlined the role of CDS, including the 
recent developments and persisting issues, and has provided an overview of the unintended 
consequences associated with ePrescribing systems in primary care, secondary care and 
paediatrics.  Additional post-implementation evaluation of ePrescribing and CDS systems is 
needed to contribute to the understanding about the usability issues encountered with such 
systems, the workarounds taken to overcome such issues and what features are beneficial 
for users and why. Finally, a narrative literature review, which explored the training of users 
on ePrescribing systems, highlighted the range of approaches that were used but also 
revealed the need for further research in this area so that organisations are better informed 
of evidence based training strategies.  
This PhD programme of work will explore users’ experiences of using an ePrescribing system 
in a UK secondary care hospital Trust, particularly focusing on aspects related to the system’s 
design, customisation and the training users received at this site. The next chapter of this 
thesis describes the methods used to conduct this research, including an explanation of the 
rationale for the qualitative approach taken and the specific methods employed in order to 






Study Design and Methodology  
 
6.1 Introduction 
This chapter outlines the study aim and objectives and the research methodology used. This 
PhD programme of work incorporates two related studies, the second of which arose from 
the first. The method of both studies will be presented in turn. This chapter will begin by 
stating the main aim and objectives of the study followed by the rationale for the 
methodological approach used, and how validity, reliability and generalisability were 
considered.  
6.2 Aim and Objectives 
 
6.2.1 Aim 
The aim of this research was to explore users’ experiences of using a commercial ePrescribing 
system in a large UK teaching Hospital.  
6.2.2 Objectives 
 To explore the key challenges facing users when using specific design features of the 
ePrescribing system; 
 To understand the benefits and challenges of customising and using customised 
features of a commercial ePrescribing system; 
 To ascertain the benefits and challenges of interruptive and passive clinical decision 
support approaches; 
 To explore the training approaches used to educate clinicians on the use of a 






6.3 Methodological Approach 
A qualitative methodology was selected to meet the study’s aims and objectives. This 
allowed a detailed understanding of participants’ attitudes and experiences to be gathered 
and actual usage of ePrescribing systems to be captured. This was in contrast to using a 
quantitative approach that would have served to test a hypothesis or enumerate the 
occurrence of events, which was not the purpose of this research.[260] 
A decision was made to conduct this study using the framework approach. This method was 
developed in the 1980s by Ritchie and Spencer for the purpose of applied policy research 
from a need to address clearly set and predefined objectives, based on specific informational 
needs.[261]  This method was chosen for a number of reasons. Firstly, the specific areas of 
interest have been identified through literature review and experience of the researcher 
working as a pharmacist in secondary care. Therefore, approaching the study without such 
preconceptions, for example, using a grounded theory approach would be unrealistic. [262, 
263]   Secondly, a descriptive method of analysis, for example phenomenology, would seek 
to generate a rich description, or an essence, of users’ lived experiences of an ePrescribing 
and how their life-world contributed to that. However, this method was ultimately rejected 
for two key reasons. Firstly, the aim of this study was to move beyond description towards 
developing improvement strategies that could be adopted. Secondly, the researcher sought 
to focus on the specific system-related and training factors that contributed to users’ 
experiences of using the system. Therefore, an approach that supported an inductive 
approach to data collection, allowing theories to develop ‘bottom-up’, whilst acknowledging 
the need for structure and systematic methods to be used during the analysis was preferred. 
This provided focus to achieve the study’s goals with flexibility to explore unconsidered 
issues.[264]  
Based on the researcher’s own stance, that reality may consist of multiple truths, a 
constructivist/interpretivist approach was taken, that is, reality is constructed through 
meanings and understandings that have been developed socially and experientially.[265] 
Meaning may also be formed through interactions with others and historical experiences. Of 
note, the researcher has experience of working as a pharmacist and interacting with 
pharmacy colleagues, who have experience of using ePrescribing healthcare information 




interpret and make sense of these meanings from the data in context rather than begin with 
an existing theory.[266] 
Two different qualitative methods were chosen to provide parallel insights of different user 
experiences.[267] These include semi-structured interviews and observations. The following 
section will detail the chosen qualitative methods and rationale for their inclusion.  
6.3.1 Choice of Methods 
A range of data collection methods were available and were considered when deciding what 
methods to use to address the study objectives. Surveys, incorporating both quantitative and 
qualitative responses, could have been used. However, this would have required qualitative 
approaches to have been used initially, in order to develop and test the questions.[268] 
Additionally, there are difficulties associated with collecting in-depth data about users’ 
experiences and probing for explanations to describe any differences identified between 
groups, when using surveys. Furthermore, this method is often limited by low response rates, 
particularly among healthcare professionals, which can result in non-response bias.[269] 
Thus, this approach would not effectively meet the study aim.[270] Focus groups facilitate 
data to be collected and generated through interaction between a group, allowing 
discussion, argument and explanation. They also provide insight into a shared experience or 
could provide a forum to explore proposed improvement strategies.[267, 268] However, 
there is the risk that certain participants may fail to voice their true opinion or there may be 
difficulties managing the group dynamic, for example, if some participants are particularly 
vocal, while others are reluctant to participate, or due to a hierarchy between more senior 
and junior staff.[267] Furthermore, the practical difficulties of recruiting busy clinicians, 
which would require them to leave their ward at the same time to attend the focus group, 
meant that this approach was deemed unsuitable.   
6.3.1.1 Semi-Structured Interviews 
Semi-structured interviews were selected over either unstructured or structured interviews. 
This method is usually based on a flexible topic guide that provides structure to the 
conversation, while the use of open questions also allows respondents to provide their views 
fully and focus on the aspect affecting them.[268]  The adaptable nature of semi-structured 
interviews allows topics to be explored in detail, and not constrained by space in a 




responses was felt to be important, particularly as a range of professionals were to be 
included and their experiences of a single process were likely to be varied.  A structured 
interview however, would provide fewer opportunities for the interviewer to build rapport 
with the interviewee and may limit the responses obtained. Carrying out unstructured 
interviews would lack the focus needed to address the specific research questions. 
Additionally, they tend to be longer in nature and therefore would not be practically feasible 
due to the time constraints of busy hospital staff.[271] 
6.3.1.2 Field-usability Observations 
According to Pope et al. observing the behaviour and interactions of a team in their 
workplace allows researchers to ‘uncover everyday behaviour rather than only rely on 
interview accounts’.[268] In order to gain an understanding of the human-computer 
interaction, participants were observed using the ePrescribing system as part of their daily 
routine in their usual work environment. Events, such as ward rounds or medication 
administration rounds, were targeted as they were likely to feature high usage of the 
ePrescribing system. The researcher entered the field as a known researcher in order to 
conduct direct observations. Using this method, data could be collected that would not have 
been captured or previously considered through questioning methods alone. Furthermore, 
this approach enabled the researcher to observe what participants do, rather than rely on 
narrative reports from interviews, which may be affected by issues such as recall bias. An 
observation template (Appendix 12) was used in order to guide the collection of focused 
data. The free-text field in the template also ensured that additional, perhaps unexpected 
data, could be documented to enable new theories to emerge.[272]  
6.4 Validity and Reliability  
A range of strategies were used to limit bias and increase the reliability of the research 
findings.  
6.4.1 Theoretical Sampling 
A theoretical sampling approach was employed, defined by Glaser as ‘the process of data 
collection for generating theory whereby the analyst jointly collects, codes, and analysed their 
data and decides what data to collect next and where to find them, in order to develop their 




users of the ePrescribing system, who used the system as part of their professional role i.e., 
doctors, nurses, pharmacists and pharmacy staff. Subsequent analysis revealed concepts and 
developed understanding of the data and, due to the iterative process of this study, 
additional members of the hospital informatics team were included. Furthermore, on 
identifying the views and experiences of users of the ePrescribing system, additional insight 
was sought from key stakeholders from four different hospital Trusts who were involved with 
the training of staff in their respective Trusts.   
6.4.2 Data Triangulation 
A range of users (doctors, nurses, pharmacists, pharmacy technicians) were interviewed and 
observed across four adult wards of differing specialities (renal, cardiology, general medical 
and general surgical), to obtain a variety of perspectives and enrich understanding.[267, 274] 
Additionally, a combination of data collection methods, including semi-structured interviews 
and observations, along with the researcher’s field notes were used to test and validate any 
emerging findings.[130]  
6.4.3 Examination of disconfirming instances 
Disconfirming instances, i.e., sections of the data, which do not support the general trends 
emerging from the data were actively sought.[275] This was important to refine the analysis 
and data collection so that the majority of cases could be explained and additional themes 
explored or indeed rejected. [274, 276] This was the case when examining one junior doctor’s 
account about the use of drug interaction checks for patients prescribed cardiac medicines 
(see section 9.1.3 for further details). Although this doctor spoke about how he did not see 
a role for interaction alerts because these medications were often prescribed together, on 
closer examination the researcher felt that this example could actually be used as a reason 
to support the use of CDS and overcome naivety or a lack of knowledge about drug 
interactions. The junior doctor did not appear to fully appreciate how cardiac medicines, 
when prescribed alongside other medications could result in a range of serious interactions.  
6.4.4 Peer debriefing 
Peer debriefing is ‘the review of the data and research process by someone who is familiar 
with the research or the phenomenon being explored’.[178] During the data collection and 
analysis, emerging themes were discussed with the researcher’s study supervisors and 




unconsidered concepts and test the analysis. Credibility was also sought by discussing the 
study with fellow researchers and presenting the results at conferences, so that the findings 
could be challenged by individuals who were external to the study.  
6.4.5 Clear account of methods 
A clear account of the process for data collection and analysis has been provided in this 
chapter and all published papers, such that the reader is clear about the methods used and 
any factors that may have contributed to the findings and interpretations made. A 
comprehensive overview of the five stages of analysis used in the framework approach are 
provided in section 6.8; use of this approach allows the reader to understand how theories 
and explanations were developed from the data throughout the process.[274] 
6.4.6 Reflexivity  
Throughout data collection and analysis, a research journal was kept to record notes of any 
personal reactions or views that may help explain the development of theory, in addition to 
practical information, such as the date and time of data collection.[274] Here, the researcher 
also noted any biases or preconceptions that she may have held to enhance the credibility 
of the findings so that these could be considered as the data were analysed.  
6.4.7 Relevance  
The study site and context in which the data were collected has been described in detail. 
While these results should not be inferred as generalisable, an attempt has been made by 
using theoretical sampling techniques to present the experiences from a range of 
participants across different wards. This has provided  some transferable concepts, which 
the researcher hopes will be of relevance to different organisations where they can be 
further explored and tested.[274]   
6.5 Overview of the programme of work 
This programme of work consisted of two parts: the main study, which involved conducting 
semi-structured interviews and observing users of a commercial ePrescribing system across 
four adult wards in a large hospital NHS foundation Trust. The aim of this research was to 





The findings from the main study prompted further enquiry into the issue of how users were 
trained to use ePrescribing systems and thus led to a second follow-on -study. This study 
sought to determine what training approaches were being used by different UK hospital 
Trusts in order to educate their hospital staff on how to use these systems and gain a deeper 
understanding of what the relative benefits and challenges of these approaches were. 
Relevant data on training from the main study was incorporated into the analysis for the 
second study.   
6.6 The Main Study  
 
6.6.1 Aim 
The aim of this research was to explore users’ experiences of using a commercial ePrescribing 
system in a large UK teaching Hospital.  
6.6.2 Objectives 
 To explore the key challenges facing users when using specific design features of the 
ePrescribing system; 
 To understand the benefits and challenges of customising and using customised 
features on a commercial ePrescribing system; 
 To ascertain the benefits and challenges of interruptive and passive clinical decision 
support approaches; 
 To explore the training approaches used to educate clinicians on the use of a 
commercial ePrescribing system. 
6.6.3 The Study Site  
 
6.6.3.1 Hospital selection and description of the system 
The study took place at a large tertiary care teaching hospital in the North of England. The 
Trust is a large teaching hospital offering a range of specialities, more than any other group 
of hospitals outside of London. It has over 1,800 beds and manages over 1.3 million patient 
contacts every year. Between October 2008 and March 2011, NuTH implemented a 
commercial ePrescribing system across all general wards, excluding paediatrics. 




software for this specialised patient population. The majority of medications were prescribed 
using the system with the following exceptions at the time of starting data collection: 
chemotherapy orders (which were entered into a separate order entry system), patient 
controlled analgesia, epidurals, IV fluids and high frequency eye medication (which were 
ordered on paper charts). Orders were typically selected from suggested structured order 
sentences, which included the medication name and a range of doses and frequencies via a 
drop-down menu. Orders were screened for problems such as drug allergies, and the system 
presented these problems to the user immediately in the form of an alert, when appropriate. 
Orders could also be entered using free-text information; however, the system was not able 
to perform any clinical checks on these orders. In terms of clinical decision support, allergy 
checking was live on the study wards, drug interaction checks were inactive with the 
exception of a few tailored alerts that had been created in response to specific issues, and 
order sets had also been developed for certain treatments. Pharmacists clinically screened 
and validated medication orders electronically in the system and nurses also documented 
administration into the ePrescribing system. The ePrescribing system included a ‘pharmacy 
task list’, which was automatically populated if a patient was either prescribed a (i) high-risk 
drug, (ii) had been newly admitted and needed a medication review or (iii) had a discharge 
prescription that needed to be clinically validated.  
The ePrescribing system had been implemented on the adult study wards for over six years 
prior to the study. Therefore, any issues encountered during data collection were unlikely to 
be due to ‘teething problems’ experienced when a new system is first implemented. 
However, the system was being continuously developed throughout the data collection 
period, with certain features newly added or modified (e.g., renal dosing support). Users this 
often mentioned this in their interviews.  
6.6.3.2 Ward Selection 
Data collection occurred on a general medical ward, with a focus on gastroenterology, a 
general surgical ward, with a focus on orthopaedics, a specialist cardiology ward and a renal 




6.6.4 Ethical Approval 
This study received favourable NHS ethics approval in 2013, (IRAS Project ID: 141106 Ref: 
14/NE/0072) (Appendix 13). The study was also approved by Durham University ethics 
committee (Appendix 14).  
6.6.5 Inclusion Criteria 
Ward staff who used the ePrescribing system as part of their day-to-day work on one of the 
four study wards were eligible for inclusion. This included: 
 Doctors and non-medical prescribers, who used the ePrescribing system to enter 
drug orders; 
 Pharmacists and Pharmacy staff who used the system to clinically validate 
prescriptions and identify patients for review; 
 Nurses who use the system to administer medication and record information; 
 Hospital informatics team members who were responsible for developing the 
system across the study wards and throughout the hospital.  
6.6.6 Recruitment of participants  
The researcher was accompanied to the ward by the ward pharmacist on their first visit who 
made initial introductions to members of the ward team. Subsequently, a recruitment pack, 
containing an invitation letter (Appendix 15) and information leaflet (Appendix 16) were 
given to members of the ward staff in each of the wards by the researcher and/or ward 
pharmacist to find out if they would like to participate in a semi-structured interview or be 
observed using the system as part of their usual workflow. Each member of ward staff was 
given the opportunity to ask questions about the study and, if they agreed to participate, 
they were also asked to complete a consent form (Appendix 17). Participants were advised 
that entry into the study was entirely voluntary and that they could withdraw at any time. 
When participants suggested further members of ward staff who they felt would be 
beneficial to interview, the researcher approached that member of staff on the ward with 
the recruitment pack and invited them to take part in the study.  
Interviews were carried out until thematic saturation was reached, that is, until the themes 
suggested by interviewees began to repeat themselves and subsequent participant 




6.6.7 Main Study Interview Schedule 
Participants were questioned using open, non-leading questions from an interview schedule 
(Appendix 18). In particular the questions explored: 
 Users’ experiences of using the system and their likes and dislikes; 
 Whether the system had been tailored to their specific needs and whether these 
changes were useful; 
 The difficulties encountered when using the system; 
 The workarounds employed by users to overcome those difficulties; 
 User opinions on what improvements could be made to the system. 
Prompts were used to probe for a deeper understanding and to clarify and explore 
participant responses further. In addition, probing allowed the researcher to obtain further 
relevant information and challenge inconsistencies in a non-confrontational manner.[276] 
Short and clear questions were used to maximise understanding and clarification was given, 
if required. As a range of professionals were interviewed, questions were tailored to the 
participant experiences and knowledge, with role-specific prompts used to generate thought 
and consideration of a particular area.[276]  
6.6.8 The Main Study Semi-Structured Interviews  
Participants were interviewed at a mutually convenient time and location within the hospital 
premises. The interviews took place in an office or empty room away from the ward, which 
was quiet and allowed for candid conversations to take place. The interviews lasted between 
17- 70 minutes. All interviews were audio-recorded with permission and transcribed 
verbatim together with accompanying field notes. Notes were also made by the researcher 
to capture any non-verbal data.  
6.6.9 The Main Study Observations and Location 
The researcher recorded the range of processes carried out by users of the system, the 
difficulties participants encountered and how such issues were overcome. Detailed notes 
were also taken to include the comments and actions of participants and where possible any 
comments or statements were noted verbatim to provide rich supporting data; these were 
indexed as ‘OC’ (observed comment). The researcher also noted her own personal views and 




‘SC’ (subjective comment) to facilitate recording.[276] The researcher made all efforts not to 
be obtrusive and interrupt the participant in order to limit the Hawthorne effect.[276] On 
occasions where participants tried to ‘talk through’ their actions the researcher reminded 
the user that this was not necessary and  that the purpose was to observe the system being 
used as it normally would be.  In total, 35 hours of observations were conducted. The 
observation field notes and any related reflections were transcribed verbatim. 
6.7 The Follow-on Study  
 
6.7.1 Aim 
To describe the training strategies used to train ward staff how to use ePrescribing systems 
across four different NHS hospitals in England.  
6.7.2 Objectives 
 To outline the different training approaches used to train ward staff on how to use 
ePrescribing systems;  
 To gain an understanding of the benefits and challenges associated with using 
specific training approaches. 
6.7.3 The Research Sites 
A relevant member of staff, with suitable expertise of training prescribers on the ePrescribing 
system at their hospital Trust, was contacted at four different NHS hospitals in England. 
These NHS Trusts were purposefully selected for two main reasons: 1) they had a well-
established ePrescribing system in place, and 2) the Trusts represented a range of different 
and commercially available ePrescribing systems. These included: 
1. A large academic teaching hospital Trust in the North of England (system A). 
2. A large academic teaching hospital trust in the East of England (System B).  
3. A major teaching hospital Trust in the South of England (System C).  
4. A large acute hospital trust in the North of England, which was in the process of 




6.7.4 Ethical Approval 
Full NHS ethical approval was not required to conduct this study as it was classed as service 
evaluation. Ethical approval was obtained from Durham University in July 2015 (Appendix 
19) and all local approvals were sought and received from each individual Trust before the 
study commenced. 
6.7.5 Inclusion Criteria 
A hospital staff member with the relevant experience and/or knowledge of training 
prescribers on the ePrescribing system was eligible to take part in the study. All staff willing 
to participate must have been able to give informed consent. Any staff member without the 
relevant knowledge and/or experience of training prescribers was excluded. 
6.7.6 Recruitment of Participants 
An email was sent to a senior member of the hospital pharmacy team of each hospital, 
explaining the purpose of the study. The senior member of the pharmacy team was then 
asked if they would like to participate or identify an appropriate member of their staff with 
the relevant knowledge and experience to speak to. Individuals with the relevant knowledge 
and experience of training staff at each site were given the opportunity to participate. They 
were provided with a participant information leaflet and given the opportunity to ask 
questions. If they agreed to participate in a semi-structured telephone interview, they were 
also asked to provide verbal consent. It was explained that entry into the study was entirely 
voluntary and that they could withdraw at any time.  
6.7.7 Interview Schedule 
Participants were questioned using an interview schedule, with open-ended questions 
(Appendix 20). The questions explored: 
 The types of training and support offered to staff; 
 Whether the training  strategy and content was developed by the companies that 
install the systems or was internally created; 
 How the training was facilitated, for instance, who usually conducted the training; 
 What parts of the training went well or not so well;  




6.7.8 Semi-Structured Telephone Interviews  
Participants were interviewed over the phone at a mutually convenient time. All interviews 
were audio-recorded with permission and transcribed verbatim, together with 
accompanying field notes. The interviews lasted between 37-42 minutes.  
6.8 Data Analysis 
 
6.8.1 Framework Approach  
The researcher employed the framework approach for this study. The approach supports 
inductive qualitative inquiry, while using a clear and systematic approach for analysis. The 
transparency of the analysis process offered by using the framework approach was of 
particular importance to the researcher.  
There are five steps involved in the framework approach, each of which is described in detail 
below.[264, 276, 278, 279] 
6.8.1.1 Familiarisation: The data were initially reviewed and sorted to make it more 
manageable. The researcher immersed herself in the data by listening to the interview audio 
recordings, reading and re-reading the transcripts and studying the observation notes. From 
this, the researcher began to identify emerging and recurrent themes and key ideas in 
context, relating to the initial research questions surrounding the users’ experiences of using 
the system, what difficulties they encountered and any workarounds they took to evade such 
difficulties. Familiarisation was carried out until the range of circumstances and 
characteristics within the data had been recognised.  
6.8.1.2 Identifying a thematic framework: The researcher returned to the notes made 
during the familiarisation stage and identified key issues. The recurrent concepts and themes 
were used to construct a thematic framework that data were assigned to. This involved 
consideration of the issues identified in the original aims and objectives as well as any new 
issues that were generated through data collection. The framework developed as it was 
applied to transcripts and became more responsive to emerging themes, due to 







1. Challenges facing uses with specific system design features 
 
1.1. Challenges with the ‘Medication List’ 
1.2. Challenges viewing test results  
1.3. Challenges viewing or documenting information 
1.4. Challenges using disparate systems  
 
 
2. Error Prone Orders 
 
2.1. Unstructured orders 
2.2. Non-synchronous dosing regimens 
2.3. Non-standard dosing times 





3.1. Mandatory functions 
3.2. Repetition of tasks 
3.3. Improved visibility 
3.4. Clarification of prescriptions 
3.5. Paper orders 





4.1. Customisation of the screen layout 
4.2. Creation and use of order sentences, order sets and 
favourite lists 
4.3. Insulin ePrescribing 
4.4. Creation and use of the pharmacy task list 
4.5. Approaches to clinical decision support  
 
 
5. Training Approaches 
 
5.1. The approaches used 
5.2. Knowledge gaps 
5.3. Benefits and challenges of formal approaches 
5.4. Benefits and challenges of informal approaches 
 
 






6.8.1.3 Indexing: The thematic framework (a workable list of themes and sub-themes) was 
applied systematically to all textual data, by annotating each transcript with codes using 
NVivo qualitative data analysis Software; QSR International Pty Ltd. Version 10, 2012. This 
involved reading the data in fine detail and making a decision about whether single or 
multiple themes existed that revealed patterns and interconnections, which was important 
for subsequent analysis. By clearly annotating transcripts, this method offered transparency 
and enabled the reader to see how themes were emerging. The initial thematic framework 
was discussed with the researcher’s study supervisors and continually refined during 
indexing to include previously unconsidered themes, divide themes based on differences 
that emerged from the data and combine themes when those initially chosen were found to 
be overly refined and caused the data to be fragmented.[276]  
6.8.1.4 Charting: A spreadsheet was used to create a matrix. The data were sorted by 
grouping similar content together, according to the appropriate part of the framework and 
charted into a matrix. The charts had headings and subheadings, which were generated from 
the thematic framework or research questions. A thematic approach to charting was 
adopted. Each key theme was described on a separate chart, each sub-theme was assigned 
a column and each respondent or observation period had a row on the chart, e.g., a chart 
for customisation, which included headings and subheadings along the ‘χ’ axis and each 
respondent along the ‘γ’ axis, with the professions grouped together (Table 6). A total of five 
charts were produced for each of the key themes. Key points were summarised by the 
researcher and charted. At this stage it was important to reduce the data into manageable 
amounts, whilst retaining the ‘feel’ and ‘participant’s presence’ in the data, for example by 
retaining the participant’s own language.  The last column was kept free; to document the 
researcher’s own comments, thoughts and observations so that it could be distinguished 
from the participants. By referencing the original text, which corresponded to the thematic 










Table 6: Example of Charting 
Thematic Chart 
Challenges facing users using specific design features 
Sub-theme 
number 
1.1 1.2 1.3 1.4 Researcher Comments 
Sub-themes Challenges with the Medication List 
 
Challenges viewing test results Challenges viewing or documenting 
information 
Challenges using disparate systems  
P5; Nurse This nurse felt that it was quite easy 
to miss doses when she was 
administering medications, as lots of 
scrolling was required up and down 
and along the screen. Doses 
scheduled for non-standard times 
could be overlooked as they would be 
further along the screen. It would be 
better if the system just displayed the 
doses that were due at that time.  
 The nurse found it difficult to see on the 
system whether a medication had been 
requested from pharmacy. So, she would 
sometimes err on the side of caution and 
send a second request or possibly sometimes 
didn’t make a request at all.  
Depending on the ward different areas 
use different processes- e.g. some may 
prescribe IV infusions on the 
ePrescribing system whereas others just 
use a paper record. This can be 
confusing as the nurse may not be sure 
which one to ‘sign off’.  
 Non-standard times easily 
missed. 
 Duplicate requests.  
 Duplicate records contributing 
to confusion.  
P16; Doctor The doctor thought that the 
medication list could be quite 
complex, particularly as suspended/ 
finished courses appeared on there 
even when they were no longer being 
given. 
It was difficult to see a trend in 
some results over time if they 
were separated with lots of 
other results in the middle. For 
example, for tests that were 
taken more frequently e.g., 
such as BMs or INR results.   
MRSA status of a patient is indicated within 
a screen that can only be accessed by 
noticing a ‘yellow star’ and then clicking onto 
a separate tab ‘problems and diagnoses’, 
which would take the user to another screen. 
It would be useful if the user could hover 
over their name and find out important 
information about MRSA status etc. without 
having to take these additional steps.  
Patient’s observations are recorded on 
paper. The user had experienced 
instances where the paper chart had 
been lost. This was an issue as they 
needed that information to make a 
clinical prescribing decision.  
 
 Medication list can be 
confusing. 
 Difficult to see trends in test 
results.  
 User needs to know what 
symbols mean. 
 Lots of steps involved in 
accessing information. 
 Loss of paper records.  
P23; 
Pharmacist 
The pharmacist found it inconvenient 
having three places (med list, 
summary and chart) to check for 
medication information, which 
required lots of scrolling to figure out 
what was active, discontinued etc.  
The pharmacist recalled how it 
was not easy to review a 
patient’s blood test results 
compared with other systems 
they had used.  Although they 
could generate a graph it 
didn’t include the dates of 
results - this user preferred to 
have the results and the dates. 
They also described how they 
were scrolling so much it was 
easy to miss-read a line 
When the user was reading the drug 
information for certain medications it 
sometimes ‘cut off’ pieces of information 
about the order so the pharmacist had to 
hover over it to find out more- user thinks 
that it should be clearly visible on the screen 
and that they should not have to make 
additional effort to see it. 
There were lots of ordering approaches 
for nurses to ‘med request’ (paper and 
electronic) so that often nurses did not 
know what to do for the best. When 
urgent there was a tendency to take a 
paper note down to pharmacy however, 
there were issues with being out of 
touch with paper orders and whether 
the order forms were available. Also, it 
was not always clear whose 
responsibility it was to order 
medications so they may be missed. 
ambiguity 
 Scrolling increases risk of 
missing information. 
 Graphs missing dates of results 
received. 
 The system curtailed some 
important information. 
 Duplicate ordering methods 
can cause confusion.  
Observations 
16.1 
Not all users routinely checked the 
drug summary when reviewing 
patients. Therefore, they did not 
actually know if the patient had been 
receiving a dose or not. Pharmacist 
admitted that she sometimes forgot 
to check that screen and as it’s very 
busy/ lots of information it was hard 
to have a quick glance. 
 A free-text prescribing note had been 
ignored for several weeks for a patient taking 
hydrocortisone. Free-text comment was less 
noticeable on the screen compared to the 
coloured boxes that display the prescribed 
dose. 
  Computer screen display very 
busy. 






6.8.1.5 Mapping and interpretation: The data were organised according to the main 
themes and sub-themes in the charts. The researcher used these charts to define concepts 
and map the nature of the phenomena to make associations between categories (Figure 8).  
The researcher compared and contrasted the data between participants and clinical areas. 
The aim at this stage was to move beyond description and instead provide explanations and 
develop strategies from the recurring patterns and associations within the data. The 
researcher attempted to develop an understanding of what was happening within a theme 
and identified links between individual characteristics and the phenomena.[276] The charts 
facilitated this process and revealed similarities in the experiences of different professionals 
when viewing medication-related information; for example, both nurses and doctors 
recalled how they found it difficult to check what dose of warfarin a patient had been 
prescribed and described how they had to be extra careful interpreting that information on 
the system. Differences were also identified between individuals of the same profession, but 
with different amounts of clinical experience. For example, more junior doctors appeared to 
have a better grasp of the system’s functionality compared to their seniors (section 10.1.2). 
As more data were examined sub-themes were grouped together or further refined.  
The researcher then began to develop explanations for the emerging patterns within the 
data. The linkages between phenomena were presented using maps, to improve 
understanding and clarity. Any linkages in the data were then examined closely and 
challenged in order to understand the associations and contributing factors. For example, 
using the scenario above, which found that junior doctors appeared to have a better grasp 
of the system functionality compared to their seniors, closer examination revealed that there 
was a difference in training approaches for these two groups, including between foundation 
year 1 and 2 trainees and speciality training doctors, when they started working for the Trust, 
which may partly explain this. The researcher also examined ‘disconfirming instances’ in the 
data to further refine the explanations presented and ensure that themes had been fully 
explored or indeed in some cases rejected. For example, investigation of one newly qualified 
junior doctor’ statement that drug interaction checks were not necessary on the cardiology 
ward because most of the drugs work ‘well together’, was actually re-coded as a possible 
reason to support the use of drug interaction CDS within the system. Many medications that 
are prescribed for cardiac conditions, interact with other cardiac medicines and/or any pre-
existing medications some of which could result in serious harm. The researcher felt that the 




patients, was in fact a reason why such checks were important in a system, as he 
demonstrated that he ‘did not know what he did not know’ and CDS could potentially 
highlight this knowledge gap (section 9.1.3). Other studies in the literature were also 
reviewed to suggest additional linkages that may exist across the data. A diary was 










6.9 Referencing quotes within the text 
Quotes and extracts taken from the researcher’s observation notes and semi-structured 
have been included in the results section. These have been entered using italics and in 
quotation marks. The participant ID code comprises of a unique ID number, followed by their 
profession only, in order to protect their anonymity (e.g., P3; Nurse). Observation extracts 
have also been given a unique ID, where the ward letter indicates a particular ward speciality, 
which is not the ward number, followed by the observation session (e.g., Observation; Ward 
A.4, refers to observations taken place on one ward, during the researchers fourth visit to 
that ward).  
The use of brackets ‘(…)’ within a quotation, means that the researcher removed a piece of 
text from the sentence, for instance to improve readability.  
Square brackets ‘[…]’, have also been used within quotations, where the researcher felt that 
it would be useful to add additional text or clarification for the reader e.g., to explain the 
meaning of an acronym.  
6.10 Participants 
 
6.10.1 Main Study  
 
The researcher conducted a total of 32 interviews lasting between 17-70 minutes and 35 
hours of ward-based observations. A breakdown of the participants and observations have 
been included below (Table 7 and table 8) (to maintain anonymity the wards have been 












Table 7: The role and ward code of participant 
 
Participant ID Code Profession Ward  
P1 Staff Nurse Ward D 
P2 Ward Sister Ward C 
P3 Staff Nurse Ward C 
P4 Charge Nurse Ward A 
P5 Staff Nurse Ward D 
P6 Pharmacist Ward A 
P7 Doctor (Speciality Trainee)  Ward D 
P8 Doctor (Speciality Trainee) Ward D 
P9 Senior Nurse Ward A 
P10 Ward Nurse Ward A 
P11 Doctor (Speciality Trainee) Ward B 
P12 Doctor (Speciality Trainee) Ward B 
P13 Doctor (Speciality Trainee) Ward B 
P14 Staff Nurse Ward B 
P15 Doctor (Foundation Level) Ward B 
P16 Doctor (Foundation Level) Ward B 
P17 Doctor (Speciality Trainee)   Ward C 
P18 Doctor (Foundation Level) Ward C 
P19 Pharmacist Ward C 
P20 Doctor (Foundation Level) Ward A 
P21 Pharmacist Ward B 
P22 Doctor (Consultant Level)  Ward C 
P23 Pharmacist  Ward A 
P24 Doctor (Speciality Trainee) Ward A 
P25 Doctor (Speciality Trainee) Ward A 
P26 Doctor (Speciality Trainee) Ward D  
P27 Pharmacist Ward B 
P28 Doctor (Consultant Level)  Ward D 
P29 Doctor (Registrar Level) Ward D 
P30 Pharmacist  Ward D 
P31 Pharmacist  Ward C  





Table 8: The observation ID, date, ward code and duration of observation periods 
 
Observation ID Date Ward  Duration 
Observations; 
Ward A.1 
1st April 2016 Ward A 2 hours (9.35am – 11.39am)  
Observations; 
Ward A.2 
27th July 2016 Ward A 1 hour 15 minutes (12 noon-13.15pm) 
Observations; 
Ward A.3 
2nd August 2016 Ward A 4 hours (09.15 am – 13.15pm) 
Observations; 
Ward A.4 








9th March 2016 Ward B 1 hour 15 minutes (11 am- 12.15pm) 
Observations; 
Ward B.2 








19th April 2016  Ward C 1 hour 12 minutes (09.08 am – 10.20 
am) 
Observations; 
Ward C.3  
19th April 2016  Ward C  1 hour (11.45 am-12.45 pm) 
Observations; 
Ward C.4  
19th July 2016 Ward C 35 minutes (09.15 am – 09.50 am) 
Observations; 
Ward C.5  












3rd March 2016 Ward D  1 hour (12.30pm- 13.30pm) 
Observations; 
Ward D.4  

















6.10.2 Follow-on Study  
The researcher conducted semi-structured interviews with participants who were involved 
with user training on four different ePrescribing systems across four different NHS 
Foundation Trusts. A breakdown of the participants is provided in table 9.  
Table 9: Second Study Interview Participants 
 
Participant ID Code Profession Site 
P33 Informatics Pharmacy Technician  Site A 
P34 Chief Clinical Information Officer Site B 
P35 Informatics Pharmacist  Site C 
P36 Informatics Pharmacist Site D  
 
6.11 Chapter Summary 
This chapter provides an overview of the qualitative study’s aims and objectives, the 
methodological approach taken, and how validity and reliability were considered by the 
researcher. The programme of work was then discussed, which outlined details of the study 
site, recruitment and how data collection was performed for both the main study and smaller 
follow-on study. Finally, the researcher has described in detail the chosen analysis method 
and procedure taken to generate findings.  
The following four chapters describe the findings obtained from these interviews and 











What are the key challenges facing users when using 
specific design features of the system? 
This chapter will explore the various challenges facing users when using specific design 
features of a commercially procured ePrescribing system as part of the main study. This 
includes design features related to (a) the patient’s electronic medication lists, (b) viewing 
and documentation of medical and laboratory information, for example viewing test results 
in a graphical format, (c) documenting allergy information and (d) viewing free-text 
comments and ‘special instructions’. Furthermore, the researcher reflects on the challenges 
related to the use and meaning of symbols and the problems experienced when disparate 
systems are used to create a discharge prescription for a patient. The researcher also 
describes the workarounds used by health care staff to overcome some of these challenges 
and how these workarounds, in themselves, could be error-prone.  
7.1 Challenges with the patient’s electronic medication lists 
 
7.1.1 Medications displayed in the list 
The patient’s electronic medication list presented a simplified list of the medication that has 
been prescribed for the patient, including the start date (e.g., 15/Jul/2016), order name (e.g., 
codeine), status (e.g., ordered or discontinued) and details such as dosage, frequency, and 
route of administration (See Figure 9). However, it did not display any information related to 
whether the medication had been administered (or not). At the top left-hand corner of the 
screen, the user had the option of selecting from a drop down menu ‘all medications (all 
statuses)’, ‘all active medications’, or ‘all discontinued medications’. The ‘all medication (all 
statuses)’ view provided a list of medications, which included those that were currently 
active as well as those discontinued, while the ‘all active medications’ tab and ‘all 









Figure 9: ‘Medication List’ set to show All Medications (All statuses) 
When a medicine was prescribed for a patient, it appeared on the patient’s active 
‘Medication List’. The medicine would normally remain on this list until it was actively 
stopped by the user i.e., the order manually changed to ‘discontinued’. However, some users 
assumed that orders, which were prescribed for only a finite period of time (e.g., seven day 
course of antibiotics), would automatically drop off this list when the treatment course had 
ended. This was not the case. Instead the user was expected to go back into the patient’s 
record and manually change the status (from active to discontinue). As a result, some 
medications on the ‘all active medication’ list were no longer being administered and, in 
some instances, the researcher observed how users could wrongly assume that the patient 
was still getting the drug when in fact they were not. One doctor explained how, on the 
previous paper-drug chart, it was more obvious to her when a medication had been 
discontinued as “there [was] a line [drawn] through it” (P24; Doctor).  
This problem was also compounded by the fact that the ‘Medication List’ view did not display 
the stop date of the medication, and so it was difficult for the user to confirm whether a 
course of medication had actually been completed or not. To obtain this information, the 
user needed to click on either the ‘Drug Chart’ or ‘Drug Summary’ tabs, but these tabs were 
not always routinely reviewed during busy periods on the ward, as the researcher noted in 
her observations: “some prescribers only accessed the Medication List [tab] and did not 
routinely view the Drug Chart or Drug Summary” (Observations Ward C.4) (Observations 
Ward D.4). One of the senior pharmacists also described how doctors “tend[ed] to use [the] 
‘Medication List’ more and (…) [were] not so aware of the things that have been suspended 




or courses of antibiotics with a soft stop [a provisional stop date for a treatment course that 
may be extended depending on the patient’s response]” (P30; Pharmacist). In one particular 
patient’s case, the pharmacist explained how they had mistakenly gone without a medicine 
for a number of days.  
“That was quite an error that you’d have an antibiotic course that had finished two 
or three days ago and the doctors still thought that somebody was on it and you go 
well “No, because that says the 15th December so they’ve not had it for six days” but 
it was still on the ‘active medication list’ so they still thought that the patient was on 
it.” (P31; Pharmacist) 
A renal doctor also recalled how a patient had received a shorter course of antibiotics than 
intended “because it had fallen off” the medication list (P26; Doctor). It was not obvious to 
her from the system that the stop-date for the shorter course had passed and they 
erroneously “just assumed that that stop date had then been extended” (P26; Doctor). The 
renal doctor explained how this could have had significant clinical consequences for this 
patient, who had a serious line infection and renal impairment. However, with the previous 
paper-based system, a circle was drawn around the last dose of the antibiotic in a 48 (or 72) 
hour time period, thus drawing attention to the fact that this medication needed to be 
reviewed or a note added on the prescription to review 48 hourly as part of the 
organisation’s “antibiotic stewardship” policy (P26; Doctor). This acted as an aide memoire 
for doctors, nurses or pharmacists during a daily drug round. Although the ePrescribing 
system did provide an equivalent reminder, in the form of a pop-up alert (see Figure 10), 
these alerts were only presented to the pharmacist or doctor when they first entered the 
patient’s record and were not presented to nurses who were involved in administration and 
could have also prompted the doctor. One could question how useful the timing of these 
particular alerts were. Users were more likely to make decisions about a patient’s medication 
when prescribing and with sight of their active medication list, rather than on first entry into 





Figure 10: Example of 'medication review alert' 
Finally, some users recalled how dose times entered on the ePrescribing system, which did 
not fall within the usual drug administration rounds, were also more likely to be missed 
because they were less visible on the ‘drug chart’ and may only be seen with scrolling left 
and right across the screen. The risk was that the user could “be scrolling down [the drug 
chart] and just see the twelve o’clock [medications] and then you’ve got to sometimes scroll 
across to see the two o’clock ones” (P10; Nurse). (See Figure 11) 
 
 
Figure 11: Drug Chart showing multiple columns between 9.00 and 11.30am increasing 




7.1.2 Medication List Layout  
The ‘Medication List’ was also potentially confusing for users because of how the 
medications were listed i.e., alphabetically or chronologically. If alphabetically, using the ‘All 
Medications (all statuses)’ tab every aciclovir order prescribed for the patient during their 
current hospital visit would be listed one after the other, close to the top of the ‘Medication 
List’. Although orders for the same drug could be conveniently grouped together in this way, 
one senior pharmacist explained how it was easy to get confused as “you might see like ten 
lots of aciclovir instead of what they’re actually on” (P6; Pharmacist). It was likely that some 
of these orders had finished and the user had to concentrate on the dates to determine 
which orders were still active or discontinued. In contrast, a chronologically ordered list, 
more typical of a paper drug chart, presented “the sort of sequence that it followed” (P2; 
Nurse), with only the most recent aciclovir order at the top and older orders appearing 
further down the list. This made it easier in a way to review a patient who was “very sick” or 
when there had “been a complaint or an incident” (P2; Nurse). In reaching a compromise, 
one user felt it would be nice to “have the important stuff at the top and then everything else 
alphabetically” (P20; Doctor). This interviewee picked out antibiotics as one of the particular 
drugs that should be placed at the top so that “you can see immediately what they’re on, 
how long they’ve been on it, whether it needs stepped down to oral or changed” (P20; 
Doctor).  He also suggested putting anti-coagulants and steroids at the top: “Anti-coagulants, 
so if they’re on Warfarin or a NOAC [novel oral anticoagulant] even just to make sure they’re 
on Tinz [tinzaparin]. And then things like steroids so you know what dose they’re on and how 
long they’ve been on it. Like cardiac drugs maybe like digoxin or something like that” (P20; 
Doctor). Another doctor who had also become accustomed to the alphabetical layout, 
“expected to see aspirin at the top now and zopiclone at the bottom” (P24; Doctor) 
questioned whether the “regular” and “when required” medications could be separated out.  
7.2 Challenges related to viewing and documenting information about 
lab test results and medication in the system 
 
7.2.1 Viewing test results in table format 
Patient test results were often displayed in table format in the EHR system, with the name 
of the ordered test e.g., Capillary Glucose (Point Of Care Test (POCT)) displayed down the 




displayed horizontally across the top of the other columns (see Figure 12). It was possible for 
some blood tests e.g., blood glucose levels, to be ordered for one patient multiple times in a 
day and the results would also appear on the same line, but with an additional column 
created. Thus, if a user wanted to view a particular test value issued on the 19/Jul/16 at 
10:41, for example, they would need to scroll across to the right of the screen until they 











The default setting for the table was to display the 100 most recent test results. One doctor 
explained how it “sometimes cuts them [the blood test results] off the end and you have to 
specifically look back for them” (P20; Doctor). For diabetic patients who had blood glucose 
readings taken quite frequently, “the flowchart screen looked quite complicated, as each 
result generated an additional column for that day, therefore requiring more scrolling left 
and right to check each result. This appeared to frustrate the doctor.” (Observations; Ward 
D.5) One pharmacist also highlighted a further risk when scrolling down the different clinical 
tests ordered, as there were “so many fine lines” that she could easily “misread by a line” 
(P23; Pharmacist). This may explain why doctors were often observed “holding a finger up 
onto the screen just below a particular test and scrolled the mouse left and right holding their 
finger as a focusing point to keep track of the particular reading of interest”.(Observations; 
Ward D.5) Furthermore, users did not have the option to view an individual blood test e.g., 
creatinine, in a table on its own; one renal doctor felt that this made it more difficult to “look 
at the trends in the blood tests and data” (P29; Doctor) because the screen contained lots of 
Additional columns created 
for each lab test result 




information. For some clinical tests e.g., blood glucose levels, it was important to compare 
results that were taken at specific times in the day i.e., a pre-breakfast result taken on one 
day with a pre-breakfast result taken on another day. Displaying the results vertically (see 
Figure 13) (rather than horizontally (as shown in Figure 12) would have allowed the user to 
compare results in this way. Consequently, one doctor felt it took “longer to analyse” blood 
test results presented horizontally and was more “prone to mistakes” (P26; Doctor). Another 
doctor shared a similar view explaining how it was “cognitively a bit smoother” (P26; Doctor) 
to interpret the information displayed in a paper insulin chart, as it included important 
contextual information about the dose time such as “breakfasts in a vertical line, lunch and 





7.2.2 Viewing test results in a graphical format  
Unlike viewing results in a table view however, it was possible for a user to view the results 
of an individual blood test in graphical format by ticking the box corresponding to the 
particular test (point 1, Figure 14), and then clicking on the graph icon in the top left-hand 
corner of the flowsheet screen (point 2, Figure 14). 
 
 
All results taken at breakfast listed vertically 
aiding review of readings taken at similar 
times of the day (compare like with like). 
 
Figure 13: Example of a typical paper blood glucose monitoring chart, showing results 









Figure 14:  Screenshot to show process for generating a graph for an individual blood test 
result 
 
One doctor found this functionality (to generate graph) really useful as it enabled him to view 
a specific trend in one or multiple test results over time.   
“You can tick sort of potassium, creatinine and urea and then you can graph them to 
show a trend, which is quite good so you can see their baseline and whether they’re 
near it or above it, which is handy and I do really like that functionality because you 
can do that with things like [blood] sugar as well” (P20; Doctor). 
However, some users experienced challenges with using this functionality, such as some 
graphs lacking key information e.g., dates, or the system failing to generate a graph if one 
particular test result value came back from the lab with an erroneous reading. This meant 
that the user had to “find that error value [in the original table] and then get rid of it and 
then reselect all the ones and then graph it” (P29; Doctor), which one renal registrar found 
1. Tick the particular result  




“silly [because] it should just miss [it] out, if there’s any errors or different units it [the system] 
(…) it should just figure it out and then give you at least a rough idea so you can actually see 
a trend” (P29; Doctor). Furthermore, one user also described how she could not generate a 
graph beyond a certain date, which was challenging when the user wanted to extrapolate 
from the data and predict when a patient may need dialysis. Consequently, the user 
sometimes had to draw the graph by hand, which took additional time.   
“There’s some flaws in the system where sometimes if you go back to a certain date you 
can’t actually plot out the graph and it is very difficult then, especially when we’re 
predicting when someone is going to need dialysis so then we just have to sort of revert 
back to the paper system and do them by hand” (P29; Doctor). 
Further investigation of this revealed that for a short period of time the laboratory 
department were entering creatinine results into the system that were in a different format 
of measurement than those that they had used previously (i.e., ml/min/1.73m2 compared to 
ml/(min)/(1.73m2) ). The ePrescribing system therefore could not interpret these results, as 
all results should be in one standardised unit of measurement, and subsequently it was not 
possible to create a graph for patients who had a creatinine result reported during this 
period.  
7.2.3 Difficulties documenting allergy information 
Users liked the way that the patient’s allergy status e.g., amoxicillin: ‘rash’, was presented in 
the top left corner of the computer screen, although some felt that the colour was not “really 
explicit” (P23; Pharmacist) and the content rather restrictive. One doctor explained how she 
needed to click on the allergy box to bring up another screen with specific information about 
the particular allergy which felt a “little bit tedious” (P8; Doctor). The process of documenting 
an allergy was considered to be “quite time consuming” (P25; Doctor) with “a lot of drop 
down boxes and a scroll through list with all the various different types of reactions” (P25; 
Doctor). A pharmacy technician was observed “trying to document ‘wasp sting’ as an allergy, 
but couldn’t because this was not a coded option from which the user could select from” 
(Observations; Ward C.2,). One doctor described how classifying the severity of the allergy 
on the system as either “mild, moderate, [or] severe” (P7; Doctor) was quite subjective and 
open to misinterpretation with some selecting ‘severe’ for “like a rash or for angioedema 




entered and so some users found it frustrating that they could not “document exactly what 
the allergy is [was]” (P12; Doctor). 
7.2.4 Difficulties viewing free-text medication-related information  
Users were not required to provide a reason on the system for why they may have chosen 
to stop or temporarily suspend a medication (e.g., an anti-hypertensive while the patient had 
acute kidney injury). However, this was important information for other healthcare 
professionals to know and one doctor felt that it should be made a mandatory field: “you 
think “OK the drug was suspended and there wasn’t a reason given and in the “see other 
comments” there is no comment so you just keep it suspended because you think that there 
may be a reason” (P11; Doctor). Even with mandatory fields, another doctor admitted 
entering vague information like “…‘on-admission’ or something” (P18; Doctor) if he had 
either forgotten or did not know the reason for prescribing a particular drug. He recognised 
that this was his “own shortcoming” but explained how “often they [the patient] don’t know 
either” (P18; Doctor).  
One doctor also described how “from a medical legal point of view” it was important to 
document special instructions related to certain medicines in the system, such as “increase 
the codeine dose from 30mg to 60mg if necessary for pain” (P12; Doctor). However, users 
were sometimes concerned that information entered into a free-text box e.g., special 
prescribing instructions, was not always clearly visible and did not “actually show up really 
clearly to the nurses” (P12; Doctor), thus could be easily ignored or overlooked. One specific 
case that the researcher observed was related to the administration of hydrocortisone to a 
patient with Addison’s Disease. The nurse had either ignored or overlooked a free-text 
comment that had given specific information about the times at which the medication should 
be administered, and had consequently been administering the wrong amount of the 








 “Hydrocortisone had been prescribed at 10mg twice daily, which defaulted to 
administration times at 7am and 6pm on the nurse’s ‘Drug Chart’. A further dose of 
20mg once daily in the morning was also prescribed therefore on the ‘Drug Chart’, it 
appeared as though the nurse should administer 30mg (20mg + 10mg) at 7am and 
10mg at 6pm. However, there was also a comment in a free text box on the 10mg 
twice daily order stating that ‘these doses should be given twice daily at 13pm and 
18pm’ (i.e., the correct dose was 20mg at 7am, 10mg at 1pm and 18pm). The nurse 
however had ignored or overlooked this comment and thus had been administering 
the 1pm dose at the wrong time.” (Observations; Ward A.1) 
A doctor therefore suggested that these special instructions should be “kind of red flagged 
to them [nurses], which [I think] would be an improvement” (P12; Doctor). Free-text 
information was also used to supplement a prescription, when users felt that the basic order 
sentences that were available were either unsuitable or lacked certain information. For 
example, one pharmacist described how they used free-text to correct prescribing errors 
where they would annotate the incorrect order in the absence of the prescriber, with an 
accompanying free-text comment for the nurse administering the medication: “‘should be 
this, just give this’” (P6; Pharmacist). Although the pharmacist admitted that it was “not 
always the right thing to do”, he explained how granting pharmacists “more powers to 
modify or change things through the usual mechanisms [on the system] would be quite 
welcomed” (P6; Pharmacist).  However some pharmacists were also “not sure how obvious” 
their special instructions were “for either the prescriber or the person administering the 
medication” (P19; Pharmacist) and remarked that such information was “probably more 
visually apparent” on a paper drug chart. Furthermore, attempts to make a special 
instruction more prominent by putting “stars and quotation marks and other things” around 
it were often not successful as it “quite often [gets] buried in a whole bunch of other text on 
the screen” (P19; Pharmacist). One pharmacist suggested that the special instruction field 
should appear “in a different colour on the drug chart (…) [to] make it stand out” (P27; 
Pharmacist). 
7.2.5 System restrictions in the free-text comments field. 
The discharge letter contained a free-text comments field, which also posed a particular 
challenge for some users. One doctor explained how only a fixed number of characters could 




changes that were made to a patient’s medications while they were an inpatient. In one 
particular case, the user highlighted how the system had “cut the last five things off” (P26; 
Doctor) so she had to spend time re-structuring the notes to “put all the essential things on 
and abbreviate and fit them in” (P26; Doctor). Similarly, another doctor also discovered by 
chance that after logging in, doctors and nurses saw different amounts of information 
contained in the free-text field on the hospital system in their own screen view. For example, 
the free-text field on the nurse ‘Drug Chart’ view was restricted to “maybe like 12 lines or 
something, so if you go past that [prescribe warfarin doses past the 12-lines] they [the nurses] 
can’t actually see it” (P24; Doctor). Therefore, although a dose may be documented and clear 
on the prescriber’s ordering screen, this doctor found that “often they [the nurse] will ring 
you on call and say ‘it’s [warfarin] (has) not been prescribed’ and it has, it’s there, and we 
realise[d] actually you can type lots of it down, but when the nurses look at it there’s only so 
many lines down they can actually see” (P24; Doctor), which was ultimately confusing.  
Another doctor found it difficult to know where to add the quantity of a controlled drug (legal 
requirement) in words and figures, as it could be entered in a range of different places where 
“sometimes it comes up on the print out and sometimes it doesn’t” (P25; Doctor) Worried 
that it might not appear, she resorted to copy[ing] and paste[ing] the same information into 
four places [on the system] and hope[d] it comes out in one of them” (P25; Doctor).  
“There is a little tab saying ‘Supply’ but it won’t let you write it in words and figures 
there, so then there’s a tab below saying ‘Supply words and figures’ so you write it there 
and sometimes it comes up on the print out and sometimes it doesn’t, so then you can 
go to ‘Special instructions’ and write it there as well. Sometimes that comes up and 
sometimes it doesn’t, so then there’s a different tab across the top called ‘Comments’ 
that you can then write it again and that usually comes up” (P25; Doctor). 
7.3 The use and meaning of symbols 
When the user first logs onto the system and selects a particular ward, they are presented 
with a patient list. The first column on this list, entitled “VIP code” (see Figure 15), sometimes 
contained a ‘star’ icon next to a patient’s name. This ‘star icon’ symbolised that important 
information had been included on the system about this specific patient, such as whether 






Figure 15: Patient List with star icon 
One pharmacist described the “little star” icon as “not that obvious” and “not something that 
you [would] always check” (P6; Pharmacist). Another pharmacist echoed this by explaining 
how the little icon failed to stand out to nurses during a “busy drug round”, thus many nurses 
did not “click on it, to read it” (P27; Pharmacist). A junior doctor described the additional 
steps that he needed to follow in order to view this information: “you’ve got to go into the 
left-hand menu and go to patient information or alerts or something and then only then does 
it tell you” (P15; Doctor). It was not clear to the user that this information was actually 
contained in the ‘Problems and Diagnoses’ tab, and may have been more intuitive to just 
‘hover’ over the star icon to find out the important information. 
Some users also found it difficult to know how to change the default order times for 
medications when they were prescribing because the tab that they needed to click on did 
not include a symbol or icon that resembled ‘administration times’ or ‘modifying a 
prescription’. One doctor described how he had not understood that he needed to click on a 
“grey box (…) with three full stops in it” (P17; Doctor), which would then “bring[s] up [options] 
to change the administration times” (P17; Doctor) (see figure 16). Thus, the process of 
modifying a dose administration time was therefore not considered to be straightforward 
and one doctor commented on how he “wouldn’t have known how to do [it] if I[he] hadn’t 
had the training” (P17; Doctor). 
 




7.4 Challenges with using disparate systems 
The so called ‘discharge system’ was used to prepare a discharge prescription and letter for 
a patient and was a different stand-alone system to that used to prescribe medicines for the 
patient while they were an inpatient (i.e., hospital system). Thus, if a doctor had documented 
a reason why a medication was suspended or discontinued on the hospital system in free 
text, this information did not automatically transfer over to the discharge system. 
Furthermore, some orders such as miscellaneous items that were entered in the free-text 
box (either on their own or selected with other medications in the ‘Medication List’) and 
combination products, such as Co-amoxiclav (clavulanic acid and amoxicillin) or Seretide 
(fluticasone and salmeterol) also did not automatically transfer over. One doctor found it 
“quite frustrating” (P12;Doctor), as he had to open up a small view of each system on his 
computer “to get a side by side sort of comparison of documented meds and discharge 
medications or what they were on (…) and [click] flick back and forth” between them (P12; 
Doctor). Another junior doctor also explained how she had missed these miscellaneous 
item(s) off the discharge prescription a couple of times “because it doesn’t transfer” (P16; 
Doctor). A senior pharmacist explained how the “prescriber has to be made aware that they 
need to re-prescribe it as a discharge order” (P30; Pharmacist), thus introducing an additional 
step in the discharge prescription issuing process and also introduced the risk that the free-
text information about why changes were made, would not get documented on the 
discharge prescription due to a lack of time. The pharmacist often had to “go in and add 
more detail (…) in the special instructions [field]” (P31; Pharmacist) such as the brand or 
formulation of the inhaler e.g., Evohaler, or include combination products that had been 
accidently missed off the patient’s discharge prescription. 
7.5 Workarounds 
As a result of challenges with the system design, users developed workarounds so that they 
could make certain processes either easier or, in their view, safer. Examples included, 
working around mandatory functions in the system that were seen to have imposed 
unnecessary barriers to the workflow process.  
7.5.1 Mandatory functions 
The system had a mandatory field, which asked users whether they had contacted the 




specific time and date be entered on the system before a patient was discharged. However, 
prescribers did not always know this information at the point of completing the necessary 
discharge paperwork as they “couldn’t make a community warfarin appointment until the 
day they were going [home]” (P12; Doctor) and the “warfarin service works by ringing you 
back [with a time and date]” (P13; Doctor). Therefore, some users admitted that they would 
“write what I am intending to do for the warfarin, so if I want them to have a warfarin follow 
up appointment on the Wednesday, even if I don’t have one, I’ll say that [I do]” (P13; Doctor). 
One doctor felt it was better to add an ‘intended’ date because otherwise the system would 
“halt a discharge and upset[s] nurses and upset[s] patients so I don’t find that helpful” (P13; 
Doctor). Another doctor explained how he would “effectively lie on the computer” by saying 
that he had “booked the appointment” (P12; Doctor) but just needed to remember to do it. 
Another doctor described how she “always managed to get an appointment” when she said 
she would, but “would always go back and change it [on the system]” (P13; Doctor) if on the 
rare occasion this was not possible. This clearly created a risk that patients might have 
received incorrect information on their discharge prescription and subsequently miss out on 
post-admission monitoring for a high-risk medication. Reflecting on the discharge prescribing 
process overall, one doctor described the system as “good in the way that it’s prompting you 
to make sure everything is done for the patient before they go” (P12; Doctor) but it was 
possibly “too specific” (P12; Doctor). 
7.5.2 Improve visibility 
If a drug was not administered, the administration box on the system would automatically 
turn from ‘blue’ (the dose was due) to ‘red’ (i.e., the dose was overdue) after one hour. If the 
nurse selected a reason from the drop-down menu e.g., ‘medication not available’ for why 
the drug was not given, the administration box would turn from ‘blue’ to ‘grey’ (the order 
was completed) (See Figure 17) However, one nurse acknowledged how she did not usually 
click the ‘not given’ reason from the drop-down menu, so that the dose administration box 
would remain blue or red, and “indicate that it [the dose] was overdue or still needed to be 
given. This, acted as a prompt that the dose should be given when the stock was obtained” 
(Observations; D.3). If the nurse had signed the dose off as ‘not given’, the dose would not 
appear on the nurse’s drug chart to be given until the following day and the patient may 
unnecessarily miss a dose of their medication. Thus, the colour of the administration box 




round specifically “scroll[ing] up and down the Drug Chart record in order to identify any red 
or blue boxes, which signified doses that were due to be given” (Observations; Ward B.2).  
 
Figure 17: Drug Chart showing overdue (red), administered (grey) and to be given (blue) 
doses. 
 
7.5.3 Clarification or correction of prescribing errors 
One pharmacist recalled how “if a doctor prescribed the wrong Seretide inhaler [on the 
previous paper drug chart] a pharmacist would just change that” (P6; Pharmacist). However, 
it was not possible to change the inhaler device “from an Accuhaler to an Evohaler” (P6; 
Pharmacist) on the new ePrescribing system and so some users used a workaround to save 
time or if the prescriber was not available. This involved signing into the pharmacist 
verification system “and instead of clicking ‘accept’ you can click ‘verify’, which will let you 
modify just about anything with the drug within reason” (P6; Pharmacist). Indeed, the 
pharmacist commented on how this “would be completely illegal” (P6; Pharmacist). This 
pharmacist added that making such changes was reserved for particular errors related to 
“chang[ing] the formulation” (P6; Pharmacist,) rather than “chang[ing] the dose […] because 
that is just not correct” (P6; Pharmacist). 
Complex intravenous antibiotic regimens were also commonly associated with prescribing 
errors (e.g., omission of the appropriate reconstitution solution and line flushes) at the 




for home use. In order to overcome this frequently occurring prescribing error on one ward 
“one of the specialist nurses within respiratory, actually documents antibiotic discharge 
prescriptions for his patients with bronchiectasis” into the “documented medications facility 
within [the ePrescribing system]” (P31; Pharmacist). The doctor then just had to right click 
and ‘convert’ those items from a documented medication into an active ‘inpatient order’ or 
into an discharge prescription order “so that they don’t get missed off” (P31; Pharmacist). 
This was considered to be a good “way of reducing the errors” (P31; Pharmacist) and also 
saved time because any errors made at the prescribing stage had a knock on effect for the 
dispensing stage because home-intravenous medications were “quite long and complicated 
things for us [the pharmacy] to dispense” (P31; Pharmacist).  
7.5.4 Prescribing IV infusions and emergency medication on paper drug 
charts  
It was possible to order IV infusions (e.g., for magnesium or insulin-dextrose) on the 
ePrescribing system, yet some users felt “more comfortable” (P24; Doctor) prescribing these 
on paper. This appeared to be related to a lack of familiarity with how to prescribe infusions 
on the system, in particular when entering “the rate in and drugs”, which this doctor felt was 
just “easier to write” (P24; Doctor) on paper. Some users worried that the prescribing 
guidance entered onto the electronic system, could be interpreted incorrectly by nursing 
staff and consequently, placed some orders both on paper and electronically. One doctor 
remarked how they would “automatically just write it [the IV infusion] on a [paper] drug chart 
because it’s a fluid” (P24; Doctor), even though “some of the nurses aren’t [were not] happy” 
(P24; Doctor) with them doing this.  
Furthermore, if a medication e.g., prasugrel for a patient with a myocardial infarction, 
needed to be ordered in an emergency, some doctors would prescribe the order on a “a 
green photocopied front of the old prescriptions sheet the old drug kardex” (P2; Nurse) 
instead of “log[ging] in and out” (P2; Nurse) of the system. This nurse also described 
problems with administering medication in an emergency such as locating a computer, 
“find[ing] a one that’s working and that’s actually charged up, [and] find[ing] a one that will 
accept your card”, which “if you’re in a hurry and you need to do something” may not be 
practical (P2; Nurse). There were also instances where patients “come onto the ward who 
don’t necessarily get admitted [onto the system]” (P24; Doctor) for example to receive a short 
procedure or test. As the patient was technically not an inpatient, the nurse or doctor could 




bloods [but] you can’t really do anything else on the system” (P24; Doctor) and if the patient 
needed a “medication or something (…) you have to just do it on a paper one [chart]” (P24; 
Doctor).   
7.6 Chapter Summary 
This chapter explored the various key challenges facing users when using specific design 
features of the system. Firstly, the researcher discussed the specific challenges of the 
medication list, including those relating to how medications were displayed and the dangers 
posed by a lack of stop dates on the medication list view. There were mixed views about the 
order in which the ‘Medication List’ should be presented, with some users displaying the list 
alphabetically, rather than chronologically, which in turn made it difficult to understand the 
sequence of the prescribed drugs. Others found the alphabetical list useful, as they expected 
to see ‘Aspirin’, for example, close to the top.  
The researcher also described the challenges of viewing test results in both table and 
graphical formats, including the amount of scrolling that was required to view test results 
over time in a table format and the inability to generate a graph if there was an error with 
an individual test result. Users described how it was difficult to interpret patient’s blood 
glucose readings over time when they were presented horizontally in chronological order, as 
it made it challenging to compare the time of day the test was taken e.g., a pre-breakfast 
reading, with another pre-breakfast reading to identify a trend.  
A number of challenges related to viewing and documenting information on the system were 
discussed, including more specifically a patient’s allergies and medication-related 
information, such as the reason why a medication had been suspended. It was also apparent 
that some information that was documented by a doctor in the ‘special comments’ field was 
not always visible to the nurse, and therefore important information could be missed. The 
researcher also identified how restrictions in some free-text fields meant that some 
information could be ‘cut off’ and not visible to other users.  
This chapter also described some of the difficulties users had with understanding the use and 
meaning of symbols. For instance the use of a small star to indicate that the patient had 
MRSA was not that obvious, and some symbols did not resemble their intended meaning. 
The use of disparate systems and issues related to information not been reliably transferred 




this chapter highlighted some of the workarounds users have taken in order to carry out 
certain processes either more quickly to overcome specific limitations of the system’s design.  
In order to address some of the challenges posed by the specific design features and 
limitations of the system, users and the hospital’s system development team customised the 
ePrescribing system in a number of ways. The next chapter describes the customisations 
made to three key features in the system: (1) the medication list, (2) insulin ePrescribing 



















What are the benefits and challenges of customising a 
commercial electronic prescribing system? 
The commercial ePrescribing system in place at the study site had been internally customised 
after its initial implementation. Some of these changes were made by users, in order to 
overcome some of the challenges discussed in the previous chapter. Similarly, the hospital’s 
system development team made changes to the system in order to improve patient safety 
and efficiency. This chapter discusses some of the benefits and challenges of customising a 
commercial system focusing on three key areas: (1) medication and patient lists, (2) insulin 
ePrescribing functionality, and a (3) pharmacy task list, based on the findings from the main 
study. 
8.1 The benefits and challenges for users when customising the 
Medication and Patient Lists. 
 
8.1.1 Customising the Medication List 
As discussed in chapter 7, users could not see certain pieces of information on the 
‘Medication List’ tab view (e.g., medication stop date) unless they scrolled left or right across 
the screen. Some users therefore customised their ‘Medication List’ tab view in order to be 
able to see this information. However, not all participants were aware that this customisation 
could be done, with one junior doctor explaining how he “didn’t even see the customise view 
button until somebody [in microbiology] showed it” to him (P20; Doctor).  One senior 
pharmacist customised the ‘Medication List’ tab view, so that she could see the “start date, 
stop date, [and] the drug” (P23; Pharmacist). However, this came at a cost, as information 
(such as the name of the prescriber) was now out of her immediate view. In contrast, another 
senior pharmacist chose to prioritise the name of the prescriber as she felt that it was more 
important to be able to quickly identify and contact them if there was an issue with a 
prescribed medicine.  
 “No, the thing that I do have [on the ‘Medication List’] though is the person that 




I’ve got the start and the stop date after the drug name so I might have to scroll to 
the right in order to find it” (P30; Pharmacist). 
This pharmacist also customised the layout of the screen such that ordered (active) 
medicines were at the top and those now completed (inactive) were at the bottom (See 
Figure 18). In her opinion, this made the list “easier to scan through” (P30; Pharmacist).  
 
Figure 18: Customised ‘Medication List’ tab view, showing ordered medicines at the top 
(active) and those completed (inactive) lower down. 
It was possible for the layout of users’ screens to differ and the researcher queried what 
impact this might have when users were looking at the screen “using another user’s log-in 
details” (Observations; Ward B.3).One doctor explained how “everyone looks on mine [my 
screen] and says ‘oh that looks wrong’ so I don’t quite know what I’ve done” (P13; Doctor). 
Some users found the font size on the ‘computer-on-wheels’ devices “quite small” (P22; 
Doctor) and increased it to make it more visible. However, one nurse described how 
increasing the font size meant that you now had to scroll more, which resulted in her 
“missing drugs and doses and stuff like that so I [she] just went back to the generic setting” 
(P4; Nurse). 
8.1.2 Customising the patient list 
Some users customised their ‘Patient List’ view tab in such a way as to group patients either 




bays within a ward (e.g., bays 1 and 2) (See figure 19). One nurse described how she had 
“split the ward into two” (P9; Nurse) on the system so that she could concentrate on one 
section at a time. She also encouraged other nurses to do the same as she felt it helped her 
to “minimise error” (P9; Nurse). One of the doctors explained how this customisation had 
also helped him locate information more quickly: “if [I] need to know whose patients and 
things and who to call, it’s quite quick reference” (P17; Doctor).  
 
 
Figure 19: Selection of individual wards and bays that can be displayed on the Patient List. 
However, the process of customising the ‘Patient List’ was not simple and was described by 
one user as “a nightmare” (P15; Doctor). He found it difficult to locate the “very small little 
drop down box” that was required before he then “select[ed] like location and then like 
encounter types [inpatient/outpatient]” (P15; Doctor). He described how if you selected the 
specific ward you wanted, then the danger was that every patient who had ever been on 
that ward appeared. This made it very difficult for him to find any of his patients; 
consequently he viewed the system as “backward” (P15; Doctor). 
8.2 The introduction of Insulin ePrescribing functionality  
 
8.2.1 Changes to how insulin was prescribed and monitored 
On July 14th 2015, ‘Insulin ePrescribing’ was introduced at the research site; this introduced 




that insulin could now be prescribed electronically “on [the system] from anywhere in the 
hospital” (P16; Doctor). This was viewed as an improvement, as previously insulin was 
prescribed on a paper drug chart. Secondly, a continuous prescription could now be 
generated for the patient on admission, with the same ‘default’ dose given every day, 
regardless of the patient’s blood glucose levels or clinical condition. This was in contrast to 
the previous prescribing process where, “a day’s worth of insulin [would typically be 
prescribed] and then they [the prescriber] would prescribe it again the following day and 
again the following day” (P30; Pharmacist). Thus, the patient’s insulin was reviewed on a 
daily basis, with dosage adjustments made according to the patient’s clinical condition. 
However, one pharmacist described a possible issue related to the frequency of medication 
reviews noting that “the risk now is [that] they forget to review it [insulin] and the patient 
gets the dose anyway and that might not be appropriate” (P30; Pharmacist). However, during 
the development of insulin ePrescribing, the system development team had sought the input 
of a local diabetologist who felt that it would be “worse if a patient doesn’t get their insulin, 
than if they get a dose of insulin that is maybe a couple of units more or less than what it 
should be” (P32; Pharmacist) justifying the decision to use a default daily dose of insulin. The 
input of the diabetologist was considered important by a pharmacist who was involved with 
the development of the insulin ePrescribing functionality, as they were able to reassure 
prescribers who resisted using the system that “you’ve gone through that [development] 
process and they go ‘oh...good point’” (P32; Pharmacist).  
Thirdly, insulin had to now be prescribed using an order set (Figure 20), which was described 
by one doctor as “a bit faffy” because they had “to like scroll down, find the insulin type that 
you want, tick it and then you click OK and then it opens up a separate page where you’ve 





Figure 20: Insulin Order Set 
 
However, this also meant that pharmacy staff could not document insulin in the electronic 
‘Documented Medications’ tab (the electronic medication history) as it was part of an order 
set and instead now needed to be recorded “as a miscellaneous prescription” (P31; 
Pharmacist). This involved typing in the specific insulin product and doses as free-text, which 
was more error prone. The insulin product e.g., Humulin M3 would also appear under ‘M’ 
[for Miscellaneous] on the ‘All Active Medication List’. In contrast, if this had been prescribed 
by selecting the structured option from the order set, Humulin M3 would appear under ‘H’ 
on the same list. This was potentially confusing for users as all of the insulin orders may be 
in different places.  
8.2.2 Changes to how blood glucose results were recorded 
The ‘Glucose Monitoring View’ was developed by the local system development team and 
displayed all anti-diabetic medicines (e.g., metformin) together with (a) any other related 
medicines (e.g., steroids) that could affect glycaemic control, and (b) relevant tests (e.g., 
blood glucose readings) on the same screen. This was considered to be “quite handy” (P20; 
Doctor) by one junior doctor. However, it was possible that other clinicians may have been 
unaware of this screen view, as they needed to first select ‘Glucose Monitoring View’ from a 






Figure 21: Medication monitoring view, with options to select view of the Glucose 
Monitoring View, Coagulation View, and General Lab Results 
 
The blood glucose readings themselves were entered on the system, either manually by a 
nurse or via Bluetooth from a blood glucose reader (which was linked to the system). This 
was considered by some as being helpful as “you can track the BM’s (blood glucose 
monitoring) […] against the insulin doses” and get “a running log basically of exactly what 
they had” (P23, Pharmacist) all from within the same screen. Indeed, one junior doctor felt 
that insulin ePrescribing was more time efficient than the handwritten alternative, as “you 
can just sit at a computer” (P16; Doctor) in one location and alter the dose, rather than have 
to visit each ward to make the change for all patients.  
However, there were some limitations.  For example, one pharmacist expressed concerns 
about the ease of remote access and how some important information, such as whether “the 
patient [had] eaten, [or were] they nil by mouth” (P23; Pharmacist) might not be on the 
system. There was therefore “a danger of [prescribers] just looking at a computer screen 
seeing the result and going “oh right yeah the BM is high let’s give them something”, but you 
don’t actually know what’s going on” (P23; Pharmacist). One junior doctor also 
acknowledged this risk, but felt that “most of the information you can get over the phone” 
(P16; Doctor). Furthermore, it was suggested that blood glucose results were not always 
available in ‘real-time, which could be dangerous if users made decisions based on outdated 





“And I don’t know as well whether there’s a bit of a delay or what the delay is in-
between taking the reading and it uploading onto the system as well” (P30; 
Pharmacist).  
Also, when blood glucose results were documented on paper, the staff member responsible 
e.g., nurse or healthcare assistant, “were very used to measuring the blood glucose, looking 
at the result, writing the result down and then acting on it if they needed to” (P30; 
Pharmacist). One pharmacist believed that these nurses or healthcare assistants were also 
more aware that they had documented a clinically relevant result onto the paper chart or if 
a trend was emerging than when results where entered automatically. She also added that 
“because the ‘writing-it-down’ step has [had now] been taken away, the ‘acting-on-it’ step 
seems to sometimes not happen” (P30; Pharmacist). She also hypothesised that certain staff, 
like healthcare assistants, “might not be as trained to recognise when something isn’t quite 
right” (P30; Pharmacist).  
Finally, the system could not process blood-glucose results directly from a patient’s own 
monitoring device (as opposed to the hospital Bluetooth devices) so the result “wouldn’t 
automatically go on [the system]” (P30; Pharmacist). Instead, nurses were supposed “to 
check with the patient how many units they did actually self-administer and then 
retrospectively upload that data” (P30; Pharmacist). This pharmacist questioned the 
workings of this new process as health care professionals (nurses or healthcare assistants) 
relied on the patient to accurately recall the right result(s) and input these correctly. 
8.3 The benefits and limitations of an internally developed pharmacy 
task list 
The system development team produced a ‘pharmacy task list’ in the ePrescribing system 
(see Figure 22). This was a list of ‘high priority’ tasks that needed to be performed for certain 
patients within a selected ward or clinical area. Tasks were automatically added to the list, 
like when a ‘high-risk’ medication such as warfarin, insulin or an antiepileptic was prescribed. 
A user could also create a task that prompted another member of staff to review a patient if 
they had concerns. For example, one senior pharmacist noticed how some of the junior 
pharmacists had set up tasks related to “U&E triggers and that kind of thing so (…) [there 
are] a lot of different ways to prioritise who you see first” (P27; Pharmacist). As all members 
of the pharmacy team (i.e., pharmacists, pharmacy technicians and pharmacy assistants) 




information within the system. For example, staff working within a clinical area could create 
“clinical handover[s] or a pharmacy supply handover[s]” (P21; Pharmacist) to advise their 
colleagues that a patient had certain administration requirements, which would be visible, 
even if the patient had been transferred between wards. Another pharmacist described how 
the task list was beneficial because he could “see any discharges there, any medication 
histories needing doing, any urgent handovers” (P6; Pharmacist). He found this particularly 
valuable when he was “the only pharmacist for the directorate and because of sicknesses, 
absences, holidays, meetings, (…) [he was responsible for] 7 or 8 wards” (P6; Pharmacist). 
This was echoed by a second pharmacist who explained how he would have never known if 
a patient was on a ‘high risk’ medication unless he “was physically on the ward checking 
[their] medical notes” (P21; Pharmacist) and so he “would have to spend a couple of hours 
on such and such ward and another couple of hours on that ward” (P21; Pharmacist). High 
risk patients, such as those on lithium or phenytoin, were now easier to identify using the 
task list, which meant that he was potentially able to resolve issues quicker and possibly care 
for more patients. Users were also able to add tasks manually, thus helping to “target [their] 
workload a little bit better” (P30; Pharmacist). 
 
 









In contrast, one pharmacist described how the task list had “indirectly increased our [the 
pharmacy team’s] workload” (P21; Pharmacist) as he “would have never been asked to cover 
more than one ward in the past” (P21; Pharmacist).  
Users also discussed some further limitations of the pharmacy task list. Firstly, it could not 
prioritise high risk patients, but only signalled if they were on high risk drugs. For example, 
the system only informed the pharmacist “if phenytoin or carbamazepine has been 
prescribed”, and not “if there’s an epileptic patient on the ward” (P21; Pharmacist). One 
pharmacist felt that it was more prudent if she saw a patient on a “high dose opiate” (P27; 
Pharmacist), than on the high risk drug carbamazepine, even though no alert was triggered 
for the former drug. The system, in this case would be unable to provide information that 
would allow the pharmacist to distinguish between whether the user was taking 
carbamazepine for pain, or for the high risk indication epilepsy, contributing to this 
ambiguity.  
“It [the task list] triggers an alert for carbamazepine and most patients that are on 
carbamazepine, certainly in my experience, are on it for pain and whilst they need 
seeing, while I’m doing that I’m missing somebody that’s been admitted on a high 
dose opiate” (P27; Pharmacist). 
Secondly, and related to this, if a high risk drug e.g., insulin had not been prescribed for a 
diabetic patient, perhaps because it had been accidently missed on admission, the pharmacy 
task list would also not be able to “flag those things up” (P30; Pharmacist).  
“The thing that it can’t do is, so it can’t identify when a patient who normally is on 
insulin hasn’t had their insulin prescribed and that I think is a bit of a risk so we’re 
very pro-active about targeting high risk things that have been prescribed, but we 
probably end up missing more things that aren’t prescribed appropriately because it 
can’t flag those things up” (P30; Pharmacist). 
To mitigate these two limitations, the pharmacy team introduced a new service whereby the 
pharmacy technician who performed a medicines reconciliation review (the process of 
performing medication history and supplying any medications) “assign[ed] a priority level to 
the patient based on their clinical judgement” (Observation; Ward C.2); this was entered into 




medicines would be classified as high risk” (Observation; Ward C.2), as would patients with 
complex health needs. 
A third limitation of the pharmacy task list was that not all medicines perceived as high risk 
were actually added to the list. One pharmacist noted how “we’ve got warfarin [but] we 
don’t have [triggers for] any other NOACs [novel [Direct] oral anticoagulants]” (P27; 
Pharmacist) and another pharmacist noticed how “some of the antiepileptics do not 
necessarily create an alert” (P21; Pharmacist), which appeared to frustrate them, as they 
thought that “if we create[d] an alert about phenytoin, I don’t see why we shouldn’t do 
sodium valproate or topiramate” (P21; Pharmacist).  
A fourth limitation of the pharmacy task list was that it also did not consider external factors, 
such as the type or speciality of the ward. For example, a cardiology pharmacist explained 
how her ward had a high patient turnover, which shifted the priority towards managing those 
patients who had either been newly admitted or were being discharged, rather than 
reviewing longer-stay patients. She acknowledged that although her workload was guided, 
in part, by the task list, she also felt that it was important to see, “what’s been written on the 
ward board, nursing staff coming and saying that there’s a discharge or [Name] phoning me 
to say they’ve just put another discharge on” (P31, Pharmacist). Another pharmacist 
explained how you “just have [to] use your own judgement” (P23; Pharmacist) because “the 
system is never going to be able to completely recognise” the different priorities and urgency 
of some pharmaceutical care issues. 
Some pharmacists therefore kept a paper ‘to-do’ list. One pharmacist checked the “electronic 
task list and then printed a patient list, which he would annotate with notes such as ‘DHx[drug 
history] to do’ and information about drugs that required monitoring/or were in need of a 
review and this was then used as his ‘working task list’” (Observations; Ward B.1). The paper 
task list was useful for this pharmacist because he could add tasks that he considered 
important (albeit in paper) but were perhaps not classed or detected as ‘high-risk’ by the 
system. Examples included “GKI [Glucose, Potassium, Insulin Infusion] and heparin infusions, 
which may still be documented on paper” (Observations; Ward B.1). 
Another senior pharmacist commented that “when she was doing her surgical rotation she 
did not use a paper list as the turnover was so high” (Observations; Ward C.1). In contrast, 




there was a higher proportion of patients staying for longer on this ward compared to the 
elective surgical ward and working practices varied. It was noted during the researcher’s 
observations that the electronic task list contained tasks “that were outdated e.g., a one for 
20th Feb: ‘check INR’ although this was a month ago” because the user had not ‘signed off’ 
tasks that had been completed, on the system” (Observations; Ward D.2). This emphasises 
the importance of maintaining the task list, especially when patients have been in hospital 
for a significant amount of time. 
8.4 Chapter Summary 
This chapter describes the various benefits and challenges experienced by users and the 
organisation’s system development team when customising specific features of the system. 
These included: (1) customisation of the screen layout, which made it easier to view certain 
key pieces of information to improve patient safety. However, this sometimes came at the 
expense of making other information less visible and users were not always aware of how to 
customise their ‘Medication List’ view; (2) the inclusion of insulin ePrescribing and electronic 
recording of blood glucose results, which potentially contributed to safer and more efficient 
insulin prescribing. However, it also possibly contributed to clinical decisions being made in 
the absence of information that was not available on the system such as whether the patient 
was fasting; (3) the pharmacy task list allowed users to prioritise their workload and work 
more efficiently. However, some users highlighted shortcomings of this tool and were 
concerned that it lacked the sensitivity to detect all high-risk patients. 
The system development team also introduced a range of CDS functionality into the system, 
incorporating a combination of approaches such as interruptive alerts and more passive 
methods (e.g., the use of colour coding, order sentences, order sets and favourite lists, or 
mandatory fields). The following chapter outlines the benefits and challenges associated 








The benefits and challenges of interruptive and passive 
Clinical Decision Support approaches  
The previous chapter provided an overview of how a commercial ePrescribing system had 
been internally customised by both users and the hospital’s system development team after 
implementation. It focussed on the customisations made in certain three key areas: (1) 
medication and patient lists, (2) insulin ePrescribing functionality, and a (3) pharmacy task 
list. The system development team also incorporated a range of CDS functionality, including 
both interruptive (e.g., alerts) and passive approaches (e.g., order sentences and visual aids 
such as colour) that helped guide users through the medication use process. This chapter will 
explore the use of interruptive and passive CDS approaches and describe users’ perspectives 
on the benefits and challenges of using these types of functionality based on data from the 
main study.  
9.1 Interruptive Clinical Decision Support 
 
9.1.1 Clinical Reminder 
CDS alerts were used to support prescribers when writing a prescription for a patient. One 
doctor described how some alerts, such as the warfarin review alert, were particularly 
“useful (…) if you don’t know the patient” as “it pops up and you’re like they’re on warfarin” 
(P13; Doctor). Another junior doctor also appreciated how the alerts reminded him to review 
a patient or medication, particularly if he was “having a really busy day and you’ve got to 
prescribe loads of stuff and then you go’ actually I’d forgotten about that’” (P15; Doctor). 
One doctor also suggested developing an electronic task list or ‘jobs list’ for doctors, which 
“deliver alerts all together” (P11; Doctor) that they needed to follow up on, such as review a 
patient’s blood glucose level or antibiotics. This could potentially be used instead of or 
alongside interruptive alerts so that even if alerts were overridden there would be a 
permanent place on the system that users could visit and visually see a list of tasks that still 
needed to be performed.  
Users also commented on the potentially beneficial role of CDS for ‘boardered patients’ 




staying on an alternative ward, e.g., a renal patient staying on a general medical ward) as 
they potentially helped guide decision making for patients with co-morbidities that extended 
beyond their specialism. Renal patients were often under the care of various clinical teams, 
and one renal doctor suggested “having an alert for people [clinicians] who come to our ward 
to prescribe for our [renal] patients just to remind them that actually this is a kidney, this is a 
dialysis patient” (P26; Doctor). Therefore, the CDS could highlight important issues that non-
renal-specialist care providers may not be familiar with, such as dosing requirements or 
blood monitoring.   
“We have a lot of outliers, vascular teams and things like that and I just wonder 
whether it [the special prescribing needs of renal patients] gets thought about so 
much.” (P26; Doctor) 
For doctors who specialised in renal medicine an Acute Kidney Injury (AKI) alert was 
considered as not “particularly helpful” (P7; Doctor). In this doctor’s view such alerts were 
superfluous as the user “already knew the patient had an AKI and you were already trying to 
manage it” (P7; Doctor). She also described how the alert had not triggered for certain 
patients in the past, such as those who had a “really bad CKD [chronic kidney disease] or 
someone who was having [a] massive GI [gastrointestinal] bleed” (P7; Doctor). The system 
development team decided to subsequently switch this alert off on the renal ward.  
Interruptive alerts also reminded doctors that they needed to review certain medications. 
One doctor “like[d] the way” the system had in-built alerts that reminded her of “medication 
[stop dates] and keeps on reminding you of medication, if you don’t review it” (P11; Doctor). 
However, a pharmacist suggested that users ought to be required to enter a stop date for 
medications that normally have a short course length e.g., electrolyte replacement therapy, 
as prescribers “shouldn’t be able to prescribe them [phosphate or potassium supplements] 
without a stop date” (P21; Pharmacist). This was because there was the risk that if a stop 
date was not added, the prescription could continue for longer than intended. As a result 
“you see people on Sando K [an oral potassium supplement] for two weeks” (P21; 
Pharmacist), which could result in hyperkalaemia (a higher than normal potassium level) 
from overtreatment. A doctor agreed, and went as far as suggesting that she “would quite 
like not to be able to prescribe things like Sando K (a potassium supplement) without there 




question of whether the entry of certain information should be a mandatory requirement in 
placing some orders. 
Another doctor felt that the content of some medication review alerts could also be 
improved as they were “a bit non-descript in that it just says: ‘this is finished’ (…) but again 
it doesn’t differentiate between what’s sort of significant” (P20; Doctor). A pharmacist also 
commented on how the content of the “window that comes up with BNF advice” (P21; 
pharmacist) was “not really small enough or concise enough”, and sometimes presented “a 
whole page [of information] there” (P21; Pharmacist). In his view, the important points such 
as “prescribe daptomycin CK [creatinine kinase tests] before and once a week” (P21; 
Pharmacist)” could be easily missed or ignored. Another pharmacist felt that warnings should 
move beyond simply stating that there was a problem and provide specific “information of 
[on] why a pop up has come up when they’ve decided to prescribe that medicine” (P31; 
Pharmacist).  
9.1.2 Alert Timing  
The time at which alerts were presented to users was also felt to be important, and in some 
cases was found to be inappropriate. For instance, one doctor commented on how an 
antibiotic review alert often seemed to appear when they were “in the middle of doing 
something else and so (…) you usually just click out of them and try and get on with what 
you’re doing” (P7; Doctor). This may have implications for patients, as another doctor 
explained how he had received an alert about an “antibiotic (…) that’s passed its review date” 
at the same time as receiving other non-critical alerts, and consequently had mistakenly just 
clicked through and “disregarded it as a useless box” (P20; Doctor). Users often became 
desensitised to multiple warnings, which were displayed at the same time. Indeed, one 
doctor described the medication review alerts as “a big grey thing, with a thing on it saying 
(…) ‘to review this’ ” and she admitted just “click[ing] it off” (P24; Doctor). Instead this doctor 
suggested that the system development team should consider changing the colour of these 
alerts from grey to green or to another more appropriate colour so that they stood out.  
“If they [system development team] maybe just changed what they [the alerts] 
looked like we’d be like oh ‘what’s this?’ and look into it a bit more.  Make it like green 
or something.  But until something happens like the antibiotics [an incident involving 




everything until something bad happens and then, you get a bit complacent I think” 
(P24; Doctor). 
One doctor also felt that it would be “helpful and less [of a] nuisance” if alerts were delivered 
“all together” (P11; Doctor) for one patient so that they could work through them at their 
convenience. However, this doctor also acknowledged that interruptive alerts were useful in 
a handover situation, particularly “if it’s not your patient [then] the [system] tells you 
something is going on with that patient” (P11; Doctor).  
9.1.3 Drug-Drug Interaction and Contraindication Alerts 
A further key role of CDS at the prescribing stage was to remind a prescriber about the 
consequences of ordering two interacting drugs together or drug contraindications. Doctors 
welcomed alerts that provided them with clinical information that could inform their 
decision making. Doctors found an alert that warned them about the risk of overgrowth of 
Clostridium difficile in patients who were prescribed a proton pump inhibitor (PPI) with 
antibiotics particularly useful because it usually prompted them to “suspend their [patient’s] 
PPI or switch to ranitidine” (P20; Doctor). However, another doctor had witnessed a 
prescriber “suspend a PPI [proton pump inhibitor] when they’re [the patient was] only getting 
two doses of antibiotics so it didn’t really need suspending, [but] because that warning comes 
up, then they did that” (P12; Doctor). In this particular case, the patient was then prescribed 
ranitidine as an alternative to the PPI but “would have been better staying on the PPI” (P12; 
Doctor) as they had a stomach ulcer. One doctor suggested that certain information, which 
is currently available within the system, needed to be incorporated into the algorithms 
behind the CDS functionality.  For instance a PPI/antibiotic warning would only be generated 
“if the stop date [of the antibiotic] is more than however many days (…) and ignore it if it’s 
only [a short course]” (P12; Doctor).  
The ePrescribing system had the capability to warn users about all drug-drug interactions, 
however, the system development team had chosen not to switch on this functionality with 
the exception of a few drug-drug combinations, which were “a real issue” (P32; Pharmacist). 
During testing, the system development team had found that many of the alerts that had 
been generated by the system were for medication combinations that were often “used 
therapeutically in this organisation” (P32; Pharmacist). One doctor valued this absence of 
drug-drug interaction alerts because the system: “doesn’t ever stop you, which is great when 




acknowledge that some alerts may be useful for “FY1s, [foundation year 1] FY2s [foundation 
year 2] or even some of the stranger [less common] ones [interactions]” (P12; Doctor) where 
users may lack the knowledge to identify potential issues.  
Although the system development team had intended to improve user satisfaction by 
limiting the volume of alerts presented, a lack of drug-drug interaction CDS in contrast also 
had been associated with some specific problems. Firstly, one doctor thought that it was “a 
bit useless having a computerised system that is not being utilised to do things like that 
[interaction checks], to link to the BNF [British National Formulary] to have these things (…) 
[it was] “a bit of a loss that they’re [the organisation] not using the system a bit better in 
terms of safety” (P26; Doctor) to prevent errors. One junior doctor thought that the system 
“shouldn’t allow you to discharge a patient from hospital on two drugs that are, you know, 
contraindicated” (P15, Doctor). Another doctor, who had previously worked at a different 
organisation where drug-drug interaction alerts had been used more extensively, also 
commented on how there was “nothing stopping you prescribing aspirin, clopidogrel, 
warfarin, tinzaparin (all drugs with antiplatelet/ anticoagulant properties) every combination 
you want” (P12; Doctor), which could have serious clinical consequences for the patient i.e., 
bleeding. Instead, another doctor posed that “if a drug does interact (…) it would be good to 
have a box, a small box come up with a short, succinct reason why” (P25; Doctor) for the 
prescriber to consider. In contrast, one newly qualified junior doctor actually felt that drug-
drug interaction alerts were not necessary in the clinical area (cardiology) where he worked, 
as the drugs “work in quite good harmony” (P18; Doctor). Even if a patient was prescribed a 
standardised group of medicines for the treatment of myocardial infarction (MI), for 
example, it is dangerous to assume that these drugs would not interact with any of the 
patient’s pre-existing medications or would be contraindicated based on any of the patient’s 
pre-existing conditions or changing pharmacokinetic and pharmacodynamic parameters.  
Furthermore, it was possible for users to assume that certain drug-drug interaction checks 
were taking place when in fact, they were not. One pharmacist commented on how “people 
think it’s more clever than it is” (P31, Pharmacist) and could contribute to additional work 
for the prescriber. During observations the researcher noted how: 
“A prescription for Ticagrelor (an antiplatelet) was generated by a junior doctor, an 
alert appeared, which stated that ‘no drug interaction checks were being performed 




performed for all other drugs. However, although the system was performing 
background checks, alerts were currently switched off and therefore would not have 
been presented, even if a potential drug-interaction did exist” (Observations; W24.4, 
Cardiology Ward).  
Realising that the system did not perform all drug-drug interaction checks, a junior doctor 
commented on how he had to manually search for information about drug interactions that 
took time and how it was likely to be more efficient for the computer to do.    
“It’s actually quite difficult if you prescribe something to go and look up every 
interaction in the back of the BNF, but for a computer to do it, it’s really easy because 
it just cross-references it doesn’t it, with other drug names” (P15, Doctor) 
The system did however utilise drug- allergy warnings that were generated if a medication 
or substance was prescribed that a patient had a documented allergy to, or was at a high risk 
of causing a cross-sensitivity reaction. For example “if you say ‘someone is allergic to 
tramadol’ and you prescribe codeine it still goes ‘ding”’ (P15; Doctor), which allowed the 
prescriber to use their “clinical judgement” (P15; Doctor)  and decide how they were going 
to manage that problem. 
9.1.4 Alerts generated at administration stage 
Interruptive alerts were also used at the administration stage. One senior nurse liked a 
“reminder” alert generated by the system, which prompted him to check whether the 
controlled drug that he was about to administer was the correct preparation (i.e., modified 
release or immediate release) (P4; Nurse). He felt that it was probably beneficial for junior 
staff nurses “because it makes them question what they’re doing so they might have to ask 
somebody else” (P4; Nurse). One nurse also valued how the system “alerts you straight away 
(…) if you, click on to go and give them their paracetamol, [too early] not realising that it’s a 
few minutes out” (P3; Nurse). In contrast, another nurse described her frustration with this 
alert, explaining how the paracetamol alert prevented her from signing the dose off ‘as given’ 
until the minimum time dosing interval had been reached (i.e., the previous dose of 
paracetamol must have been administered at least 4-hours ago). She therefore needed to 
remember to return to the patient at a later point and sometimes found them “fast asleep” 
(P10; Nurse). Although this nurse admitted that she could “understand why” (P10; Nurse) 




worked around this alert. For example, one nurse was observed “leaving medication pots 
containing paracetamol doses for patients who were not due their dose for another 5 or 10 
minutes, despite the presence of a CDS alert, so that they did not have to return to that 
patient” (Observations; Ward A.3). The use of this workaround posed the question about 
whether refinements were needed, such as tailoring alerts to specific clinical areas or 
patients.  
9.2 Passive Clinical Decision Support 
Passive CDS approaches were also used in the system and included types of functionality 
such as the pharmacy task list (discussed in chapter 8). Further examples that were discussed 
include the use of mandatory fields and colour to direct users towards certain pieces of 
information on the system and the use of order sentences, order sets and favourite lists, 
which will be covered in more detail.  
9.2.1 Mandatory fields and Colour 
An alternative approach to using a hard stop alert (i.e., an alert that would be generated if a 
field was not completed) was using one colour to highlight the mandatory fields. This was 
usually a different colour to the non-mandatory fields and had already been used for certain 
orders on the system. For example, one doctor thought the “yellow boxes are [were] good 
because you know you have to fill those in before you can move on or order anything” (P24; 
Doctor). One pharmacist recalled how “when you are trying to prescribe some high risk drugs 
like cytotoxics it also has certain layers there in colour” (P21; Pharmacist) that the prescriber 
had to fill in.  
Colour was effective at supporting clinicians when they were reviewing a patient’s blood test 
results as “it highlights the abnormal results” (P12; Doctor). For example, if a blood result 
“was really abnormal, it goes red” (P7; Doctor), which meant the user is likely to “look at it 
more” (P7; Doctor). However, a large proportion of patients with abnormal renal function 
might “have trends of red” (P7; Doctor), and so a more important piece of information for 
renal clinicians was the change in the patient’s renal function from their baseline. One user 
questioned how the system could best illustrate a change in trend so as to help clinicians 




Users also used colour to familiarise themselves with certain pieces of information quickly 
on the ‘Drug Chart’ and ‘Drug Summary’. 
“I guess the colour is used on the drug summary you get used to what you’re looking 
for” (P8; Doctor).   
For instance, “reds mean that it wasn’t given to the patient, just on the administration [drug 
chart]” (P11; Doctor) and would therefore draw the user’s attention towards checking that. 
Another nurse valued the use of colour as it helped her identify the different statuses of 
medications e.g., red for STAT (immediate) and green for PRN (when required) doses. 
“I like that we have red, say for stat doses, (…) green that it’s ‘as required’ [doses] 
that’s quite good” (P9; Nurse).  
A pharmacist commented on how the colours helped her identify “straight away” (P27; 
Pharmacist) what medications were active or discontinued. 
“It’s blue if it’s active, grey if it’s recently been discontinued and then the PRN’s are 
green.  So I can see straight away because of the different colours, I can see straight 
away what is an active drug and it filters out all the stuff that I don’t necessarily need 
to see” (P27;  Pharmacist) 
One nurse suggested that it might be beneficial to display different routes of administration 
in different colours “because we all would normally think paracetamol: oral, predominantly 
we’re giving that oral. Then you might think IV but there are occasions when it’s prescribed 
as PR [rectally] and people may not look at that (…) anything that helps you to sort of look 
and recognise [would help]” ( P9; Nurse). However, she acknowledged that there may be 
difficulties with this approach particularly if the “preparation is [prescribed] either/or” (P9; 
Nurse).  
However, care is also needed to ensure consistency and that colours carry the same meaning 
throughout the system e.g., red for a serious issue that required attention such as an out of 
range blood result or overdue dose of a medication. Furthermore overusing colour can 
confuse users, as one doctor admitted that there were already “a lot of colours [in the 
system], I don’t know what they [all] mean (…) I just thought it was colourful” (P11; Doctor). 




does not negatively impact on their workflow processes, whilst ensuring users are effectively 
warned about the serious issues in a timely manner.  
9.2.2 The benefits and challenges experienced with using order sentences, 
order sets and favourite lists  
 
9.2.2.1 Description of order sentences, order sets and favourite lists 
An order sentence contains the drug name, strength, formulation and frequency, e.g., 
lisinopril  10mg tablet ONCE daily; an order set contains a group of medicines (or blood test 
requests) that can be ordered together, e.g., morphine, midazolam, hyoscine hydrobromide 
and cyclizine are the group of medicines contained in the ‘care of the dying patient’ order 
set (Figure 23). In some cases, order sets included medication and dosing options for those 
with renal insufficiency, thus making it “much easier” (P7, Doctor) to prescribe for these 
patients.  
 
Figure 23: The ‘care of the dying patient’ order set. Users can choose to include or exclude 
individual medications by clicking on the box to the left of the drug name (first column on 
the left). 
Favourite lists are groups of order sentences or clinical tests either selected from existing 
order sentences or made ‘from scratch’ by the user to improve accessibility. One junior 
doctor explained how a colleague had told him to “make favourite lists kind of at the 
beginning of each job” because “it makes your life so much easier, which it does” (P16; 




for “Oramorph (morphine sulphate solution), every hour” (P15; Doctor), because he could not 
find this dosing option in the drug dictionary, and thus it was more efficient to select this 
order sentence from his favourite list than select each component of the prescription (i.e., 
dose, frequency, route) every time he wanted to prescribe it.  
“You can see like, things like, here for example, prescribe oramorph every hour and 
that’s, you know so every time you do that you’ve got to go because it’s never an 
option it’s always four hourly, so you’ve got to go and find every hour so just having 
it there [in the favourite list]” (P15; Doctor). 
A rotational GP trainee felt that it was not worth creating a favourite list because he was 
“only here for a few months” (P12; Doctor) and some consultants “even disagree among 
themselves” (P12; Doctor). 
9.2.2.2 Development of order sets 
The hospital system development team developed order sentences and order sets (drop 
down lists) to support users when prescribing. There were key factors that guided their 
development. Firstly, the system development team drew on the views and experiences of 
relevant clinicians to gauge what existing hospital treatment protocols “would lend 
themselves to an order set” (P30; Pharmacist); they were considered “a useful way of making 
sure that all of the bits of the protocol got put on the chart” (P30; Pharmacist). Order sets 
were also developed “in response to the fact that prescribing errors had happened” (P30; 
Pharmacist”) and to possibly prevent such errors happening in the future. For example, one 
pharmacist recalled how prescribing errors were more common in patients with peritoneal-
dialysis related peritonitis (PD peritonitis). Despite the existence of a hospital protocol, 
prescribers were not familiar with the non-standard routes of administration for drugs such 
as tobramycin and vancomycin. The renal pharmacist explained how “if you’re an 
inexperienced SHO [core medical trainee] and it’s in the middle of the night it’s kind of difficult 
to get it right” (P30; Pharmacist).  The order set enabled the user to “type in PD peritonitis 
or some combination of that [and] it brings up the pre-selected drugs, the pre-selected routes 
of administration and it’s also built in a dose calculator as well, so in theory that’s a really 
good way of preventing that error from happening again” (P30; Pharmacist). 
In addition to ordering a group of medicines, order sets could also be used to order a group 




suspected liver disease. However, some participants were concerned about the risk of over-
reliance on order sets and how it could make the task of prescribing too simple and “stops 
them [prescribers] thinking about it” (P30; Pharmacist). For example, the renal transplant 
order set was described as useful for ensuring that clinicians prescribed all the relevant 
items, but perhaps not as helpful for individual patients who do not “fit the protocol”, as 
doctors have become used to “ticking [all] the boxes” (P30; Pharmacist). However, one 
disadvantage of this that was highlighted by a senior pharmacist was that inappropriate 
medicines that were part of an order set, were sometimes prescribed because the doctor did 
not recognise (and failed to double check) items that the patient was already taking such as 
a COX-2 inhibitor, which could interact with items in the order set and contribute to an 
adverse drug event such as bleeding.  
“They[the patient] might come in on a non-steroidal or a COX-2 and it’s not such a 
common name, etodolac is the big one, [it] doesn’t trigger in the doctor’s heads and 
then they come along they prescribe the post-op order set, ibuprofen comes up and 
then they prescribe two NSAIDs (non-steroidal anti-inflammatory)” (P27; 
Pharmacist). 
Whilst another doctor noted how some of the more junior doctors “might not recognise, 
they might not even consider that [dipyridamole] as [is] an anticoagulant or antiplatelet” 
(P12; Doctor) and therefore fail to identify any potential issues when this is prescribed as 
part of an order set. 
Finally, certain order sets that incorporated treatment protocols, e.g., a post-myocardial 
infarction (MI) order-set had the potential to be useful as it could help prevent accidental 
omission of orders such as “GTN sprays [which] often get forgotten” (P31, Pharmacist). 
However, some consultants tended to be “very prescriptive about which one of the second 
anti-platelet plus aspirin they want” thus this order set was perceived as being too difficult 
to develop.   
9.2.2.3 Decision support guidance within some order sets  
Decision-making guidance was occasionally found within some order sets. These are 
highlighted in the red boxes given in the example below for Methicillin Resistant 





Figure 24: Order set for MRSA Standard Eradication Therapy, with integrated prescribing 
guidance highlighted in the red boxes 
 
Indeed, one doctor suggested including “things like [treatment] protocols”, which would save 
users “a couple of clicks to go in [to] another window and kind of search for it” (P12; Doctor). 
He mentioned in particular the Venous Thromboembolism Prevention order set and how 
information like drug indication, length of treatment, and weight based doses should be 
visible at the point of prescribing. However, one of the system development team cautioned 
against the addition of more lines like this, explaining how it could potentially overload the 
user with too much information. Instead, he felt that it might be more prudent to have an 
order set that populates options based on the individual prescriber’s previous selections, or 
an algorithm that the system can work through before suggesting whether a particular 
treatment is suitable for a patient.  
“The community acquired pneumonia one, it was one of the first ones we built but 
its, it must have 30 lines in it there’s a whole load of information to take in and you’ve 
got all of your prescriptions and have to work all the way through and I don’t know 
how anyone would make sense of it, particularly when they are trying to do it quickly. 
So I think that [it] would be much better either broken down into smaller sets (…) then 
you open up more information when you click on it” (P32; Pharmacist). 
The use of algorithms that can provide patient-specific suggestions to the prescriber (e.g., 
give directed dosage recommendations based on a patient’s C - reactive protein level) 
require more complex functionality to be built into the order set. One pharmacist reflected 
on how, “the build [for that function] looks pretty complicated” (P32; Pharmacist) and 




9.2.2.4 Selection of Order Sentences and Order Sets  
 
9.2.2.4.1 Challenges identifying order sentences and order sets and the clinical 
appropriateness of these features  
In order to identify and then select a particular order sentence, the user needed to type in 
the first few letters of the particular medication and select the desired option from a drop 
down menu. One user found this “really useful” (P7; Doctor) as the drop down menu 
contained “all the doses and readings that the BNF [British National Formulary] would 
suggest for that drug” (P7; Doctor). By ‘right-clicking’ over the order sentence, prescribers 
could also quickly access additional information in the relevant section of the electronic BNF.  
“You can right click on the prescription and see the BNF page for the drug and check 
your doses that way rather than having to go to the paper form every time you need 
to prescribe something” (P7; Doctor). 
This was particularly helpful for those who were newly qualified as they didn’t need to look 
up each medication in the BNF, which saved them time. However, one newly employed 
junior doctor struggled to “find the inhaler ‘spiramax’ on the system when she typed in the 
product’s name” (Observations, Ward B.2). This was because “the default setting was set to 
‘starts with’, which may initially restrict the search” (Observations, WB.2) and the 
medication’s full name was ‘DuoResp Spiramax’. In this particular case, the junior doctor 
asked her clinical mentor why she could not find this particular order, who then explained 
that  “she may need to change the search terms from ‘starts with’ to ‘contains’ to bring up 
more options” (Observations, WB.2).  
One doctor also admitted that “calcium supplements are [were] really difficult to prescribe” 
(P13; Doctor), as the “prescription only says the ingredients and not what the actual, what 
the shortened [brand] name is” (P13; Doctor). This was echoed by a senior pharmacist who 
recalled how calcium preparations were a “common source of error for everyone” (P6; 
Pharmacist). For example, Adcal D3 Chewable Tablets contain the two active ingredients 
Calcium carbonate (1500 mg) and vitamin D3 (400 I.U.). This doctor admitted having to 





A further problem was that paediatric doses were sometimes listed alongside adult doses 
e.g., for an anti-emetic (cyclizine). One pharmacist found that certain doctors selected these 
paediatric doses in error and started adult patients on a sub-therapeutic dose of “25mg three 
times a day” (P21; Pharmacist). The hospital system development team also identified 
occasions where prescribers could not find certain order sentences that existed in the drug 
dictionary and thus resorted to “always using [the miscellaneous prescribing option] because 
they are misspelling it [the drug name]” (P32; Pharmacist). To overcome this issue, the 
system development team created an order set and assigned common miss-spellings of the 
drug’s name to the correct treatment so that, even if the prescriber typed in the wrong 
spelling, the correct order sentence would be presented as an option for them to select, thus 
increasing the sensitivity of the drug dictionary. 
“We can put in misspellings into the system (…) we make a [order] set with a miss-
spelled nickname, which then guides them to that. So they’re like little system you 
know exploitations that we’ve kind of came up with (P32; Pharmacist). 
It was also sometimes difficult for users to remember the ‘key trigger words’ to find 
particular order sets on the system. One user resorted to typing in “a variety of different 
words” (P24, Doctor) and then seeing what came up. A renal doctor explained how she 
“couldn’t remember the key word” (P26; Doctor) that brought up the ‘care of the dying 
patient’ order set and felt that the key trigger word “dying” was a “bit blunt” for this order 
set. The researcher reflected on whether there could be a user-design mismatch, with 
different users referring to the ‘care of the dying patient’ order set in different ways, such as 
‘end of life’, ‘LCP [Liverpool Care Pathway]’, ‘supportive treatment’ and ‘palliative care’ 
during their interviews.  
Issues were also identified when selecting the medication for a prescription, which was 
related to whether the medications were listed generically or by a brand name. In some cases 
a specific medication is better known by its brand name, however the system tends to list 
medications according to the generic name. This was, according to one pharmacist “good” 
because it “encourage[d] generic prescribing”  however a nurse also felt that it was not 
always as easy to distinguish between “different preparations of drugs” (P2; Nurse) for 
example, diltiazem that is available in several different modified release preparations. 
Indeed, she attributed this to one of the causes of an error, where the patient should have 




ordinary preparation” (P2; Nurse). This poses the question about whether it should be 
possible to see the brand name alongside or by hovering over the generic name for certain 
medications. 
Finally, some order sentences were also found to be not clinically appropriate. For example, 
the order sentence for ‘phosphate binder’ preparations (e.g., calcium acetate) had originally 
been set up to be administered ‘THREE times daily’, which corresponded to doses at 7am, 
12pm and 22pm. According to one of the nurses, the 22pm dose was “completely useless, 
because it has [had] to be [taken] with food” (P1; Nurse). The order sentence was 
subsequently customised by the system development team and the times now 
“automatically default[ed] to those times [mealtimes 7am, 12pm and 6pm]” (P30; 
Pharmacist).  
9.2.2.4.2 A lack of structured order sentences for titrating doses of a medication 
 
9.2.2.4.2.1 Titrating doses of a medication 
There was a lack of structured order sentences for certain medication regimes, such as 
“reducing courses of steroids or reducing courses of anything” (P30; Pharmacist), or non-
standard doses, which made it difficult for users to select and prescribe these on the system. 
Instead some prescribers created individual orders, which would be issued one after another, 
with different start and end dates for the same medicine. For example, one doctor prescribed 
a non-standard dose of folic acid “once a day on a Tuesday and once a day on a Wednesday” 
(rather than selecting a twice a week option) (P23; Pharmacist).   Another user described 
how she needed to “figure out the dates, make sure you’ve done it [prescribed it] for seven 
days, and then write instructions next to each one so they [the patient] know to kind of step 
it down” (P16; Doctor). However, this meant that there were potentially “six or eight 
separate entries” (P16; Doctor) for one medication, and sometimes the titrating course was 
“not clear to the dispensary” (P21; Pharmacist) or even contradictory. For example, a user 
could prescribe “20 milligrams a day for five days and then in a special instruction field put 
“reduce by five milligrams every five days until you’re at zero” or whatever” (P30; Pharmacist). 
Titrating courses were also problematic at the discharge stage. For instance, if the prescriber 
had prescribed multiple orders for the same medication, but with different dates (e.g., 
prednisolone 40mg from the 1st-7th May, prednisolone 35mg from the 8th-14th May etc.) and 




transfer over and thus the doses would appear without any instructions about how long they 
should be taken for. As a result, this pharmacist described how they would have to add a 
comment into the special comments field in order to make the prescribers intention clear 
for the pharmacy dispenser. 
“It’s for discharge that it’s the problem.  And some of them will prescribe I don’t know 
20 milligrams for five days, 15 milligrams for five days, 10 milligrams for five days but 
when that appears on the discharge prescription the dates don’t pull across so it’s 
not clear to whoever was dispensing it, and also they don’t appear in order on the list 
either, either increasing the order or decreasing the order it seems to be quite random 
so you have to go in and modify it to put 20 milligrams daily for five days from 
whenever and manually put all the dates in so the dispenser can then type all that 
onto the label.” (P30; Pharmacist).  
However, users suggested that it should be possible for the user to specify the starting dose, 
finishing dose, and the intervals e.g., every five days, for the system to then automatically 
populate a titrating course. In addition, a senior pharmacist felt that the titrating course 
could also be easily misinterpreted by the patient, who sometimes did not know whether 
they needed to “increase [the] dose, or (…) decrease [the] dose, or take them all together” 
(P23; Pharmacist). Furthermore, if the “consultant said actually we’ll stay on the higher 
course for a little bit longer” (P8; Doctor), this meant that the dates of subsequent doses 
could be “out of sync” and would need readjusting (or in this case re-prescribed), creating 
“quite a lot of work” (P8; Doctor).  
9.2.2.4.2.2 Warfarin 
Similarly, one nurse felt that “the potential of making a mistake with warfarin is [was] huge” 
(P2; Senior Nurse). It was not possible to order warfarin using a structured order sentence, 
so prescribers put directions in the free-text box, which she found difficult to interpret. For 
example, “you have to read the instructions 26th 3mg; 27th 5mg; 28th … now there’s nothing. 
So is that when we’re checking the INR today? Or does that mean [something else]? (…)” (P2; 
Nurse). Another nurse explained how doctors “documented the INR rather than the warfarin 
prescription [in the free-text box] so it can sometimes be a little bit misleading” (P4; Nurse). 




got easily misinterpreted by another nurse as “2 milligrams of warfarin” (P4; Nurse) to be 
given.  
The “bright yellow chart” (P26; Doctor) at the end of the patient’s bed had previously 
reminded one doctor that their patient was on warfarin and how she needed to check if their 
dose should be adjusted. However, since the implementation of the ePrescribing system, this 
visible prompt was no longer there. One doctor described how the lack of such a prompt 
contributed to the prescriber not reviewing one patient’s INR and adjusting their dose over 
the weekend. However, the doctor did acknowledge that the ePrescribing system does have 
alerts, which flag up when the warfarin needs to be prescribed but this alert was only 
presented to the user on first entering the patient’s record. One junior doctor suggested 
including a structured order sentence for the prescribing of warfarin, where the dose could 
be selected on different days via a drop down menu in order to make selecting doses easier 
and clearer. 
“You could do right on Monday I want to, drop down menu, and I want to give 3[mg] 
and then at the same time you could order an INR for Wednesday. And even if it then 
just popped up at the end so you could sign for the INR that would work, that would 
work really well actually” (P15; Doctor). 
There were also challenges related to documenting warfarin on the system, as users were 
expected to record similar information “in three separate places” “(1) a ‘warfarin review 
form’ [on the system], (2) a handwritten entry in the paper notes, and (3) on the system’s 
‘documented medication history tab’ “(Observations; WB.1). The requirement to document 
the same information in three separate places in order to adhere to the hospital’s policy, was 
noted to have increased the pharmacists’ workload. One pharmacist was observed “add[ing] 
the word ‘warfarin’ into the documented history but [with] no other details” (…) to avoid 
having to duplicate all of the same information that they had already entered into the 
warfarin review form” (Observations; WB.1). This information included (a) the warfarin dose, 
(b) how long the patient was likely to be on warfarin for (e.g., lifelong), and (c) what the 
patient’s target INR range was. Another pharmacist was also not sure “what value 
[documenting warfarin on the warfarin form] adds” (P27; Pharmacist), as she felt that all that 
information was already there on the documented medication history tab. This also meant 
that if another user, at a later date, was only to check the ‘documented medication history’ 




9.2.2.4.3 Selecting the medication, frequency route and dose for a medication order 
A senior pharmacist found that when prescribers were adding the frequency of a medication 
into an order sentence, they would “type in the first letter [of the desired frequency]” (P30; 
Pharmacist), for example, ‘o’ for once daily (latin abbreviation ‘od’), which would generate a 
list of possible frequency suggestions beginning with that letter (e.g., ONCE). However, under 
the system’s rules, the prescriber should type in “’D’ for day” in order to generate a once 
daily prescription and so doctors “often make the mistake of thinking it’s O for once daily and 
the O for once is just the STAT [immediate once only dose] dose so you sometimes get 
something prescribed as a stat dose where they’re intending it to be daily” (P30; Pharmacist). 
According to one doctor extra care was also needed when prescribing a dose that was only 
due to be given once daily just after a drug administration round because the dose would 
automatically default to be given the following day, “even though you wanted it [given 
today]” (P24; Doctor). For instance, if a patient was due ‘bisoporol’ each morning at 8am, if 
the prescriber did not order this until 8.05am, an order would not be generated until the 
following day, and so the patient could miss today’s dose unnecessarily. To get around this, 
the doctor would have to “go back and do a stat [immediate once only] dose” (P24; Doctor).  
It was also sometimes necessary to prescribe a medication by more than one route according 
to the patient’s clinical condition. For example, cyclizine (an antiemetic) was often ordered 
both orally and intravenously (IV) to allow the nurse to administer IV, if oral was not possible. 
However, one doctor explained how “if you put one on oral and an IV there’s a danger of 
them getting it twice if you don’t suspend one” (P20; Doctor) because the system allows 
duplicate orders of the same medication, without resulting in an alert or other CDS 
intervention.  Similarly, for certain medications e.g., tramadol (an opioid analgesic) it may be 
suitable to prescribe them both regularly e.g., 50mg four times a day and ‘when required’, 
so that if the patient was in more severe pain the nurse would be able to increase a single 
dose from 50mg to 100mg. However, the system did not always provide such prescribing 
flexibility as one doctor described “you can’t select multiple [frequency options] you have to 
click tramadol PRN (when required) (…) and then click again and prescribe it regularly” (P12; 
Doctor). Therefore, the doctor would order tramadol “50[mg] 4 times a day” (P12; Doctor) 
regularly and then place a PRN order; the default order sentence for the PRN option was “50 
[mg] every four hours PRN” (P12; Doctor), which increased the risk that the patient might get 




One particularly troublesome order sentence that was associated with prescribing errors and 
mis-selection of the dose was tinzaparin. Nurses encountered difficulties when administering 
the dose of the anti-thrombotic medication to a surgical patient (4,500 units), as the pre-
filled syringe that contained the dose (3,500 units) would have sometimes been mistakenly 
selected and prescribed on the system. One junior doctor suggested that this error may have 
happened because:  
“Sometimes the anaesthetists or the surgeons downstairs prescribe it [tinzaparin] 
and because they’re not familiar with it [the system], they prescribe 3,500 units and 
that’s in a 0.35 pre filled syringe. And then I’ve seen a couple of times where that’s 
come up to the ward and someone’s tried to amend it and they’ve gone discontinue, 
re-order, and just typed 4,500 units but still in the 0.35 ml syringe and that doesn’t 
work. And then the nurses come to you and go this is impossible” (P15; Doctor).  
This also raises the question of whether including an indication alongside the order sentence 
for the specific doses of tinzaparin may help reduce such selection errors.  
A second problem also emerged with tinzaparin because the prescribed doses were not 
automatically rounded on the system. This made it difficult for nurses to administer certain 
doses without contacting the prescriber. A nurse explained how some doses that the doctor 
worked out were “ridiculous, it will work out as say 14,235 [units]” (P14; Nurse), so then the 
nurse has to contact the doctor or the doctor would ask the nurse “will we go up or go down, 
just go to whichever is the nearest you know if its nearer to 14,000 go to 14,000; if its nearer 
to 14,500 go to 14,500” (P14; Staff Nurse, General Medical Ward). Furthermore, the quantity 
of the injection i.e., the ‘millilitres’ of the syringe volume that contained the full dose (e.g., 
14,500 units) was not automatically calculated by the system, which made some nurses very 
wary of administering such doses. One nurse explained how she would always ask another 
nurse to ‘second check’ her calculations and observe the administration, even though this 
was not required under hospital policy. 
“So, say a patient was to have 15,500 units, so you’re going to have to use an 18,000 
unit syringe and calculate so it will have tinzaparin 18,000 units, underneath it will 
have 15,500 units. You’ve got to be careful. (…) In my mind, you’re not just giving a 




something that you’re having to calculate and it could be completely wrong. It 
doesn’t ask for a double signature but I always do” (P14; Nurse). 
9.2.2.5 Modification of Order Sentences and Order Sets 
Some users described the difficulties they experienced when modifying orders (e.g., 
increasing or decreasing the dose of a medication). For example, if the order sentence 
included a strength of the product e.g., ‘darbepoetin 40 microgram pre-filled syringe, inject 
40 micrograms ONCE daily’, the whole order would need to be cancelled because, even if the 
40 microgram dose was changed, the 40 microgram pre-filled syringe would still appear on 
the prescription. 
“The mistake they sometimes make in that instance is like for example if something 
is a particular syringe size like darbepoeitin for example if they’re on 40 micrograms 
and they want to increase it to 60 micrograms if they’ve prescribed it as darbepoeitin 
40 microgram pre-filled pen and the dose is 40 micrograms if they do cancel and 
reorder it’s still darbepoeitin in a 40 microgram syringe and they’ve changed the dose 
to 60 and the nurses would know that they would get a 60 microgram syringe but the 
correct way to do that would be cancel discontinue and re-prescribe it from scratch” 
(P30; Pharmacist). 
The same issue occurred for tinzaparin, which was sometimes prescribed in error at one dose 
and then modified to another; however, the strength did not automatically update. This 
relied on “the nurses on the orthopaedic ward [to] know that it’s four and a half thousand 
that we want [for a surgical patient], so they’d know to look at it more closely and give four 
and a half thousand” (P12; Doctor). One pharmacist did not feel that “doctors generally 
appreciate[d] the subtlety of that difference” (P30; Pharmacist), while to a pharmacist it was 
“dead obvious because when you’re going to supply it you need the right strength of syringe” 
(P30; Pharmacist). It is possible that the system could be ‘more intuitive’ and link the dose 
and strength so as to guide the prescriber when ordering tinzaparin, thus ensuring that the 
correct syringe is selected and prescribed with the correct dose for the indication.  
It was also a similar case for oral capsules e.g., Ramipril 2.5mgs where the user would need 
to “cancel, discontinue, and then add Ramipril with the new dose or you could do cancel and 
reorder and it would bring up the same prescription and then you could just change the 2.5 




strength of the product e.g. ‘ramipril capsules’, the dose could be simply modified by the 
user as the pharmacist above described.  
9.3 Chapter Summary  
This chapter described how the hospital’s system development team had utilised both 
interruptive and passive forms of CDS and the benefits and challenges associated with these 
approaches. Some interruptive methods e.g., alerts at the prescribing and administration 
stages, were valued by users as they could potentially contribute to reductions in medication 
errors. However, the conservative approach that the Trust had taken with regards to using 
drug-drug interaction alerts resulted in some users actively requesting for more safeguards 
to improve patient safety. Passive approaches such as mandatory fields and colour also aided 
users when ordering or reviewing a patient’s medications. Finally, this chapter discussed 
some of the specific benefits and challenges associated with order sentences, order sets and 
favourite lists. For instance the researcher described these functionalities and their 
usefulness e.g., more efficient prescribing by being able to prescribe groups of medications 
or blood tests from pre-defined sets. However, the researcher also highlighted some 
limitations of the system, which made it difficult for users to generate an electronic order.  
The following chapter is the final results chapter and discusses the different training 
approaches taken by the hospital Trust in order to educate users on how to use the system, 
including a discussion of their relative merits and drawbacks followed by an overview of the 





Part I: What training approaches were used to educate 
clinicians on the use of a commercial electronic 
prescribing system?  
In the previous three results chapters, this thesis has explored (a) the key challenges facing 
users when using specific design features of the ePrescribing system and  how these gave 
rise to workarounds; (b) the benefits and challenges of a customising a commercial 
ePrescribing system and (c) the benefits and challenges of interruptive and passive CDS 
approaches. A further key factor that affected users’ experiences was training. Some users 
were unaware of the system’s known pitfalls or how to customise the system to enhance 
their experience of using it. This chapter is divided into two parts: Part I discusses the 
different formal and informal training approaches taken by the hospital Trust to educate 
clinicians on the use of the system, and the relative merits and drawbacks of these. These 
data were generated as part of the main study. Part II describes the different training 
approaches used in four hospital Trusts across the country and some of the benefits and 
limitations of these based on findings from the follow-on study.  
10.1 Training Approaches 
 
10.1.1 Formal training approaches for foundation doctors 
Users described a range of ways in which they were formally trained to use the system. The 
formal training itself comprised of both lectures and workshop sessions, where the users 
were expected to work through a set of tasks such as prescribing “warfarin, doing insulin, 
how to reschedule, how to suspend, and do all of those steps” (P32; Pharmacist). Some of 
these tasks included scenarios that were informed by internal error reports, describing some 
of the known challenges of the system: “setting up your patient lists correctly, because we’ve 
had patient mis-selection (…) what is a start date and time because people get that wrong, 
how do you reschedule a medication (…), it’s not easy to spot how to do that” (P33; System 
Development Team). One doctor found these scenarios helpful, particularly the patient list 
customisations task because he needed “to know whose patients and things and who to call, 
it’s quite quick reference sort of thing and then just all the identifiers to make sure you’ve got 




involved shadowing the existing doctors on the ward and working through a training exercise 
where they were “given a fake patient and then like a workbook to work through common 
things” that they would do, which one doctor found helpful “for the first couple of weeks 
when you were still kind of getting used to it [the system] and you could refer back to that 
book if you got stuck” (P16; Doctor). The foundation year doctor training was mandatory and 
protected time was given to this training during their induction week, which one user 
thought was vital because “otherwise we maybe wouldn’t have done it” (P16; Doctor). 
A member of the system development team explained how foundation year doctors were 
given “the basics” such as “this is how you go into the system, this is how you go into your 
patient, this is how you prescribe, this is how you review, this is how you reschedule [a 
medication]” (P33; System Development Team). However, by focusing on the basic elements 
of the system, there was a risk that some users did not “know about the hidden functions 
that would actually make your [their] life a lot easier” (P29; Doctor). For example, one junior 
doctor, who was interviewed shortly after he had begun working for the Trust, was unaware 
that order sets for certain treatments existed: “Do they exist? I don’t know (…) I’ve never seen 
them” (P18; Doctor). Instead, one member of the system development team commented on 
how the Trust expected more specific (informed) training to be provided by “the junior 
doctors that are [were] rotating off that ward or the more senior people” on the ward (P33; 
System Development Team). She felt that these staff were better placed to deliver “that kind 
of level of training” as they were more familiar with the particular order sets or “different 
things that they [newly employed doctors] need to do” (P33; System Development Team).  
The lectures were not felt to be particularly useful by some users, with one junior doctor 
describing them as “pointless because no one was listening most the time” (P17; Doctor). This 
may have been related to the environment in which the lectures were conducted in, with 
another doctor remarking how “crowding 80 people into a really hot lecture theatre at four 
o’clock on a Friday afternoon to try and teach them how to use [the ePrescribing system] 
without any physical hands on [exercises], it’s just not going to work” (P15; Doctor). A 
specialist registrar doctor recalled being overwhelmed by the large volumes of information 
that she received as a junior doctor, and only remembered picking up small pieces of 
information from the lectures. The workshop sessions and shadowing, where users gained 
‘hands-on’ experience of using the system were considered by one doctor to be “much 
better” (P18; Doctor) than lectures, and “really the only way to learn” (P18; Doctor). Another 




One doctor described diving “in at the deep end and started using the real system” (P15; 
Doctor), which he actually thought “was much more beneficial” (P15; Doctor) during his 
induction week. He was able to familiarise himself with the ‘live’ version of the system during 
the shadowing induction week, and customise it so that it was “all set up” after shadowing 
(P15; Doctor); this was in contrast to other users who were given access to the training 
system, in addition to the ‘live’ system during the shadowing week.   
10.1.2 Formal training approaches for non-foundation doctors 
The system training offered to non-foundation level doctors (e.g., specialist trainer level, 
registrars or consultants) when they began working for the Trust was less comprehensive 
than that given to foundation-level doctors. Their training comprised of “a one hour, an hour 
and a half in a lecture theatre and do a quick demo and then we [the trainers] signpost[ed] 
them to training videos” (P32; Pharmacist). One doctor explained how this level of training 
“was fine” for her because she had used the system previously as a foundation level doctor 
and felt comfortable using it. She “pick[ed] up a few new things” (P24; Doctor) at the training 
but admitted that she “would have really struggled (…) with what training they gave us” (P24; 
Doctor) if she had not used the system before.  She described how her colleague had come 
from a different hospital (with a different system) and felt less prepared: “she was like ‘I don’t 
know how to use it, I’ve just been shown for like half an hour how to do it and I’m expected 
to prescribe things’ ” (P24; Doctor). Another specialist training doctor described her 
experience as “a baptism of fire” (P8; Doctor), finding it “quite difficult to start off”, and so 
resorted to “hassled [hassling] other people how to actually use it” (P8; Doctor).  
One of the foundation level doctor commented on how they had “to train some of the 
consultants” on the system (P18; Doctor). This was also witnessed during the observations: 
“a consultant came into the doctor’s office, they asked one of the foundation level doctors if 
it was possible to see an echo on the system or where it was. The junior doctor replied that it 
was possible and directed the consultant to the bottom left hand corner of the computer 
screen where the tab ‘echo’ was” (Observations, WA.3). One consultant also admitted how 
she had not “learnt how to prescribe [miscellaneous drugs] properly” because she did not 
“use it [the system] often enough and regular enough to know the qwerks and tweaks” (P28; 
Doctor). She relied on her junior staff to prescribe on the system, although admitted having 
to “upskill” (P28; Doctor) herself during the time of junior doctor strikes. The staff mix on 




surgical ward highlighted how the day-to-day medical service on the ward was typically 
provided by more junior doctors rather than registrars or consultants, as those members of 
staff were often in surgery or clinics. Thus, this junior doctor remarked that there was no one 
who he could ask for help with using the system as he was “the most experienced person on 
this floor with regards to [the ePrescribing system]” (P15; Doctor).  
One speciality registrar commented on how it would have been useful if there had been “a 
separate session going into a computer lab” (P29; Doctor) in addition to the lecture that she 
recieved. Another speciality training doctor felt that users were at risk of “get into bad habits 
of how to prescribe things” and not “look[ing] at things properly” (P24; Doctor) without more 
comprehensive training, and that refresher training or “a drop-in thing where people kind of 
get talked through the new bits of it” (P24; Doctor) would be helpful. A senior pharmacist 
questioned the safety of locum doctors using the system without adequate training and 
especially if they have not used the particular system before “because they’ve had no prior 
experiences and they’re just doing as they find, [and] its quite frustrating for us; it must be 
very frustrating for them as well” (P6; Pharmacist). 
Pharmacists did not receive any formal training on the system after starting at the Trust. 
Instead, they learnt informally from their peers with one senior pharmacist recalling how his 
training comprised of “two informal sessions in a room, a crowded room, four of us round 
one computer” with their clinical mentor (P6; Pharmacist). No formal training was offered 
when pharmacists changed roles e.g., from a pre-registration pharmacist (who did not 
clinically validate prescriptions) to a pharmacist (who did clinically validate prescriptions), 
which resulted in one pharmacist feeling that he was left to “see how you go, figure it out 
yourself” through “trial and error” (P6; Pharmacist). One pharmacist felt that pharmacy 
users’ knowledge of the system was actually “better compared to that of other clinical staff” 
(P21; Pharmacist), and they were “sort of seen as the experts of how to use the ePrescribing 
system” (P6; Pharmacist). There also appeared to be open channels of communication 
between the pharmacy ward staff and the system development team about the system. For 
instance one pharmacist described how she occasionally sends an “email off to the [system 
development team] team saying please can we have an order set” in response to an identified 
problem (P30; Pharmacist), or when there have been issues with the system. Another 
pharmacist recalled how “an email came out from the informatics team telling us about it, 




10.1.3 Informal training approaches 
 
10.1.3.1 Peer Training and Support 
Peer training and support occurred across all professions and all levels of staff. One doctor 
recalled how “the outgoing FY1’s [foundation year 1 doctors] talked us through things” (P13; 
Doctor), with one explaining how they customised their medication list screen in a particular 
way and “found this particularly useful and [I] set mine up like that” (P13; Doctor). Another 
doctor was told by the existing junior doctor during her induction training week that she 
should customise his medication list: “they showed me there and then, and I did it” (P16; 
Doctor). However, this doctor was responsible for providing subsequent training to 
colleagues, and admitted giving the new users “a quick tour of [the ePrescribing system] and 
like where the most important things are but (…) [didn’t] change anyone’s orders of 
[medication] lists or anything” (P16; Doctor). A colleague of this doctor also recommended 
that she should “make favourite lists kind of at the beginning of each job and it makes your 
life so much easier” (P16; Doctor). Another doctor explained how nursing staff had helped 
her out with “changing like start times of things, (…) knowing that you had to give a stat first 
dose so it’s just all the little quirks that you get used to” (P13; Doctor).  
Ward based training was also considered useful as it was “tailored to what you need to do, 
which differs on each ward” (P18; Doctor). One consultant described how when the 
transplant order set bundle was implemented, “we educated all the clinical fellows (…) their 
supervisor was involved, all the consultants knew, because it was in the minutes at our 
monthly meeting, and then [the pharmacist] did some work with the nurses as well” (P28; 
Doctor). The ward took a similar approach to training when they “introduced the different 
forms of tacrolimus so the long-acting and then the generic form that we use mostly, [the 
pharmacist] did education about it with the nurses” (P28; Doctor).  
However, the researcher observed differences in the amount and type of informal training 
provided to new users across the different wards: “the training given to one newly qualified 
foundation year 1 doctor on the general medical ward was less hands on than what was given 
on the surgical ward” (Observations; WA.3). There was also differences in the amount of 
informal training provided within the same clinical area. For example, the cardiology 
pharmacist had been asked to deliver training “four times a year, once with the registrars 




cardiothoracic ward] as they rotate[d] round (…) highlighting the qwerks [of the system] (…) 
[and] how to put an allergy to beta-blockers” (P31; Pharmacist). However, no such training 
was in place for the cardiology ward because “they haven’t asked us [the pharmacy team] to 
do it” (P31; Pharmacist) and so “normally it’s a case of ‘hello I’m the pharmacist this is the 
first day of your rotation, these are the things I need you to change’ and then you just slowly 
train them that way” (P31; Pharmacist).  
Due to the informal nature of the training, it was also vulnerable to interruptions as observed 
by the researcher: “a current junior doctor who had been working in the organisation for one 
year was training a newly qualified doctor how to prepare a discharge prescription during 
their induction shadowing week. The newly qualified doctor, asked the existing doctor ‘how 
do you know what she [the patient] was on before?’, the existing doctor was about to tell the 
newly qualified doctor but got distracted by a query from a nurse about a patient, she 
subsequently did not tell the new doctor how to use the system in order to find out what the 
patient was taking pre-admission by looking on the ‘documented medications medication 
list’” (Observations; WB.2).  
Some healthcare professionals felt that they lacked sufficient knowledge to answer specific 
questions from colleagues around the use of the prescribing system. One pharmacist for 
instance commented on how “quite often the doctors will ask us how to actually prescribe 
something on the system” (P23; Pharmacist).  However, because she did not “have access to 
that [the prescriber’s] screen” (P23; Pharmacist) she did not feel that she could help. A staff 
nurse had also experienced doctors asking them to give advice related to prescribing on the 
system but the nurse admitted that “we don’t have experience with the prescribing 
aspect,[so]  we often tend to be of limited help with that” (P1; Nurse).  Consequently, one 
pharmacist described how he had to “teach yourself [himself] all of these functions that you 
don't actually use it for, for prescribing functions” in order to support the medical staff (P6; 
Pharmacist).   
One pharmacist described this informal training process as “not good enough” (P21; 
Pharmacist), with another pharmacist noting how some doctors who “learn off their 
colleagues (…) are probably learning bad habits” (P30; Pharmacist). One doctor admitted 
learning through a process of “trial and error” (P22: Doctor), while another only discovered 
that a medication course had ceased when the “nurses [are] telling you it’s not prescribed, 




related to how the start and stop dates of medications were displayed in the default 
‘Medication List’ view, as discussed in section 7.1.1.  One nurse also recalled how the trainer: 
“let us navigate around [the system] (…) and let us make mistakes so we could learn from 
them, not on real patients obviously, which is quite good” (P9; Nurse).  
10.1.4 Ancillary Training Tools 
The final training approach participants discussed was the role of ancillary training tools, 
including the hospital Intranet (as a training source) and a workbook training manual.  These 
could be accessed by users at a time that was most convenient to them, including out of 
hours, so that the user could “refer back to that book if you [they] got stuck” (P16; Doctor). 
One user explained how she “went to the library after work and spent an hour going through 
tutorials and bits and bobs” (P26; Doctor). However, one foundation level doctor described 
the training manual as: “a massive booklet, which shows you how to do everything with[the 
ePrescribing system]”, and so he had only “skimmed” over it (P15; Doctor). A speciality 
training doctor felt that it “would be handy if there was a quick guide with common ones 
[shortcuts e.g., order sets]” available (P12; Doctor) and that this would be “definitely very, 
very useful” (P12; Doctor) if positioned next to the computer i.e., attached to the computers-
on-wheels.  One doctor remarked how she did not feel that she was “getting as much out of 
it [the system] (…) because I [she] just simply don’t know all the functions” (P29; Doctor).  
10.2 Gaps in user’s computer skills knowledge 
Certain users also discussed their lack of computer skills and how this affected their 
performance. One staff nurse who had recently returned after a number of years away 
reflected on how different she found the change from paper prescribing to electronic 
prescribing. She found the system “completely new” and was not “very computer literate” 
and even found “moving a mouse tricky”. She worried that she might “break it [the system]” 
(P10; Nurse). One pharmacist also remarked that although “a lot of people that use 
computers know that a right click will give you options” (P30; Pharmacist), she also 
recognised that some users might not.  Performing this ‘right’ click was needed to create a 
discharge prescription, and so users must have an understanding of these rather basic 




10.3 Part I Chapter Summary 
This chapter discusses users’ experiences of the different informal and formal training 
approaches taken by this hospital Trust in order to train users on how to use the system, 
including practical, classroom based sessions, lectures, ancillary training tools and peer 
training strategies. The second part of this chapter examines how users were trained in four 






Part II: How are users trained to use electronic 
prescribing systems in other hospital Trusts? 
Part II of this chapter provides an overview of the range of formal and informal training 
approaches that were used to train users of ePrescribing systems across four large hospital 
Trusts, one of which was the main study site described in part I. This included classroom-
based approaches and lectures, in addition to super-users, ancillary training tools and e-
learning. These findings were generated as part of the follow-on study.  
10.4 Formal, Structured Training Approaches 
All stakeholders described using an element of formal, structured training in order to educate 
prescribing staff on how to use the system when they first began working for their particular 
hospital Trust. These specific approaches varied between Trusts and depended on the role 
of the user. A trainer at one Trust for example described how she delivered a one hour 
lecture to junior doctors “where we talk to them about the prescribing system and about 
errors that we see (…) Give them a brief overview, a demonstration of the system” followed 
by “a 2 hour session (…) in front of computers” (P33; Site A). She acknowledged how 
foundation level doctors were given “loads of information” during their induction training 
week, which was possibly “quite overwhelming” for them and reflected on how they may 
“forget pretty much all of that [training]” (P33; Site A). A member of the ePrescribing team 
from a different Trust explained how they provided “a combination of classroom training and 
also some handbooks” to prescribers (P34; Site B). Prescribers at a third Trust needed to 
“complete and pass our [their] e-learning ePrescribing course, which is about how to use the 
system” (P35; Site C) as part of their initial training. 
10.4.1 Practical, Classroom Based Sessions  
 
10.4.1.1 Training Domain 
Three hospital Trusts used classroom based sessions, during which the user was given a short 
demonstration of how to use the system and then permitted to practice in a ‘training 
domain’ or “safe playground environment” (P34; Site B) that mirrored the live system. This 
allowed users to both familiarise themselves with the layout and functionality, and also gain 
some practical experience. At one Trust, this training domain was accessible to foundation 




patient scenarios were incorporated into the training domain so that users could gain ‘real-
life’ experience of using the system. However, some members of the ePrescribing team 
acknowledged that the resources required to “create dummy patients on the system” (P33; 
Site A), and develop and manage the other elements of the training, was “absolutely huge” 
(P33; Site A). One member of an ePrescribing tem also felt that it was difficult to ensure that 
the training domain reflected “the live system as much as possible” (P36; Site D) because 
“recent developments in the live system” may “not necessarily [be] mirrored in the training 
domain immediately” (P36; Site D). This could be “frustrating for users” as they would “be 
taught one thing and then go onto the system” and find that “it’s slightly different or 
significantly different” (P36; Site D). 
10.4.1.2 Clinical Scenarios 
The members of the different ePrescribing teams often discussed using material that was 
based on ‘real-life’ scenarios during their training sessions so as to try and “make it as real 
as possible” (P35; Site C). Trainers tried to “tailor the content and the examples to that area 
[specialism of user], for example, if it was paediatricians they [the trainers] will try and make 
sure that they are using examples when it comes to prescribing or ordering from paediatrics” 
(P36; Site D). This involved “tell[ing] them [users] how to prescribe certain drugs for a child 
of a certain age and weight” (P36; Site D). Similarly, at another Trust, users were required to 
“complete particular tasks and workflows from a clinical perspective”, which involved “how 
to admit a patient and how to discharge a patient, (…) how you prepare their medicines, when 
you do your discharge prescribing around the time of discharge. So it’s become a much more 
workflow orientated way rather than individual tasks” (P34; Site B). According to this 
member of the ePrescribing team, taking this approach “made a lot more sense to people” 
(P34; Site B) with another reflecting on how the training should incorporate the “interaction 
[of the ePrescribing system] with other clinical systems” (P35; Site C) such as a separate 
specialist system for prescribing chemotherapy. 
Another interviewee also commented on how they had “tried to spend a bit more time 
[during training] on the more complicated prescribing [tasks], so things like anticoagulation, 
insulin and also the prescribing of fluid” (P34; Site  B). This decision was informed by the 
“committee for safety of medicines [expert team] within the hospital” (P34; Site B) that 
concentrated on areas of “high risk” and was also “heavily influenced by feedback from 




challenges or “quirks of the system”, as the system had been developed in the US and so 
“occasionally [with] terms” (P34; Site B) that would be more common in that country, were 
included. 
10.4.1.3 Trainer experience 
At one Trust, the ePrescribing team had tried to match the trainer’s clinical role e.g., doctor 
to the clinical role of the user group being trained. For example, they would select a doctor 
to deliver “a session for the doctors (…) [and] similarly if it was nurses we would get one of 
our nurses on” (P34; Site B). However, another site acknowledged how it was not always 
possible to get clinicians as trainers because they “tend[ed] to be more expensive and you 
can’t get clinicians from every background of the people you’d be training” (P36; Site D). 
There were some benefits in using trainers from different backgrounds, as “occasionally you 
get a doctor [who] might ask ‘well, if I’ve done that, what will the nurses see?’ so you need a 
trainer than can answer those sort of questions” (P34; Site B). 
10.4.1.4 Top-up Training 
Additional training sessions were often provided to support users who were identified as 
having “a real problem” (P35; Site C) with a particular element of the system. Although 
“extremely uncommon” (P36; Site D), it was felt necessary for some of the more “experienced 
staff” (P36; Site D) who were less computer literate or for a user who had changed roles or 
acquired additional responsibilities (e.g., a nurse who gained a prescribing qualification). In 
this case, one Trust provided the nurse with a “specific prescribing session to basically go 
through all the same things that the doctor or a pharmacist would have got in terms of 
prescribing” (P36; Site D). Top-up training may also be required after a system update, 
although one member of an ePrescribing team highlighted how doctors “don’t look at their 
Trust email account” (P34; Site B) so it is difficult to make them aware of this requirement.   
10.4.2 Assessment 
The use of assessment as part of user training appeared to vary between Trusts, with one 
having no formal assessment but rather “a number of (…) learning objectives that we need 
to achieve” (P36; Site D). Other Trusts held a “short assessment at the end of the classroom 
training” (P34; Site B) to “identify those people who have perhaps struggled with the training” 




them back on a another day for a bit more training” (P34; Site A). A different Trust that used 
e-learning for the majority of their training required the user to complete a mandatory 
assessment and “get 90% in [order] to pass” (P35; Site C) and start using the system. If an 
individual was identified as struggling, they would then be provided with one-to-one training 
to help support them.  
10.4.3 e-Learning 
One Trust trained all of their staff using an e-Learning based approach exclusively. The 
“interactive” (P35; Site C) training covered all aspects of how to use the system and was 
modelled around a “watch and do” approach that was considered mandatory for all users. 
According to this member of an ePrescribing team, this approach was a more efficient way 
of training large numbers of users “because of the size of the Trust” (P35; Site C). The training 
was comprehensive enough to cover the scope of tasks undertaken by a wide range of 
different users, whilst also been specific enough to ensure that users engaged with the 
training. The Trust had previously used three different sets of e-learning depending on the 
user’s ‘prescribing’ or ‘administration’ roles, but this approach was unsatisfactory as nurse 
prescribers needed to both “administer and prescribe, and some of the prescribing they don’t 
do” (P35; Site C). This particular interviewee was conscious that including unnecessary 
material in a training package ran the risk of such users becoming disengaged and “lose[ing] 
them through the process” (P35; Site C). To overcome this, the Trust moved towards using a 
modular training course consisting of “about (…) 22 modules (…) covering all aspects of how 
to use the system from finding a patient, adding allergies, adding heights and weights,[to] 
adding your initial prescription and then modifying your prescription” (P35; Site C). The 
individual user would then complete relevant modules that were tailored to their role, so a 
consultant would, for example, “have to do modules 1-6, 8, 10 and 12” (P35; Site C). They 
also created tailored training ‘streams’ for new roles based on the pre-existing modules and 
newly employed doctors received a 10 minute face-to-face session referred to as the “safe 
prescribing part” (P35; Site C), which was about ensuring that aspects “not covered at all, 
that we need to highlight to them, other areas that they need to take care when they are 
prescribing” were discussed (P35; Site C). 
Another Trust planned to use e-learning as a form of ‘pre-training’ so that users could “log 
in and do some basic things around you know, how to log in and how to orientate yourself 




next” (P34; Site B). Following the classroom-based session, this member of an ePrescribing 
team commented on how the e-learning could potentially be used again to reinforce or sum 
up the face-to-face training, or to help refresh users who were “having any problems” (P34; 
Site B). This member of an ePrescribing team recognised how further guidance may be 
needed “particularly [at] weekends when there are fewer people around” (P34; Site B). 
Another member of an ePrescribing team discussed the potential for e-learning to be used 
“in the context of locums” (P36; Site D) as it was an accessible and convenient approach to 
ensure that locum staff received a minimum level of training before they began using the 
system. One Trust actually required locum nurses to have completed the “e-learning in 
advance” (P35; Site C) before they could book a shift. It was not possible, however, to apply 
the same rules for locum doctors at this site because they were not booked via a central 
agency. Often locum doctors would “turn up, [and] the [existing] doctor would go, ‘here you 
go, here is my password, user name and everything for my systems- go ahead and work, take 
over” (P35; Site C). To address this sharing of passwords and locums essentially working 
under another colleague’s log in, the Trust took the decision that locum medical staff who 
were going to work for “three nights or less” (P35; Site C) were allowed to skip the formal e-
learning and instead “just do the quick assessment” (P35; Site C) to ensure that they were 
“doing things under their own log-ins and not someone else’s” (P35; Site C). It was hoped that 
by delivering mandatory training sessions to all other ward staff, they would be able to 
provide the locum with additional support if needed. However, it is worth noting that some 
ward staff at this Trust only received very basic or minimal training, and therefore were 
unlikely to be highly proficient at using the system.  
10.4.4 Ancillary Training Tools 
All sites provided ancillary training tools to users. At Site A, examples of these tools included 
‘how-to guides’ which consisted of a “one side of A4 on how to prescribe a STAT [once only, 
immediate] dose” (P33; Site A), video demonstrations “about prescribing, about 
administration, about blood ordering, those kind of things” (P33; Site A) and “little PDFs that 
you can print out or look up electronically [on the intranet]” (P33; Site A). The foundation 
level doctors were also provided with a handbook as part of their induction training, which 
included “top tips about customising your view” (P33; Site A) and other tips about using the 
system. Importantly, users were able to access these tools electronically from anywhere in 
the hospital site. Another Trust physically printed and handed these documents to users, 




The ancillary training tools at one Trust were “all internally made” (P33; Site A) and at 
another Trust had been developed based on “feedback” from “members of staff” (P34; Site 
B) who were not part of the informatics team. This was echoed by another member of an 
ePrescribing team who described designing their ‘handy hints guides’ around “things that 
people have problems with that we know” and “incidents related to ePrescribing” (P35; Site 
C). Another Trust also provided ‘tip-sheets’, which were “designed to support them [users] 
whilst they’re out in clinical areas doing work” (P34; Site B) and provide information about 
“how you do x, y and z” (P34; Site B).  However, despite there being, as one member of an 
ePrescribing team described: “a mountain of information available to them [users]” (P33; 
Site A), it was not always clear how much users actually availed of it. As one interviewee 
commented “if they [the users] have problems or questions they tend, I doubt that they go to 
the crib sheet as much as they ask colleagues or you know another prescriber to see if they 
can help” (P36; Site D).  
10.5 Informal Training Approaches 
 
10.5.1 Ward Based Learning 
Some Trusts tried to move away from the more traditional ‘classroom’ based approaches to 
ward based learning. For example, foundation level doctors at one Trust had spent time 
“shadowing” (P33; Site A) other doctors on the ward that they were going to start working 
on, during their induction week. Although the general training would be delivered by the 
Trust, it was felt that “the nitty gritty day-to-day of what you do in that area that should be 
coming from those, the junior doctors that are rotating off that ward or the more senior 
people who are in that area” (P33;  Site A). In this way, the training delivered was more 
specific and tailored to the user and potentially more relevant with “a F1 [foundation first 
year level doctor] will ask a F2 [foundation second year doctor] and suchlike whose got a bit 
more experience in the system” (P36; Site D). Another Trust also used peer training and 
described how they had “trained up two or three nursing members of staff for each ward” 
who then go on to educate other ward staff during “their local ward meetings” (P34; Site B). 
A further advantage of using peer-training strategies is also that these ‘trainers’ were felt to 
be always available and could troubleshoot on demand.  
Ward based super-users had also been used in some Trusts, either appointed on a formal or 




Site C) who could “support the junior doctors”; this approach appeared to have been 
“push[ed] (…) as much as possible” (P35; Site C). However, one member of an ePrescribing 
team reflected on how it was important to get the right individuals who were “really 
enthusiastic” about (using the system) in the role of super-users, rather than “a team of 
people that didn't really know what the system was about, had been told they were going on 
‘this training session’ and came along because they had nothing else to do” (P33; Site A). 
According to this member of an ePrescribing team, this enthusiasm of the super-user affected 
the success of the roll out as “it was really, really obvious when we went to those wards, (…) 
we [the super-users/ trainers know what we’re doing and it was much smoother” whereas 
on the wards with less-engaged super-users “they went and hid in the linen cupboards, it was 
a nightmare!” (P33; Site A). Another member of an ePrescribing team highlighted how it was 
often a challenge to make sure that super-users were “available when you need them (…) 
and [how] getting the numbers that you actually need to support staff is [was] very difficult” 
(P36; Site D). Another user echoed this and mentioned how “everybody else in that 
department abdicates responsibility to them” (P34; Site B) and the super-user could “become 
swamped with stuff and they still have their own jobs to do” (P34; Site B). 
10.6 Chapter Summary 
Part 1 of Chapter 10 discusses users’ experiences of the different informal and formal training 
approaches taken by one hospital Trust in order to train users on how to use the system, 
based on the data from the main study. Part II of Chapter 10 provides an overview of the 
training approaches used to train users of ePrescribing systems across four large hospital 
Trusts (the main study site and three other sites) as part of the follow-on study. The members 
of the different ePrescribing teams discussed using a range of different methods such as 
formal classroom based sessions, interactive e-learning exercises and some informal 
strategies such as the use of super-users and peer-support. Indeed, a combination of 
different approaches has been used at some Trusts to potentially satisfy the learning styles 
of different users. It was also clear that regardless of the approach taken, the content should 
be tailored and informed by ‘real life’ practice or patient scenarios to engage the user. 
Certain challenging areas remain, such as how to effectively educate users about changes to 





Discussion and Conclusions 
 
11.1 Introduction 
An aim of this PhD programme of work was to explore the literature pertaining to the recent 
developments and persisting issues with ePrescribing and CDS systems and to provide a 
comprehensive overview of the unintended consequences of these systems across both 
adult and paediatric patients. These revealed a taxonomy of factors, which have contributed to 
errors during use of these systems e.g., the screen layout, default settings and inappropriate 
drug-dosage support. The researcher then conducted an empirical study to explore users’ 
experiences of using a commercial ePrescribing system. This research used a qualitative 
approach, more specifically semi-structured interviews and observations, to generate a 
deeper understanding about how users used the system. This included the benefits and 
challenges associated with customising the system, actual practices and workarounds, areas 
in which the system could be further optimised to improve safety and usability, and the 
importance of user training. A further literature was then performed to complement 
emerging themes relating to how users are trained to use ePrescribing systems, which were 
generated as part of the qualitative study. Finally, this literature review and the results from 
the qualitative study led on to a follow on study, whereby the researcher conducted semi-
structured interviews to examine how users were trained to use ePrescribing systems across four 
NHS Hospital Trusts. This revealed a range of approaches that were used to train users such as 
tailored training, lectures and e-learning.  
 Human factors are hugely important and systems must be designed and optimised with user 
involvement and an in-depth understanding of how users interact with these systems in their 
usual practice. Several key findings are discussed in more detail later in the chapter, 
including:  
 The difficulties users experienced when viewing and documenting information on 
the system and across disparate systems, and the need to reduce the number of 
screens that users must navigate through to find important information such as a 




 The importance of end-user testing and involvement in all stages of the development 
and implementation of ePrescribing systems, in particular when designing symbols 
and icons to ensure that they have a transferable meaning.  
 The issues that users described with the prescribing process, including differences 
between users’ and developers’ meaning of certain terminology, which resulted in 
confusion and delays when identifying order sets and medication errors.  
 More patient specific information should be utilised within CDS algorithms and the 
role of indication-based prescribing, which can suggest appropriate doses and 
treatments.  
 Unstructured orders such as titrating doses of steroids are error-prone and system 
developers should focus on how to create structured orders in ePrescribing systems. 
 There is scope for the use of mandatory fields to encourage users to provide a course 
length for short-term medications and to expand the use of DDI alerts for high-risk 
drug combinations.  
 The development of a pharmacy task list allowed users to prioritise their workload 
and identify high-risk patients. However, further refinements are needed, such as 
incorporation of additional patient specific information to help pharmacists judge 
the level of patient risk more accurately.  
 Users discussed some of the benefits and challenges of different training 
approaches. Training that was tailored to the users’ role was appreciated; however, 
due to resource limits this was not always possible.  
 And finally, e-learning may offer a potential way of training large numbers of users 
in a consistent and standardised way, and further research should explore users’ 
experiences of this approach.   
11.2  Strengths and Weaknesses of the Programme of Research 
This research provided detailed insights into the recent developments and persisting issues 
and unintended consequences of ePrescribing and CDS systems based on a series of three 
comprehensive literature reviews. A qualitative study was then conducted to explore users’ 
experiences of using and being trained on a commercial ePrescribing system in a U.K. hospital 
Trust. A literature review and follow-on study then revealed the range of approaches used 
to train users on an ePrescribing system. However, there were a number of important 




within one hospital Trust, which used a single ePrescribing system. The results are therefore 
unlikely to be generalisable to other hospital sites. However, some users had worked at 
different hospitals and used different systems prior to starting at the study site, often making 
direct comparisons between systems. A range of participants (e.g., doctors, nurses, 
pharmacists and pharmacy technicians) were recruited across four different wards (i.e., 
general medicine, general surgery, renal and cardiology) as part of this programme of work 
and it is possible that users may have experienced similar or different issues using the system 
in other specialities e.g., paediatrics or neurology. However, some interviewees had rotated 
across these different wards and commented on their experiences. Data collection continued 
until thematic saturation was reached on these four wards. 
Use of both semi-structured interviews and observations of different types of healthcare 
professionals allowed for data triangulation. A number of interviews (n=4) were also 
conducted with key stakeholders at the main study site and three further hospital Trusts to 
explore the training approaches used at these sites and the benefits and challenges of 
different approaches (the follow-on study). Although common themes did emerge from 
these interviews, the number of interviews conducted was small and only concentrated on 
a limited number of training approaches.  
11. 3 Reflexivity and the Role of the Researcher 
 
The researcher had significant experience of working as part of a hospital pharmacy team 
and had also conducted several literature reviews exploring the use of ePrescribing. The 
experiences and knowledge acquired as part of this helped the researcher construct 
understanding and meaning from the data, which may have differed to a non-clinical 
researcher. However, it was important that the researcher was aware of their role in the co-
construction of knowledge. To maintain validity and reliability, the researcher took steps to 
make their own thoughts and interpretations clear during the data collection and analysis 
stages. This helped to acknowledge and set aside her own biases and preconceptions.[178] 
For example during observations, the researcher annotated any of their own thoughts or 
reflections with ‘OC’ (Observer Comment), this could then be distinguished from actions or 
comments made by participants, which were annotated with ‘SC’ (Subjective Comment). This 
was useful when returning to the data during the analysis stage to give any background 
context to the field notes and allowed the researcher to honestly reflect on how their own 




analysis, the researcher included a column where she documented any of her own emerging 
thoughts and ideas. This helped ensure that the analysis process was transparent and 
allowed the research team and stakeholders to evaluate how themes were formed. 
Furthermore, the researcher kept a research journal, documenting any thoughts, 
preconceptions and emerging ideas about the data, to enhance the credibility of the 
findings.[274] Importantly, the researcher also considered the intersubjective reflexivity 
between herself and the participants, i.e., the mutual meanings emerging within the research 
relationship.[280] Finlay described how a researcher’s mutual understanding of a 
participant’s experiences along with theory may be used to direct probing and further 
questions. In addition, Finlay noted how researchers who ‘self-identify’ with the participant 
may be better able to build rapport and be better, more engaged listeners during an 
interview.[280] This stems from a mutual understanding about a concept and thus the  
researcher and participant were, perhaps unconsciously, able to build a relationship. 
However, how the participant perceives the researcher (and vice versa) may also bring about 
challenges and could negatively influence the relationship. For example, if there was a 
perceived ‘power imbalance’ or anxiety if the researcher was identified as an external 
‘auditor’. Unconscious factors that contributed to the researcher-participant relationship 
were also noted by the researcher of this PhD. For instance, although the researcher never 
explicitly introduced herself as a pharmacist, she was introduced to the ward staff by a 
member of the hospital pharmacy team, in addition she wore an ‘NHS Lanyard’, which was a 
requirement as part of the Hospital’s security arrangements. This may have given 
participants the impression that the researcher was also part of the pharmacy team or 
‘belonged’ to the NHS in some capacity as opposed to an external researcher. If asked, the 
researcher did acknowledge their prior experience, although this information was often 
assumed. This was felt to be useful when interviewing ward staff because they were able to 
speak freely and use medical-jargon, allowing the participant to freely describe an 
experience, as if they were talking to a colleague, rather than have to ‘translate’ it into plain 
English. For example, one doctor discussed some of the issues with having dual ePrescribing 
and paper prescribing process in place for different medications. He used medical jargon, 
without the need to explain terminology, referring to the difficulties prescribing a “a GKI 
infusion (…) because there’s a chart and there’s an [ePrescribing] thing at the minute so 
sometimes nurses just want one, sometimes they want both (P20; Doctor).” He also indicated 
that he expected the researcher to understand the meaning behind their statement, for 




[ePrescribing] or have it not if you know what I mean” (P20; Doctor). This gave the researcher 
the opportunity to ask the participant to expand on what they meant or lead into a further 
related question allowing the conversation to flow and lead to a deeper understanding of 
the user’s experience.  
The strength of the researcher-participant relationship was also felt to have helped minimise 
the Hawthorne effect during observation sessions as the researcher noted how participants 
did not appear to change their behaviour based on how they would normally work. For 
instance, the researcher observed a nurse workaround an alert that warned her against 
administering a dose of paracetamol too early. The nurse proceeded to dispense the dose 
and hand it to the patient because the dose was due in 8 minutes time, even though this was 
technically too early (Observations; WA.3). The researcher reflected on the fact that the 
nurse had perhaps felt comfortable acting in this way because she was working within her 
clinical and professional judgement, which she possibly expected the researcher to 
understand.  
The researcher was conscious of how her own experiences could contribute to data 
collection and analysis. She therefore took steps to declare any biases and document 
throughout the analysis how any interpretations were formed. However, the researcher also 
reflected on how her role positively contributed to the data collection process and allowed 
strengthening of the researcher-participant relationship and thus overall was considered to 
be a valuable component of this research.  
 
11.4  Main Findings 
 
11.4.1  Viewing and Documenting Information 
 
11.4.1.1 Screen Display: Reducing the Use of Multiple Pages 
One key issue with the ePrescribing system related to how medications were displayed and 
organised in the ‘Medication List’, which was a source of both error and frustration for users. 
In particular, the use of multiple screens, which fragmented the display of medication 
information, made it difficult for some users to interpret exactly what the patient was 
prescribed. Khajouei and Jasper’s systematic review also highlighted how users had to scroll 




memory of orders, which is clearly error prone.[215] This programme of work also 
highlighted how the stop date of the medication was not always visible and possibly 
contributed to some doctors mistakenly thinking that the patient was still receiving the 
medication when in fact it had been stopped. The ‘Medication List’ should allow users to 
view the start and stop dates of all prescribed medications and the status of the medication 
i.e., whether it is active, discontinued, suspended or documented, on one screen without the 
need to scroll. It should be clear to the user if the list has been curtailed in any way, thus 
prompting them to scroll or navigate to another screen to see this information. In terms of 
allergy information, users may also have found it helpful if the full medication name(s) was 
displayed when the cursor hovered over the allergy field, thus reducing the need to open a 
second screen.[127] 
It was not always possible to view all (or a sufficient amount of) blood test results on one 
screen in order to interpret a trend. Displaying blood glucose results vertically and grouping 
them according to the time of the day may have made it easier for users to compare results 
taken at similar times of the day. Indeed, the Health and Social Care Information Centre 
issued guidance for displaying results in graphs and tables, and recommended that users 
should be able to adjust the system to display the graphs and tables according to their own 
preferences.[281]  
11.4.1.2 Viewing Information across Disparate Systems  
Users also expressed difficulties when viewing information across disparate systems, such as 
the hospital prescribing system and the discharge system. Ahmed et al. also found that 
hospitals in England often concurrently used different standalone ePrescribing systems, 
depending on whether discharge medications and chemotherapy were being prescribed.[38] 
Use of disparate systems is a risk, and from an organisational perspective, it is important to 
take steps to minimise any associated errors e.g., putting a local policy or protocol in place 
to ensure this information is manually re-entered across both systems or that users must 
confirm checking both systems prior to prescribing chemotherapy. Meanwhile, organisations 
must demand more from their system vendors in terms of interoperability to drive progress 
in this area. System vendors and organisations must prioritise interoperability between 
different stand-alone systems and explore strategies that allow this. While integration may 
introduce some challenges, such as issues with sharing patient data and the compatibility of 




from policy makers to incentivise progress in this area or to standardise the format of 
data.[282]  
The researcher found issues with warfarin prescribing, which had to be entered in free-text 
on the system and was felt to be more error prone. The functionality to allow insulin to be 
prescribed electronically was only implemented 6 years after the ePrescribing system was 
introduced at the study site as this process was more complex than for other medications. 
Ahmed et al. also found that many inpatient systems did not support the prescribing of a 
reducing or increasing dose of certain medications, such as warfarin and insulin, and so these 
often remained on paper.[38] Westbrook et al. described two separate hospitals in Australia 
and similarly reported how certain orders such as heparin infusions, patient controlled 
analgesia (site A) and variable dose regimens (e.g., titrating courses of steroids), warfarin and 
patient controlled analgesia (site B) remained on paper charts following the initial 
implementation of an ePrescribing system.[283] Koppel et al. acknowledged how due to 
issues with electronically charting some medications (e.g., insulin), these medications 
remained on paper, which can cause confusion and loss of information.[115] These examples 
demonstrate how sites delay or do not use ePrescribing functionality for some medications,  
in particular certain high risk medications such as warfarin and insulin, resulting in dual paper 
and electronic systems been used.  System developers and organisations should therefore 
create simple ways of prescribing variable or asynchronous doses in a standardised way on 
the system. For example, an electronic medication order could include a drop down menu of 
different warfarin doses with particular days of the week. Further research should explore 
and evaluate the design of prescribing functionality for titrating doses to help inform 
practice.   
11.4.1.3 Presentation and Meaning of Symbols  
Well-designed symbols and icons offer advantages over text by being quickly and easily 
recognisable. They can also save space on an otherwise busy screen. However, this thesis 
uncovered how a number of symbols used in the system were not that obvious to the user. 
An American Medical Informatics Association (AMIA) task force convened by the AMIA board 
of directors reviewed the literature on usability in health IT and gathered lessons learned on 
system usability and human factors from other industries e.g., aviation.[284] They 
recommended having a minimum set of ‘design patterns’ that were shared and common to 




different systems. This could help standardise how users interact with different systems, 
such that certain workflows e.g., checking whether a patient has a hospital acquired 
infection, documented in the system become routine.[284] Phansalkar et al. evaluated the 
display of DDI alerts in 14 EHR systems (8 home-grown and 6 commercial) using an 
instrument that assesses system compliance to human factors principles.[103] One of the 
assessment criteria under the prioritisation category, asked whether the alert utilised shapes 
or icons in order to indicate the priority of the alert? (i.e., an inverted triangle to indicate a 
higher priority level). This study found that only two of the 14 systems appropriately used 
symbols to indicate the priority level of the DDI, such as a red exclamation point within a stop 
sign shape for the most serious interaction and an exclamation point with an inverted yellow 
triangle for lower severity alerts.[103] System developers need to make better use of 
symbols going forward to aid prioritisation of alerts. The authors also stressed the 
importance of using such symbols consistently throughout the system e.g., for laboratory 
warnings.[103]  Salman et al., described using participatory icon design, where 78  users from 
a Turkish hospital were sent a list of clinical tasks that were routinely performed (e.g., nurse 
observation) and asked to draw an icon which represented that specific task.[285] The most 
frequently drawn icons were then used within the system as part of this experiment.[285] 
This work did not evaluate the effectiveness of these icons but it described how users were 
involved in the design process, which is clearly very important.   
11.4.2 Challenges with the Prescribing Process  
 
11.4.2.1 Prescribing Challenges and a ‘User-Design’ Mismatch 
This PhD programme of work also revealed how users sometimes misunderstood certain ‘key 
trigger words’ or letters. For example, users assumed that ‘O’ could be entered for once daily; 
however, the system recognised this as a once only (STAT) dose and so users’ recalled 
situations where medications were not prescribed for the correct course length. Horsky et 
al. investigated a medication dosing error that occurred during the use of a US CPOE system 
and revealed that users possibly had a different understanding of the meaning of the data 
label “Total Volume” compared to the system developer. The authors posed that users 
understood “Total Volume” to mean the total dose that should be administered to a patient 
compared to the system developers who understood “Total Volume” to mean the total 
volume of the IV bag that was to be administered to the patient. In this US CPOE system, 




specify a particular stop time, which had a default setting of seven days. This was likely to 
have contributed to a large overdose of IV potassium chloride being administered to a US 
patient.[117] Howe et al. reviewed patient safety reports documented between 2013-16 
from the Pennsylvania Patient Safety Authority database and found that 1,956 (0.11%) of the 
reported safety events mentioned an EHR vendor and were classed as causing ‘possible’ 
patient harm.[286] One example described how one part of a ‘thyroid group’ test was missed 
off an order placed on the EHR system because of a “confusing translation between the 
physician order and the EHR”.[286] This PhD programme of work also revealed how users 
found it difficult to recall the ‘key trigger words’ to identify a specific order set e.g.,  ‘the care 
of the dying order set’. This poses the question of how organisations assigned ‘key trigger 
words’ and how much users were involved in this process? One of the key challenges faced 
by Wright et al. when conducting a study to explore usage patterns of order sets in seven US 
hospitals was the range of naming conventions used across sites.[287] Similarly, a 
recommendation from this US study was to share the content of common, approved order 
sets for specific conditions (e.g., based on a national guideline for the treatment of a 
myocardial infarction) or for a hospital service (e.g., an order set for all blood tests that a 
patient should receive on admission) so that they could be used across different sites. Wright 
et al. suggested that these could then be tailored to local needs (e.g., addition or removal of 
a particular medication according to the hospital protocol). This may also present an 
opportunity to standardise terminology used across systems. Furthermore, system 
developers should consider assigning multiple commonly used terms to one order set. This 
would increase the searchability of certain orders and produce more ‘hits’, saving the user 
valuable time when prescribing. 
11.4.2.2 Order Sentence Design and Indication-Based Prescribing 
Prescribers had difficulties selecting the correct medical product that could be prescribed at 
a range of doses depending on the indication. One such example was the low molecular 
weight heparin, tinzaparin, which was used for the prophylaxis and treatment of 
thromboembolism in medical and surgical patients. One possible suggestion that may 
prevent errors was for the system to automatically select a syringe of appropriate strength 
(i.e., 3,500 unit dose syringe) after the prescriber has selected the required dose e.g., 3,500 
units. A recent report from the US Food and Drug Administration entitled Computerised 
Prescriber Order Entry Medication Safety (CPOEMS) Uncovering and Learning from Issues and 




complete functionality, such as presenting users with inappropriate doses.[127] It would 
therefore also seem sensible for flexibility to be built into the system for the user to modify 
the strength in the event that the particular drug was out of stock. The CPOEMS report also 
referred to an example where the correct units for a non-standard dose could not be selected 
from the CPOE system because this option was ‘greyed out’ in the drop down menu.[127] 
This can frustrate users and result in workarounds such as creating free-text orders. 
Healthcare organisations should routinely review the types of medications and regimens 
ordered using free-text orders to identify potential order sentences that may need to be 
adjusted or included in the ePrescribing formulary. Puaar and Dean Franklin conducted a 
qualitative study to describe the causes of prescribing errors associated with the use of 
ePrescribing systems from prescribers’ perspectives using Reason’s accident causation 
model.[288] They revealed how order sentences that were not tailored to the patient 
resulted in rule-based mistakes. For instance, a doctor admitted that they did not use the 
BNF or refer to a pharmacist as much because they assumed “that must be the dose” 
displayed in the structured order sentence.[288] By incorporating more patient specific 
information into the decision making algorithms used in the system, it is possible that more 
appropriate doses are presented for a surgical patient. Chertow et al. demonstrated how a 
renal dosing support system that presented users with an alert, which suggested doses for 
patients with renal insufficiency, was successful at improving the doses prescribed.[86]  
 
Selection errors in particular can occur when users mistakenly choose an option such as an 
order sentence from a drop down menu. This type of error can result in significant 10x over 
and under-dose prescribing errors, with real consequences to patient safety.[120] For 
instance Jani et al. encountered an order for trimethoprim oral twice a day that was 
prescribed as 2.5mg instead of 25mg for a paediatric patient. This could have resulted in 
inadequate treatment of an infection and was classified as having a potentially moderate 
outcome.[186] Shulman et al. also identified an error when diamorphine was prescribed 
using a drop-down menu at a dose of 7mg/kg instead of 7mg; although intercepted, this error 
could have been potentially fatal with the patient receiving a 70-times overdose.[122] The 
design of drop down menus that contain order sentences should be carefully considered to 
prevent juxtaposition errors. For example, one could ensure that look-alike-sound-alike 
medications are not listed next to each other and that potentially tall man lettering is 




prescribed for an indication that was not listed in the patient’s diagnosis problem list reduced 
wrong patient orders.[150] Similarly, in a separate study, Galanter et al. observed that 
indication-based alerts intercepted 1.4 errors per 1,000 alerts in a set of 39 commonly 
confused, similar-sounding medication names (e.g., metoprolol and metoclopramide).[289] 
With each prescription starting with a diagnosis, Schiff et al. suggested that the indication 
should be entered onto the system, which in turn could inform other forms of CDS such as 
dosing suggestions.[216] The addition of a drug indication could also help educate patients 
and their healthcare providers about why a medication has been prescribed, with the 
potential for more far reaching benefits such as supporting improved medication adherence 
interventions. The patient’s wider healthcare team would also be able to scrutinise and 
clinically check the prescription knowing why it had been prescribed, rather than having to 
contact the prescriber or patient for this information.[216] 
11.4.2.3 Challenges Associated with Unstructured Orders  
The researcher identified discrepancies between the prescribed structured order and the 
free text comment accompanying the order. Palchuk et al. found discrepancies in 16.1% 
(n=470) of the 2,914 electronic prescriptions reviewed in their study conducted in the 
ambulatory care setting.[154] For example, dexamethasone 4mg tablets were prescribed as 
‘40mg QAM’ (quaque ante meridium, meaning every morning), with a comment to say 
‘please take 40mgs QAM once a week’. If administered according to the structured order 
sentence, this error could have resulted in immunosuppression and thus was classified as a 
potential ADE. Of note, Palchuk et al. found that 83.8% (n=394) of the discrepancies 
identified had the potential to cause an ADE, and 16.8% (n=79) of these were thought to 
have the potential for a severe ADE that could lead to a hospital admission and/or death. 
They also discovered that the majority of prescriptions with discrepancies (29.2%, n=137) 
were complex regimens where the dose may have varied throughout the day or over a period 
of time. Palchuk et al. gave the example of how a reducing course of bupropion (a medication 
used to support smoking cessation) was prescribed using a structured order of 1 tablet(s) BID 
(bis in die, meaning twice daily), with free-text instructions to ‘start use 1 week prior to 
tobacco quit attempt. start at 1 tab[let] po (per os, meaning orally) qd (quaque die, meaning 
four times a day) × 3d (for three days), then bid (bis in die, meaning twice a day)’.[154] Singh 
et al. also reported how pharmacists identified 532 errors (almost 1% of all prescriptions 
made) where information entered in the structured template, on an ePrescribing system 




authors estimated that the risk of discrepancy errors occurring in prescriptions that included 
a free-text comment was to be around 5%.[290] Similar to Palchuk et al., they found that a 
comparable proportion of these errors (20% n=112) could have resulted in moderate to 
severe harm to the patient, and noted how complex orders such as a tapering course of 
steroids were associated with a higher risk of error.[290]  Schiff et al. found that clinicians 
resorted to workarounds to prescribe complex prescriptions that were more difficult to write 
electronically on the ePrescribing system, such as tapering courses of prednisolone.[105] 
Due to the inherent risk of errors resulting from discrepancies between structured and 
unstructured orders, Palchuk et al. advocated educating users about the limitations of 
ePrescribing systems and how these systems can allow conflicting structured orders and 
free-text orders to be entered.[154]  
However, when considering how to prevent discrepancies between the structured order and 
the free-text comment, one needs to question why free text was required in the first place. 
Zhou et al. suggested that prescribers used the free-text field to speed up the prescribing 
process, particularly in high pressure situations e.g., when trying to prescribe insulin in 
urgent care, because finding the correct formulation from a long list of medications was 
difficult.[80] They also reflected on whether users had resorted to prescribing in free-text 
because they were misspelling the medication name and so the system could not recognise 
or suggest a structured order.[80] Zhou et al. explored this further and found that over three 
quarters (75.2%; n= 1,814) of the prescriptions ordered using free-text had an exact name 
match in the system, i.e., if properly searched using the correct spelling, the prescriber 
should have been able to prescribe the medication using a structured order.[80] Free-text 
may also have been used as a way of avoiding the need to enter uncertain information into 
structured fields. For instance, if a patient did not know what dose or brand of insulin they 
were taking, the doctor could still prescribe ‘insulin’ as a free-text order, but without the 
specifics (brand or dose) required for a structured order.[80] Zheng et al. investigated the 
appropriateness of clinicians’ use of ‘exit strategies’ i.e., the actions taken to avoid use of 
structured fields on an EHR (e.g., documentation of a clinical problem in free-text instead of 
using a structured code on the system) and found that 63% (n=153) of medication orders 
and 72% (n=81) of the patient’s documented problems (e.g., Parkinson's disease) were 
inappropriately entered using free-text when a structured format existed within the 
system.[291] The authors suggested that clinicians may have lacked an understanding of 
medical coding and using structured orders, or perhaps had difficulties finding their desired 




clinicians preferred to use free-text when they were less sure about their diagnosis; in this 
way, they could actually reflect their uncertainty.[291] These studies do not reflect on how 
it might not be possible for the prescriber to place some orders in a structured way; this 
programme of work found that free-text prescriptions were often used when there was no 
structured order sentences available that facilitated the prescribing of a reducing course of 
steroids or warfarin for example. This is an important consideration as reducing doses are 
not uncommon, thus system developers need to consider how these might be incorporated 
in the system. Sittig and Singh developed a set of national patient safety goals for EHRs and 
noted that because of the risks posed by free-text orders and communication, one goal 
should be to mandate the use of ePrescribing for all medication orders, lab tests and 
radiologic tests, and facilitate the coding of information as much as possible so that it can be 
utilised by the system’s CDS functionality.[292] One suggestion offered by a junior doctor 
interviewed as part of this research was to allow users to select individual daily doses from 
a drop down menu or provide a structured order template for titrating regimens, whereby 
the user could enter the starting dose, finishing dose, and intervals, thus allowing the full 
course to be automatically generated in a structured way. 
To the researcher’s knowledge, there has been little research that has looked at where, when 
and how the free-text prescriptions or comments are presented to users and what is the 
most effective approach, and so this should be investigated further.[80, 154, 290] However, 
work that has explored the human factors design principles of CDS alerts is likely transferable 
and suggests that both the placement (i.e., where the box is displayed in relation to the main 
order information) and visibility (i.e., the font and contrast of the free-text comment box in 
relation to other ‘competing’ information on the screen) are important and may serve as a 
starting point for improvements.[56]   
11.4.3 CDS 
 
11.4.3.1 Expand Use of CDS 
The hospital’s system development team had taken a conservative approach to the 
implementation of interruptive CDS alerts, recognising the potential for alert fatigue 
amongst its users. This limited use of interruptive CDS alerts was appreciated by some users, 
yet criticised by others who called for wider use of CDS to make certain processes safer e.g., 




that only 26.6% (n=100) of these orders generated specific warnings in different systems, 
thus indicated underutilisation of CDS alerts in many US systems.[105]  Amato et al. reviewed 
2,522 error reports from six different sites in the US, between January to December 2013 to 
identify and classify those related to the use of CPOE.[293] For instance, patients receiving 
the same drug or a drug in the same therapeutic class accounted for 16.2% (n=222) of all 
errors in this study and could have been potentially avoided with the use of duplicate dose 
alerts. Magrabi et al. also reviewed incident reports entered in to the US Food and Drug 
Administration Manufacturer and User Facility Device Experience database and found that 
the absence of CDS contributed to some of these incidents occurring.[294] For example, 
alerts were not generated to warn users about mismatches in blood groups.[294]  
Studies have also described user overdependence on ePrescribing systems for clinical 
guidance or information.[256] This programme of work revealed how some users assumed 
that checks were operational in the system, when in fact they were not. In some cases, a 
warning was displayed to inform the user that it was not able to perform any checks on a 
particular medication (e.g., unlicensed or newly added to the formulary). These alerts gave 
the impression to users that checks were being performed for other types of medications, 
even though the majority of other alerts had been silenced by the system development team. 
This finding highlighted some of the unintended consequences of having non-clinical alerts 
in the system. Wright et al. found that an alert was not generated as intended for patients 
receiving low-molecular weight heparins (an anticoagulant) because the alert build had 
unintentionally only been set up to fire when an unfractionated heparin was prescribed.[295] 
Additionally, an alert that recommended reviewing a patient’s carbamazepine (an anti-
epileptic) levels every year was found to have triggered for all brands of carbamazepine 
except one.[295] This exception related to a specific brand that had been newly added to the 
drug formulary since this alert was built and thus, patients who were prescribed this brand 
could have missed important therapeutic drug monitoring. Malfunctioning alerts were 
detected by testing, reviewing alert data and alert override reasons, reviewing user reports 
and conducting demonstrations of the system.[295] This emphasises the need for robust 
procedures when testing CDS functionality.  
11.4.3.1.1 Drug-Drug interaction alerts  
In particular, this programme of work revealed how users felt CDS could be beneficial for 




Phansalkar et al’s., list of high priority drug-drug interactions may be a useful starting point 
for organisations considering what specific CDS drug-drug alerts to implement.[61] The 
authors identified interacting drug pairs within the medication knowledge base used across 
two large academic medical centres, and assigned a severity level to them, where level 1 was 
the most serious, level 2 was of moderate severity and level 3 was the least serious 
interactions. A refined set of the most serious level 1 alerts (31 candidate DDIs) was then 
reviewed by an expert panel (n=21). The panel settled on a final list of 15 DDI alerts that 
should, in their opinion, never be co-prescribed (e.g., selective serotonin reuptake inhibitors 
(SSRI’s) and Monoamine oxidase inhibitors (MAOIs).[61] A second study examined whether 
these 15 DDI alerts were present in five international EHR systems and  found that all 15 only  
existed in two of the systems tested.[106] Furthermore, the numbers of alerts generated 
were comparatively low across these systems, with only 4.4% (n=768) triggered in the 
outpatient US system and none in the Belgian and Korean systems.[106] The inclusion of 
these alerts into a system is therefore unlikely to contribute to a high volume of alerts and 
subsequent alert fatigue amongst users.[106] The challenge is determining how to present 
level 2 DDI alerts, which are more commonly prescribed and may have different effects on 
patients, depending on their clinical condition. Recent studies have highlighted how there is 
a lack of standardised guidelines on how DDIs alerts in general were classified in terms of 
severity in different EHR systems.[59, 106] Cornu et al. therefore recommended developing 
a framework for the standardised evaluation of DDIs to determine their clinical 
relevance.[106] It may also be useful to have a centralised DDI knowledge base that is 
managed and updated by experts and that could be used by knowledge bases across 
different EHR system providers.  
Furthermore, moving on from the work conducted by Phansalkar et al., to identify high and 
low risk DDI alerts for inclusion into an EHR.[61, 62] It may also be useful to undertake a 
similar exercise for other forms of CDS alerts, such as drug-allergy alerts, drug-laboratory 
alerts or drug-disease alerts, to identify high, medium and low-severity issues that could 
inform how they are best presented within the system. 
11.4.3.1.2 Mandatory Fields 
The researcher described how the system displayed a prompt to users to encourage them to 
add a start and stop date for short courses of antibiotics. In another recent study, CDS 




problems related to antibiotic prescribing.[296] Allen et al. also found that the introduction 
of standardised order sets and recording of antibiotic indication and duration fields within 
the ePrescribing system contributed to fewer days of appropriate antibiotic therapy for adult 
patients in an ICU ward.[297] Similarly, in another study, prescribers were required to select 
an approved antimicrobial indication before they could proceed with an order, and the 
completion of this mandatory field was associated with a reduction in targeted antimicrobial 
use from 1250 to 988 doses administered per 1000 patient-days per year.[298] This suggests 
that there may be a role for mandatory fields to ensure stop dates and/or indications for 
short courses of medications are added.  
This research found how some users felt that the introduction of other mandatory fields on 
the system was not compatible with the usual workflow.  Niazkhani et al. pointed out how 
ePrescribing systems, imposed a “sequential and inflexible order of activities” on the user, 
which in some cases did not match the intended workflow or usual practice.[234] Blijleven 
et al. found that sometimes the system required overly specific information to be entered in 
order to proceed (e.g., the exact type of knee surgery that a patient received several years 
ago) and explained how sometimes such information was not known to the user.[299]  
11.4.3.2 Tailored Alerts  
This PhD programme of work revealed how there may be scope to tailor alerts to certain 
clinical areas or patients. For example, renal dosing alerts could be potentially used to guide 
clinicians’ decision making on a non-renal specialist ward. Recent reports have questioned 
the safety of boarding patients (patients who are sent to a ward either before they are 
formally admitted or to a ward that is managed by a different consultant than the patient’s 
main consultant).[300] The ‘CDS Five Rights’, specify that the most effective CDS should 
provide the (1) right information to the (2) right individuals, in the (3) right formats through 
the (4) right channels at the (5) right points of the workflow.[301] Therefore, it is important 
to consider all individuals involved in the patient care and ensure that alerts are directed 
towards the most appropriate people.[302] Baysari et al. highlighted how junior doctors 
were often the recipients of CDS alerts during ward rounds, yet senior doctors were making 
the prescribing decisions without ever seeing these alerts.[303] This emphasises the 
importance of targeting the right individuals at the right time.[303] Riedmann et al. also 
suggested that it may be beneficial to target alerts towards certain clinicians based on their 




fewer alerts than a junior cardiologist.[304] However, the impact of this would need to be 
further investigated and tested, as potentially useful alerts should not be switched off for 
users who may have benefitted from them. As highlighted in Chapter 9.1.3, one newly 
qualified doctor felt that drug-drug interaction alerts would not be beneficial on the 
cardiology ward as most of the routine medications worked in good harmony. This exposed 
perhaps a rather naïve outlook and highlights the dangers when users are not aware of what 
they don’t know. Indeed, Grizzle et al. noted how allowing clinicians to customise their own 
alerts could be dangerous and raised questions of liability within an organisation.[305] There 
is considerable literature that supports the finding that CDS alerts are not patient specific 
enough, which results in large volumes of inappropriate alerts being generated.[55, 64] It is 
clear that there needs to be better use of information already stored within the system about 
the patient, to guide CDS generation and development. Evidence suggests that utilising 
patient specific data into the decision making algorithms, can be beneficial at reducing the 
alert burden.[73, 306] Cornu et al. optimised their Belgian ePrescribing system  in the 
following ways: (a) customisation of the severity of the DDI for different classes and for 
individual medications within class-class interactions, so that the alerts were more specific 
to the medication prescribed, (b) a new alert design, (c) the creation of individual screening 
intervals (i.e., assigning a time period for which the interaction poses a clinical risk), and (d) 
a follow up process involving a second check by a clinical pharmacist for level 1 alerts. In this 
way, the severity of the alert was tailored towards the scale of the problem, based on patient 
specific factors, and the authors found that there was an improvement in alert acceptance 
(2.2% pre versus 52.4% post context enhanced alerts).[307] Seidling et al. estimated that 
approximately 80% of drug-drug interaction alerts were potentially sensitive to context 
factors (based on their review of 100 critical DDI alerts)[72] and in a separate study, Seidling 
et al. also developed a CDS algorithm that determined patient specific maximum therapeutic 
doses and alerts for 170 compounds.[308] The authors found that generating a maximum 
dosage alert resulted in fewer overdoses being prescribed (4.5% n= 552 pre-intervention and 
2.6% n=425 post-intervention). [308] During the design of the alert algorithm, it was 
interesting how the authors set the maximum dose limits at 30% higher than that set by 
clinical guidelines to reduce unnecessary alerts as a result of slight deviations.[308] Those 
involved in designing alerts should carefully consider what the maximum dose limit should 




11.4.3.3 Alert Design  
Following implementation of the ePrescribing system at the study site, certain physical clues 
(e.g., a warfarin chart at the end of the patent’s bed) were no longer visible. Instead, alerts 
were added to the system, to remind users to review the patient’s INR. If a patient had a 
significantly elevated INR, alerts could also be sent to more than one healthcare professional 
e.g., an anticoagulation nurse specialist or pharmacist. However, the alerts at the study site 
were not found to be particularly useful, with the warfarin review alert presented to the user 
when they first entered the patient’s electronic medical record (which could be for any 
purpose) rather than the patient’s specific medication record (where medication changes are 
made), which may have been more successful. Bates et al. developed Ten Commandments 
for effective CDS, which included how these systems should (1) anticipate the needs of the 
user in real time and (2) fit into the users’ workflow.[309] The authors emphasised the 
importance of delivering information at the appropriate time, which in turn increased the 
likelihood of tasks being performed.[309] Miller et al. also described the philosophy behind 
the design of the Vanderbilt hospital’s CPOE system, and stressed the importance of 
accurately timing the alerts to the situation. They explained how alerts that highlighted a 
contraindication between two drugs were most appropriately displayed on first selecting the 
potentially contraindicated drug, rather than after the full order (including selection of a drug 
dose and frequency) has been finalised. A study in primary care that observed 112 GP 
consultations suggested that even presenting alerts at the point of drug selection may be too 
late, as by this stage the GP might have already discussed with the patient what they were 
intending to prescribe even before they placed the order on the ePrescribing system.[310] 
Hayward et al. recommended that information to inform the decision making should be 
provided far earlier i.e., when the GP is first considering prescribing.[310] They also 
suggested that certain information about the patient e.g., allergies should be presented on 
summary pages and visible at all times.[310] This would benefit healthcare providers that 
review the patient’s record prior to seeing them.  
Alerts should also visually present the users with the severity of the problem.[104] Horsky et 
al. suggested classifying alerts into two or three severity levels such as “critical”, “significant” 
and “caution” and be colour coded.[311] Alerts should also facilitate the user taking 
appropriate action from that alert, for instance, providing a direct link to the warfarin order 
or an alternative dose.  Wright et al. found that only one system (out of nine tested) allowed 




current order, edit problem list or cancel existing order).[312] Genes et al. developed two 
CDS pain assessment alerts for geriatric patients, one allowing a ‘one-click’ pain score update 
to be obtained directly from the alert.[313] Participants appreciated this functionality with 
one doctor commenting on how: “before, you would click on the vitals and there would be 
800 different boxes to check so it always takes a long time to find the pain assessment. So I 
liked that it is very easy to see the button and it takes you only to the pain scale”.[313] Horsky 
et al. noted how: “the overall perceived difficulty of interaction with a system is directly 
related to the number of clicks required” therefore any reduction in effort for the user to 
search for information, navigate the system and complete a specific task will contribute to 
improved usability.[311] Hanna et al., also discussed how doctors complained that there 
were too many ‘mouse clicks’ and PIN entries to carry out the intended action in one 
ePrescribing system.[314] Phansalkar et al. advise that the corrective action suggested by an 
alert should be easy to perform.[56] 
11.4.4 Customisation to Improve Efficiency and Safety 
 
11.4.4.1 Customisation of the Medication and Patient List 
The first of Bates and colleagues’ ten commandments for effective CDS was: “Speed Is 
Everything”.[309] Users at the study site customised the ‘Medication and Patient Lists’ so 
that they could access certain pieces of information quicker. According to Sopan et al.  users 
tend to find their target faster from a shorter list and are more likely to miss it from within a 
long list.[315] They recommended restricting clinicians’ view to only those patients who they 
were caring for filtering the list e.g., by characteristics such as age or date of admission or 
the clinical department.[315] Other design changes to the patient list, such as increasing the 
buffer space between the width and weight of rows were also suggested. Sopan et al. 
predicted that these changes could be achieved with minimal effort and have an impact on 
patient safety.[315] However, the findings from my research suggested that users often 
found it difficult to customise the medication list or patient list, even when the functionality 
existed. In particular, the box that the users needed to click on was very small and not easily 
recognisable and the process of clicking through multiple drop-down boxes was quite 
laborious. Designers of ePrescribing systems must carefully consider how tabs and data 
labels appear and seek the feedback of users to ascertain whether certain tools are clearly 
visible. Secondly, any action must be acheived using as few clicks as possible so that it does 




The researcher also obtained a number of different perspectives on how the ‘Medication 
List’ should be displayed e.g., chronologically or alphabetically or sorting by active or 
discontinued medication. Zhang et al. noted how: “users always learn and users are always 
different”, thus providing users with the option to customise a system could improve their 
performance.[316]  
Phansalkar et al. warned that the number of colours used for coding in an environment 
should be kept to a minimum, ideally fewer than 10.[56] The meaning of any colour must 
also be obvious or learnable, with minimal training to prevent misinterpretation. Horsky et 
al. suggested that the same colours should be consistently applied throughout the system 
i.e., if red indicates the highest severity level and orange a lower level, this principle should 
be used across alerts, reminders and values.[317] A traffic light coding system could be used 
to distinguish prescribed medications that have stopped as red, suspended items as amber, 
or currently active as green. However, this may not account for all of the different statuses 
used in the system, such as ‘documented medications’ (medications documented within the 
patient’s medication history), which could be confusing and would require further thought. 
For specific users e.g., those who are colour blind, an alternative method to quickly 
communicate important information may be needed, for instance using a combined 
approach which incorporates symbols as well as careful consideration of the colour 
combinations used (good colour pairings include any dark colour with white).[318]  
11.4.4.2 Efficiency and Identification of High Risk Patients: The role of the 
Pharmacy Task List 
Some may argue that pharmacy staff should review every hospitalised patient’s medication 
on a daily basis. This is often not possible due to other commitments and limited resources. 
Furthermore, not all patients are likely to benefit from a full pharmacist review e.g., a young 
patient, who is not taking any medications. The Carter review outlined the need to improve 
efficiency and productivity in the NHS, recommending that pharmacists and pharmacy 
technicians spend more time on patient-facing medicines optimisation activities.[36] 
Therefore, tools that can identify certain high risk patients or individuals who may benefit 
from a pharmacist’s review could help achieve this goal.  As discussed in Chapter 8.3, the 
ePrescribing development team introduced a pharmacy task list with users highlighting 




A more robust tool that could effectively predict risk and prioritise hospital inpatients 
according to where pharmacist intervention is needed, is likely to be incredibly useful both 
at the study site and across the NHS. Falconer et al. developed and validated an electronic 
assessment risk tool for clinical pharmacist interventions in New Zealand.[319] They 
identified 38 ‘flags’ that were used to grade risk in patients and found that those classed as 
‘high risk’ had a significantly higher number of unintentional medication discrepancies than 
those who were classed as medium or low risk. Examples of ‘flags’ included patients who 
were prescribed more than eight admission medicines, those aged over 75, and had been 
readmitted within 30 days. However, this study failed to demonstrate a statistically 
significant link between some flags and medication discrepancies, possibly owing to the small 
sample size.[319] Hickson et al. developed a non-electronic pharmaceutical assessment 
screening tool (PAST), which required the pharmacist to manually assign a patient acuity level 
(PAL) to inpatients.[320] However, 43% (n=15) of patients reviewed had a pharmacist 
documented acuity level that did not adhere to the pharmacy department’s patient acuity 
screening tool’s guidance, which suggests that the tool needed further refinement.[320] It 
was also possible that senior pharmacists perceive risk differently and future work should 
focus on finding agreement amongst pharmacists i.e., where all patients would be assigned 
a high PAL score because of their condition.[320]  
11.4.4.3 Changes in Practice: Insulin ePrescribing 
The introduction of Insulin ePrescribing by the hospital system development team resulted 
in several changes in practice e.g., the ability to review blood glucose levels and prescribe 
insulin remotely; the advantages and disadvantages of these changes were discussed in 
Chapter 8.2. Campbell et al. also identified changes in practices as an unintended 
consequence of CPOE. In particular, they found issues with ‘STAT’ orders (orders to be given 
immediately) in general, which were often missed by the nurse with potential consequences 
for the patient. In these cases the prescriber failed to verbally communicate to the nurse that 
the order had been made as they were under the impression that the nurse would see and 
act upon it straight away because the order had been made on the system.[120] In other 
words, the system gave the ‘illusion of communication’.[120] There is a still an important role 
for verbal communication among staff when ePrescribing systems are used and this should 
be emphasised to users.[120] Electronic whiteboards could also provide a visual clue to 
nurses of patients who have been prescribed a new ‘STAT’ order and research should 




insulin ePrescribing also brought about a change in prescribing practice, with the daily re-
prescribing of insulin now replaced with a continuous prescription for the patient, which 
again had advantages and disadvantages. The US Department of Health and Human Services’ 
Office of the National Coordinator for Health Information Technology (ONC) stipulated that 
system vendors must conduct formal usability testing of EHR functionality, which should 
include at least 15 end-user representatives; however, Ratwani et al. found that only 9 (22%) 
of the 41 vendors included in their study used at least 15 participants with clinical 
backgrounds, 1 vendor used no clinical participants, and 7 (17%) used no physician 
participants.[126] System developers must clearly improve here.   
 
11.4.5 User Training on Electronic Prescribing Systems: Multiple Schools of 
Thought 
 
11.4.5.1 Practical Exercises and Clinical Scenarios  
The researcher identified a range of ways in which users were trained on how to use 
ePrescribing systems. There appeared to be a lack of consensus amongst interviewees about 
what the best way to train users was, and how training could be more effectively and 
efficiently delivered to users across a hospital Trust. Borycki et al. developed an EHR portal 
system, which provided healthcare professional students access to different EHRs in a 
simulated environment.[247] This included granting fourth year medical students access to 
dummy patient cases during problem based learning sessions; students felt that this 
exposure had been useful and suggested use of such a system earlier in their studies.[247] 
Simulation training also gives users immediate feedback about how they are using the 
system and  can be designed  in a more standardised way with set learning objectives.[321] 
Arnold and Fuller described the use of a ‘simulation module’ that was modelled on 
problematic interface design features of an EHR system.[322] This module presented users 
with a ‘storyline’ or scenario that was based on recovering from an error made by a fictional 
colleague. This gave them exposure to contributing factors to that error (e.g., a drop down 
menu).[322] One site in particular had specifically designed the training exercises to mimic a 
user’s normal workflow i.e., starting with admitting a patient, prescribing medications, 
ordering blood tests and writing a discharge prescription. Fowler-Byers and White suggested 




in the particular care setting.[323] Pantaleoni et al. also described the use of training themes 
that were designed according to the healthcare provider’s role; some users “greatly 
appreciated that [the trainer] adapted content to my [their] experience level” and thanked 
the trainers for delivering material that was “specific to psych [psychology]”.[324] This 
emphasised the need to ensure that the training was clinically relevant. Some hospital Trusts 
ensured that their training staff were also clinically trained, and where possible would match 
the trainer to the user i.e., a nurse would ideally train other nurses on the system. Role 
specific trainers are more likely to have a deeper understanding of the specific tasks and 
problems that other users from a similar profession may encounter during use of the system. 
Stevens et al. described an alternative approach whereby fourth-year medical students were 
given comprehensive training over a six weeks course and payment to train doctors on a new 
EHR system being implemented in a US Hospital.[325] The medical students found the 
experience incredibly positive, as it allowed them to develop teaching skills and use the 
system. The hospital doctors were also very receptive and scored the trainers extremely well 
on a post-training survey.[325] This approach may be transferable to UK hospitals and could 
offer a cost-effective approach to delivering role-specific training. 
11.4.5.2 Workforce Training Demands  
Healthcare organisations need to ensure that all their staff are competent at using IT systems 
both now and in the future. The researcher found that certain users (e.g., locum doctors) at 
some hospitals did not receive any formal training on the system. Studies have shown that 
insufficient training on an ePrescribing system can contribute to errors.[105, 192] People 
often have very different learning styles or availability to attend training, which may 
necessitate the use of a combined strategy.[250]  e-learning has been used to deliver training 
en-masse, at a flexible time and location for different users. The material would be 
standardised and thus delivered consistently, time and time again. However, there is a lack 
of good quality research that explores how users should be trained on how to use healthcare 
IT systems, including ePrescribing systems.[326] Whilst e-learning offers benefits, there may 
be some barriers to using it as the sole training approach.  For instance, there were significant 
costs associated with developing and maintaining software and ensuring that there was 
sufficient and appropriate hardware to allow users to complete e-learning.[327] Further 
work is therefore needed to judge the success and acceptability of using e-learning and 
whether it may be more effective as preparatory training before users receive classroom 




determine the best way to measure users’ competency and understanding of using 
ePrescribing systems. Each of the four hospital sites included in this programme of work had 
taken a different approach to assessment, with some conducting no assessments to others 
requiring a mandatory assessment to be completed with a 90% pass mark before using the 
‘live’ system.  
11.4.5.3 Informal Training 
Ward based training helped users develop a deeper understanding of the ePrescribing 
system. A report from the Agency for Healthcare Research and Quality described the 
experiences of grantees who had implemented inpatient CPOE systems and how users 
valued having access to super users or members of the implementation team to answer 
questions.[328] Yuan et al. also recognised the influence super-users had on their peers and 
in their study compared super users who had either volunteered for the position with those 
who had been nominated by their manager because they were considered to be the most 
‘technologically savvy’.[329] The authors found that super users who had volunteered to 
perform the role used more ‘effort-intensive behaviours’ to support the implementation 
process, for example proactively asking staff if they needed any help and regularly shared 
information about the EHR with their colleagues. In contrast, the super users who had been 
nominated by their seniors were more reactive and did not provide as much detail about 
why the system worked in a certain way.[329] Yuan et al. described how some users 
appeared to be burdened by their training role, thus it is important to consider the additional 
strain and fatigue that this role may place on them in different clinical settings.[329]  
11.5  Recommendations 
This research has identified a number of key recommendations that apply to system 
developers, hospital organisations, users, policy makers and researchers. These 
recommendations fall under three main areas: the system design, CDS and training 








Table 10: Recommendations from this PhD programme of work related to the system 
design, CDS and training approaches 
The System Design 
Responsible Person(s) Recommendation 
System developers The ‘Medication List’ view should allow users to see all medications that 
the patient is/ has been prescribed on one screen, including the status 
(e.g., whether it is active, suspended or discontinued etc.). 
System developers A patient’s blood test results should be visible on one screen and the user 
should be able to customise how this information is presented e.g., 
vertically or horizontally.  
System developers Words or phrases in data labels should not be truncated. If shortened, it 
should be possible to view the full word or phrase by ‘hovering’ over the 
data label. 
Hospital organisations  The risks associated with using disparate systems should be identified, 
eliminated (e.g., better integration) and reduced (e.g., education).  




Similar design principles for symbols and icons should be used 
consistently across systems and further investigated.  
System developers; 
hospital organisations 
Users should be allowed to develop a personalised patient list that can be 
filtered by age, clinical area and/or admission date.  
System developers Users should be able to increase the height and width between 
medication or patient lists.  
System developers; 
hospital organisations 
Users should be allowed to customise their ‘Medication List’ either 
chronologically or alphabetically.  
System developers; 
hospital organisations 
Colour should be used consistently and sparingly throughout the system 
e.g., alert severity level and be easily learnable. 
System developers; 
hospital organisations 
Shades of colour should be used to represent changes in certain levels 
e.g., light red to dark red to reflect an out-of-range result at either end of 







Systems should recognise variations of a phrase or spelling to help users 





Users should be required to enter the drug indication, which can then 
generate indication based dosing suggestions.  
System developers; 
hospital organisations 
Ensure availability of order sentences with a prescribed dose, formulation 
and strength, which should be linked to prevent prescribing errors. Users 
should be able to amend this where appropriate.  
System developers Drop down menus should not be overly long and look-alike-sound-alike 
medication names should not be listed next to each other. Tall man 
lettering could potentially be used to prevent the risk of selection errors 
but further research is needed to support this.  
System developers; 
hospital organisations 
Develop structured order sentences for complex medication regimens 
e.g., titrating courses of steroids and variable daily doses.  
System developers; 
hospital organisations 
A mandatory stop date/ review date should be included for certain 




Improve the sensitivity and specificity of CDS by incorporating more 
patient specific information into the decision-making algorithms. 
System developers Alerts should present a concise description of why they have been 
presented to the user. Alerts should assist the user to complete the 




Alerts should be assigned a severity level.  
System developers; 
hospital organisations; 
users; policy makers 
Users and clinical experts should be involved in all stages of the system 
development, and feedback should be sought regarding the impact of the 
system on workflow.  
Hospital organisations Organisations should carefully consider the best way to display non-
clinical alerts to users.  
System developers, 
hospital organisations 
Further development and investigation into the use of the pharmacy 




Approaches to training 
Hospital organisations All users should receive a minimum level of training, so that they can 
familiarise and learn to navigate the system and get instant feedback 
about their use.  
Hospital organisations Clinical scenarios that are used in user training should: (a) reflect the 
user’s usual workflow and (b) describe common errors that can be made 
when using the system and how one should avoid them. 
Hospital organisations The content of the training material should be tailored to the user’s 
specific role or level of experience.  
Hospital organisations It would be advantageous for the trainer to have a clinical background 
that matches the user group (e.g., a nurse training a group of nurses).  
Hospital organisations Trainers should be enthusiastic and dedicated.   
 
11.6  Areas of Future Research 
This PhD has identified several areas of further research that could improve patient safety, 
usability of ePrescribing systems and service delivery.  
11.6.1 System Design 
The design and use of computer technology, and how people interact with this technology is 
a widely researched area.  Further research is needed in three key areas (1) CDS, (2) 
pharmacy prioritisation tools and (3) paediatric ePrescribing systems.   
11.6.1.1 CDS 
CDS must be optimised and this programme of work has identified several areas of further 
research. The wording and phrases used in systems for key trigger words (e.g., the naming 
of order sets) used within the system needs more consideration. Secondly, the effect of 
introducing additional DDI alerts on alert overrides, patient outcomes and user satisfaction, 
across a range of different users in the UK setting also needs to be further investigated. 
Factors that contribute to alert success (i.e., alert acceptance and action taken by a clinician) 
and failure (i.e., inappropriate overrides) should be further explored and disseminated. The 




workflows and user input to determine the most appropriate time for alert presentation. 
More research is needed to help standardise severity levels of different medication-related 
CDS alerts across systems.[106]  
11.6.1.2 Electronic prioritisation tools 
The acceptability of a user-task list or ‘prioritisation tool’ for clinical users including 
pharmacy, medical and nursing staff should be investigated. Such a tool could help 
organisations audit practice, enable users to organise their work remotely and may also 
result in fewer interruptive alerts, if issues could be documented on a ‘log’ rather than 
disturbing the user’s workflow. The pharmacy task list developed and employed at the study 
site was appreciated by users but further improvements are needed; additional indicators 
need to be identified and included into the task list to improve the specificity and sensitivity 
of the tool. Furthermore, patients should be assigned an acuity level that will help users 
identify high-risk patients and inform prioritisation of pharmacy services. The effect of this 
on patient outcomes, cost effectiveness and user satisfaction should be explored.  
11.6.1.3 Paediatric ePrescribing systems 
As the systematic review in chapter 4 highlighted, unintended consequences have occurred 
during the use of paediatric systems. There has been little research exploring the impact of 
ePrescribing systems on the rates of medication errors in the UK. Therefore, further research 
should address this knowledge gap and help to further explore issues with paediatric system 
design and functionality.  
11.6.2 Training 
The training of users of ePrescribing systems has been under researched. This programme of 
work suggested that clinically experienced trainers should ideally be matched with their user 
group. However, this was often impractical due to a lack of resources. The use of healthcare 
professional students to train staff should be considered and further explored. E-learning 
offers a potentially efficient way of training large volumes of users; however, further 
research is needed to understand the advantages and disadvantages associated with using 
this approach and how it should be employed (i.e., as a sole approach or as part of a blended 




needs to be further investigated, as well as the best ways of ensuring that staff are 
competent.  
11.7  Concluding Remarks 
This thesis presents a PhD programme of work, comprising of a series of systematic literature 
reviews (Chapters 2 to 5), and qualitative methods to explore staff experiences of using an 
ePrescribing system in one UK hospital Trust (Chapters 6 to 10). This led onto a follow-on 
pilot study, which examined how users were trained to use ePrescribing systems across four 
NHS hospital Trusts (Chapter 10). As a result, this research has highlighted various issues with 
the design and usability of ePrescribing systems. Human factors design principles should be 
considered during the design and ongoing development of these systems and users should 
be involved throughout. The researcher encountered issues with the ‘Medication List’ and 
how information was presented. She also gained an understanding of the challenges users 
faced when viewing blood test results and using certain symbols. Ultimately, such issues can 
result in workarounds or pose a risk to patient safety. In particular, this programme of work 
uncovered benefits and challenges associated with the use of order sentences, order sets 
and favourite lists. There appeared to be a lack of user involvement in the design and 
development of the system. Interruptive CDS had been introduced conservatively at this 
study site; some users found that this was good because it did not disrupt their workflow. 
However, other users called for additional CDS to be implemented to reduce the risk of errors 
occurring in the future. Further research may guide what CDS to include and how this should 
be presented.  
Future research should also consider the development of digital tools that can support 
healthcare professionals to target their services towards patients who would benefit from 
their input the most.  
Finally, this PhD programme of work explored the training approaches used to train users on 
ePrescribing systems. Several approaches were identified, yet the question of how we should 
best train users to use ePrescribing systems remains unanswered. This training should really 
be introduced at an undergraduate level, thus preparing users for using such systems safely 








1.  National Patient Safety Agency, Safety in Doses: Improving the use if medicines in the 
NHS (2007) National Reporting and Learning Service. 
2. Pirmohamed, M., James, S., Meakin, S., et al., Adverse drug reactions as cause of 
admission to hospital: prospective analysis of 18 820 patients. BMJ, 2004. 329(7456): 
p. 15-9. 
3. Kohn, L.T., J. Corrigan, and M.S. Donaldson, To err is human : building a safer health 
system. 2000, Washington, D.C., Great Britain: National Academy Press.  
4. James, J.T., A new, evidence-based estimate of patient harms associated with 
hospital care. J Patient Saf, 2013. 9(3): p. 122-8. 
5. Elliott R, C.E., Campbell F, Jankovic D, et al., Prevalence and Economic Burden of 
Medication Errors in The NHS in England. Rapid evidence synthesis and economic 
analysis of the prevalence and burden of medication error in the UK. Policy Research 
Unit in Economic Evaluation of Health and Care Interventions. 2018, Universities of 
Sheffield and York. 
6. Howard, R.L., Avery, A.J., Slavenburg, S., et al., Which drugs cause preventable 
admissions to hospital? A systematic review. Br. J. Clin. Pharmacol, 2007. 63(2): p. 
136-147. 
7. Dean, B., N. Barber, and M. Schachter, What is a prescribing error? Qual Health Care, 
2000. 9(4): p. 232-7. 
8. Lewis, P.J., Dornan, T., Taylor, D., et al., Prevalence, incidence and nature of 
prescribing errors in hospital inpatients: a systematic review. Drug Saf, 2009. 32(5): 
p. 379-89. 
9. Dean, B., Learning from prescribing errors. BMJ Qual. Saf, 2002. 11(3): p. 258-260. 
10. Bates, D.W., Boyle, D.L., Vander Vliet, M.B., et al., Relationship between medication 
errors and adverse drug events. J Gen Intern Med, 1995. 10(4): p. 199-205. 
11. Bates, D.W., Cullen, D. J., Laird, N., et al., Incidence of adverse drug events and 
potential adverse drug events. Implications for prevention. ADE Prevention Study 
Group. JAMA, 1995. 274(1): p. 29-34. 
12. Reason, J., Human Error. 1990, Cambridge, UK: Cambridge University Press. 
13. Reason, J., Human error: models and management. BMJ, 2000. 320(7237): p. 768-
770. 
14. Dornan, T.A., Heathfield, H., Lewis, P., et al., An in Depth Investigation into Causes of 
Prescribing Errors by Foundation Trainees in Relation to their Medical Education. 
EQUIP Study. A Report to the General Medical Council, 2009. 
15. Leape, L.L., Bates, D.W., Cullen, D.J., et al., Systems analysis of adverse drug events. 
JAMA, 1995. 274(1): p. 35-43. 
16. Dean, B., Schachter, M., Vincent C., et al., Causes of prescribing errors in hospital 
inpatients: a prospective study. Lancet, 2002. 359. 
17. Tully, M.P., Ashcroft, Darren M., Dornan, T., et al., The Causes of and Factors 
Associated with Prescribing Errors in Hospital Inpatients. Drug Saf, 2009. 32(10): p. 
819-836. 
18. Avery, T., Barber, N., Ghaleb, M., et al., Investigating the prevalence and causes of 
prescribing errors in general practice: The PRACtICe Study (PRevalence And Causes of 
prescrIbing errors in general practiCe), A report for the GMC, 2012. 
19. Slight, S.P., Howard, R., Maisoon, G., et al., The causes of prescribing errors in English 




20. Robertson, A., Cresswell, Kathrin., Takian, A., et al., Implementation and adoption of 
nationwide electronic health records in secondary care in England: qualitative 
analysis of interim results from a prospective national evaluation. BMJ, 2010. 341. 
21. Bates, D.W., Using information technology to reduce rates of medication errors in 
hospitals. BMJ,  2000. 320(7237): p. 788-791. 
22. Bates, D.W., Leape, L.L., Cullen, D.J., et al., Effect of computerized physician order 
entry and a team intervention on prevention of serious medication errors. JAMA, 
1998. 280(15): p. 1311-1316. 
23. Kaushal, R., et al., Electronic prescribing improves medication safety in community-
based office practices. J Gen Intern Med, 2010. 25(6): p. 530-6. 
24. Kaushal, R., K.G. Shojania, and D.W. Bates, Effects of computerized physician order 
entry and clinical decision support systems on medication safety: a systematic 
review. Arch Intern Med, 2003. 163(12): p. 1409-16. 
25. Ammenwerth, E., Schnell-Inderst, P., Machan, C., et al., The effect of electronic 
prescribing on medication errors and adverse drug events: a systematic review. J Am 
Med Inform Assoc, 2008. 15(5): P. 585-600 
26. Radley, D.C., Wasserman, M. R., Olsho, L. E. W. et al., Reduction in medication errors 
in hospitals due to adoption of computerized provider order entry systems. J Am Med 
Inform Assoc 2013. 20(3): p. 470-476. 
27. Nuckols, T.K., Smith-Spangler, C., Morton, S.C., et al., The effectiveness of 
computerized order entry at reducing preventable adverse drug events and 
medication errors in hospital settings: a systematic review and meta-analysis. Syst 
Rev, 2014. 3: p. 56. 
28. British Medical Association and Pharmaceutical Society of Great Britain., British 
national formulary 72.  
29. van Rosse, F., Maat, B., Rademaker, C.M.,  et al., The effect of computerized physician 
order entry on medication prescription errors and clinical outcome in pediatric and 
intensive care: a systematic review. Pediatrics, 2009. 123. 
30. Avery, A.J., Rodgers, S., Cantrill, J.A., et al., A pharmacist-led information technology 
intervention for medication errors (PINCER): a multicentre, cluster randomised, 
controlled trial and cost-effectiveness analysis. The Lancet. 2012. 379(9823): p. 1310-
1319. 
31. NHS Connecting for Health, ePrescribing Functional Specification for NHS Trusts 2007  
32. Department of Health, Jeremy Hunt challenges NHS to go paperless by 2018. 2013. 
33. National Health Service, Five Year Forward View. 2014. 
34. NHS England, Safer Hospitals, Safer Wards: Achieving an Integrated Digital Care 
Record. 2013. 
35. NHS England, The Integrated Digital Care Fund: Achieving integrated health and care 
records. 2014. 
36. An independent report for the Department of Health by Lord Carter of Coles. 
Operational productivity and performance in English NHS acute hospitals: 
Unwarranted variations, 2016. 
37. Crowe, S., Cresswell, K., Avery, A.J., et al., Planned implementations of ePrescribing 
systems in NHS hospitals in England: a questionnaire study. JRSM Short Rep, 2010. 
1(4): p. 33. 
38. Ahmed, Z., McLeod, M.C., Barber, N., et al., The Use and Functionality of Electronic 
Prescribing Systems in English Acute NHS Trusts: A Cross-Sectional Survey. PLOS ONE, 
2013. 8(11): p. e80378. 
39. Schade, C.P., Sullivan, F.M., de Lusignan, S., et al., e-Prescribing, Efficiency, Quality: 
Lessons from the Computerization of UK Family Practice. J Am Med Inform Assoc. 




40. Pedersen, C.A., P.J. Schneider, and D.J. Scheckelhoff, ASHP national survey of 
pharmacy practice in hospital settings: Prescribing and transcribing—2016. Am J 
Health Syst Pharm, 2017. 74(17):1336-1352. 
41. Slight, S.P. and E.S. Berner, Meaningful Use of Electronic Health Records: Experiences 
From the Field and Future Opportunities. JMIR Med Inform. 2015. 3(3): p. e30. 
42. Henderson, J., H. Britt, and G. Miller, Extent and utilisation of computerisation in 
Australian general practice. Med J Aust, 2006. 185(2): p. 84-7. 
43. ePrescribing Toolkit for NHS Hospitals. 2017 [Available from: 
http://www.eprescribingtoolkit.com/. 
44. Kruse, C.S. and K. Goetz, Summary and Frequency of Barriers to Adoption of CPOE in 
the U.S. J Med Syst. 2015. 39(2): p. 15. 
45. Poon, E.G., Blumenthal, D., Jaggi, T., et al., Overcoming Barriers To Adopting And 
Implementing Computerized Physician Order Entry Systems In U.S. Hospitals. Health 
Aff, 2004. 23(4): p. 184-190. 
46. Kuperman, G.J., Bobb, A., Payne., et al., Medication-related clinical decision support 
in computerized provider order entry systems: a review. J Am Med Inform Assoc, 
2007. 14(1): p. 29-40. 
47. Bright, T.J., Wong, A., Dhurjati, R., et al., Effect of clinical decision-support systems: a 
systematic review. Ann Intern Med, 2012. 157(1): p. 29-43. 
48. Durieux, P., Trinquart, L., Colombet, I., et al., Computerized advice on drug dosage to 
improve prescribing practice. Cochrane Database Syst Rev, 2008 16(3): p. Cd002894. 
49. Pearson, S.A., Moxey, A., Robertson, J., et al., Do computerised clinical decision 
support systems for prescribing change practice? A systematic review of the 
literature (1990-2007). BMC Health Serv Res, 2009. 9: p. 154. 
50. Kawamoto, K., Hongsermeier, T., Wright, A., et al., Improving clinical practice using 
clinical decision support systems: a systematic review of trials to identify features 
critical to success. BMJ, 2005. 330(7494): p. 765. 
51. Garg, A.X., Adhikari, N. K., McDonald, H., et al., Effects of computerized clinical 
decision support systems on practitioner performance and patient outcomes: a 
systematic review. JAMA, 2005. 293(10): p. 1223-38. 
52. Kaushal, R., Jha, A. K., Franz, C., et al., Return on investment for a computerized 
physician order entry system. J Am Med Inform Assoc, 2006. 13(3): p. 261-6. 
53. Wolfstadt, J.I., Gurwitz, J. H., Field, T.S., et al., The effect of computerized physician 
order entry with clinical decision support on the rates of adverse drug events: a 
systematic review. J Gen Intern Med, 2008. 23(4): p. 451-8. 
54. Ash, J.S., Sittig, Dean F., Campbell, E.M., et al., Some Unintended Consequences of 
Clinical Decision Support Systems. AMIA Annu Symp Proc, 2007. p. 26-30. 
55. van der Sijs, H., Aarts, J., Vulto, A., et al., Overriding of Drug Safety Alerts in 
Computerized Physician Order Entry. J Am Med Inform Assoc, 2006. 13(2): p. 138-
147. 
56. Phansalkar, S., Edworthy, J., Hellier, E., et al., A review of human factors principles 
for the design and implementation of medication safety alerts in clinical information 
systems. J Am Med Inform Assoc, 2010. 17(5): p. 493-501. 
57. Tolley, C.L., Slight, S.P., Husband, A.K., et al., Improving medication-related clinical 
decision support. Am J Health Syst Pharm, 2018. 75(4): p. 239-246. 
58. Lapane, K.L., Waring, M. E., Schneider, K. L., et al., A mixed method study of the merits 
of e-prescribing drug alerts in primary care. J Gen Intern Med, 2008. 23(4): p. 442-6. 
59. McEvoy, D.S., Sittig, D.F., Hickman, T., et al., Variation in high-priority drug-drug 
interaction alerts across institutions and electronic health records. J Am Med Inform 




60. Paterno, M.D., Maviglia, S.M., Gorman, P.N., et al., Tiering Drug–Drug Interaction 
Alerts by Severity Increases Compliance Rates. J Am Med Inform Assoc., 2009. 16(1): 
p. 40-46. 
61. Phansalkar, S., Desai, A.A., Bell, D., et al., High-priority drug-drug interactions for use 
in electronic health records. J Am Med Inform Assoc, 2012. 19(5): p. 735-43. 
62. Phansalkar, S., van der Sijs, H., Tucker, a.D.,  et al., Drug-drug interactions that should 
be non-interruptive in order to reduce alert fatigue in electronic health records. J Am 
Med Inform Assoc, 2013. 20(3): p. 489-93. 
63. Mille, F., Schwartz, C., Brion, F., et al., Analysis of overridden alerts in a drug-drug 
interaction detection system. Int J Qual Health Care, 2008. 20(6): p. 400-5. 
64. Slight, S.P., Seger, D.L., Nanji, K.C., et al., Are we heeding the warning signs? 
Examining providers' overrides of computerized drug-drug interaction alerts in 
primary care. PLoS One, 2013. 8(12): p. e85071. 
65. Nanji, K.C., Slight, S.P., Seger, D.L., et al., Overrides of medication-related clinical 
decision support alerts in outpatients. J Am Med Inform Assoc, 2014. 21(3): p. 487-
91. 
66. Russ, A.L., Zillich, A.J., McManus, M.S., et al., A human factors investigation of 
medication alerts: barriers to prescriber decision-making and clinical workflow. AMIA 
Annu Symp Proc. 2009: p. 548-52. 
67. Seidling, H.M., Phansalkar, S., Seger, D.L., et al., Factors influencing alert acceptance: 
a novel approach for predicting the success of clinical decision support. J Am Med 
Inform Assoc, 2011. 18(4): p. 479-84. 
68. Taegtmeyer, A.B., Kullak-Ublick, G. A. Widmer, N., et al., Clinical usefulness of 
electronic drug-drug interaction checking in the care of cardiovascular surgery 
inpatients. Cardiology, 2012. 123(4): p. 219-22. 
69. Coleman, J.J., van der Sijs, H., Haefeli, W.E., et al., On the alert: future priorities for 
alerts in clinical decision support for computerized physician order entry identified 
from a European workshop. BMC Med Inform Decis Mak. 2013. 13(1): p. 1-8. 
70. Lin, C.-P., Payne, T.H., Nichol, W.P., et al., Evaluating Clinical Decision Support 
Systems: Monitoring CPOE Order Check Override Rates in the Department of 
Veterans Affairs' Computerized Patient Record System. J Am Med Inform Assoc. 
2008. 15(5): p. 620-626. 
71. Strom, B.L., Schinnar, R., Aberra, F., et al., Unintended effects of a computerized 
physician order entry nearly hard-stop alert to prevent a drug interaction: a 
randomized controlled trial. Arch Intern Med, 2010. 170(17): p. 1578-83. 
72. Seidling, H.M., Klein, U., Schaier, M., et al., What, if all alerts were specific - 
estimating the potential impact on drug interaction alert burden. Int J Med Inform, 
2014. 83(4): p. 285-91. 
73. Duke, J.D. and D. Bolchini, A Successful Model and Visual Design for Creating Context-
Aware Drug-Drug Interaction Alerts. AMIA Annu Symp Proc, 2011. 2011: p. 339-348. 
74. Duke, J.D., X. Li, and P. Dexter, Adherence to drug-drug interaction alerts in high-risk 
patients: a trial of context-enhanced alerting. J Am Med Inform Assoc, 2013. 20(3): 
p. 494-8. 
75. Isaac, T., Weissman, J. S., David, R.B., et al., Overrides of medication alerts in 
ambulatory care. Arch Intern Med, 2009. 169.(3)  p.305-11 
76. Jani, Y.H., N. Barber, and I.C. Wong, Characteristics of clinical decision support alert 
overrides in an electronic prescribing system at a tertiary care paediatric hospital. Int 
J Pharm Pract, 2011. 19(5): p. 363-6. 
77. Gonzalez-Gregori, R., Dolores Hernández Fernandez De Rojas, M., López-Salgueiro, 
R., et al., Allergy alerts in electronic health records for hospitalized patients. Ann 




78. Weingart, S.N., Massagli, M., Cyrulik, A., et al., Assessing the value of electronic 
prescribing in ambulatory care: a focus group study. Int J Med Inform, 2009. 78(9): 
p. 571-8. 
79. Fernando, B., Morrison, Z., Kalra, D., et al., Approaches to recording drug allergies in 
electronic health records: qualitative study. PLoS One, 2014. 9(4): p. e93047. 
80. Zhou, L., Mahoney, L.M., Shakurova, A., et al., How many medication orders are 
entered through free-text in EHRs?--a study on hypoglycemic agents. AMIA Annu 
Symp Proc, 2012. 2012: p. 1079-88. 
81. Slight, S.P., Beeler, P.E., Seger, D.L.., et al., A cross-sectional observational study of 
high override rates of drug allergy alerts in inpatient and outpatient settings, and 
opportunities for improvement. BMJ Qual Saf, 2017. 26(3): p. 217-225. 
82. Hsieh, T.C., Kuperman, g.J., Jaggi, T., et al., Characteristics and consequences of drug 
allergy alert overrides in a computerized physician order entry system. J Am Med 
Inform Assoc, 2004. 11(6): p. 482-91. 
83. Topaz, M., Seger, D.L., Slight, S.P., et al., Rising drug allergy alert overrides in 
electronic health records: an observational retrospective study of a decade of 
experience. J Am Med Inform Assoc, 2015. 23(3):601-8. 
84. Gillaizeau, F., Chan, E., Trinquart, L., et al., Computerized advice on drug dosage to 
improve prescribing practice. Cochrane Database Syst Rev, 2013(11): p. Cd002894. 
85. Killelea, B.K., Kaushal, R., Cooper, M., et al., To what extent do pediatricians accept 
computer-based dosing suggestions? Pediatrics, 2007. 119(1): p. e69-75. 
86. Chertow, G.M., Lee, J., Kuperman, G.J., et al., Guided medication dosing for 
inpatients with renal insufficiency. JAMA, 2001. 286(22): p. 2839-44. 
87. Peterson, J.F., Kuperman, G.J., Shek, C., et al., Guided prescription of psychotropic 
medications for geriatric inpatients. Arch Intern Med, 2005. 165(7): p. 802-7. 
88. Sellier, E., Colombet, I., Sabatier, B., et al., Effect of alerts for drug dosage adjustment 
in inpatients with renal insufficiency. J Am Med Inform Assoc, 2009. 16(2): p. 203-10. 
89. Peterson, J.F., Rosenbaum, B. P., Waitman, L.R., et al., Physicians' response to guided 
geriatric dosing: initial results from a randomized trial. Stud Health Technol Inform, 
2007. 129(Pt 2): p. 1037-40. 
90. Boussadi, A., Caruba, T., Zapletal, E., et al., A clinical data warehouse-based process 
for refining medication orders alerts. J Am Med Inform Assoc, 2012. 19(5): p. 782-5. 
91. Kirkendall, E.S., S.A. Spooner, and J.R. Logan, Evaluating the accuracy of electronic 
pediatric drug dosing rules. J Am Med Inform Assoc, 2014. 21(e1): p. e43-9. 
92. Wachter, Robert., The Digital Doctor: Hope, Hype, and Harm at the Dawn of 
Medicine's Computer Age. 2015, United States: McGraw-Hill Education. 
93. Johnson, K.B., Lee, C.K., Spooner, S.A., et al., Automated dose-rounding 
recommendations for pediatric medications. Pediatrics, 2011. 128(2): p. e422-8. 
94. Wetterneck, T.B., Walker, J.M., Blosky, M.A., et al., Factors contributing to an 
increase in duplicate medication order errors after CPOE implementation. J Am Med 
Inform Assoc, 2011. 18(6): p. 774-82. 
95. The Joint Commission, Medication Management Standard: MM.05.01.01, EP. 
96. Voils, C.I., B. Sleath, and M.L. Maciejewski, Patient perspectives on having multiple 
versus single prescribers of chronic disease medications: results of a qualitative study 
in a veteran population. BMC Health Serv Res, 2014. 14(1): p. 490. 
97. Crosson, J.C., Schueth, A.J., Isaacson, N., et al., Early adopters of electronic 
prescribing struggle to make meaningful use of formulary checks and medication 
history documentation. J Am Board Fam Med, 2012. 25(1): p. 24-32. 
98. Grossman, J.M., Gerland, A., Reed, M.C., et al., Physicians' experiences using 




99. Rodriguez, R., B. Staley, and R.C. Hatton, Evaluating incorporation of drug restrictions 
into computerized drug order entries after transition to an electronic health record. 
Hosp Pharm, 2013. 48(7): p. 568-73. 
100. Fischer, M.A., Vogeli, C., Stedman, M., et al., Effect of electronic prescribing with 
formulary decision support on medication use and cost. Arch Intern Med, 2008. 
168(22): p. 2433-9. 
101. Weinger, M.B., Pantiskas, C., Wiklund, M.E., et al., Incorporating human factors into 
the design of medical devices. JAMA, 1998. 280(17): p. 1484. 
102. Zachariah, M., Phansalkar, S., Seidling, H.M., et al., Development and preliminary 
evidence for the validity of an instrument assessing implementation of human-
factors principles in medication-related decision-support systems–I-MeDeSA. J Am 
Med Inform Assoc, 2011. 18. Suppl 1:i62-72. 
103. Phansalkar, S., Zachariah, M., Seidling, H.M., et al., Evaluation of medication alerts in 
electronic health records for compliance with human factors principles. J Am Med 
Inform Assoc, 2014. 21(e2): p. e332-40. 
104. Payne, T.H., Hines, L.E., Raymond, C.C., et al., Recommendations to improve the 
usability of drug-drug interaction clinical decision support alerts. J Am Med Inform 
Assoc. 2015. 22(6): p. 1243-1250. 
105. Schiff, G.D., Amato, M.G., Eguale, T., et al., Computerised physician order entry-
related medication errors: analysis of reported errors and vulnerability testing of 
current systems. BMJ Qual Saf, 2015. 24(4): p. 264-71. 
106. Cornu, P., Phansalkar, S., Seger, D.L., et al., High-priority and low-priority drug–drug 
interactions in different international electronic health record systems: A 
comparative study. Int J Med Inform. 2018. 111: p. 165-171. 
107. van der Sijs, H., Aarts, J.,  van Gelder, T., et al., Turning off frequently overridden drug 
alerts: limited opportunities for doing it safely. J Am Med Inform Assoc, 2008. 15(4): 
p.439-48. 
108. Cox, Z.L., Nelsen, C.L., Waitman, l.R., et al., Effects of clinical decision support on 
initial dosing and monitoring of tobramycin and amikacin. Am J Health Syst Pharm, 
2011. 68(7): p. 624-32. 
109. Tiwari, R., Tsapepas, D.S., Powell, J.T., et al., Enhancements in healthcare information 
technology systems: customizing vendor-supplied clinical decision support for a high-
risk patient population. J Am Med Inform Assoc, 2013. 20(2): p. 377-80. 
110. Cresswell, K.M., Bates, D.W., Williams, R., et al., Evaluation of medium-term 
consequences of implementing commercial computerized physician order entry and 
clinical decision support prescribing systems in two 'early adopter' hospitals. J Am 
Med Inform Assoc, 2014. 21(e2): p. e194-202. 
111. Russ, A.L., Zillich, A.J., McManus, M.S., et al., Prescribers' interactions with 
medication alerts at the point of prescribing: A multi-method, in situ investigation of 
the human-computer interaction. Int J Med Inform, 2012. 81(4): p. 232-43. 
112. Long, A.J., Chang, P., Li, Y.C., et al., The use of a CPOE log for the analysis of physicians' 
behavior when responding to drug-duplication reminders. Int J Med Inform, 2008. 
77(8): p. 499-506. 
113. Campion, T.R., Jr., et al., Characteristics and effects of nurse dosing over-rides on 
computer-based intensive insulin therapy protocol performance. J Am Med Inform 
Assoc, 2011. 18(3): p. 251-8. 
114. Field, T.S., Rochon, P., Lee, M., et al., Computerized clinical decision support during 
medication ordering for long-term care residents with renal insufficiency. J Am Med 
Inform Assoc, 2009. 16(4): p. 480-5. 
115. Koppel, R., Metlay, J.P., Cohen, A., al., Role of computerized physician order entry 




116. FitzHenry, F., Doran, J., Lobo., B., et al., Medication-error alerts for warfarin orders 
detected by a bar-code-assisted medication administration system. Am J Health Sys 
Pharm, 2011. 68(5): p. 434-441. 
117. Horsky, J., G.J. Kuperman, and V.L. Patel, Comprehensive Analysis of a Medication 
Dosing Error Related to CPOE. J Am Med Inform Assoc, 2005. 12(4): p. 377-382. 
118. Brown, C.L., Reygate, K., Slee, A., et al., A literature review of the training offered to 
qualified prescribers to use electronic prescribing systems: why is it so important? Int 
J Pharm Pract, 2017. 25(3):195-202. 
119. Brown, C.L., Mulcaster, H.L., Triffitt, K.L., et al., A systematic review of the types and 
causes of prescribing errors generated from using computerized provider order entry 
systems in primary and secondary care. J Am Med Inform Assoc, 2017. 24(2):432-
440. 
120. Campbell, E.M., Sittig, D.F., Ash, J.S., et al., Types of Unintended Consequences 
Related to Computerized Provider Order Entry. J Am Med Inform Assoc, 2006. 13(5): 
p. 547-556. 
121. Gandhi, T.K., Weingart, S.N., Seger, A. C., et al., Outpatient prescribing errors and the 
impact of computerized prescribing. J Gen Intern Med, 2005. 20(9): p. 837-41. 
122. Shulman, R., Singer, M., Goldstone, J., et al., Medication errors: a prospective cohort 
study of hand-written and computerised physician order entry in the intensive care 
unit. Criti Care, 2005. 9(5): p. R516-R521. 
123. Ash, J.S., Sittig, D.F., Dykstra, R., et al., Exploring the unintended consequences of 
computerized physician order entry. Stud Health Technol Inform, 2007. 129(Pt 1): p. 
198-202. 
124. Ash, J.S., Sittig, D.F., Poon, E.G., et al., The extent and importance of unintended 
consequences related to computerized provider order entry. J Am Med Inform Assoc, 
2007. 14(4): P. 415–423. 
125. Khajouei, R. and M.W. Jaspers, The impact of CPOE medication systems' design 
aspects on usability, workflow and medication orders: a systematic review. Methods 
Inf Med, 2010. 49(1): p. 3-19. 
126. Ratwani, R.M., Benda, N.C., Hettinger., et al., Electronic health record vendor 
adherence to usability certification requirements and testing standards. JAMA, 2015. 
314(10): p. 1070-1071. 
127. Brigham and Women’s Hospital (BWH) Center for Patient Safety Research and 
Practice, Computerized Prescriber Order Entry Medication Safety (CPOEMS): 
Uncovering and Learning From Issues, Brigham and Women’s Hospital (BWH) Center 
for Patient Safety Research and Practice-U.S. Food and Drug Administration (FDA) 
Computerized Prescriber Order Entry Medication Safety (CPOEMS) Project, 2015. 
128. Moher, D., Liberati, A., Tetzlaff., et al., Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA statement. BMJ, 2009. 339 :b2535 
129. Critical Appraisal Skills Programme (CASP). CASP Checklist 2014; Available from: 
http://media.wix.com/ugd/dded87_29c5b002d99342f788c6ac670e49f274.pdf  
130. Mays, N. and C. Pope, Qualitative Research: Rigour and qualitative research. BMJ, 
1995. 311(6997): p. 109-112. 
131. Caudill-Slosberg, M. and W.B. Weeks, Case study: identifying potential problems at 
the human/technical interface in complex clinical systems. Am J Med Qual, 2005. 
20(6): p. 353-7. 
132. Chan, J., Shojania, K.G., Easty, A.C., et al., Usability evaluation of order sets in a 




133. Baysari, M.T., Reckman, M.H., Li, L., et al., Failure to utilize functions of an electronic 
prescribing system and the subsequent generation of 'technically preventable' 
computerized alerts. J Am Med Inform Assoc, 2012. 19(6): p. 1003-10. 
134. Adelman, J.S., Aschner, J.L., Schechter, C.B., et al., Evaluating Serial Strategies for 
Preventing Wrong-Patient Orders in the NICU. Pediatrics, 2017. 139(5) e20162863.  
135. Savage, I., Cornford, T., Klecun, Ela., et al., Medication errors with electronic 
prescribing (eP): Two views of the same picture. BMC Health Serv Res, 2010. 10(1): 
p. 135. 
136. Goldman, R.E., C. Dube, and K.L. Lapane, Beyond the basics: refills by electronic 
prescribing. Int J Med Inform, 2010. 79(7): p. 507-14. 
137. Westbrook, J.I., Baysari, M.T., Li, L..,et al., The safety of electronic prescribing: 
manifestations, mechanisms, and rates of system-related errors associated with two 
commercial systems in hospitals. J Am Med Inform Assoc, 2013. 20(6): p. 1159-67. 
138. Odukoya, O.K., J.A. Stone, and M.A. Chui, E-prescribing errors in community 
pharmacies: exploring consequences and contributing factors. Int J Med Inform, 
2014. 83(6): p. 427-37. 
139. Snyder, A.M., Klinker, K., Orrick, J.J.,  et al., An in-depth analysis of medication errors 
in hospitalized patients with HIV. Ann Pharmacother, 2011. 45(4): p. 459-68. 
140. Jaderlund Hagstedt, L., C.E. Rudebeck, and G. Petersson, Usability of computerised 
physician order entry in primary care: assessing ePrescribing with a new evaluation 
model. Inform Prim Care, 2011. 19(3): p. 161-8. 
141. Zhan, C., Hicks, R.W., Blanchette, C.M., et al., Potential benefits and problems with 
computerized prescriber order entry: analysis of a voluntary medication error-
reporting database. Am J Health Syst Pharm, 2006. 63(4): p. 353-8. 
142. Odukoya, O.K. and M.A. Chui, Relationship between E-Prescriptions and Community 
Pharmacy Workflow. J Am Pharm Assoc, 2012. 52(6): p. e168-e174. 
143. Wentzer, H.S., U. Bottger, and N. Boye, Unintended transformations of clinical 
relations with a computerized physician order entry system. Int J Med Inform, 2007. 
76 Suppl 3: p. S456-61. 
144. Nanji, K.C., Rothsschild, J.M., Boehne, J.J., et al., Unrealized potential and residual 
consequences of electronic prescribing on pharmacy workflow in the outpatient 
pharmacy. J Am Med Inform Assoc, 2014. 21(3): p. 481-6. 
145. Khajouei, R., Wierenga, p.C., Hasman, A., et al., Clinicians satisfaction with CPOE ease 
of use and effect on clinicians' workflow, efficiency and medication safety. Int J Med 
Inform, 2011. 80(5): p. 297-309. 
146. Odukoya, O.C., Chui, M. A., Examining the impact of e-prescribing use on community 
pharmacy workflow. J Am Pharm Assoc, 2012. 52 (2): p. 262  
147. Chan, J. Shojania, K.G., Easty, A.C., et al., Does user-centred design affect the 
efficiency, usability and safety of CPOE order sets? J Am Med Inform Assoc, 2011. 
18(3): p. 276-81. 
148. Lambert, B.L., S.R. Schroeder, and W.L. Galanter, Does Tall Man lettering prevent 
drug name confusion errors? Incomplete and conflicting evidence suggest need for 
definitive study. BMJ Qual Saf, 2016. 25(4): p. 213-217. 
149. Gerrett, D., Gale, A.G., Darker, I.T., et al., Tall Man Lettering:Final Report of The Use 
of Tall Man Lettering to Minimise Selection Errors of Medicine Names in Computer 
Prescribing and Dispensing Systems ITQ Invitation Reference No. : ER-07-0612 NHS 
Connecting for Health, 2009.  
150. Galanter, W., Kalck, S., Burns, M.,  et al., Indication-based prescribing prevents 
wrong-patient medication errors in computerized provider order entry (CPOE). J Am 




151. Slight, S.P., Eguale, T., Amato, M.G., et al., The vulnerabilities of computerized 
physician order entry systems: a qualitative study. J Am Med Inform Assoc, 2016. 
23(2): p. 311-6. 
152. Eslami, S., Abu-Hanna, A., de Keizer, N.F., et al., Errors associated with applying 
decision support by suggesting default doses for aminoglycosides. Drug Saf, 2006. 
29(9): p. 803-9. 
153. Bobb, A.M., T.H. Payne, and P.A. Gross, Viewpoint: Controversies Surrounding Use of 
Order Sets for Clinical Decision Support in Computerized Provider Order Entry. J Am 
Med Inform Assoc. 2007. 14(1): p. 41-47. 
154. Palchuk, M.B., Fang, E.A., Cygielnik, J.M., et al., An unintended consequence of 
electronic prescriptions: prevalence and impact of internal discrepancies. J Am Med 
Inform Assoc. 2010. 17(4): p. 472-476. 
155. Dhavle, A.A., Yang, Y., Rupp, M.T., et al., Analysis of Prescribers' Notes in Electronic 
Prescriptions in Ambulatory Practice. JAMA Intern Med, 2016. 176(4): p. 463-70. 
156. Walsh, K.E., Adams, W.G., Bauchner, H., et al., Medication errors related to 
computerized order entry for children. Pediatrics, 2006. 118(5): p. 1872-9. 
157. Cresswell, K.M., D.W. Bates, and A. Sheikh, Ten key considerations for the successful 
optimization of large-scale health information technology. J Am Med Inform Assoc, 
2017. 24(1): p. 182-187. 
158. Wright, A., Hickman, T.T., McEvoy, D., et al., Analysis of clinical decision support 
system malfunctions: a case series and survey. J Am Med Inform Assoc, 2016. 23(6): 
p. 1068-1076. 
159. Leung, A.A., Keohane, C., Lipsitz, S., et al., Relationship between medication event 
rates and the Leapfrog computerized physician order entry evaluation tool. J Am Med 
Inform Assoc, 2013. 20(e1): p. e85-90. 
160. Jaspers, M.W., A comparison of usability methods for testing interactive health 
technologies: methodological aspects and empirical evidence. Int J Med Inform, 
2009. 78(5): p. 340-53. 
161. Velez-Diaz-Pallares, M., Delgado-Silveira, E., Carretero-Accame, M.E., et al., Using 
Healthcare Failure Mode and Effect Analysis to reduce medication errors in the 
process of drug prescription, validation and dispensing in hospitalised patients. BMJ 
Qual Saf, 2013. 22(1): p. 42-52. 
162. Friedman, M., Wyatt, J, Evaluation Methods in Biomedical Informatics (Health 
Informtics) Second Edition, 2005: Springer. 
163. Russ, A.L., Zillich, A.J., Melton, B.L., et al., Applying human factors principles to alert 
design increases efficiency and reduces prescribing errors in a scenario-based 
simulation. J Am Med Inform Assoc, 2014. 21(e2): p. e287-96. 
164. National Institute for Clinical Excellence, Medicines optimisation: the safe and 
effective use of medicines to enable the best possible outcomes. 2015. 
165. Tolley, C.L., Forde, N.E., Coffey, K.L., et al., Factors contributing to medication errors 
made when using computerized order entry in pediatrics: a systematic review. J Am 
Med Inform Assoc, 2018. 25(5):575-584.  
166. Smith, M.D., Spiller, H.A., Casavant, M.J., et al., Out-of-Hospital Medication Errors 
Among Young Children in the United States, 2002–2012. Pediatrics, 2014. 
167. Miller, M.R., Robinson, K.A., Lubomski, L.H., et al., Medication errors in paediatric 
care: a systematic review of epidemiology and an evaluation of evidence supporting 
reduction strategy recommendations. Qual Saf Health Care, 2007. 16(2): p. 116-126. 
168. Kaushal, R., Bates, D.W., Landrigan, C., et al., MEdication errors and adverse drug 
events in pediatric inpatients. JAMA, 2001. 285(16): p. 2114-2120. 
169. Hughes, R.G. and E.A. Edgerton, Reducing pediatric medication errors: children are 




170. Gerstle, R.S. and C.U. Lehmann, Electronic Prescribing Systems in Pediatrics: The 
Rationale and Functionality Requirements. Pediatrics, 2007. 119(6): p. e1413-e1422. 
171. Chedoe, I., Molendijk, H.A., Dittrich, S.T.A., et al., Incidence and Nature of Medication 
Errors in Neonatal Intensive Care with Strategies to Improve Safety. Drug Saf, 2007. 
30(6): p. 503-513. 
172. King, W.J., Paice, N., Rangrej, J., et al., The effect of computerized physician order 
entry on medication errors and adverse drug events in pediatric inpatients. 
Pediatrics, 2003. 112(3 Pt 1): p. 506-9. 
173. Reckmann, M.H., Westbrook, J.I., Koh, Y., et al., Does computerized provider order 
entry reduce prescribing errors for hospital inpatients? A systematic review. J Am 
Med Inform Assoc, 2009. 16. 
174. Ghaleb, M.A., Barber, N., Dean Franklin, B., et al., Systematic Review of Medication 
Errors in Pediatric Patients. Ann Pharmacother, 2006. 40(10): p. 1766-1776. 
175. Ferranti, J.M., Horvath, M.M., Jeanette., J., et al., Using a computerized provider 
order entry system to meet the unique prescribing needs of children: description of 
an advanced dosing model. BMC Med Inform Decis Mak, 2011. 11(1): p. 14. 
176. Johnson, K.B. and C.U. Lehmann, Electronic Prescribing in Pediatrics: Toward Safer 
and More Effective Medication Management. Pediatrics, 2013. 131(4): p. e1350-
e1356. 
177. Thomas, D.R., A General Inductive Approach for Analyzing Qualitative Evaluation 
Data. Am. J. Eval, 2006. 27(2): p. 237-246. 
178. Creswell, J.W. and D.L. Miller, Determining Validity in Qualitative Inquiry. Theory 
Pract, 2000. 39(3): p. 124-130. 
179. Doherty, C. and C. Mc Donnell, Tenfold Medication Errors: 5 Years’ Experience at a 
University-Affiliated Pediatric Hospital. Pediatrics, 2012. 129(5): p. 916-924. 
180. Holdsworth, M.T., Fichtl, R.E., Raisch, D.W., et al., Impact of computerized prescriber 
order entry on the incidence of adverse drug events in pediatric inpatients. Pediatrics, 
2007. 120(5): p. 1058-66. 
181. Walsh, K.E., Landrigan, C. P., Adams, W.G., et al., Effect of computer order entry on 
prevention of serious medication errors in hospitalized children. Pediatrics, 2008. 
121. 
182. Doherty, C. and C. McDonnell, Tenfold medication errors in pediatric hospital 
practiceCan J Anaesth, 2011. 58: p. S168. 
183. Kazemi, A., Ellenius, J., Pourasghar, F., et al., The Effect of Computerized Physician 
Order Entry and Decision Support System on Medication Errors in the Neonatal Ward: 
Experiences from an Iranian Teaching Hospital. J Med Syst 2011. 35(1): p. 25-37. 
184. Stultz, J.S., K. Porter, and M.C. Nahata, Sensitivity and specificity of dosing alerts for 
dosing errors among hospitalized pediatric patients. J Am Med Inform Assoc, 2014. 
21(e2): p. e219-25. 
185. McPhillips, H.A., Stille, C.J., Smith, D., et al., Potential Medication Dosing Errors in 
Outpatient Pediatrics. The Journal of Pediatrics, 2005. 147(6): p. 761-767. 
186. Jani, Y.H., N. Barber, and I.C.K. Wong, Paediatric dosing errors before and after 
electronic prescribing. Qual Saf Health Care, 2010. 19(4): p. 337-340. 
187. Scharnweber, C., Lau, B.D., Mollenkopf, N., et al., Evaluation of medication dose 
alerts in pediatric inpatients. Int J Med Inform, 2013. 82(8): p. 676-83. 
188. Kirk, R.C., Goh, D.L-M., Packia, J., et al., Computer Calculated Dose in Paediatric 
Prescribing. Drug Saf, 2005. 28(9): p. 817-824. 
189. Jani, Y.H., Ghaleb, M.A., Marks, S.D., et al., Electronic Prescribing Reduced Prescribing 




190. Summary of Product Characteristics: Ceftriaxone 1g Powder for solution for injection. 
2015; Available from: https://www.medicines.org.uk/emc/medicine/5469 [last 
accessed 14th May 2017]. 
191. Caruso, M.C., Gittelman, M.A., Widecan, M.L., et al., Pediatric emergency 
department discharge prescriptions requiring pharmacy clarification. Pediatr Emerg 
Care, 2015. 31(6): p. 403-8. 
192. Condren, M., Honey, B.L., Carter, S.M., et al., Influence of a systems-based approach 
to prescribing errors in a pediatric resident clinic. Acad Pediatr, 2014. 14(5): p. 485-
90. 
193. Cochran, G.L., Klepser, D.G., Morien, M., et al., From physician intent to the 
pharmacy label: prevalence and description of discrepancies from a cross-sectional 
evaluation of electronic prescriptions. BMJ Qual Saf, 2014. 23(3): p. 223-230. 
194. Warrick, C., Naik, H., Avis., et al., A clinical information system reduces medication 
errors in paediatric intensive care. Intensive Care Med, 2011. 37(4): p. 691-4. 
195. Nelson, C.E. and S.M. Selbst, Electronic prescription writing errors in the pediatric 
emergency department. Pediatr Emerg Care, 2015. 31(5): p. 368-72. 
196. Kim, G.R., Chen, A.R., Arceci, R.J., et al., Error reduction in pediatric chemotherapy: 
Computerized order entry and failure modes and effects analysis. Arch Pediatr 
Adolesc Med, 2006. 160(5): p. 495-498. 
197. Stultz, J.S. and M.C. Nahata, Appropriateness of commercially available and partially 
customized medication dosing alerts among pediatric patients. J Am Med Inform 
Assoc, 2014. 21(e1): p. e35-42. 
198. Sethuraman, U., Kannikeswaran, N., Murray, K.P., et al., Prescription errors before 
and after introduction of electronic medication alert system in a pediatric emergency 
department. Acad Emerg Med, 2015. 22(6): p. 714-9. 
199. Kadmon, G., Bron-Harlev, E., Nahum, E., et al., Computerized order entry with limited 
decision support to prevent prescription errors in a PICU. Pediatrics, 2009. 124(3): p. 
935-40. 
200. Apkon, M., Leonard, J., Probst, L., et al., Design of a safer approach to intravenous 
drug infusions: failure mode effects analysis. Qual Saf Health Care, 2004. 13(4): p. 
265-271. 
201. Potts, A.L., Barr, F.E., Gregory, D.F., et al., Computerized Physician Order Entry and 
Medication Errors in a Pediatric Critical Care Unit. Pediatrics, 2004. 113(1): p. 59-63. 
202. Kaestli, L.Z., Cingria, L., Fonzo-Christe, C., et al., Prospective risk analysis and incident 
reporting for better pharmaceutical care at paediatric hospital discharge. Int J Clin 
Pharm, 2014. 36(5): p. 953-62. 
203. Tora, H., Bo, H., Bodil, L., et al., Potential drug related problems detected by electronic 
expert support system in patients with multi-dose drug dispensing. Int J Clin Pharm, 
2014. 36(5): p. 943-52. 
204. van Tilburg, C.M., Leistikow, I.P., Rademaker, C.M.A., et al., Health care failure mode 
and effect analysis: a useful proactive risk analysis in a pediatric oncology ward. Qual 
Saf Health Care, 2006. 15(1): p. 58-63. 
205. Pacheco, G.S., Viscusi, C., Hays, D.P., et al., The Effects of Resident Level of Training 
on the Rate of Pediatric Prescription Errors in an Academic Emergency Department. 
J Emerg Med. 43(5): p. e343-e348. 
206. Patterson, E.S., Zhang, J., Abbott, P., et al., Enhancing electronic health record 
usability in pediatric patient care: a scenario-based approach. Jt Comm J Qual Patient 
Saf, 2013. 39(3): p. 129-35. 
207. Wald, J.S., Webb, J.R.,  Haque, S., Children’s EHR Format Enhancement: Final 




290-2009-00021I). AHRQ Publication No.15-0077-EF, Agency for Healthcare 
Research and Quality  Rockville, November 2015. 
208. Kazemi, A., Fors, U.G., Tofighi, S., et al., Physician order entry or nurse order entry? 
Comparison of two implementation strategies for a computerized order entry system 
aimed at reducing dosing medication errors. J Med Internet Res, 2010. 12(1): p. e5. 
209. Manrique-Rodríguez, S., et al., Smart pump alerts: All that glitters is not gold. 
International Journal of Medical Informatics, 2012. 81(5): p. 344-350. 
210. Hou, J.-Y., Cheng, K-J., Bai, K-J., et al., The effect of a computerized pediatric dosing 
decision support system on pediatric dosing errors. J Food Drug Anal, 2013. 21(3): p. 
286-291. 
211. Lehmann, C.U., Pediatric Aspects of Inpatient Health Information Technology 
Systems. Pediatrics, 2015. 135(3): p. e756-e768. 
212. Jani, Y.H., N. Barber, and I.C. Wong, Republished error management: Paediatric 
dosing errors before and after electronic prescribing. Postgrad Med J, 2011. 
87(1030): p. 565-8. 
213. Ekedahl, A., Problem prescriptions in Sweden necessitating contact with the 
prescriber before dispensing. Res Social Adm Pharm, 2010. 6(3): p. 174-84. 
214. Walsh, K.E., Landrigan, C.P., Adams, W.G., et al., Effect of Computer Order Entry on 
Prevention of Serious Medication Errors in Hospitalized Children. Pediatrics, 2008. 
121(3): p. e421-e427. 
215. Khajouei, R. and M.W. Jaspers, CPOE system design aspects and their qualitative 
effect on usability. Stud Health Technol Inform, 2008. 136: p. 309-14. 
216. Schiff, G.D., E. Seoane-Vazquez, and A. Wright, Incorporating Indications into 
Medication Ordering--Time to Enter the Age of Reason. N Engl J Med, 2016. 375(4): 
p. 306-9. 
217. Lowry, S.Z., Quinn, M.T., Ramaiah, M., A Human Factors Guide to Enhance EHR 
Usability of Critical User Interactions when Supporting Pediatric Patient Care, 
National Institute of Standards and Technology, 2012. 
218. Sard, B.E., Walsh, K.E., Doros, G., et al., Retrospective evaluation of a computerized 
physician order entry adaptation to prevent prescribing errors in a pediatric 
emergency department. Pediatrics, 2008. 122(4): p. 782-7. 
219. Maat, B., Au, Y.S., Bollen, C.W., et al., Clinical pharmacy interventions in paediatric 
electronic prescriptions. Arch Dis Child, 2013. 98(3): p. 222-7. 
220. Ginzburg, R., Barr, W.B., Harris, M., et al., Effect of a weight-based prescribing 
method within an electronic health record on prescribing errors. Am J Health Syst 
Pharm, 2009. 66(22): p. 2037-41. 
221. Han, Y.Y., Carcillo, J.A., Venkataraman, S.T., et al., Unexpected increased mortality 
after implementation of a commercially sold computerized physician order entry 
system. Pediatrics, 2005. 116(6): p. 1506-12. 
222. Abboud, P.A., Ancheta, R., McKibben, M., et al., Impact of workflow-integrated 
corollary orders on aminoglycoside monitoring in children. Health Informatics J, 
2006. 12(3): p. 187-98. 
223. Russell, R.A., Triscari, D., Murkowski, K., et al., Impact of Computerized Order Entry 
to Pharmacy Interface on Order-Infusion Pump Discrepancies. J Drug Deliv, 2015. 
2015: p. 6. 686598 
224. Webber, E.C., Warhurst, H.M., Smith, S.S., et al., Conversion of a Single-Facility 
Pediatric Antimicrobial Stewardship Program to Multi-Facility Application with 
Computerized Provider Order Entry and Clinical Decision Support. Appl Clin Inform, 




225. Russell, R.A., K. Murkowski, and M.C. Scanlon, Discrepancies between medication 
orders and infusion pump programming in a paediatric intensive care unit. Qual Saf 
Health Care, 2010. 19 Suppl 3: p. i31-5. 
226. Taylor, J.A., Loan, L.A., Kamara, J.,  et al., Medication administration variances before 
and after implementation of computerized physician order entry in a neonatal 
intensive care unit. Pediatrics, 2008. 121(1): p. 123-8. 
227. Gattari, T.B., Krieger, L.N., Hu, H.M., et al., Medication Discrepancies at Pediatric 
Hospital Discharge. Hosp Pediatr, 2015. 5(8): p. 439-45. 
228. Lehmann, C.U. and G.R. Kim, Computerized provider order entry and patient safety. 
Pediatr Clin North Am, 2006. 53(6): p. 1169-84. 
229. Vaidya, V., Sowan, A.K., Mills, M.E., et al., Evaluating the safety and efficiency of a 
CPOE system for continuous medication infusions in a pediatric ICU. AMIA Annu Symp 
Proc, 2006: p. 1128. 
230. Cordero, L., Kuehn, L., Kumar, R.R., et al., Impact of computerized physician order 
entry on clinical practice in a newborn intensive care unit. J Perinatol, 2004. 24(2): p. 
88-93. 
231. Dean Franklin, B., O'Grady, K., Donyai, P., et al., The impact of a closed‐loop electronic 
prescribing and administration system on prescribing errors, administration errors 
and staff time: a before‐and‐after study. Qual Saf Health Care, 2007. 16(4): p. 279-
284. 
232. Alhanout, K., Bun, S-S, Retornaz, K., et al., Prescription errors related to the use of 
computerized provider order-entry system for pediatric patients. Int J Med Inform, 
2017. 103: p. 15-19. 
233. Lee, F., Teich, J.M., Spurr, C.D., et al., Implementation of physician order entry: user 
satisfaction and self-reported usage patterns. J Am Med Inform Assoc, 1996. 3(1): p. 
42-55. 
234. Niazkhani, Z., Pirnejad, H., Berg, M., et al., The Impact of Computerized Provider 
Order Entry Systems on Inpatient Clinical Workflow: A Literature Review. J Am Med 
Inform Assoc, 2009. 16(4): p. 539-549. 
235. Rinke, M.L., Bundy, D.G., Velasquez, C.A., et al., Interventions to Reduce Pediatric 
Medication Errors: A Systematic Review. Pediatrics, 2014. 
236. Ash, J.S., M. Berg, and E. Coiera, Some Unintended Consequences of Information 
Technology in Health Care: The Nature of Patient Care Information System-related 
Errors. J Am Med Inform Assoc, 2004. 11(2): p. 104-112. 
237. Her, Q.L., Amato, M.G., Seger, D.L., et al., The frequency of inappropriate 
nonformulary medication alert overrides in the inpatient setting. J Am Med Inform 
Assoc, 2016. 23(5): p. 924-33. 
238. Ruiz, J.G., M.J. Mintzer, and R.M. Leipzig, The impact of E-learning in medical 
education. Acad Med, 2006. 81(3): p. 207-12. 
239. Noblin, A., Cortelyou-Ward, K., Cantiello, J., et al., EHR implementation in a new 
clinic: a case study of clinician perceptions. J Med Syst, 2013. 37(4): p. 9955. 
240. Jimenez, A., E-learning supports EHR implementations. In addition to meaningful use, 
we need to define meaningful training. Health Manag Technol, 2010. 31(11): p. 22-
3. 
241. Borycki, E.M., Kushniruk, A.W., Joe, R., et al., The University of Victoria 
Interdisciplinary Electronic Health Record Educational Portal. Stud Health Technol 
Inform, 2009. 143: p. 49-54. 
242. Bredfeldt, C.E., Awad, E.B., Joseph, K., et al., Training providers: beyond the basics of 




243. Kushniruk, A.W., Borycki, E.M., Armstrong, B., et al., Bringing electronic patient 
records into health professional education: towards an integrative framework. Stud 
Health Technol Inform, 2009. 150: p. 883-7. 
244. Foster, S., Murray, D., Richardson, J., et al., Competency based training program for 
electronic prescribing improves patient safety. Pediatr Crit Care, 2011. 1): p. A19. 
245. Ayoub, N., Sheikh, A.L., Ahsan, S., et al., Developing competency through webinar to 
establish oncology pharmacy services at the Aga Khan Hospital Dar-es-Salaam 
Tanzania. J Oncol Pharm Pract, 2014. 1): p. 10. 
246. Borycki, E.M., B. Armstrong, and A.W. Kushniruk, From Prototype to Production: 
Lessons Learned from the Evolution of an EHR Educational Portal. AMIA Annu Symp 
Proc, 2009. 2009: p. 55-59. 
247. Borycki, E.M., B. Armstrong, and A.W. Kushniruk, From prototype to production: 
lessons learned from the evolution of an EHR educational portal. AMIA Annu Symp 
Proc, 2009. 2009: p. 55-9. 
248. Ross, C. and P. Banchy, The key to CPOE: thoughtful planning, flexible training and 
strong staff involvement leads to a successful CPOE implementation. Health Manag 
Technol, 2007. 28(11): p. 22-24. 
249. American Health Information Management Association, Building the Work Force for 
Health Information Transformation, American Medical Informatics Association, 
2006. 
250. McCain, C.L., The Right Mix to Support Electronic Medical Record Training: Classroom 
Computer-Based Training and Blended Learning. Journal for Nurses in Professional 
Development, 2008. 24(4): p. 151-154. 
251. Edwards, G., R.R. Kitzmiller, and S. Breckenridge-Sproat, Innovative health 
information technology training: exploring blended learning. Comput Inform Nurs, 
2012. 30(2): p. 104-9. 
252. Laramee, A.S., Bosek, M., Kasprisin, C.A., et al., Learning from within to ensure a 
successful implementation of an electronic health record. Comput Inform Nurs, 2011. 
29(8): p. 468-77. 
253. Topaz, M., Rao, A., Masterson Creber, R. et al., Educating clinicians on new elements 
incorporated into the electronic health record: theories, evidence, and one 
educational project. Comput Inform Nurs, 2013. 31(8): p. 375-9.  
254. Halamka, J., Aranow, M., Ascenzo, C., et al., E-Prescribing Collaboration in 
Massachusetts: Early Experiences from Regional Prescribing Projects. J Am Med 
Inform Assoc, 2006. 13(3): p. 239-244. 
255. Ash, J.S. and D.W. Bates, Factors and forces affecting EHR system adoption: report of 
a 2004 ACMI discussion. J Am Med Inform Assoc, 2005. 12(1): p. 8-12. 
256. Campbell, E.M., Sittig, D.F., Guappone, K.P., et al., Overdependence on Technology: 
An Unintended Adverse Consequence of Computerized Provider Order Entry. AMIA 
Annu Symp Proc, 2007. 2007: p. 94-98. 
257. Sittig, D.F., Ash, J.S., Guappone, K.P.,  et al., Assessing the Anticipated Consequences 
of Computer-based Provider Order Entry at Three Community Hospitals Using an 
Open-ended, Semi-structured Survey Instrument. Int J Med Inform, 2008. 77(7): p. 
440-447. 
258. van Stiphout, F.,  Zwart-van Rijkom, J. E. F., Maggio, L.A., et al., Task analysis of 
information technology-mediated medication management in outpatient care. Br J 
Clin Pharmacol, 2015. 80(3): p. 415-424. 
259. Biggs, J., Aligning teaching for constructing learning, The HIgher Education Academy, 




260. Pope, C. and N. Mays, Reaching the parts other methods cannot reach: an 
introduction to qualitative methods in health and health services research. BMJ, 
1995. 311(6996): p. 42-45. 
261. Ritchie, J. & Spencer, L. 1994. Qualitative data analysis for applied policy research by 
Jane Ritchie and Liz Spencer in A. Bryman and R. G. Burgess, ‘Analysing qualitative 
data’, (pp.173-194). London: Routledge. 
262. Walker, D. and F. Myrick, Grounded theory: An exploration of process and procedure. 
Qual Health Res. 2006. 16(4): p. 547-559. 
263. Glaser, B.G. and A.L. Strauss, The discovery of grounded theory : strategies for 
qualitative research. Observations. 1967, Chicago.  
264. Gale, N., Health, G., Cameron, E., et al., Using the framework method for the analysis 
of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 
2013. 13(1): p. 117. 
265. Harrison, H., Birks, M., Richard, F.,  et al., Case Study Research: Foundations and 
Methodological Orientations. 2017. 18(1). 
266. Creswell, J.W., Research design : qualitative, quantitative, and mixed methods 
approaches. Fourth edition, International student edition. 2014, Thousand Oaks, 
CA;London: Sage Publications. 
267. Barbour, R.S., Introducing qualitative research : a student's guide. 2nd ed. 2014, 
London: SAGE. 
268. Pope, C., P. van Royen, and R. Baker, Qualitative methods in research on healthcare 
quality. Qual Saf Health Care, 2002. 11(2): p. 148-152. 
269. Cunningham, C.T., Quan, H., Hemmelgarn, B., et al., Exploring physician specialist 
response rates to web-based surveys. BMC Med Res Methodol. 2015. 15: p. 32. 
270. Lyratzopoulos, G., Elliott, M., Barbiere, J.M., et al., Understanding ethnic and other 
socio-demographic differences in patient experience of primary care: evidence from 
the English General Practice Patient Survey. BMJ Qual Saf, 2012. 21(1): p. 21-29. 
271. Cohen D, C.B. Qualitative Research Guidelines Project. 2006  [cited 2014; Available 
from: http://www.qualres.org/HomeUnst-3630.html. 
272. Cohen D, C.B. Qualitative Research Guidelines Project. 2006  [cited 2014 26.11.14]; 
Available from: http://www.qualres.org/HomeObse-3594.html. 
273. Glaser, B.G. and A.L. Strauss, The discovery of grounded theory: Strategies for 
qualitative research. 2009: Transaction publishers. 
274. Mays, N. and C. Pope, Qualitative research in health care. Assessing quality in 
qualitative research. BMJ, 2000. 320(7226): p. 50-2. 
275. Smith, J.A., Qualitative psychology : a practical guide to research methods. 2003, 
London: SAGE Publications. 
276. Ritchie, J., Qualitative research practice : a guide for social science students and 
researchers. 2nd ed. 
277. Creswell, J.W., Qualitative inquiry and research design : choosing among five 
approaches. 2nd ed. 2007, Thousand Oaks, CA: SAGE. 
278. Pope, C., S. Ziebland, and N. Mays, Analysing qualitative data. BMJ, 2000. 320: p. 114 
- 116. 
279. Miles, M.B. and A.M. Huberman, The qualitative researcher's companion. 2002, 
Thousand Oaks, CA: Sage Publications. 
280. Finlay, L., Negotiating the swamp: the opportunity and challenge of reflexivity in 







281. Clinical Applications and Patient Safety Project NHS CUI Programme Team, 
Displaying Graphs and Tables User Interface Design Guidance, Health and Social Care 
Information Centre, 2015. 
282. Julia Adler-Milstein, Moving Past the EHR Interoperability Blame Game. NEJM 
Catalyst, 2017. 
283. Westbrook, J.I., Reckmann, M., Li, L., et al., Effects of Two Commercial Electronic 
Prescribing Systems on Prescribing Error Rates in Hospital In-Patients: A Before and 
After Study. PLoS Med, 2012. 9(1): p. e1001164. 
284. Middleton, B., Bloomrosen, M., Dente, M.A., et al., Enhancing patient safety and 
quality of care by improving the usability of electronic health record systems: 
recommendations from AMIA. J Am Med Inform Assoc, 2013. 20(e1): p. e2-e8. 
285. Salman, Y.B., Kim, J.Y., Karahoca, A., et al., Participatory icon design for medical 
information systems. Hong Kong: International Association of Design Research, 2007. 
286. Howe, J.L., Adams, K.T., Hettinger, A., et al., Electronic health record usability issues 
and potential contribution to patient harm. JAMA, 2018. 319(12): p. 1276-1278. 
287. Wright, A., Feblowitz, J.C., Pang, J.E., et al., Use of Order Sets in Inpatient 
Computerized Provider Order Entry Systems: A Comparative Analysis of Usage 
Patterns at Seven Sites. Int J Med Inform, 2012. 81(11): p. 733-745. 
288. Puaar, S.J. and B.D. Franklin, Impact of an inpatient electronic prescribing system on 
prescribing error causation: a qualitative evaluation in an English hospital. BMJ Qual 
Saf, 2017. 
289. Galanter, W.L., Bryson, M.L., Falck, S., et al., Indication Alerts Intercept Drug Name 
Confusion Errors during Computerized Entry of Medication Orders. PLOS ONE, 2014. 
9(7): p. e101977. 
290. Singh, H., Mani, S., Espadas, D., et al., Prescription errors and outcomes related to 
inconsistent information transmitted through computerized order entry: a 
prospective study. Arch Intern Med, 2009. 169(10): p. 982-9. 
291. Zheng, K., Hanauer, D.A., Padman, R., et al., Handling anticipated exceptions in 
clinical care: investigating clinician use of ‘exit strategies’ in an electronic health 
records system. J Am Med Inform Assoc, 2011. 18(6): p. 883-889. 
292. Sittig , D.F. and H. Singh Electronic Health Records and National Patient-Safety Goals. 
NEJM, 2012. 367(19): p. 1854-1860. 
293. Amato, M.G., Salazar, A., Hickman, T-T.T., et al., Computerized prescriber order 
entry–related patient safety reports: analysis of 2522 medication errors. J Am Med 
Inform Assoc, 2017. 24(2): p. 316-322. 
294. Magrabi, F., Ong, M-S., Runciman, W., et al., Using FDA reports to inform a 
classification for health information technology safety problems. J Am Med Inform 
Assoc, 2012. 19(1): p. 45-53. 
295. Wright, A., Ai, Angela., Ash, J., et al., Clinical decision support alert malfunctions: 
analysis and empirically derived taxonomy. J Am Med Inform Assoc, 2018. 25(5): p. 
496-506. 
296. Giuliano, C.A., Binienda, J., Kale-Pradhan, P.B., et al., “I Never Would Have Caught 
That Before”: Pharmacist Perceptions of Using Clinical Decision Support for 
Antimicrobial Stewardship in the United States. Qual Health Research. 2018 
28(5):745-755. 
297. Allen, J., Bush, J., Timmins, J., et al., 667: Impact of a multimodal antibiotic 
stewardship program in the ICU results from a 16-hospital system. Crit Care Med, 
2018. 46(1): p. 320. 
298. Di Pentima, M.C., S. Chan, and J. Hossain, Benefits of a Pediatric Antimicrobial 




299. Blijleven, V., Koelemeijer, K., Wetzels, M., et al., Workarounds Emerging From 
Electronic Health Record System Usage: Consequences for Patient Safety, 
Effectiveness of Care, and Efficiency of Care. JMIR Hum Factors, 2017. 4(4): p. e27. 
300. McAlister, F.A. and K.G. Shojania, Inpatient bedspacing: could a common response to 
hospital crowding cause increased patient mortality? BMJ Qual Saf 2018. 27(1): p. 1-
3. 
301. Campbell, R.J., The five rights of clinical decision support: CDS tools helpful for 
meeting meaningful use. Journal of AHIMA, 2013. 84(10): p. 42-47 (web version 
updated February 2016). 
302. Osheroff, J.A. Improving outcomes with clinical decision support: an implementer's 
guide. 2012. Health Information and Management Systems Society. 
303. Baysari, M.T., Westbrook, J.I., Richardson, K.L.,  et al., The influence of computerized 
decision support on prescribing during ward-rounds: are the decision-makers 
targeted? J Am Med Inform Assoc, 2011. 18(6): p. 754-759. 
304. Riedmann, D., Jung, M., Hackl, W.O., et al., How to improve the delivery of medication 
alerts within computerized physician order entry systems: an international Delphi 
study. J Am Med Inform Assoc, 2011. 18(6): p. 760-766. 
305. Grizzle, A.J., Mahmood, M.H., Ko, Y., et al., Reasons provided by prescribers when 
overriding drug-drug interaction alerts. Am J Manag Care, 2007. 13(10): p. 573-8. 
306. Czock, D., Konias, M., Seidling, H.M.,  et al., Tailoring of alerts substantially reduces 
the alert burden in computerized clinical decision support for drugs that should be 
avoided in patients with renal disease. J Am Med Inform Assoc, 2015. 22(4): p. 881-
887. 
307. Cornu, P., Steurbaut, S., Gentens, K.,  et al., Pilot evaluation of an optimized context-
specific drug–drug interaction alerting system: A controlled pre-post study. Int J Med 
Inform, 2015. 84(9): p. 617-629. 
308. Seidling, H.M., Schmitt, S.P., Bruckner, T., et al., Patient-specific electronic decision 
support reduces prescription of excessive doses. Qual Saf Health Care, 2010. 19. 
309. Bates, D.W., Kuperman, G.J., Wang, S., et al., Ten Commandments for Effective 
Clinical Decision Support: Making the Practice of Evidence-based Medicine a Reality. 
J Am Med Inform Assoc, 2003. 10(6): p. 523-530. 
310. Hayward, J., Thomson, F., Milne, H.,  et al., ‘Too much, too late’: mixed methods 
multi-channel video recording study of computerized decision support systems and 
GP prescribing. J Am Med Inform Assoc, 2013. 20(e1): p. e76-e84. 
311. Horsky, J., Schiff, G.D., Johnston, D., et al., Interface design principles for usable 
decision support: A targeted review of best practices for clinical prescribing 
interventions. J Biomed Inform, 2012. 45(6): p. 1202-1216. 
312. Wright, A., Sittig, D.F., Ash, J.S., et al., Clinical decision support capabilities of 
commercially-available clinical information systems. J Am Med Inform Assoc, 2009. 
16(5): p. 637-44. 
313. Genes, N., Kim, M.S., Thum, F.L., et al., Usability Evaluation of a Clinical Decision 
Support System for Geriatric ED Pain Treatment. Appl Clin Inform, 2016. 7(1): p. 128-
42. 
314. Hanna, K., Ahonen, R., Pekka, M., et al., Medication safety and the usability of 
electronic prescribing as perceived by physicians—A semistructured interview among 
primary health care physicians in Finland. J Eval Clin Pract, 2017. 23(6): p. 1187-1194. 
315. Sopan, A., Plaisant, C., Powsner, S., et al., Reducing wrong patient selection errors: 
exploring the design space of user interface techniques. AMIA Annu Symp Proc, 2014. 
2014: p. 1056-65. 
316. Zhang, J., Johnson, T.R., Patel, V.L., et al., Using usability heuristics to evaluate 




317. Horsky, J., Phansalkar, S., Desai, A., et al., Design of decision support interventions for 
medication prescribing. Int J Med Inform, 2013. 82(6): p. 492-503. 
318. Helander, M., Landauer,  T.K., and Prabhu, P.V., Handbook of human-computer 
interaction. 2nd ed. 1997, Elsevier. 
319. Falconer, N., Liow, D., Zeng, I., et al., Validation of the assessment of risk tool: patient 
prioritisation technology for clinical pharmacist interventions. Eur J Hosp Pharm, 
2017, http://dx.doi.org/10.1136/ejhpharm-2016-001165 
320. Hickson, R.P., Steinke, D.T., Skitterall, C., et al., Evaluation of a pharmaceutical 
assessment screening tool to measure patient acuity and prioritise pharmaceutical 
care in a UK hospital. Eur J Hosp Pharm, 2016. http://dx.doi.org/10.1136/ejhpharm-
2015-000829 
321. Vuk, J., Anders, M.E., Mercado, C.C., et al., Impact of simulation training on self-
efficacy of outpatient health care providers to use electronic health records. Int J Med 
Inform, 2015. 84(6): p. 423-429. 
322. Arnold, T. and Fuller, H.J.A.,  Generic Customizable Simulation Modules to Emphasize 
Error Risk in Medication Order Entry. Proc Int Symp Hum Factors Ergon Healthc, 2016. 
5(1): p. 150-153. 
323. Byers, J.F. and S.V. White, Patient safety:principles and practice. 2004, New York, 
Springer. 
324. Pantaleoni, J.L., Stevens, L.A., Mailes, E.S., et al., Successful Physician Training 
Program for Large Scale EMR Implementation. Appl Clin Inform, 2015. 6(1): p. 80-95. 
325. Stevens, L.A., Pantaleoni, J.L. and Longhurst, C.A., The value of clinical teachers for 
EMR implementations and conversions. Appl Clin Inform, 2015. 6(1): p. 75-9. 
326. Goveia, J., van Stiphout, F., Cheung, Z., et al., Educational interventions to improve 
the meaningful use of Electronic Health Records: a review of the literature: BEME 
Guide No. 29. Med Teach, 2013. 35(11): p. e1551-60. 
327. Childs, S., Blenkinsopp, E., Hall., Amanda., et al., Effective e-learning for health 
professionals and students—barriers and their solutions. A systematic review of the 
literature—findings from the HeXL project. Health Info Libr J, 2005. 22: p. 20-32. 
328. Dixon BE, Zafar A.,  Inpatient Computerized Provider Order Entry: Findings from the 
AHRQ Health IT Portfolio (Prepared by the AHRQ National Resource Center for Health 
IT), AHRQ National Resource Center for Health Information Technology, 2009. 
329. Yuan, C.T., E.H. Bradley, and I.M. Nembhard, A mixed methods study of how clinician 
 ‘super  users’ influence others during the implementation of electronic health 















Improving medication-related clinical decision support 
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Purpose. Current uses of medication-related clinical decision support (CDS) and 
recommendations for Improving these systems are reviewed. 
Summary. Using a systematic approach. articles published from 2007 
through 2014 were identified in MEDLINE and EMBASE using MeSH terms 
and Keywords relating to the 5 basic medication-related CDS functionalities. 
A total of 156 full-text articles and 28 conference abstracts were re- viewed 
across each of the 5 areas: drug-drug interaction (DDI) checks (n= 78), drug 
allergy checks (n=20), drug dose support (n=55), drug- duplication checks 
(n = 11). and drug formulary support (n = 20). The success of medication-
related CDS depends on users finding the alerts valuable and acting on the 
information received. Improving alert specificity and sensitivity is important 
for all domains. Tiering is important for improving the acceptance of DDI 
alerts. The ability to perform appropriate cross- sensitivity checks is key to 
producing appropriate drug allergy checks. Drug dosage alerts should be 
individualized and deliver practical recommendations. How the system is 
configured to identify certain drug duplications is Important to prevent 
possible patient toxicity. Accurate knowledge databases are needed to 
produce relevant drug formulary alerts and encourage formulary 
adherence. Medication-related CDS is still relatively immature in some 
organizations and has substantial room for improvement For example, 
decision support should consider more patient-specific factors. Human 
factors principles should always be considered, and alert specificity must 
be improved in order to reduce alert fatigue. 
Conclusion. Standardization, integration of patient specific parameters 
and consideration of human factors design principles are central to 
realizing the potential benefits of medication-related CDS. 
Keywords: decision-making. Decision support systems, clinical; electronic 
prescribing: medical order entry systems: medicat101 errors; patient safety 
 




Appendix 2: Search Strategy for: Improving medication-
related clinical decision support (Drug-Drug Interaction 
search) 
 
1. Clinical decision support 
2. Decision Support Systems, Clinical 
3. CDS 
4. Decision support 
5. Decision Making 
6. Alert 
7. Clinical Alarms 
8. Reminders 
9. Electronic prescribing 
10. EP 
11. Computerized provider order entry 
12. Computerized physician order entry 
13. CPOE 
14. Computer assisted 
15. Medical order entry 
16. Medical Order Entry Systems 
17. Electronic Health Records 
18. Reminder Systems 
19. Medication Systems 
20. Drug Interactions 
21. Drug drug interaction 
22. Drug drug 
23. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 (CDS Terms) 
24. 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 (EP Terms) 
25. 20 or 21 or 22 (Drug-Interaction alert Terms) 







Appendix 3: A Systematic Review Of The Types And 
Causes Of Prescribing Errors Generated From Using 
Computerized Provider Order Entry Systems in Primary 
and Secondary Care 
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ABSTRACT 
Objective: To understand the different types and causes of prescribing errors 
associated with computerized provider order entry (CPOE) systems, and recommend 
improvements in these systems. 
Materials and Methods: We conducted a systematic review of the literature published 
between January 2004 and June 2015 using three large databases: the Cumulative 
Index to Nursing and Allied Health Literature, Embase, and Medline. Studies that 
reported qualitative data about the types and causes of these errors were included. A 
narrative synthesis of all eligible studies was undertaken. 
Results: A total of 1185 publications were identified, of which 34 were included in the review. 
We identified 8 key themes associated with CPOE-related prescribing errors: computer 
screen display, drop-down menus and auto- population, wording, default settings, non-
intuitive or inflexible ordering, repeat prescriptions and automated processes, users’ work 
processes, and clinical decision support systems. Displaying an incomplete list of a patient’s 
medications on the computer screen often contributed to prescribing errors. Lack of system 
flexibility resulted in users employing error-prone workarounds, such as the addition of 
contradictory free-text comments. Users’ misinterpretations of how text was presented in 
CPOE systems were also linked with the occurrence of prescribing errors. 
  
 
Discussion and Conclusions: Human factors design is important to reduce error 
rates. Drop-down menus should be designed with safeguards to decrease the 
likelihood of selection errors. Development of more sophis- ticated clinical decision 
support, which can perform checks on free-text, may also prevent errors. Further 
research is needed to ensure that systems minimize error likelihood and meet users’ 
workflow expectations. 
 
Key words: computerized provider order entry, clinical decision support, alerts, medication errors, patient safety, decision-making 
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Appendix 4: Search strategy for: A Systematic Review Of 
The Types And Causes Of Prescribing Errors Generated 
From Using Computerized Provider Order Entry Systems 
in Primary and Secondary Care as conducted in Medline 
and Embase via Ovid. 
 
1. Computerized prescriber order entry 
2. Computerized provider order entry/ 
3. Electronic physician order entry 
4. Electronic order entry 
5. Electronic prescribing/ 
6. Electronic prescription 
7. Computerized physician order entry 
8. CPOE 
9. Computerized order entry 
10. Medical order entry systems 
11. 1 or 2 or  3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 
12. Clinical decision support 
13. Decision support system/  
14. CDS 
15. Drug therapy, computer assisted 
16. 12 or 13 or 14 or 15 
17. Electronic medical record/  
18. Electronic health record 
19. Electronic patient record 
20. 17 or 18 or 19 
21. Medication Errors 
22. Unintended consequences 
23. Prescribing error 
24. 21 or 22 or 23 
25. 11 or 16 or 20 
26. 24 AND 25 
27. Limit 26 to yr=2004-current 
28. Limit 27 to English Language 
29. Limit 28 to journal 




Appendix 5: A table summarising the key findings of the included articles from: a systematic 
review of the prescribing errors generated from using CPOE in primary and secondary care 
 







Title Aim Method Locatio
n 
Sector Summary of qualitative findings  
Types of Error Causes of Error  
 









Phase 1:  To assess 
the effectiveness 
of an automated 
measure of 
wrong-patient 
electronic orders.  
 











Phase 1: Evaluation of a 
‘re-tract and re-order 
tool’. Semi-structured 
interviews with 
providers (n= 223 
providers) identified by 
the tool to determine if 
a true wrong-patient 
order had been made; 
and classification of the 
cause of error e.g. a 
juxtaposition error, 
interruption error or 
other.  
 
Phase 2: Intervention 
efficacy trial of an 
identification verify 































and barriers of a 
computer-based 
reminder 









reminder that has 




drug use, during 
routine practice. 
Semi-structured 
interviews with house 
staff physicians from 




NB: Reports on the 
results of one part of a 
larger piece of work; 
pre/post evaluation 
study of a clinical 




 Inappropriate drug 
choice 
 Demands of 
reading the 
reminder 
 Incorrect alert 
content  
Yes 





from a mixed 
methods 
exploration 











Phase1 study:  
Observations: (29 
hours of observation in 




clinicians and staff 
members) 





















 Juxtaposition errors 
 Inadvertent order entry. 
 Pick-lists Yes 
  
 







To analyze and 



















 Dose Errors 
 Inappropriate orders 
 Drug omission 
 Lack of CDS 
 Out of date content 
 Workarounds 
 Inflexibility 




timing of alerts. 
Yes 
5.  Ash et al. 
(2007) 














related to CPOE 
implementation in 
U.S. hospitals. 
Results taken from a 
survey which formed 




The survey included 





 Wrong patient 
 Dosage errors 
 Omission errors 
 Overlapping medication 
errors 
 Potential for errors to 
appear in multiple 
records (vs on paper 
where a mistake is 
usually limited to where 
it was written) 
 Reduced scrutiny  
 Overdependence 
 Lack of flexibility 
 Lack of paper-
based clues e.g. 
visiting a bedside to 
retrieve a drug 
chart 
 Alert fatigue 
 Loss of critical 
thinking 
 Lack of system 
integration 
Yes 









To describe the 
unintended 
consequences 
related to the 
implementation of 
CPOE in the 
outpatient setting 
Observations (29 hours 
of 13 clinicians) 
 




 Juxtaposition  errors 
e.g. wrong route or 
wrong frequency 
 Drop down menus 
 Alert fatigue 
Yes 
7.  Baysari et al. 
(2012) 
Failure to utilize 
functions of an 
electronic 
prescribing 











alerts occur and 
the proportion 





























inclusion in this 
review.) 









The purpose of 
this study was to 
identify and 
describe the 




related to CPOE 
implementation. 












Conference discussions  
U.S. Hospital  Juxtaposition errors 
 Improper data 
placement 
 Wrong patient 
 Confusing order 
presentation 
 Pick lists 
 Workflow process 
mismatch 
 Incomplete display 
screens 


























U.S. Hospital  Dose error  Ambiguous dosing 
 The use of 
templates created 












copy and paste 
functions were 
correct. 
10.  Chan et al.  Usability 
evaluation of 




To perform a 
heuristic 
evaluation of a 
CPOE order set 
system to uncover 
existing usability 
issues prior to 
implementation. 
Heuristic evaluation of 
a CPOE test platform 
according to 10 










 Wrong orders  Inconsistent error 
prevention 
 Lack of useful CDS 
No 









entry and clinical 
decision support 
prescribing 
systems in two 
‘early adopter’ 
hospitals 






and CDS in early 
















 Delayed treatment 
 Out of date medical 
records 
 Selection Errors 
 Duplicate Orders 
 Wrong Timing 
 Free-text errors 
 Issues with system 
interoperability 
 Workarounds 
 Lack of system 
flexibility 
 Drop-down menus 
 
Yes 
12.  Goldman et 
al. (2010). 
Beyond the 






about the role of 
CPOE applications 
in improving 




Focus group: (n=64 













 Medication and patient 
mix-ups 
 Selection errors 
 Clumsy technology 











13.  Horsky et al. 
(2005) 
Comprehensive 
analysis of a 
medication 
To describe a 
dosing error event 







 Overdose of potassium 
chloride 
 Ambiguous use of 






related to CPOE 
approach to 
analysis. 







involved in the 
incident (number 
not specified) 
3. Analysis of order 
entry logs 




 Excessive duration of a 
potassium chloride 
infusion 














 Free-text entries 
were not visible to 
other users 
 All medication 
orders cannot be 
viewed from one 
screen 




 A lack of user 
understanding 
about how to use 
the system 
effectively.  






entry in primary 
care: Assessing 
ePrescribing 
with a new 
evaluation 
model 
To develop and 
apply a model to 
evaluate 






in primary care. 
 
1. Development of 
an evaluation 
model 
2. Assessment of 
EHRs using the 
evaluation model 
3. Interviews with 
prescribers 
(n=between 1 
and 4 prescribers 





 Misunderstanding of 
doses 
 Inappropriate drugs 




 Incorrect dosage 
functions 
 Ability to work on 
>1 patient at one 
time 
 Inadequate 






method was then 
applied to assess 




 Erroneous display 
of dosage 
 Reduced scrutiny of 
orders  




CPOE ease of use 






To study the 
satisfaction of 
end-users of a 
CPOE system 
concerning ease of 














was a direct 
relation between 
user satisfaction 
and the results of 
a usability 





choice answers and 
free-text responses 
(n=106  doctors;   
n= 327 nurses) 
 
NB: Reports on the 
results of one part of a 
larger piece of work; a 
literature review, 
observations, 
interviews and a 
usability evaluation 







 Dosing errors  Suboptimal 
presentation of 
buttons used to 
calculate 
Yes 









To identify and 
quantify the role 








Survey:  (n= 291 








 Wrong dose 
 Duplicate doses 
 Omitted doses 
 Gaps in therapy 
 Inappropriate 
medication 
 Selection errors 
 Wrong patient 
 Delayed doses 
 Fragmented order 
screens 
 Erroneous assumed 
dose 
 Procedural linked 
medications 
 Lack of CDS 








o Interviews: (n=14 
house staff; n=19 
‘expert 
participants’) 
o Focus groups 
with house staff: 
(n=5 average 
group size, 10; 
range, 7-18) 






comprising of 4 
house staff, 3 
attending 
physicians, and 9 
nurses and 3 
pharmacists. 
or warn clinicians 
about issues 
 Inappropriate 
timing of alerts 
 Incomplete display 
of a patient’s 
medication list 
 Issues with the 
design of lists e.g. 
small font and long 
alphabetical lists. 
 Unclear login 
processes 
 Inflexible ordering 
processes.  










in the outpatient 
pharmacy 









workflow in an 
outpatient 
pharmacy.. 




Observations (40 hours 





 Missing or unclear 
doses 
 Missing or conflicting 
information 
 Repeat errors on refill 
prescriptions 
 Inappropriate drug 
choice 
 Wrong patient 
 Incomplete display 
of drug name on 
the pharmacy 
system due to 
mismatch in text 
box size compared 
to the prescribers 
system. 
 Failure to update 
prescription 
changes on the 
prescribing system  
 Formulary issues 
Yes 















 Selection errors (wrong 
patient, drug, or dose) 
 Incomplete or duplicate 
directions 
 Autofill functions 






















group interviews with 
n=28 participants 




Think aloud protocol 
(n=15 participants) 
 Unclear directions 


















Total participants: n=40 
(17 pharmacists and 23 
technicians) 
 
Direct observations:  
(n=16 participants: 7 










interviews: (n=7 group 
interviews, consisting 







o Wrong drug 
duration-  
o Wrong drug 







 Participants suggested 
that prescribers may 
have inputted or 
selected incorrect 
information such as 
dose, strength or 
formulation, which if 
not detected could have 
consequences for the 
patient.  
 Multiple patient 
charts visible, 
therefore doctors 
may prescribe for 
the wrong patient. 
 Selection errors 
from lists 
 Communication 
























Direct observations (45 
hours of 11 
Pharmacists and  15 







 Wrong drug 
 Wrong strength 
 Wrong pharmacy 
 Wrong prescriber notes 
 Wrong drug quantity 
 Wrong duration of 
therapy 
 Wrong dosing directions 















factors using a 
variety of data 
collection 
methods. 
Pharmacists and 9 
technicians) 
 
 Wrong formulation  Inadvertent entry 
or selection (drop-
down menus) 





 Mismatch between 





 Inadvertent mouse 
wheeling  
21.  Robertson 





CPOE and the 
effects of 
variation in drug 
name display 
A study to assess 
drug name design 
and display issues 
in CPOE including: 
look-alike-sound-
alike pairs, similar 
name adjacency 
errors, font, and 
visual display to 
better understand 
their potential to 
contribute to 
medication errors. 
Assessment of leading 
vendor and home-
grown CPOE systems in 
six major academic 
medical centres via 
remote walk-throughs 
and on-site visits. (n=10 









 Drug name  
identification errors 
 Inconsistent listing 
of drugs either by 
their brand or 
generic name 
 Inconsistent use of 
capital letters 
 Inability to order or 
search for drugs by 
a brand name 




 Lack of 
standardised font, 
text size or 
capitalisation 
across and within 
systems.  
Yes 















review:  (75 patients; 




U.K. Hospital  Wrong patient 
 Wrong drug 
 Selection error 
 Dose, form, frequency 
error 
 Default timings 
 Scrolling error 
 Loss of  physical 











interviews: (n=26 staff;  
n=19 patients) 
 Duplication error 
 Omission errors 
 Lack of CDS 
warnings 
 Drugs ‘hidden’ in 
order sets 
 Drop-down menus 
 Inflexible system 
 Issues with visibility 
of information on a 
screen 










testing of current 
systems. 




reported as a 
‘contributing 
cause’ (b) develop 
‘use cases’ based 
on the error 
reports to perform 
vulnerability 
testing of current 
CPOE systems. 
Phase 1: Medmarx data 
analysis: taxonomy and 




Phase 2: CPOE 
vulnerability testing on 
test-case scenarios 
(n=21 test case 
scenarios on 16 sites 












 Incorrect instructions 
 Wrong dose/strength 
 Wrong schedule 
 Duplicate order 
 Wrong drug 
 Wrong route 
 Comment field issue 
 Wrong time 
 Wrong patient 
 Wrong formulation 
 Multiple systems in 
use 
 Use of 
abbreviations 





 Typing error 
 Paper and 
electronic hybrid 
system issues 
 System limitations 




 Alert overrides 
 Transcription issues 
(copy and paste) 
 Free-text confusion 
 Order-set issues 
 Out of date/ 
incorrect drug 
dictionary 














of 10,000 error 
report narratives 
and vulnerability 
testing of current 
systems 
Analysis and 
coding of the 
structured and 
narrative details of 
CPOE errors 







(a) Qualitative and 






(b) Vulnerability testing 
of CPOE systems and 
creation of a taxonomy 
of CPOE errors by type, 
cause and prevention 
strategy (n=21 test case 
scenarios on 16 sites 
using 13 different CPOE 
systems) 
U.S. and  
Canada 
Various  Missing information 
 Wrong dose/ strength 
 Wrong schedule 
 Duplicate orders 
 Wrong formulation/ 
dosage form 
 Free-text issues 
 Multiple electronic 
systems in use 
 Abbreviations 
 Failure to follow 
protocol 
 Lack of computer 
training/ 
knowledge 
 Hybrid systems in 





 Alert overrides. 
Yes 
























how their design 
could be improved 
to advance patient 
safety.  







Vulnerability testing of 
test scenarios in 
different electronic 
prescribing systems 
(n=13, at 16 sites) 
U.S. and 
Canada 
Various  Inappropriate drug 
choice/ combination 
 Wrong strength/ units 
 Failure of the 
system to detect 
errors 
 Confusing wording 
of alert warnings 
 Issues with alert 
timing 
 Lack of consistency 
in the severity level 
















To test the 
vulnerabilities of a 
wide range of 
CPOE systems to 
different types of 
medication errors, 








Entry of test scenarios 
(n=21) onto CPOE 
systems at 16 leading 
sites, in order to 
observe the ease or 
difficultly with which 




Various  Duplicate orders 
 Inappropriate drug/ 
combination 
 Manner of order 
entry i.e. either 
structured or 
unstructured 
 Lack of CDS 
functionality 
 Confusing alert 
wording 
 Issue with the 
timing of alerts 
 Variable severity 
level assigned to 
alerts 
Yes 
27.  Slight et al. 
(2013) 
The causes of 
prescribing 








and provide key 
recommendations 











Focus groups ( n=6, 





 Selection errors  Drop-down menus 
 Inappropriate 
alerts 
 Speed of the 
system 
Yes 














and describe the 
nature and causes 






of the medication 
notes from patients 
stated to be on 
antiretroviral therapy 
to identify errors: 
(n=26 patients) 
 






U.S. Hospital  Wrong dose 
 Missing information 
 Incorrect prescribing 
decision 
 Drug interactions 
 Wrong formulation/ 
strength 




 Lack of knowledge 
about the drug 
 Inappropriate drug 
information within 
the CDS system 
 Verbal or 
transcribing 
miscommunication 
 Alert overrides 






(number not stated) 
 
Expert panel review: 
(n=3 experts) to define 
the type and 
responsible step in the 
medication use process 
29.  Vaziri et al. 
(2009) 
Are we setting 
about improving 
the safety of 
computerised 
prescribing in the 
right way? A 
workshop report. 
Evaluate the 










literature in this 
area, with the aim 














 ‘Prescribing errors’   Nuisance alerts 
 Low specificity 
alerts 
 Alert fatigue 










failure mode and 
effect analysis to 
reduce 
medication 
errors in the 






To identify actions 
to reduce 
medication errors 
in the process of 
drug prescription, 
validation and 
dispensing, and to 
evaluate the 
impact of their 
implementation.  
Healthcare failure 
modes and effect 
analysis of the process 





medication error study 
to determine the rate 
of medication errors, 
which were collected 
and classified by two 
observers. (n=1722 
observations) 
Spain Hospital  Wrong patient 
 Selection errors 




 Drop-down menus 
Yes 












utility problems of 
clinicians 
interacting with 
CPOE in real life 
settings. 
Observations (n=48 





interviews with 4 
physicians and 2 
nurses) 
 
Analysis of the user 




Hospital   Wrong prescriber 
 Wrong units 
 Inappropriate drugs due 
to re-activation of  
completed  treatments 




 User-access rights 
 Lack of system 
flexibility 
 Issues with the log-
in process 
 Interface issues and 
lack of 
standardised way 





32.  Westbrook 
et al. (2013) 





















To determine if 
the rates of 
system-related 
prescribing errors 
is greater than the 
rate of errors 
prevented  
Medication chart 
review to identify 
errors (n=629 inpatient 
admissions) 
 




Classification of the 
errors according to the 
types of mechanism 





Hospital  Selection errors (wrong 
drug, wrong strength, 
wrong route) 
 Wrong time 
 Wrong frequency 
 Wrong formulation 
 Duplicate order 
 Drop-down menu 
 Failure to change 
the default time/ 
date 
 System limitations 
 Incorrect element 
of an order 
sentence due to 




 Errors associated 






prescribing system.  
Yes 





an increase in 
duplicate 
medication order 
errors after CPOE 
implementation. 




before and after 









(n=630 patients)  
 
Medication chart 
review- events were 
assessed to determine 
whether an error had 
occurred, the stage at 
which the error 
occurred and the type 
of error. Content 
analysis of all duplicate 
orders: (n=167 




using Likert style 





 Items ‘hidden’ in 
order sets  
 Failure of CDS to 
check new orders 
against completed 
orders 
 CDS does not 
trigger alerts for 
duplicate orders for 
different routes of 
administration 
 Improper use of 
the system (failure 
to discontinue a 




questions: (n= 51 




responded, 1 year post 
CPOE implementation 
when the route is 
changed to oral. 
 Misleading design 
and content of 
alerts 
 Issues with the 
timing of alerts 




















Also to explore the 
potential value 





Comparison of the 
number of medication 
errors reported from 
facilities that had CPOE 
in place and those that 
did not (n= 235,164 
error reports) 
 
Examination of the 
characteristics of 
reported errors that 
were caused by CPOE 
(n=7029 CPOE related 
medication errors) 
 








 Dose errors 
 Wrong formulation 
 Extra doses 
 Wrong patient 
 Wrong time 
 Unauthorised drug 
 Wrong strength 
 Lack of knowledge 
 Use of 
abbreviations 
 Dose calculations 
 Lack of CDS 
 Distraction 
 Computer interface 
 Interoperability 
issues 
 Drop-down menus 
Yes 
Abbreviations  
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ABSTRACT 
Objective: To identify and understand the factors that contribute to medication errors associated with the use of computerized 
provider order entry (CPOE) in pediatrics and provide recommendations on how CPOE systems could be improved. 
Materials and Methods: We conducted a systematic literature review across 3 large databases: the Cumulative Index to Nursing 
and Allied Health Literature, Embase, and Medline. Three independent reviewers screened the titles, and 2 authors then 
independently reviewed all abstracts and full texts, with 1 author acting as a constant across all publications. Data were ex tracted 
onto a customized data extraction sheet, and a narrative synthesis of all eligible studies was undertaken. 
Results: A total of 47 articles were included in this review. We identified 5 factors that contributed to errors with the use of a CPOE 
system: (1) lack of drug dosing alerts, which failed to detect calculation errors; (2) generation of inap- propriate dosing alerts, such as 
warnings based on incorrect drug indications; (3) inappropriate drug duplication alerts, as a result of the system failing to consider 
factors such as the route of administration; (4) dropdown menu selection errors; and (5) system design issues, such as a lack of 
suitable dosing options for a particular drug. 
Discussion and Conclusions: This review highlights 5 key factors that contributed to the occurrence of CPOE- related 
medication errors in pediatrics. Dosing support is the most important. More advanced clinical decision support that can suggest 
doses based on the drug indication is needed. 
 







Appendix 7: Search Strategy for Factors contributing to 
medication errors made when using computerized order 
entry in paediatrics: a systematic review as conducted in 
Embase (Ovid) 
 
Full Search Strategy: Embase (Ovid)  
 
1.  computerized prescriber order entry.mp 
2. exp computerized provider order entry/  
3. Electronic physician order entry.mp.  
4. electronic order entry.mp.  
5. exp electronic prescribing/  
6. electronic prescription.mp.  
7. computerized physician order entry.mp.  
8. CPOE.mp.  
9. computerized order entry.mp.  
10. Medical order entry systems.mp.  
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10  
12. clinical decision support.mp.  
13. exp decision support system/  
14. decision support system.mp.  
15. exp computer assisted drug therapy/  
16. 12 or 13 or 14 or 15  
17. exp electronic medical record/  
18. electronic health record.mp.  
19. electronic patient record.mp.  
20. 17 or 18 or 19  
21. paediatrics.mp.  
22. exp pediatrics/  
23. paediatric.mp.  
24. child/  
25. infant/  
26. adolescent/  
27. 21 or 22 or 23 or 24 or 25 or 26  
28. 11 or 16 or 20  
29. exp medication error/  
30. medication error.mp.  
31. unintended consequence.mp.  
32. 29 or 30 or 31  







34. limit 33 to english language 
Appendix 8: Data extraction table for: factors 
contributing to medication errors made when using 
computerized order entry in paediatrics: A systematic 
review 
 
 Author Title Reference Count
ry 
Methods and Setting Key issues identified of 
interest 






















U.S. Quantitative pre-post 
study design to 










Lack of monitoring 
 
Poor design of corollary 
orders 
 
Lack of workflow-integrated 
clinical decision support tools 
designed according to human 
factors design principles.  
 
2.  Apkon 
M et al.  












U.S. Staff quantitative 
survey and Failure 
Modes and Effects 
Analysis 
 
11 bed paediatric ICU 




CPOE unable to support 
calculation at the time of 
ordering.  
 
Manual transfer of calculated 
dose/rate combinations into 
the CPOE system 
 






















department with 14 










Lack of automated dosage 







4.  Cochran 
GL et al.  
From physician 

























Discrepancies were more 
frequent in peditaric clinics 
compared to adult clinics.  
 
Oral liquids were commonly 
associated with discrepancies 
as well as creams and eye 
drops.  
 
Duration of therapy and 
administration directions, and 
wrong drug errors were 
reported.  
 
Free text option appeared to 




et al.  





















Liquid medications more error 
prone due to calculation 
errors.  
 
Automated dose rounding to 
the nearest teaspoon rather 
than nearest millilitre.  








errors: 5 years' 












investigation of error 
causes  
 
Evaluation of all 
voluntary reports of 
medication related 
safety reports in a 
300-bed quaternary 
paediatric centre. 
10- fold under and over dose 
errors 
 
Overrides of CPOE and CDS 
warnings.  
 











































investigation of error 
causes Reports 
describing 10 fold 
medication errors 
were further analysed 
– drug class, 
under/overdose, 
outcome and whether 
it had reached the 
patient. Severity of 
error was calculated. 
10- fold under and over dose 
errors 
 









8.  Ekedahl 

























to record instances 
where pharmacists 





7 hospital pharmacies 
and 7 city pharmacies, 
in Sweden. 
Younger patients had the 
highest rate of contact 
needed. 
 
Errors included wrong 
product (drug, strength, 
admin form) and insufficient 
information. 
 
Juxtaposition selection errors  














01 Aug 2015. 
U.S.  Quantitative 
prospective study to 
determine the 
discrepancy rates at 
the time of discharge 
when multiple 
sources of medication 
documentation exist.  
 
Inpatients admitted 
to a defined general 
paediatric inpatient 








g R et al.  














41, 2009 Nov 
15. 
U.S. Quantitative  
 
Before and after study 
after introductions of 
a weight based clinical 
decision support tool 
for certain 
medications.   
 
One institution 
comprising of multiple 
family medicine clinics 
throughout the New 








11.  Han Y.Y. 












116 (6) (pp 
1506-1512), 







mortality rates among 
children who were 
admitted via 
interfacility transport 







































Medication tracking issues  
 




13.  Hou J.-
Y. et al.  























made using a  CPOE 
system alone and a 










Inappropriate alert overrides  
 
 
14.  Jani Y.H. 
et al.  
Paediatric 
dosing errors 






19 (4) (pp 
337-340), 





Before and after 
study; comparison of 
the incidence and 
severity of paediatric 
dosing errors before 
and after 
implementation of 
CPOE with basic CDS. 
 






Lack of knowledge 
 




15.  Jani Y.H. 



















Before and after 
study; comparison of 
the incidence and 
severity of paediatric 
dosing errors before 
and after 
implementation of 
CPOE with basic CDS. 
 






Lack of knowledge 
 










16.  Jani Y.H. 











152 (2) (pp 
214-218), 








conducted in a 
nephrology 
outpatient clinic at an 











Duplicate alerts did not detect 
duplicate doses if second 
order had different strength 
or formulation of the same 
drug.  
17.  Kadmon 
G et al.  
Computerized 





errors in a PICU. 
Pediatrics. 
124(3):935-
40, 2009 Sep. 
Israel Quantitative  
 
Retrospective  pre-
post study of 
prescription error 
rates  pre-CPOE, post 
CPOE and post CPOE 




CDS needed for significant 
reduction in errors 
 
Lack of  under dose CDS  
 
Missing signature errors- lack 
of mandatory function 
18.  Kaestli 
















62, 2014 Oct. 
Switze
rland 
Failure Modes and 
Effect Causality 
Analysis (FMECA) of 
the paediatric 
medication discharge 




The analysis focused 
on the entire 
medication process, 
from prescription at 
the hospital to drug 
administration at 
home, with special 
attention given to 




occurred over 46 

















19.  Kazemi 
A et al.  







errors in the 
neonatal ward: 
experiences 








Iran Quantitative  
 
Comparison of the 
effect of 
Computerized 
Physician Order Entry 
(CPOE) without and 



















Dose adjustment difficulties 
 
Failure to update the dose 





20.  Kazemi 
A et al.  
Physician order 





strategies for a 
computerized 
order entry 










Iran Prospective  
Quantitative  
 
17 bed neonatal ward 
 
Comparison of 
medication error rate 
when physician order 
entry was followed by 
nurse verification or 
nurse order entry 
followed by physician 
verification and 





Alert overrides  
 
Other errors occurred when 
one or more of the dose 
decision criteria (age, weight, 
GFR, etc.) had changed since 
the last prescription but the 
prescriber did not change the 
prescribed order and 
repeated the previously 
ordered dose and frequency.  
21.  Killelea 
BK et al.  












of all electronic 
medication orders 
entered into a CPOE 







Dosing alert overrides. 
 
Lack of context specific 
dosing.  
 
Absence of patient weight in 
the system, which prevented 










22.  Kim G.R. 














160 (5) (pp 
495-498), 





Before and after study  
 





department in one 
hospital  
After CPOE implementation, 
there was a higher risk of 
medication orders not 
matching the patient’s 
treatment plan, this was due 
to: 
 
i. No automated drug-
protocol linkage 
ii. New or experimental drugs 
did not appear on the 
predefined CPOE menu, 
requiring users to enter them 
manually. 
23.  Kirk RC 




















Manual adjustment of 
computer calculated doses 
 


















9, 2014 Feb. 
U.S. Quantitative,  
 
Retrospective cross-
sectional review of 
medication orders 
and alerts  
 
577-bed quaternary 
care medical centre 
High proportion of potentially 
inaccurate doses within CPOE 
CDS system. Only 55.1% of 

























study with nested 


















Free-text entry was more 
commonly associated with an 
intervention 
 
Younger patients (0-2 years) 
had a higher risk of 
intervention.  
 
Oral dosage forms and oral 
routes of administration were 
methods with a relatively high 










ez S et 
al.,  
Smart pump 
alerts: all that 









Spain  Quantitative 
evaluation of the use 
of smart infusion 
pumps  
 
11 bed PICU 
Inappropriate CDS warnings 
 
Dose limits did not account for 
normal dose rounding.  
28.  McPhilli











7, 2005 Dec. 
U.S. Quantitative  
 
Review of automated 
pharmacy data from 3 
health maintenance 
organizations for 120 
children with a new 
dispensing 




 No difference in potential 
medication error dosing error 
rate between an organization 
with CPOE without child 
specific CDS did not  have a 
lower potential medication 
dosing error rate compared to 
the organisations using 
handwritten prescriptions 
 
Prescribers still had to 
calculate and enter weight-
based doses for most drugs. 
 
29.  Mille, 
Frederic 
et al.,  
Analysis of 
overridden 










France Quantitative and 
qualitative 
prospective analysis 




High alert override rate; 
including high false-positive 
alerts.  
 
Lack of context specific alerts 
e.g., did not take into 
consideration the date and 
time of administration, so 
could not identify active drug-
interactions 
 
Alerts lacked important 
information within the 




30.  Nelson, 
Courtne
y E et al.  
Electronic 
prescription 













review of a random 
selection of electronic 
prescriptions written 
in a paediatric 
emergency 
department. 
Incomplete directions and 
dose/direction errors were 
the most common error types 
(37% of all errors) 
 
CPOE did not rule out all 
significant clinical errors 
 
 Incomplete drug directions 
were still seen due to the 
option to free-text  
 
The persistence of dosing and 
direction errors suggest that 
residents are not effectively 
using the resources 
connected to the CPOE and 







31.  Pacheco 
G.S. et 
al.  
The effects of 
resident level of 
training on the 
rate of pediatric 
prescription 
















of computer based 
outpatient 






Errors made during the 


























U.S. An iterative, scenario-
based approach was 
used to identify 
unique considerations 
in paediatric care and 
relevant human 
factors concepts by 
panel members with 















Avoid truncating information 
One-click growth chart 
Avoid automated changes to 
default dose 
Safeguards to prevent orders 
for the wrong units 
Decision Support for dosing 
low-weight patients 
Allow entry of medical  history 
data received atother 
institutions. 
 
33.  Potts, 

















Comparison of the 
medication error rate 
at the ordering stage 
before and after 
implementation of a 
CPOE system in a 






Lack of CDS e.g., age or 
indication specific dosing 
support  
34.  Russell 
R.A. 
 
et al.  
Impact of 
Computerized 




















and after study 
utilizing a prospective, 
observational design 
 
72 bed paediatric 
intensive care unit  
An increase in the proportion 
of omitted medications post-
intervention. 
 
































orders and infusion 
pump programming in 
a paediatric intensive 
care unit. 
 
30 bed paediatric 
intensive care unit 






et al.  
Retrospective 
















study; comparison or 
orders before and 










Users override mandatory 
fields 
Users changed information on 
















82 (8) (pp 
676-683), 





Review of medication 
orders and 
medication dose alert 
data 
 





188 bed tertiary care 
paediatric hospital 
 
NB: in this study 
paediatrics were 
classified as those <21 




overdose alert presentation 
 
Inappropriate information in 
the database e.g., the most 
recent dose of erythromycin 
dose when used as a motility 
agent 
 























U.S Quantitative  
 
Prospective before 






department in a free-
standing children’s 
hospital that is a level 






Alert overrides, and false-
positive alerts  
 
Alerts did not consider the 
drug indication 
 
39.  Stultz 
J.S. 
 
et al.  
Sensitivity and 
specificity of 










Review of orders and 
medication dosing 
































care units, emergency 




Lack of indication based 
dosing CDS  





















42, 2014 Feb. 
U.S.  Quantitative 
 
Review of pharmacy 
records 
Each order that 
caused a dosing alert 





hospital with over 350 
beds including 
paediatric intensive 









False positive alerts 
 
Dosing CDS, which was not 
based on the formulation, 
failed to consider factors such 
as pre-menstrual age. 
41.  Taylor, 
James A 
 





















the order and what 
was administered 
were recorded, 
reasons for the 
variance was also 
classified. 
 
30 bed- Neonatal 







Route of administration error 
 



























Review of drugs 
dispensed and alerts 
generated for all 
patients in Sweden 














Drug disease inferred 
 







43.  Vaidya, 
Vinay 
 
et al.  
Evaluating the 
safety and 
efficiency of a 
CPOE system for 
continuous 
medication 












Missing prescriber’s signature 
 
 








Analysis: a useful 
proactive risk 











Modes and Effect 
Analysis  
 
11- members of a 
multidisciplinary team  
Wrong dose 
 
Miss calculation  
45.  Walsh 
K.E. 
 
 et al.  
 
Medication 
errors related to 
computerized 
order entry for 
children. 
Pediatrics. 
118 (5) (pp 
1872-1879), 




U.S.  Quantitative  
 
Retrospective review 






hospital, 40 general 
and surgical 
paediatric inpatient 
beds, 4 paediatric 
intensive care unit 
beds and 15 neonatal 
intensive care unit 
beds.  





Selection errors from a drop-
down menu 
 
Order set errors- orders 
erroneously prescribed due to 
‘select all’ functionality. 
 
Lack of patient specific CDS 
 
Duplicate dose error due to a 
lack of flexibility in the 
computer order system 
46.  Walsh 
K.E. 
 











121 (3) (pp 
e421-e427), 
2008. Date of 
Publication: 
March 2008. 
U.S.  Interrupted time-
series regression 
analysis, review of 




care  unit, paediatric 
























U.K.  Quantitative 
 
Prospective audit of 





Incorrect infusion rate 
selection 
 
No base solution prescribed 
 
Selection error from a drop-








, E C 
 
et al.  




























9 facilities within a 
paediatric academic 
centre that care for 







Interface issues- monitoring 
system change, training gaps 






















Appendix 9: A literature review of the training offered to 
qualified prescribers to use electronic prescribing 
systems: Why is it so important? 
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Abstract 
Objectives A key element of the implementation and ongoing use of an elec- tronic prescribing (ePrescribing) 
system is ensuring that users are, and remain, sufficiently trained to use the system. Studies have suggested that 
insufficient training is associated with suboptimal use. However, it is not clear from these studies how clinicians 
are trained to use ePrescribing systems or the effective- ness of different approaches. We sought to describe  the  
various  approaches used to train qualified prescribers on ePrescribing systems and to identify whether users 
were educated about the pitfalls and challenges of using these systems. 
Methods We performed a literature review, using a systematic approach across three large databases: 
Cumulative Index Nursing and Allied Health Literature, Embase and Medline were searched for relevant English 
language articles. Arti- cles that explored the training of qualified prescribers on ePrescribing systems   in a 







Key findings Our search of ‘all training’ approaches returned 1155 publica- tions, of which seven were included. A 
separate search of ‘online’ training found three relevant publications. Training methods in the ‘all training’ cate- 
gory included clinical scenarios, demonstrations and assessments. Regarding ‘online’ training approaches; a team 
at the University of Victoria in Canada developed a portal containing simulated versions of electronic health 
records, where individuals could prescribe for fictitious patients. Educating prescribers about the challenges and 
pitfalls of electronic systems was rarely discussed. 
Conclusions A number of methods are used to train prescribers; however, the lack of papers retrieved suggests a 
























Appendix 10: Search Strategy for ‘All training’ search 
from Medline (Ovid) database 
 
Keyword terms were searched across ‘af’ (all fields).  
 
1. Computerized prescriber order entry 
2. Computerized provider order entry/ 
3. Electronic physician order entry 
4. Electronic order entry 
5. Electronic prescribing/ 
6. Electronic prescription 
7. Computerized physician order entry 
8. CPOE 
9. Computerized order entry 
10. Medical order entry systems 
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 
12. Clinical decision support 
13. Decision support system/  
14. CDS 
15. Drug therapy, computer assisted 
16. 12 or 13 or 14 or 15 
17. Electronic medical record/  
18. Electronic health record 
19. Electronic patient record 
20. 17 or 18 or 19 
21. Education/  




26. Medical education/ 
27. Clinical competence/ 
28. Competence assessment 
29. Prescriber training 
30. Prescriber assessment 
31. 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 
32. 11 or 16 or 20 
33. 31 and 32 







Appendix 11: Articles included and excluded following review of abstract and full text for a 
literature review of the training offered to qualified prescribers to use electronic prescribing 
systems 
 
Articles included and excluded following review of abstract: All Training 
Number Paper (Author, Year) Title Database Study Type Country Justification for exclusion 
Publications excluded after review of abstracts 
 
1 Avery AJ, 2014 Research into practice: Safe 
prescribing.  
Embase Report Summary UK Primary care 
 
Lack of focus on training and competency on an 
electronic prescribing system 
  
2 Baysari MT, 2012 Understanding doctors' perceptions 
of their prescribing competency and 




Qualitative Australia Lack of focus on training and competency on an 
electronic prescribing system 
 
3 English T, 2010 Obstacles to Rolling Out an EMR in a 
Residency. 
Embase   Non- hospital setting 
 
Lack of focus on training and competency on an 
electronic prescribing system 
  
4 Haffey F, 2014 Smartphone apps to support hospital 
prescribing and pharmacology 
education: A review of current 
provision. 
Embase  UK Lack of focus on training and competency on an 
electronic prescribing system 
 








6 Kaur D, 2015 E learning: Moving towards a 
technologically advanced and 
progressive psychiatry!. 
Embase Conference; workshop India Lack of focus on training and competency on an 
electronic prescribing system 
 
7 Larson KA, 2004 Reducing medication errors in a 
surgical residency training program. 
Embase 
Medline 




8 Miller AS, 2003 The training process (Part 1). Embase   Unable to access  
9 Ross S, 2012 Prescribing and the core curriculum 
for tomorrow's doctors: BPS 
curriculum in clinical pharmacology 
and prescribing for medical students. 





10 Adibe BA, 2010 Electronic health records: potential to 
transform medical education. 
Medline Supplementary piece, 
commentary 
US Lack of focus on training and competency on an 
electronic prescribing system 
 
11 Bloice MD, 2014 Casebook: a virtual patient iPad 
application for teaching decision-
making through the use of electronic 
health records. 
Medline Learning Tool 
Development 
Austria Lack of focus on training and competency on an 
electronic prescribing system 
 
12 Chi J, 2014 Clinical education and the electronic 
health record: the flipped patient.  
Medline 
CINAHL 
Opinion piece.  US Lack of focus on training and competency on an 
electronic prescribing system 
 
 
13 Elliott K, 2011 A student-centred electronic health 
record system for clinical education. 
Medline Qualitative Australia Lack of relevance for qualified doctors 
 
Lack of focus on training and competency on an 
electronic prescribing system 
  
14 Han H, 2013 Writing and reading in the electronic 
health record: an entirely new world. 
Medline Qualitative  US Lack of focus on training and competency on an 








15 Hart J, 2010 University of Arkansas for Medical 
Sciences electronic health record and 
medical informatics training for 
undergraduate health professionals. 
Medline 
CINAHL 
Report US Lack of relevance for qualified doctors/ prescribers 
 
 
16 Keenan CR, 2006  Electronic medical records and their 
impact on resident and medical 
student education. 
Medline Literature Review US Lack of focus on training and competency on an 
electronic prescribing system 
 
17 Knight AM, 2012 The effect of computerised provider 
order entry on medical student’s 
ability to write orders.  
Medline Comparative study US Lack of relevance for qualified doctors  
18 Knight AM, 2007 The good news about CPOE and 
medical student ordering ability. 
Medline Comparative study US Lack of relevance for qualified doctors  
19 Morrison F, 2011 Developing an online and in-person 
HIT workforce training program using 
a team-based learning approach. 
Medline Qualitative US Lack of focus on training and competency on an 
electronic prescribing system 
 
20 Moser SE, 2010 Precepting medical students in the 
era of EHRs. 
Medline Report US Lack of relevance for qualified prescribers 
 
21 Pageler NM, 2013 Refocusing medical education in the 
EMR era. 
Medline Viewpoint US Lack of focus on training and competency on an 
electronic prescribing system (focus on EMR) 
 
22 Pippitt K, 2013 Medical student education in the 
EMR era requires access to the EMR. 
Medline Comment; letter US Lack of relevance for qualified doctors 
 
Lack of focus on training and competency on an 
electronic prescribing system 
  
23 Reis S, 2013 The impact of residents' training in 
Electronic Medical Record (EMR) use 




Comparative study Israel Lack of focus on training and competency on an 
electronic prescribing system 
24 Schenarts PJ, 2012 Educational impact of the electronic 
medical record [Review] 
Medline Literature Review UK Lack of focus on training and competency on an 








25 Schifferdecker KE, 
2012 
Adoption of computer-assisted 
learning in medical education: the 
educators' perspective. 




26 Baillie L, 2013 A survey of student nurses’ and 
midwives’ experiences of learning to 










27 Ornes LL, 2007 Computer competencies in a BSN 
program 
CINAHL Report of curriculum 
evaluation 
US Lack of qualified, prescriber relevance  




Australia Primary care  
29 Wong B, 2012 Computerised provider order entry 
and residency education in an 
academic medical centre. 
CINAHL Qualitative  Canada Lack of focus on training and competency on an 




Development and implementation of 
a biomedical informatics course for 





Mexico Lack of focus on training and competency on an 
electronic prescribing system 
 
31 Warboys I, 2014 Electronic Medical Records in Clinical 
Teaching 
CINAHL Evaluation  US Lack of relevance to qualified prescriber training  
32 Shachak A, 2012 End-user support for a primary care 
electronic medical record; a 
qualitative case study of a vendor’s 
perspective 
CINAHL Qualitative Canada Primary care setting  
33 Byrne MD, 2012 Informatics Competence in the EHR 
Era… ‘electronic health record’. 
CINAHL Opinion piece US Lack of qualified prescriber training relevance  
34 Hart MD, 2008 Informatics competency and 
development within the US nursing 
population workforce: a systematic 
literature review 
CINAHL Systematic Review US Lack of relevance for training of qualified 
prescribers 
 
35 Price D, 2009 Interprofessional education in 
academic family medicine teaching 
units: a functional program and 
culture 
CINAHL Report on 
interprofessional 
practice experience 
Canada Lack of prescriber training/ relevance. 
 








36 Turner MP, 2010 Stratifying computer literacy; a 
competency measurement strategy 
CINAHL Report US Lack of relevance to prescriber training  
37 Gomes AW, 2013 Strengthening Our Collaborations: 
Building an Electronic Health Record 
Educational Module 
CINAHL Report of module 
development 
US Lack of relevance to qualified prescribers  
38 Kassum D, 2009 Targeting adoption, training and 
device deployment strategies. 
CINAHL Quantitative 
evaluation 
US Lack of qualified prescriber training relevance  
39 Robertson, M, 2003 The education needs of health 
information managers in an 
electronic environment: what 
information technology and health 
informatics skills and knowledge are 
required. 
CINAHL Quantitative  Australia Lack of qualified prescriber training relevance  
40 Janssen DG, 2011 The effect of nursing leadership and 
teaching methodologies on the level 
of adoption on an electronic health 
record (EHR) implementation 
CINAHL Quantitative US Lack of qualified prescriber training relevance  
41 Schumacher D, 2010 The electronic medical record and 
clinical nursing student instruction: 
tips and tricks for success.  
CINAHL Report of challenges 
when educating 
nursing student and 
faculty about updates 
to the EMR. 
US Lack of qualified prescriber training relevance.  
42 Aleem S, 2013 Translating 10 Lessons from Lean Six 
Sigma Project in Paper-Based Training 
Site to Electronic Health Record-
Based Primary Care Practice: 
Challenges and Opportunities. 




43 Ulicny MP, 2011 Using an Electronic Health Record in 
an Introduction to Professional 
Nursing Course 
CINAHL Abstract of nurse 
training approach. 
US Lack of qualified doctor/ prescriber training 
relevance 
 
44 Wolf MS, 2013 Shifting upstream: Efficacy trial of a 
low literacy, EMR medication 
education strategy. 
Embase Conference US Lack of prescriber training relevance  









45 Maxwell S, 2012 e-Learning initiatives to support 
prescribing.  
Embase Review UK Lack of focus on training and competency 




46 Tierney MJ, 2013 Medical education in the electronic 
medical record (EMR) era: benefits, 




Perspective piece US Lack of focus on training and competency 




47 Ellaway RH, 2013 Medical education in an electronic 
health record-mediated world. 
Medline Thematic analysis Canada Lack of focus on training and competency 
on an electronic prescribing system 
 
48 Pattillo R, 2010 Cleveland Clinic leads the way in 
electronic medical record training 
CINAHL Issue Brief US Lack of qualified doctor/ prescriber 
relevance 
 
49 Hoyt R, 2013 Evaluating the Usability of a Free 
Electronic Health Record Training 
CINAHL Quantitative and 
Qualitative 
US Lack of qualified prescriber training 
relevance 
 
50 Edwards G, 2012 Innovative health information 
technology training: exploring 
blended learning. 
CINAHL Mixed Methods US Lack of prescriber training relevance  
51 Laramee A, 2011 Learning from within to ensure a 
successful implementation of an 
electronic health record. 
CINAHL Qualitative Canada Lack of focus on training and competency 
on an electronic prescribing system (Not 
clear if EHR included electronic prescribing) 
 
52 McCain CL,  2008 The right mix to support  
electronic medical record training: 
classroom computer-based training 
and blended learning.  
CINAHL Lessons learnt from 
training strategy 
US Lack of focus on training and competency 
on an electronic prescribing system (not 
clear if EHR includes electronic prescribing) 
 





Kushniruk AW, 209 Bringing electronic patient records 
into health professional education: 
towards an integrative framework. 
Medline Educational tool 
development 
Canada     
54 Ayoub N, 2014 Developing competency through 
webinar to establish oncology 
pharmacy services at the Aga Khan 
Hospital Dar-es-Salaam Tanzania. 
Embase Conference; training 
service development 







55 Foster S, 2011 Competency based training program 
for electronic prescribing improves 
patient safety. 
Embase Evaluation of training 
program (Conference 
Abstract) 
UK   
56 Borycki EM, 2009 The University of Victoria 
Interdisciplinary Electronic Health 
Record Educational Portal. 
Medline Development of 
educational portal for 
EHRs 
Canada   
57 Bredfeldt CE, 2013 Training providers: beyond the basics 
of Electronic health records. 
Medline Mixed methods US   
58 Jimenez, A 2010 E-learning supports EHR 
implementations. In addition to 
meaningful use, we need to define 
meaningful training 
Review of References Viewpoint US   
59 Ross C, 2007 The key to CPOE: thoughtful planning, 
flexible training and strong staff 
involvement leads to a successful 
CPOE implementation. 
CINAHL Case history of 
implementation 













Articles included and excluded following review of abstract: Online Training 
Number Paper (Author, Year) Title Database Study Type Country Justification for exclusion 
Publications excluded after review of abstracts 
 
1 McCullagh P, 2001 Student-centered distance learning in health 
and medical informatics 
Embase Conference Poster UK Lack of focus on training 
and competency on an 
electronic prescribing 
system 
2 Masic I, 2013 The history and new trends of medical 
informatics 
Embase Review Bosnia and Herzegovina Lack of focus on training 
and competency on an 
electronic prescribing 
system 
3 McGuire MJ, 2013 Evolution of an internet-based quality 
focused medical education process in an 
ambulatory care organization 
Embase Conference Abstract US Lack of focus on training 
and competency on an 
electronic prescribing 
system 
4 Welton N, 2010 The University of Washington electronic 
medical record experience. 
CINAHL US Report on development of 
educational resources. 
Lack of qualified prescriber 
training relevance 
Publications excluded after review of full text 
 
5 McKinney M, 2012 
 
(NB No abstract, must 
review full text) 
Docs helping docs embrace IT; organization 
uses online tools to promote value of the 
technology 
Medline Project Report US Lack of prescriber 
training/ competence 
relevance 
6 Topaz M, 2013 Educating clinicians on new elements 
incorporated into the electronic health 
record; theories, evidence and one 
educational project 
Medline Training program 
development 
US Lack of focus on training 
and competency on an 
electronic prescribing 
system 
Publications included after review of full text 
 
7 Borycki EM, 2009 From prototype to production: lessons 
learned from the evolution of an EHR 
educational portal 
Medline Development of 
educational portal for 
EHRs 
Canada Yes 
8 Jimenez A, 2010 E-learning supports EHR implementations. In 
addition to meaningful use, we need to 
define meaningful training 







9 Ayoub N, 2014 Developing competency through webinar to 
establish oncology pharmacy services at the 
Aga Khan Hospital Dar –es-Salaam Tanzania 
Embase Conference; training 
service development 
Pakistan; Tanzania Yes 









Participant Reference Number: 
Profession of participant: 




Contact key informant day before scheduled observation to remind them of visit and confirm time 
and place to meet. 
 
Day of observation 
 
1. Researcher introduces self and thanks participant for agreeing to take part in the 
study. 
‘Hello. It is very nice to meet you. I am Clare Brown, a PhD student at Durham University, 
currently carrying out research in collaboration with Newcastle Upon Tyne Hospital. I want to 
thank you very much for agreeing to take part in this study, we are very grateful for your time.’ 
 
2. Brief overview of study aims and explains that the electronic prescribing system is 
available to demonstrate what they mean.  
‘I am investigating the effectiveness of electronic prescribing systems from the point of view of 
those that use the systems. In order to do this I will observe you today using the system. This 
information will be used in order to develop systems that work better for you and your colleagues. 
Do you have any questions about this so far?’  
 
3. Obtain consent to continue  
‘If you are still happy and would like to take part in the study I would be grateful if you could 
complete the consent form here?’  
 





4. Confirm information discussed will be anonymised and participant may withdraw 
themselves and any data from the study at any time. 
 
‘I would like to emphasise that any notes I take will be completely anonymous as will be our 
conversations. You can choose to withdraw from the study at any time, including after I have 
observed you.’ 
 
5. Explain will take notes 
You might notice that I am jotting down things as you work. This will be used as a prompt for me 
later when writing up my findings. I will not record anything that is identifiable and you may see 
the results of my findings if you wish. 
 
6. Any further questions? 
Do you have any further questions? If you are happy I will take a step back now and allow you to 
carry on. 
 
7. Observations Template 
1. What tasks are being carried out by individual clinicians who use the EP system? 
2. What problems do clinicians encounter with the EP system? 
3. What contributed to problems? 
4. How do clinicians overcome such problems? 
 
8. Ending the session 
“Thank you very much for allowing me to observe you today. I appreciate your time and if you 
would like to contact me in the future about this work or if you have any concerns you may email 
me.
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Appendix 14: Main study Durham University ethics approval 
 





Appendix 15: Main study participant invitation letter 
 
Clare Brown MPharm 
School of Medicine, Pharmacy and Health,  
Wolfson Research Institute, 
Durham University,  
Queen’s Campus University Boulevard,  
Stockton-on-Tees, TS17 6BH, UK 
Tel: +44 191 334 0548   
Fax: +44 191 334 0374 
email: c.l.brown@durham.ac.uk 
 
{Date}   
 
Dear Participant (name) 
 
Study Title: An evaluation of the impact of an electronic prescribing system in a U.K.  
Hospital Trust 
 
Newcastle Hospitals NHS Foundation Trust in collaboration with Durham University are 
currently conducting a study to explore staff experiences of using the electronic prescribing system 
recently implemented in the Trust.  
We would like to hear your thoughts on using the system and how it could be improved. 
We hope that being part of this study will not only provide useful feedback to the research team 
but also help improve the electronic prescribing system throughout the hospital.   
Please find enclosed an information sheet that explains the background to the study, and 
what would be expected of you should you agree to participate. Please email 
c.l.brown@durham.ac.uk indicating whether or not you would be interested in participating. It is 
up to you to decide whether or not to take part. If you decide to take part, you are still free to 
withdraw at any time in the future. All information supplied is treated in confidence. Thank you 
for your consideration. If you have any questions regarding this study or require further 





Miss Clare Brown 
PhD Student, Durham University, 
 
Dr. Sarah Patricia Slight,  
Senior Lecturer in Pharmacy Practice, Durham University,     
Chief Investigator, 
 
Mr. Neil Watson,  
Director of Pharmacy and Medicine Management, 
Principal Investigator at Newcastle Hospitals Research Site





Appendix 16: Main study participant information sheet 
 
Study Title: An evaluation of the impact of an electronic prescribing system in a U.K.  
Hospital Trust 
Participant Information Sheet 
 
Names of Investigators: Dr. Sarah Patricia Slight, Miss. Clare Brown, Mr. Neil Watson, Mr. 
Andrew Heed 
Invitation paragraph 
You have been invited to take part in a research study. Before you decide whether or not to take 
part, it is important for you to understand why the research is being done and what it will involve. Please 
take time to read the following information carefully. If there is anything that is unclear or if you would 
like more information, please ask. Thank you for reading this. 
 
Background 
The introduction of an electronic prescribing system can increase the likelihood of preventing 
medication-related errors. Computerised tools can eliminate illegible orders, provide dosing suggestions, 
assist with calculations and monitoring, and improve compliance with preventive service protocols. 
However, the use of an electronic prescribing system can also promote medication error risks in addition 
to reducing them. Examples included fragmented computer screen displays that prevented a coherent view 
of patients’ medications, failure to differentiate between look-alike drug names, and inflexible ordering 
formats generating wrong medication orders. Reducing the risks of iatrogenic harm is a key issue for the 
NHS.  
The aim of this study is to explore your views and experiences of the different design features of 
the electronic prescribing system. 
 
What does the study involve? 
This study explores the electronic prescribing system and its many different dimensions currently 
in use at Newcastle Hospitals NHS Foundation Trust. We would like to hear your thoughts on using the 
system and how it could possibly be improved.  
Why have I been chosen to take part? 
Your ward has recently implemented or is currently implementing an electronic prescribing system, 
and you have been chosen because you may be able to provide useful feedback on the use of various 
elements of this system.  
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part, you will be given 
this information sheet to keep and will be asked to sign and return the consent form. You are also free to 
withdraw at any time and without giving a reason. 
What do I have to do? 
By agreeing to take part, you may be required to participate in an interview. This interview will be 





conducted by a member of our research team at a mutually convenient time and place, and will take 
approximately 30-40 minutes. We would like to explore your experiences of using the electronic prescribing 
system and how the system could be further improved. If you agree, the interview will be digitally recorded; 
if you object to this, however, we will just take notes. You can ask that the digital recorder be switched off 
at any time during the interview if you prefer. 
What if something goes wrong? / Who can I complain to? 
In case you have a complaint on your treatment by a member of research staff or anything to do 
with the study, you can approach the chief investigator, Dr. Sarah Patricia Slight, School of Medicine, 
Pharmacy and Health, Wolfson Research Institute, Durham University, Queen’s Campus, University 
Boulevard, Thornaby, Stockton-on-Tees, TS17 6BH. Phone: +44 (0191) 334 0548. Email: 
s.p.slight@durham.ac.uk. Independent advice can also be sought from Newcastle Trust’s R&D 
Department. Phone +44 (0191) 282 5959 or E-mail: trust.r&d@nuth.nhs.uk 
Will my taking part in this study be kept confidential? 
All information supplied will be kept confidential. Any information reported from the interview 
will not enable you to be recognised. You will not automatically be expected to take part in any future 
research. All information, which is collected about you during the course of the research, will be kept on a 
password-protected database and held securely in accordance with the regulations. Access to the 
information will be limited to the study staff and investigators only. Any personal data will be destroyed as 
soon as is practical and reasonable to do so (approx. 4 weeks after the date of interview). Any information 
about you, which leaves the research unit, will have your name and address removed so that you cannot be 
recognised from it.  
What will happen to the results of the research study? 
We plan to submit the findings of this study to medical journals (papers) for publication. You will 
not be identified in any report/publication.  
Who is organising and funding the research?  
This study is part of research funded by the Durham University.  
Who has reviewed the study? 
This study has been reviewed and approved by the SMPH Ethics Committee Durham University. 
 
 
Contact for Further Information 
 
Miss. Clare Brown, School of Medicine, Pharmacy and Health, Wolfson Research Institute, Durham 
University, Queen’s Campus, University Boulevard, Thornaby, Stockton-on-Tees, TS17 6BH. Phone: +44 
(0191) 334 0548. Email: c.l.brown@durham.ac.uk Dr. Sarah Patricia Slight, School of Medicine, 
Pharmacy and Health, Wolfson Research Institute, Durham University, Queen’s Campus, University 
Boulevard, Thornaby, Stockton-on-Tees, TS17 6BH. Email: s.p.slight@durham.ac.uk. Mr. Andrew Heed, 
Lead Clinical Informatics Pharmacist, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Queen 
Victoria Road, New Victoria Wing, Royal Victoria Infirmary, Newcastle Upon Tyne, NE1 4LP Email: 
Andrew.Heed@nuth.nhs.uk  
 
Thank you very much for considering taking part in this research study.
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Appendix 17: Main study consent form 
 
Study Title: An evaluation of the impact of an electronic prescribing system in a U.K.  
Hospital Trust 
 
Ethical Approval Ref:  (to be added)   
 
Name of Researcher: ___________________________     
   
Name of Participant:  ___________________________ 
 
 
1. I confirm that I have read and understand the information sheet version number 
…………dated………… for the above study and have had the opportunity to ask 
questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason. I understand that should I withdraw then the 
information collected so far cannot be erased and that this information may still 
be used in the project analysis. 
4. I understand that the interview will be recorded and that anonymous direct quotes 
from the interview may be used in the study reports.  
 
5.          All information supplied will be kept confidential. Any information reported will 
not enable you to be recognised.   
 
6.            I agree to take part in the above study.   
 
______________________ ______________     ____________________ 
Name of Participant   Date          Signature 
 
________________________ ______________     ____________________ 
Name of Person taking consent Date          Signature 
2 copies: 1 for participant and 1 for the project notes
Please initial box 
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Appendix 18: Main study participant interview schedule 
 
Study Title: An evaluation of the impact of an electronic prescribing system in a U.K.  
Hospital Trust 
Participant Interview Schedule 
 
A common introduction will be used as follows: 
In this interview and, as a member of ward staff in this hospital, we would like to gain your impressions 
of using the electronic prescribing system. We are interested in your opinions whether these are 




1. What are your experiences of using the system? 
Prompt: What were your likes and dislikes? 
2. How has the system been tailored to your individual needs? 
Prompt: What is most useful? Not so useful? 
3. What do you find difficult about using the system? 
Prompt: Difficulty placing orders, receiving lab results, finding particular information?  
 
4. Have you or your colleagues developed “short-cuts” to enable you to get around these 
difficulties? 
5. How do you think this electronic system could be improved? 
6. Do you have any other comments? 
 
Concluding remarks will end the interview: 
That was the last question on this interview. As I mentioned earlier, all data are stored anonymously 
and you will not be identifiable from any uses of these data. If you would like any further information 
about the study, please don’t hesitate to contact me. My details have been provided on the information 
sheet.  
 
Thank you for taking part in this interview.
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Appendix 19: Ethical approval for training study 
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Study Title: Electronic prescribing systems and the training offered to newly employed 
prescribers. 
 
Participant Interview Schedule 
 
A common introduction will be used as follows: 
 
In this interview, we would like to hear about the types of training offered to newly 
employed prescribers in using the electronic prescribing system at your trust and any 
particular lessons learnt. We are interested in what you felt went well and perhaps did 
not go so well. If there are any questions you do not feel you can answer, we can easily 
skip over that question.  
  
Before we begin it is important that I have an audio-record of your consent to take part 
in this interview, could you please answer the following questions: 
 
1. Can you please confirm that you have read and understand the 
information sheet for the above study and have had the opportunity 
to ask questions? 
2. Do you understand that your participation is voluntary and that you 
are free to withdraw at any time, without giving any reason? Do you 
understand that should you withdraw then the information collected 
so far cannot be erased and that this information may still be used in 
the project analysis? 
3. Do you understand that the interview will be recorded and that 
anonymous direct quotes from the interview may be used in the study 
reports?  
4. Do you understand that all information supplied will be kept 
confidential? Any information reported will not enable you to be 
recognised.   
5. Finally, do you agree to take part in the above study? 




1. What types of training and support are offered to staff? 
 
Prompt: classroom based sessions, on-line training approaches? 
 
 
2. Is the training offered and supported by the companies that install the 
systems? If not, who provides or designs the training?  
 




3. How is the training facilitated? 
 
Prompt: Who conducts the training at the site? What are staff asked to do as part of 
their training? What scenarios do they work through? 
 
 
4. What parts of the training went well or not so well in your opinion? 
 
Prompt: Low staff attendance? Online convenient for staff?  
 
 
5. What lessons have been learnt from the training already provided? 
 
Prompt: More trainers required? Increased technical support needed? 
 
 
6. What are the resources and cost associated with the training? 
 
Prompt: Number of trainers required? Number of sessions provided to each member 




Concluding remarks will end the interview 
 
That was the last question on this interview. As I mentioned earlier, all data are stored 
anonymously and you will not be identifiable for any uses of these data. If you would like any 
further information about the study, please don’t hesitate to contact me. My details have been 
provided on the information sheet.  
 
Thanks you for taking part in this interview.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
